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SUMMARY 
 
The use of various forms of complementary and alternative medicine (CAM) has been 
increasing steadily over the last a couple of decades in both developing and developed 
countries. Although there has been no national population-based study on CAM use in 
Australia, a number of regional studies have indicated the consistent trend of increasing CAM 
use. This has drawn attention from the community, health professionals and governments on 
issues associated with its use, such as quality, safety and the efficacy of CAM interventions. In 
addition, there have been questions about the validity of the reported prevalence data due to 
the heterogeneity of the CAM therapies and the way samples that were drawn for these 
studies. 
 
This thesis presents findings of a series of systematic literature reviews of CAM usage 
internationally and in Australia, which provided the basis for the planning of a national 
population-based study. Most importantly, the thesis presents the key findings and detailed 
analyses of findings of this Australian CAM usage study based on a national representative 
sample. 
 
The first systematic review considered provides comprehensive overview of the current CAM 
use in the general populations around the world. In the second review, concerning the 
situation in Australia, the usage of CAM by the general population in different regions and 
specific patient groups was evaluated. Finally, the use of all modalities of Chinese medicine 
worldwide was also systematically appraised. Although there are a number of methodological 
issues that might have an impact on the validity of the prevalence data of overall and specific 
CAM use, over the last decade, the use of the most common forms of CAM such as herbal 
medicine in a number of countries has increased markedly. In Australia, despite the fact that 
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there has been no national population-based study, existing literature on regional health 
studies suggests that, in general, a higher level of use of CAM therapies in Australia than in 
other Western countries.  
 
The national population-based survey was planned to investigate the national profile of CAM 
use in Australia, and to identify possible regional differences. The survey employed a random 
digit dialling (RDD) sampling method and interviews were carried out using computer-
assisted telephone interviews (CATI) for data collection. A sample size of 1,067 participants 
was calculated and allocated between the six Australian states and two territories in proportion 
to Australian census data. National quotas for age and gender were applied to enhance the 
representativeness of the study populations. After undertaking a pilot study to refine the 
survey instruments and the CATI program, the major survey was conducted between May and 
June 2005. Comparison of respondents’ demographic statistics with the Australian Census 
data confirmed the representativeness of the study sample. 
 
Through the three systematic reviews and consultation with experts in the field, a total of 17 
CAM therapies were included in the study. The 17 forms of CAM consist of substance-based 
therapies, such as Chinese herbal medicine; manipulation therapies, such as chiropractic; 
nutrition therapies, such as multi-vitamins; exercise-based therapies, such as Qigong; and 
mind-body therapies, such as meditation. 
 
The most striking finding of this study is that the prevalence of overall CAM use in Australia 
is considerably higher than estimated in previously regional studies. Over two thirds (68.9%, 
95% CI: 66.1% to 71.7%) of participants had used at least one of the 17 CAM therapies in the 
previous 12 months. Of these CAM users, 64.0%, (95%CI: 60.5% to 67.5%) had visited a 
CAM practitioner, that is, 44.1% of the total survey participants. Concerning the specific use 
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of the 17 forms of CAM, the 10 most popular forms, in decreasing order, were clinical 
nutrition, Western massage therapy, meditation, Western herbal medicine, aromatherapy, 
chiropractic, yoga, naturopathy, acupuncture and Chinese herbal medicine.  
 
The high prevalence of CAM may be partially explained by regional (state) variations. 
Overall, the state of New South Wales had the highest CAM use (72.1%), closely followed by 
Queensland (71.0 %) and Victoria (69.8%), with South Australia being the lowest of 
prevalence (60.8%). In addition, significant regional differences were found for specific forms 
of CAM therapies. For example, the use of acupuncture and osteopathy was significantly 
lower in the states of Western Australia and South Australia. The prevalence of visits to 
acupuncturists, herbalists, naturopaths and osteopaths were also significantly lower in South 
Australia, compared to New South Wales and Victoria. 
 
Consistent with the existing literature, the most common characteristics of CAM users were 
likely to be younger (aged from 18 to 34), female, employed, well educated, have private 
health insurance cover and have higher than average incomes. In terms of the frequency of 
practitioner visits and the expenditure related to CAM, the estimated number of visits to CAM 
practitioners by adult Australians in the 12 month period was comparable to the estimated 
number of visits to medical doctors. The annual “out of pocket” expenditure on CAM, 
nationally, was estimated as A$4.13 billion. 
 
Importantly, additional information was also sought about each of the four forms of CAM, 
which in Australia are subject to statutory regulation in one or more states: Chinese herbal 
medicine, acupuncture, chiropractic and osteopathy. The perceived and actual benefits and 
risks of using these four forms of CAM therapies and other matters related to its use, such as 
the attitudes towards the national and private health insurance coverage are presented. 
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In summary, this first national CAM survey in Australia gathered critical data concerning the 
usage of CAM, investigated potential regional differences and estimated expenditure 
associated with these therapies. It also suggested that while the concurrent use of Western 
medicine and CAM was common, the communication among the different health-care 
professions and the consumers had been grossly inadequate. These findings have a number of 
implications such as interpretation of the perceived benefits and risks associated with the 
frequent CAM use, the needs of product and practitioner regulation, economic impact on 
users, actions required from health insurance companies and related government agencies as 
well as research and education programs. 
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CHAPTER 1. INTRODUCTION  
 
 
1.1 Background 
 
The use of complementary and alternative medicine (CAM) is increasing in the Western 
world.1-7 This trend is apparent from comparisons of the findings of population studies 
conducted in the United States (US) in 19902 and 19973 and from national population health 
surveys in the US in 19994 and 2002.1 It is significant that a comprehensive national study is 
currently being planned by the US National Center for Complementary and Alternative 
Medicine (NCCAM).8 Surveys in other countries, including the United Kingdom,5 Canada6 
and Japan7 have revealed a similar trend. In Australia, estimates of CAM usage have been 
based on the Omnibus Health Surveys conducted in the State of South Australia in 1993,9 
2000,10 and 2004.11 The findings of these studies are generally in accord with those in the 
US.1-4 
 
Increasing CAM usage in the US, Australia and other Western countries is also reflected in 
the expenditure on CAM, which is of concern to consumers and governments. It has been 
estimated that a total of $US27 billion was spent out-of-pocket on CAM in the US in 1997.3 
Consistently, based on the South Australian Health Survey, 11 an estimated $AU1.8 billion 
was spent by Australians on CAM in 2004. It has also been estimated that there were 
approximately 1.9 million Western herbal medicine and naturopathy practitioner consultations 
in Australia in 2003.12 
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In recognition of the increasing use of CAM, state and national governments in Australia have 
recently introduced regulatory measures for certain forms of CAM. For example, the State of 
Victoria introduced statutory regulation of Chinese medicine in 2000,13 the first jurisdiction 
outside China to do so. Two other Australian states, Western Australia and New South Wales, 
are developing similar legislation. At the national level, the Office of Complementary 
Medicine was established within the Australian Therapeutic Goods Administration (TGA) in 
1999 to align the regulation of some forms of CAM with that of conventional medicines.14 
These actions are welcome; however, they relate only to certain specific forms of CAM and 
do not address a range of issues that are critical for public safety and confidence in CAM. Of 
particular concern are potential adverse interactions due to the concurrent use of CAM and 
conventional health-care services and products. 
 
There has been no nationwide study to investigate CAM use in Australia, and the states of 
Queensland, New South Wales and Victoria have higher numbers of some types of CAM 
practitioners, such as Western herbal medicine practitioners and naturopaths, than other 
Australian states.12 Thus, there is a view that there might be differences in the prevalence of 
use of different forms of CAM between states/territories of Australia, and, as mentioned 
above, Chinese herbal medicine and acupuncture have been subject to statutory regulation in 
Victoria since 2000, which may have influenced the use of Chinese medicine in this state. 
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1.2 Rationale 
 
As mentioned above, in recent years numerous population studies have been conducted to 
determine the national prevalence and expenditure of CAM in many countries.1-7,9-11,15-17 In 
Australia, at least three regional studies were conducted between 1993 and 2004.9-11 High 
levels of the use of CAM and expenditure on it were reported. However, systematic 
reviews 18,19 also suggested that there are considerable discrepancies in the findings of 
different studies on the use of various forms of CAM. In general, a clear definition of CAM 
and a system of classification of CAM modalities, an appropriated-designed survey 
instrument, as well as rigorous sampling and data collection methods are the major factors 
impacting on the internal and external validity of these studies. Considerable efforts have been 
made to address these issues in the current study. 
 
Extrapolation of the findings of Australian regional studies 9-11 to a national level could be 
problematic. As mentioned above, it is generally accepted and also observed in previous 
studies 12 that some CAM practitioners are more concentrated in New South Wales, Victoria 
and Queensland. Other limitations of these regional studies include possible overlapping 
CAM modalities (e.g. Chinese medicine, herbal medicine and Ginseng) and also that the range 
of CAM modalities included were differed,9-11 for example, the exclusion of some popular 
CAM modalities (e.g. massage, see Chapter 2, Table 2.2). 
 
Although conventional medical therapies are still predominant in the treatment and 
management of diseases/conditions, there is evidence that many Australians are turning to 
various forms of CAM to supplement, and sometimes replace, conventional treatments. It is 
apparent that patients with chronic diseases, such as arthritis,20 diabetes,21 asthma,22 and 
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chronic inflammatory conditions, commonly use CAM therapies.23 A small number of high-
quality clinical trials have demonstrated that some forms of CAM have a marginal benefit for 
a narrow range of such chronic illnesses. These therapies include manipulation for low-back 
pain,24 acupuncture for improving function and pain relief in osteoarthritis.25 Thus, it is of 
interest to explore some common forms of CAM that being used by the general populations 
for a range of medical conditions. 
 
Currently in Australia, limited studies were conducted to explore matters that related to CAM 
use. Thus, where relevant, matters such as the extent to which medical doctors are aware of 
their patients’ use of CAM, the perceived and actual benefits and risks of CAM use, the 
relationship between CAM use and regulatory and health insurance coverage matters, and 
some related economic considerations, such as personal expenditure on CAM were also 
explored. 
 
In summary, the need for a nationwide population-based study on CAM utilisation in 
Australia is warranted. This study was undertaken to investigate the national epidemiological 
profile of CAM use in Australia, and to reveal possible regional differences. A total of 17 
CAM therapies were included in the study. They included substance-based therapies, such as 
Chinese herbal medicine; manipulation therapies, such as chiropractic; nutrition therapies, 
such as multi-vitamins; exercise-based therapies, such as Qigong; and mind-body therapies, 
such as meditation. Additional information was also sought about each of the four forms of 
CAM, which in Australia are subject to statutory regulation in one or more states: 
acupuncture, Chinese herbal medicine, chiropractic and osteopathy. 
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1.3 Objectives and Research Questions 
 
The aims of the present study were to collect information about the use of CAM in the 
Australian general population, specifically, to investigate the prevalence of use, out-of-pocket 
expenditure on CAM and to evaluate other matters related CAM use such as health insurance 
coverage, regulation and, perceived and actual benefits and risks of using several specific 
forms of CAM. 
 
The overall objectives and associated research questions are: 
 
1. Delineate the current utilisation of CAM in Australia. 
a. What is the total prevalence of use of CAM (practitioner visits and products)? 
b. What are the relative popularities of different forms of CAM? 
c. What is the prevalence and frequency of CAM practitioner visits? 
d. Are there regional (state) differences in CAM use in Australia? 
e. How is the public demand for CAM changing? 
2. Estimate the expenditure associated with CAM products/services in Australia and assess 
the socio-economic characteristics of CAM users.  
a. What is the out-of-pocket expenditure? 
b. What are economic consequences and drivers for CAM use? 
3. Explore the rationale for CAM use by consumers and their general concerns. 
a. Are there differences in the forms of CAM used related to age, gender, national 
region or other socio-demographic characteristics? 
b. What specific benefits and risks are perceived by the users of common forms of 
CAM? 
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c. What benefits and risks do users of common forms of CAM consider they have 
actually received? 
d. What proportion of CAM users voluntarily discusses their use of CAM with their 
medical doctors? And what are the main reasons for non-disclosure of use? 
4. Evaluate the extent, demand for and consequences of health insurance cover for CAM 
products/therapies. 
a. What is the extent of health insurance coverage on CAM?  
b. What proportion of users receives health insurance rebates for CAM? 
c. What is the public demand for insurance coverage on CAM? 
d. Does the availability of insurance cover affect the demand and utilisation of CAM? 
5. Explore attitudes towards statutory CAM regulation. 
a. Does statutory regulation have an impact on the demand/use of specific forms of 
CAM? 
6. How do the survey results compare with those of other national and international studies? 
 
  
11 
1.4 Significance of the Study 
 
The use of CAM therapies by Australians has increased markedly over the last two to three 
decades and it seems certain that this trend will continue. Given this situation, the present 
study was intended to address a broad range of issues concerning the use of CAM in Australia 
that have not been answered conclusively by previous studies. This study has created a 
national, population-based epidemiological profile of CAM use by the Australian adult 
population, including an investigation of differences between individual states and territories. 
Specifically, the study has provided reliable and comprehensive information on the prevalence 
of use of individual forms of CAM, rationales for using CAM and the perceptions of users of 
the risks and benefits of CAM therapies.  
 
The findings also provide insights into the attitudes of CAM users and non-users of the 
provision of health insurance cover for CAM therapies and how the availability of insurance 
cover may influence the use of CAM products and services. A fuller understanding of such 
issues is essential for determining the need for, and the nature of initiatives by governments 
and health-care agencies to enhance public safety and confidence in CAM therapies. Such 
considerations should include adequate regulatory controls on CAM products and CAM 
practitioners, training of health-care professionals (CAM and conventional health-care 
providers), public education, and health services planning (including health economics). The 
study outcomes will also assist in defining additional research needs, ranging from socio-
economic to scientific/clinical research related to safety and efficacy of CAM therapies. 
 
The risks associated with the use of CAM are of growing concern. Therefore, important 
objectives of the proposed study were to investigate the level of understanding by users of the 
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potential for adverse effects of individual forms of CAM, the incidence and nature of adverse 
effects and, critically, the effectiveness of communication between patients and health-care 
practitioners. Thus, the study has provided information on the levels of awareness of health-
care professionals of their patients’ use of CAM and the extent to which CAM users 
understand the risks and benefits of CAM. The outcomes reinforce the need for health-care 
professionals to be aware of their patients’ therapeutic choices and the need for them to advise 
their patients about the appropriate and safe use of CAM. 
 
The information collected in the study on the demographic characteristics of CAM users, on 
their rationales for deciding to use CAM, on the specific health conditions for which common 
forms of CAM are being used will provide a much-needed population data-set for health care 
researchers (for future population studies and basic and clinical research) and help identify 
priorities for further research on the use of CAM, including laboratory and clinical research on 
the efficacy and safety of CAM therapies. This is consistent with the recommendations of the 
Federal Government’s Review of Complementary Therapies in the Australian Health-care 
System. 26 In addition, the data collected will also guide government agencies in the 
development of further regulatory controls for CAM and provide consumers with relevant and 
timely advice on CAM use. The findings will also guide educational institutions concerned 
with both the training of conventional health-care practitioners and CAM practitioners in 
respect of designing curricula which recognise the broad range of therapies being used by the 
population. 
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1.5 Organisation of the Thesis 
 
This thesis comprises eight chapters. Chapter 1 provides a brief overview of the background, 
rationale, objectives and details the specific research questions addressed by the study, as well 
as the significance of the study. Chapter 2 comprises three systematic reviews of CAM 
utilisation literature. The first review is concerned with global utilisation of CAM, the second 
summarises specifically CAM use among the general Australian population and by individuals 
with various diseases/conditions, and the third review exclusively covers Chinese medicine 
utilisation. 
 
Chapter 3 discusses methodological issues associated with conducting a CAM population 
study in Australia. This chapter also addresses the approaches adopted to achieve a 
representative study population sample, the data collection process (computer-assisted 
telephone interviews), and the challenges of addressing commonly encountered problems, 
such as the definition and classification of CAM modalities. 
 
The results and discussions of the national CAM population survey are divided into four 
sections: Chapter 4 presents a national profile of CAM utilisation in Australia through a 
multivariate analysis of the survey data. It examines CAM utilisation as a whole, including its 
prevalence of use and, prevalence and frequency of visiting CAM practitioners.  
 
Chapter 5 presents detailed analyses of the regional differences in CAM use in Australia. 
Chapter 6 presents the findings on the four CAM modalities that are currently regulated in 
Australia, at either national or state level, that is, acupuncture, Chinese herbal medicine, 
chiropractic and osteopathy. Specific data related to these therapies such as expectations of the 
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users, actual outcomes, and adverse events related to their use were sought from survey 
participants. 
 
Chapter 7 presented additional results arising from the CAM survey including the expenditure 
on CAM, the rationales for CAM use, concurrent use of both CAM and Western medicine, 
and other matters such as, health insurance coverage and regulatory issues. The general 
discussion, conclusions, policy implications, limitations of the study and some possible 
solutions are included in Chapters 8. 
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CHAPTER 2. LITERATURE REVIEW  
 
2.1 Definition of Complementary and Alternative Medicine 
(CAM) 
 
There have been many debates surrounding a single definition of complementary and 
alternative medicine (CAM), but none have been conclusive.27 Considering the diversity of 
CAM modalities, the definitions of CAM in the current literature are inconsistent, and vary 
significantly in different social contexts. 
 
The term “complementary and alternative medicine” and its short form, “CAM”, are terms 
most commonly used in the literature. “Complementary” generally mean that such medicine 
(including therapies and products) is being used in addition to conventional Western 
medicine. “Alternative” implies it is being used independently. Other terms are widespread, 
and are used interchangeably, to describe CAM.28 They include: traditional, oriental, holistic, 
unconventional, non-conventional, unorthodox, essential and unproven medicine. 
 
One of the major biologically based CAM therapies, “megavitamins”, sometimes referred to 
dietary supplements is somewhat vaguely defined. A national CAM study in the US3 referred 
to these dietary supplements as vitamins not prescribed by a medical doctor. The US National 
Health Interview Survey1 referred to these as vitamins used in excess of the recommended 
daily allowances (RDA) established by the National Academy of Sciences, Food and Nutrition 
Board.
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Although the various definitions of CAM are debatable, after carefully examining the 
literature it is apparent that most of these definitions are made in relation to conventional 
(Western) medicine. This viewpoint is supported in a recent editorial published in the Journal 
of Alternative and Complementary Medicine.29 
 
In a US landmark study on CAM utilisation in 1990, the research team referred to CAM as 
“interventions neither taught widely in medical schools nor generally available in US 
hospitals”.2 At the same time, in an attempt to clarify the issue, the British Medical 
Association came up with the following:30 
 
“Both alternative and complementary types of medicine are described by the term "non-
conventional". This is not an exclusionary term and illustrates the level of acceptance of these 
methods by the medical community. Complementary medicine is defined as those techniques 
which are used while the patient is using conventional ones. These include methods such as 
chiropractic and osteopathy. Alternative medicine includes techniques which are used to the 
exclusion of conventional medicine. These methods have been specified as incompatible with 
conventional practice (i.e. certain types of herbal remedies).” 
 
In 1995, in a letter27 sent to the British Journal of General Practice, Ernst and his colleagues 
commented that: “Complementary medicine is diagnosis, treatment and/or prevention which 
complements mainstream medicine by contributing to a common whole, by satisfying a 
demand not met by orthodoxy or by diversifying the conceptual frameworks of medicine”. 
They further commented that an inclusive, positive approach, not defining what 
complementary medicine does not represent but what it actually means, would clearly be more 
constructive.
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More recently, the definition of CAM appears to refer to a broad range of therapies and 
products. A document produced by the World Health Organisation (WHO)31 refers to CAM as 
“a broad set of health care practices that are not part of that country's own tradition and are not 
integrated into the dominant health care system”. Similarly, the National Center for CAM 
(US) defined CAM as “a group of diverse health-care and medical practices and products that 
are not presently considered to be an integral part of conventional medicine”.32 Perhaps a 
more encompassing definition of CAM was provided by the Office of Alternative Medicine 
(OAM) expert panel at the Conference on CAM Research Methodology in Bethesda, MD, in 
April 1995:33 
 
“A broad domain of healing recourses that encompasses all health systems, modalities, other 
than those intrinsic to the politically dominant health systems of a particular society or culture 
in a given historical period. CAM includes all such practices and ideas self-defined by their 
users as preventing or treating illness or promoting health and well-being. Boundaries within 
CAM and between the CAM domain and the domain of the dominant system are not always 
sharp or fixed”. 
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2.2 Classification of CAM Modalities 
 
No conclusive definition of CAM has been advanced. Debates continue in an attempt to 
classify CAM;29 so do discussions on the CAM therapies that should be included to produce 
the overall CAM prevalence in various societies.33 Most notably, there were critics of the 
abovementioned US landmark CAM survey in 1990.2 Rosner 34 argued for the inclusion of 
chiropractic as an alternative or complementary therapy to conventional medicine, as it has 
been largely accepted by the general public as a form of effective health care. Similarly, 
Fridman et al.35 argued for the inclusion of relaxation techniques as a single form of CAM. 
Both views were published in the “New England Journal of Medicine”, in the issue following 
publication of the 1990 CAM survey.2 
 
Some so-called CAM modalities, such as Chinese medicine in China and ayurvedic medicine 
in India, have been used for thousands of years as medical systems in different countries. 
Some forms of CAM, such as osteopathy, homeopathy, and chiropractic, originated from, and 
to various extents have been incorporated into Western medical systems. However, some 
CAM may be considered outside the boundaries of current, well-established Western medical 
theory. An example is folk medicine which the medical community has rejected in the past, 
due to the lack of scientific evidence that meets mainstream medical standards. But to the 
extent that such therapies are better researched and produce convincing scientific evidence, 
they may become gradually accepted. 
 
Excessively large numbers of modalities fall under the umbrella of the term CAM. Given the 
growing popularity of CAM use, the NCCAM36 divided these into five major domains. Table 
2.1 is a synthesis of these classifications. 
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Table 2.1 CAM modalities classified in the National Center for Complementary and 
Alternative Medicine (NCCAM) 
Classifications CAM therapies (NCCAM samples) 
Alternative medical systems • Homeopathic medicine  
• Naturopathic medicine  
• Traditional Chinese medicine  
• Ayurvedic medicine 
Mind-body interventions • Meditation, prayer, mental healing, and therapies that 
use creative outlets such as art, music, or dance 
Biologically based therapies • Dietary supplements: vitamins, minerals, herbs or 
other botanicals, amino acids, and substances, such 
as enzymes, organ tissues, and metabolites 
Manipulative and body-based 
methods 
• Chiropractic 
• Osteopathic  
• Massage 
Energy therapies • Qigong, reiki, therapeutic touch, pulsed fields, 
magnetic fields 
 
 
Differences in the comprehensiveness of CAM modalities can be observed by making 
comparisons between two recent studies conducted in the US and Australia.1,11 The South 
Australian health survey11 employed a prompt card in a face-to-face interview and asked 
participants whether they had used any one of seven forms of CAM or “other CAM”. The 
2002 US National Health Interview Survey1 included questions on 27 types of CAM 
therapies, which had been considered to be commonly used in the US. Comparisons between 
an investigation of popular forms of CAM only, and a relatively comprehensive classification 
of CAM deserves further deliberation. 
 
Most surveys on CAM prevalence used a questionnaire with a list of common therapies. The 
list has been adapted from previous studies and/or aimed to reflect the diverse cultures or 
make up of the population being studied. However, the current thesis does not provide 
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judgement on how many on which CAM modalities comprise the definitive spectrum. In order 
to make comparisons with the existing classifications of CAM in Australian, a systematic 
search on published studies on CAM usage in Australia was conducted. 
 
A total of five studies9-11,37,38 were identified as Australian regional surveys based on random 
or representative samples. The detailed methodologies and CAM modalities in these studies 
are summarised in Table 2.2. The CAM modalities used in these surveys, not surprisingly, 
varied considerably, and even changed over time in studies.9-11 Nevertheless, this 
methodology comparison provided the essential data of CAM usage in the Australian context, 
and formed the basis of the list of CAM therapies used in the present study. Internationally, 
two systemic reviews on CAM utilisation in different countries that based on representative 
populations were referred,18,19 and a number of questionnaires that used in CAM utilisation 
surveys worldwide were consulted. 
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Table 2.2 CAM modalities and data collection method in Australian regional surveys 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection 
method Forms of CAM included in studies 
MacLennan 
et al. (2006)11 
South Australia 
(2004) 
Representative 
South Australian 
aged ≥15 (3,015) 
Omnibus Health 
Survey: face-to-face 
interview 
1. vitamins;  
2. mineral supplements;  
3. herbal medicines;  
4. aromatherapy oils;  
5. Chinese medicines;  
6. homeopathic medicines; 
7. other; 
8. soy products. 
MacLennan 
et al. (2002)10 
South Australia 
(2000) As above (3,027) As above 
1-7  as for MacLennan et al. 2006 plus 
8. evening primrose oil; 
9. ginseng. 
MacLennan 
et al. (1996)9 
South Australia 
(1993) As above (3,004) As above 
1-7  as for MacLennan et al. 2006 plus 
8. evening primrose oil; 
9. ginseng;  
10. PMTese; 
11. Esten. 
Wilkinson 
et al. (2001)37 
Rural region of 
New South 
Wales (1999) 
Randomly selected 
from electoral 
database (300) Postal questionnaire 
1. vitamins/mineral & supplements;  
2. herbal therapy;  3. aromatherapy;  
4.   traditional Chinese medicine;  5. homeopathy;  
6.   meditation;  7. iridology;  8. chiropractic;  
9.   acupuncture;  10. reflexology;  11.massage; 
12.  naturopathy;  13. osteopathy;  14 other. 
Kermode 
et al. (1998)38 
North coast of 
New South 
Wales (1995) 
Randomly selected 
adults (645) Telephone interview 
1. nutritional (18 items listed); 
2. plant medicine (2 items listed); 
3. homeopathic (4 items listed); 
4. other. 
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2.3 Prevalence of CAM Use 
2.3.1 Foreword 
Despite the difficulties in defining CAM and describing the classifications of CAM 
modalities, the utilisation of CAM has been widely researched and there is extensive literature 
on the subject. In 2001, there were at least nine survey studies on the use of CAM among the 
general population of the US.39 In Australia, CAM use among the general population has been 
investigated in sequential health surveys in the states of South Australia,9-11and New South 
Wales.37,38 
 
To design the current study, it was essential to conduct a systematic review of the relevant 
literature. Presented in this chapter are three systematic reviews covering the following topics: 
1) CAM use in the general population around the world (mainly Western English-speaking 
countries, due to the limitation of getting published English literature in some countries); 2) 
CAM used specifically in Australia. This includes CAM use among the general population 
and in defined populations, such as cancer patients and adolescents; 3) a purposely-designed 
systematic review of Chinese medicine. This is considered important because of the 
extraordinary popularity of Chinese medicine use around the world, and the instigation of 
Chinese medicine statutory regulation in some states in Australia. All identified studies are 
presented in corresponding tables in this chapter but may not be fully discussed. 
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2.3.2 CAM Utilisation Worldwide: A Systematic Review 
This review aimed to systematically evaluate findings from published surveys on the uses of 
CAM by the general population. The secondary aim was to determine the methodological 
quality of these CAM surveys, to identify the methodological strengths and weaknesses to 
inform the design of the present national population-based CAM survey. 
 
2.3.2.1 Methodology 
 
The identification of literature in the CAM field is challenging. Establishing the prevalence 
and utilisation of CAM is complicated and time-consuming, given that there is often no 
simple means of identifying such publications. Some databases (e.g. MEDLINE) have 
developed literature filters for different types of publications, such as clinical trials and 
reviews. Such a filter for epidemiological studies is currently not available. Optimal retrieval 
of reports in biomedicine literature depends on the appropriate use of Medical Subject 
Headings (MeSH), descriptors and keywords among authors and indexers.40 
 
A comprehensive list of key terminologies for the search strategy in MEDLINE was initially 
developed. Modified strategies were then used in other databases. Major MeSHs for CAM 
include “Complementary Therapies”, “Medicine, Oriental Traditional” and “Medicine, 
Traditional”. The MeSH search was used in conjunction with the keyword search. A 
systematic search of the literature was conducted on the following databases: MEDLINE 
(Ovid platform), EMBASE and CINAHL, covering all years since their inception up to 
September 2005. The search strategy for MEDLINE is presented in Table 2.3. 
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Table 2.3 Search strategy to identify CAM utilisation studies in MEDLINE 
1. exp Complementary Therapies/ 
2. exp Alternative Medicine/ 
3. exp Medicine, Traditional/ 
4. exp Medicine, Oriental Traditional/ 
5. exp Drugs, Non-Prescription/ 
6. exp Plants, Medicinal/ 
7. exp Medicine, Herbal/ 
8. ((complementary or alternative or unconventional or traditional or unproven or integrat$ 
or oriental or non-orthodox or holistic or essential) adj (therap$ or medicine$ or health or 
treatment$ or remed$)).tw. 
9. or/1-8 
10. exp Prevalence/ 
11. exp Health Surveys/ 
12. exp Questionnaire/ 
13. exp Data Collection/ 
14. exp Epidemiologic Studies/ 
15. (use$ or usage$ or utili?ation or utili?e$ or survey$ or prevalence or questionnaire$ or 
pattern$ or interview$ or frequency).tw. 
16. or/10-15 
17. 9 and 16 
18. Randomized Controlled Trials/ 
19. Clinical Trials/ 
20. randomized controlled trial.pt.  
21. clinical trial.pt. 
22. or/18-21 
23. 17 not 22 
24. limit 23 to animal 
25. limit 23 to human 
26. 24 not 25 
27. 23 not 26 
28. limit 27 to English 
[/ indicates Medical Subject Heading term, $ = truncation, ? = substitution exp = exploded, 
tw = text word, pt = publication type, adj = adjacent; and/, or/, not/ are Boolean operators] 
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The databases were searched irrespective of publication status, although only articles 
published in English were included in the review. To qualify for inclusion, papers had to use 
specific survey methods, either questionnaires or interviews, to collect information relating to 
CAM use, and also meet one of the following criteria: 
 
1. The study must have been based on a random or representative sample of a national 
general population. 
2. The study must have been based on a random or representative sample of a general 
population for a defined regional area AND such a national study was not available. 
 
Articles were excluded if one of the following criteria applied: 
1. The study was an utilisation study on CAM use by a subpopulation, such as a cohort of 
patients with particular conditions (cancer, diabetes etc.) or a specific group of people (e.g. 
older people or adolescents). 
2. The study investigated a single form of CAM (e.g. chiropractic), rather than CAM as a 
whole. 
3. The report did not describe the study methods, e.g. a review or a general article that did 
not mention how the data of CAM prevalence were collected, or a report on studies 
described elsewhere. 
4. The full publication was not written in English. 
5. It was not published in an academic journal or a formal report document (where a copy of 
the report was not supplied elsewhere). 
 
In addition to the literature search across major databases, the references of all relevant papers 
were examined to identify further literature. This approach has been found particularly useful 
in identifying studies that are not included in the electronic databases. All identified 
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publications were read in full, and data were extracted for their substantive information on the 
target population, study design, CAM modalities, prevalence of CAM use and other 
significant findings. 
 
In order to access the most recent literature, new article-alert functions, available from the 
MEDLINE and EMBASE (through Science Direct) were activated in May 2004. These enable 
researchers to save search terms with databases when the searches are automatically 
performed over a defined period. Weekly searches were performed and article alters were 
produced continually. Literature reviews in this thesis include articles retrieved up to March 
2006. 
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2.3.2.2 Results  
 
The initial search identified over 1,200 articles. After reading titles and abstracts, a large 
proportion of the articles was excluded because they covered matters other than utilisation or 
prevalence (e.g. CAM regulation, integration approach and clinical trials) or duplicated other 
publications. The remaining 307 articles that presented data on CAM use were read in full. Of 
these, 290 articles were then excluded because they did not meet the inclusion criteria (see 
Chapter 2.3.2.1), for example, regional studies and studies on patients or health professionals. 
Two articles were identified by citation tracking of eligible articles. 15,41 Two additional 
articles were obtained in November 200542 and January 200611 when being notified by new-
article alerts. Thus a total of 21 studies are included in the current review. 1-7,9-11,15-17,41-48 The 
key data of included articles are summarised in Table 2.4. 
 
The use of CAM in the general population was systematically reviewed by both Ernst18 and 
Harris et al.19 in 2000. In 2001, Wootton and her colleagues also conducted a review of CAM 
use among the US population.39 An overview of these three reviews and the current review are 
presented in Table 2.5. The majority of studies that were selected in the three reviews are also 
included in the current review. Reasons for exclusion are presented in Table 2.5.49-58 As 
mentioned earlier, there have been many CAM utilisation studies in the past decade. 12 
studies conducted after the publication of the three reviews mentioned above were identified 
and fulfilled the inclusion criteria.1,4-7,10,11,16,17,42,43,48  
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Table 2.4 Results of CAM utilisation studies in the general population 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Eisenberg 
et al. (1993)2 USA (1990) 
Randomly selected 
adults (1,539)† CATI (67%) 
33.8% used one of 16 forms of CAM; ‡ 12.3% 
visited CAM providers; out-of-pocket CAM 
expenditure was about US$10.3 billion. 
Thomas et al. 
(1993)44 UK (1993) 
Randomly selected 
adults from UK 
electoral registers (676) Self completed questionnaire (73%) 
8.5% used one of 6 forms of CAM: acupuncture; 
chiropractic; homeopathic; hypnotherapy; medical 
herbalist; and, osteopathy. 
MacLennan 
et al. (1996)9 
South 
Australia 
(1993) 
Random and 
representative samples 
aged 15+ (3,004) 
South Australian Health Omnibus 
Survey, face-to-face interview 
(73%) 
48.5% used one of 11 forms of CAM. 20.3% 
visited CAM practitioners; total CAM expenditure 
was A$930 million. 
Millar et al. 
(1997)45 Canada (1995) 
Representative samples 
aged 15+ (17,626) 
National Population Health Survey: 
personal interview (n/m) 
15% had consulted some forms of CAM 
practitioner. 
Paramore 
et al. (1997)15 USA (1994) 
Representative samples, 
all ages (3,450) 
National Access to Care Survey: 
CATI (75%) 
24.4% visited practitioners for one of 4 forms of 
CAM: chiropractic; therapeutic massage; 
relaxation techniques; and, acupuncture. 
Astin 
(1998)46 USA (n/m) 
Randomly selected 
adults (1,035) 
National Family Opinion Survey: 
mail survey (69%) 40% used one of 17 forms of CAM. 
Eisenberg 
et al. (1998)3 USA (1997) 
Randomly selected 
adults (2,055) CATI (60%) 
42.1% used one of 16 forms of CAM; 19.5% 
visited CAM providers; out-of-pocket CAM 
expenditure was about US$27.0 billion. 
CATI: computer assisted telephone interview. n/m: not mentioned. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey.  
† Adults: 18 years of age or older. ‡ refers to the use of at least one of the listed forms of CAM. 
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Table 2.4 Results of CAM utilisation studies in the general population (continued) 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Landmark 
Report 
(1998)41 USA (1997) 
Randomly selected adults 
with health insurance 
coverage† (1,500) Telephone interview (n/m) 42% used some forms of CAM. 
Druss et al. 
(1999)47 USA (1996) 
Randomly selected adults† 
(16,068) 
The US Medical Expenditure 
Panel Survey: CAPI, (77.7%) 
8.3% visited one of 12 types of CAM 
practitioner during 1996. 
Ramsay et al. 
(1999)6 Canada (1997) 
Randomly selected adults† 
(1,500) CATI (25.7%) 
50% used one of 22 forms of CAM; out-of-
pocket CAM expenditure was about CAD$3.8 
billion. 
Ernst et al. 
(2000)17 UK (1999) 
Randomly selected adults† 
(1,204) 
Telephone interview (no record 
was kept of those declined to 
participate) 
20% used any CAM; CAM expenditure was 
£1.6 billion. 
Millar et al. 
(2001)48 
Canada 
(1998/99) 
Representative adults† 
(14,150) 
National Population Health 
Survey: personal interview with 
1994/95 survey subjects (88.9%) 
17% had consulted CAM practitioners (forms 
of CAM were not presented). 
Thomas et al. 
(2001)5 UK (1998) 
Randomly selected adults† 
(5,010) Postal questionnaire (59%) 
28.3% used one of 8 forms of CAM.13.6% 
visited CAM practitioners; out-of-pocket 
expenditure on visits to CAM practitioners was 
£580 million. 
MacLennan 
et al. (2002)10 
South 
Australia 
(2000) 
Random and representative 
samples aged 15+ (3,027) 
South Australian Health Omnibus 
Survey: face-to-face interview 
(70.4%) 
52.1 % used one of 9 forms of CAM. 23.3% 
visited CAM practitioners; total CAM 
expenditure was A$2.3 billion. 
CATI: computer assisted telephone interview; CAPI: computer assisted personal interview. n/m: not mentioned. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey.  
† Adults: 18 years of age or older.  
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Table 2.4 Results of CAM utilisation studies in the general population (continued) 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method  
(response rate, %) General findings* 
Menniti-
Ippolito et al. 
(2002)43 Italy (1999) 
Representative samples, all 
ages (70,898) 
A national Institute of Health 
Survey: face-to-face interviews 
(n/m) 15.6% of Italians used CAM during 1997-1999. 
Ni et al. 
(2002)4 USA (1999) 
Representative adults† 
(30,801) 
National Health Interview Survey: 
CAPI (70%) 28.9% used one of 12 forms of CAM. 
Yamashita 
et al. (2002)7 Japan (2001) 
Randomly selected 
samples aged 20+ (1,000) CATI (23%) 
76% used one of 11 forms of CAM; out-of-
pocket expenditure was US$153 per 
participant. 
Barnes 
et al. (2004)1 USA (2002) 
Representative adults† 
(31,044) 
National Health Interview Survey: 
CAPI (74.3%) 
62.1% used one of 27 forms of CAM; when 
prayer specific for health reasons was excluded, 
it was 36%. 
Thomas 
et al. (2004)16 UK (2001) 
Representative samples 
aged 16+ (1,794) 
Omnibus survey: face-to-face 
interview (65%) 
10% visited one of 23 types of CAM 
practitioner. 
Nielsen 
et al. (2005)42 Denmark (2000) 
Representative samples 
aged 16+ (16,690) 
Danish Health and Morbidity 
Survey: face-to-face interview 
(74.2%) 
14% used CAM in the past 14 days (no 
individual forms of CAM were asked). 
MacLennan 
et al. (2006)11 
South Australia 
(2004) 
Random and 
representative samples 
aged 15+ (3,015) 
South Australian Health Omnibus 
Survey: face-to-face interview 
(71.7%) 
52.2% used one of 8 forms of CAM; 26.5% 
visited CAM practitioners; total CAM 
expenditure was A$1.8 billion.  
CATI: computer assisted telephone interview; CAPI: computer assisted personal interview. n/m: not mentioned. 
Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. 
† Adults: 18 years of age or older. 
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Table 2.5 An overview of CAM utilisation studies included in the systematic reviews 
Reviewed by 
Published studies 
Ernst 
(2000) 
Harris 
(2000) 
Wootton 
(2001) 
This 
thesis 
Reason for not being 
reviewed in this thesis 
Haidinger (1988)53 √       Paper published in German 
Yung (1988)58   √     Regional study in UK 
Eisenberg (1993)2 √ √ √ √   
Thomas (1993)44 
  √   √   
Vaskilampi (1993)55 
  √     Published as a book chapter  
Verhoef (1994)56 
  √     Rural study in Canada 
Vickers (1994)57 √      
Reported results from the 
1993 Thomas study 
MacLennan (1996)9 √ √   √   
Emslie (1996)52 √       Regional study in UK 
Bernstein (1997)49 
  √    Subjects were aged 45-75 
Chi (1997)51 √       Chinese medicine only 
Haussermann 
(1997)54 √       Paper published in German 
Millar (1997)45 √ √   √   
Paramore (1997)15 √ √ √ √   
Astin (1998)46 √   √ √   
Burg (1998)50 
  √     Regional study in the US 
Eisenberg (1998)3 √ √ √ √   
Landmark Report 
(1998)41 √ √ √ √   
Druss (1999)47     √ √   
Ramsay (1999)6       √   
Ernst (2000)17       √   
Millar (2001)48       √   
Thomas (2001)5       √   
MacLennan (2002)10       √   
Menniti-Ippolito 
(2002)43    √  
Ni (2002)4       √   
Yamashita (2002)7       √   
Barnes (2004)1       √   
Thomas (2004)16       √   
Nielsen (2005)42       √   
MacLennan (2006)11       √   
No. of studies  12 12 6 21   
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Study Design and Methods 
 
All except the three Australian studies were conducted at a nationwide level. These 21 studies 
investigated CAM use by a total of 227,086 people in seven countries: eight studies were 
conducted in the US (and included a total of 87,492 participants), 1-4,15,41,46,47 four studies in 
the UK5,16,17,44 (8,684 participants); three studies in Canada6,45,48 (33,276 participants) and 
three studies in Australia9-11 (9,046 participants); the remaining three studies were in 
Denmark42 (16,690 participants), Italy43 (70,898 participants) and Japan7 (1,000 participants). 
The median sample size for all the studies was 3,015. However, the median sample size 
decreases to 1,500 when health surveys not specifically for CAM are excluded. 
 
Over half (13 in total) of the studies were conducted as a supplement to a national health 
survey. In most studies, data were collected through postal questionnaires (two studies in the 
UK and one in the US), telephone interviews (seven studies), or face-to-face interviews (11 
studies). In general, the sample selection methods used to ensure proper representation of the 
study populations were rigorous. The majority (90%) of the studies targeted the adult 
populations, defined in different countries as 15+, 16+, 18+, or 20+. The Italian study,43 with a 
maximum sample size of 70,898, included all children and adults. A recent Australian study11 
also asked questions about CAM use by children (through their households’ adult 
participants). In general, the populations represented in these studies are considered to be 
appropriately specified. The overall response rates range from 23% to 88.9%. However, the 
two highest response rates were obtained from sub-sample interviews with previous national 
surveys. When these are excluded, the response rates ranged from 23% to 75%, with a mean 
of 63%. Four studies did not provide a response rate. 
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Results of CAM Utilisation Studies 
 
The majority of studies (16 in total) employed a list of CAM to estimate overall prevalence. 
The types of CAM modalities ranged from four15 to 27 forms.1 Similarly, in the UK, the 
number of CAM investigated were six, eight and 23 in 1993, 1998 and 2001, 
respectively.5,16,44 Thus, the prevalence presented in Figure 2.1 does not taken account of the 
comprehensiveness or totality of CAM, and should be interpreted with caution.  
 
The overall prevalence of CAM varied between 8.5% in the UK in 199344 and 72% in Japan 
in 2001.7 Well over one in three Americans used CAM,3 and one in two Canadians and 
Australians were CAM users in the year preceding the relevant studies.6 Figure 2.1 suggests 
that the use of CAM, as well as the prevalence of visits to CAM practitioners, has been 
increasing over the past 15 years. In particular, marked increases were observed in sequential 
studies in the US (33.8% in 19902 to 42.1% in 19973), and UK studies by Thomas et al. 
showed an increase from 8.5% in 199344 to 28.3% in 1998.5 However, only six forms of CAM 
were investigated in the 1993 UK study,44 and the authors considered this to be a pilot study 
aimed at testing the feasibility of the methodologies employed. 
 
The prevalence of visits to CAM practitioners was also reported in the US, UK, Canada and 
Australia. The lowest prevalence was reported in a 1996 US study (8.3%),47 and the highest 
prevalence appeared in a 2004 Australian study (26.5%).11 Overall prevalence on both CAM 
use and visits to CAM practitioners was commonly estimated over a one-year period 
(preceding to the survey), except the 1999 Italian study,43 which obtained prevalence over a 
two-year period, and a Danish study in 2000,42 which were based on a 14-day prevalence. 
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Data on total costs and out-of-pocket expenditure have also been extracted from these studies, 
where available. The substantial costs drew considerable comment in some studies. For 
example, CAM expenditure in the US increased by 45%, reaching US$ 21 billion in 1997.3 
Moreover, from 1993 to 2000, the overall CAM costs in Australia had more than doubled to 
A$2.3 billion; and in 2000, Australians paid out-of-pocket four times more for CAM than 
their contributions for all pharmaceuticals.10 In Canada, out-of-pocket expenditure was about 
$3.8 billion Canadian dollar in 1997.6 
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Figure 2.1 Prevalence of CAM use in seven countries 
Note: Years were at the time of conducting studies, which are different from the dates of publication 
US: United States; UK: United Kingdom; CAN: Canada; AUS: Australia; ITA: Italy; DEN: Denmark; JAP: Japan. 
US90, US97A (Eisenberg et al.2,3); US94 (Paramore et al. 15); US96 (Druss et al.47); US97B (Landmark report41); US98 (Astin46); US99; (Ni et al.4); 
US02 (Barnes et al.1); UK93, UK98, UK01 (Thomas et al.5,16,44); UK99 (Ernst et al.17); CAN95, CAN99 (Millar et al. 45,48); CAN97 (Ramsay et al.6); 
AUS93, AUS00, AUS04 (MacLennan et al.9-11); ITA99 (Menniti et al.43); DEN00 (Nielsen et al.42); JAP01 (Yamashita et al.7). 
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2.3.2.3 Discussion  
 
It is apparent that there are considerable uncertainties about the true prevalence of CAM 
among the general populations of countries. Uncertainties are even observed within countries. 
As discussed earlier, many of these uncertainties arise because of the complex problem of 
defining CAM and the modalities it includes. Nevertheless, when specific CAM questions 
were designed as part of a national health survey, it is likely that professional social scientists 
and statisticians were employed for the development of instruments and for data analyses. 
 
Most studies provided estimates on the prevalence of use of individual forms of CAM, except 
for a 2000 Denmark study42 and a 1999 Canadian study.48 Two therapies (acupuncture and 
chiropractic) were included in all studies and, perhaps, are the most frequently reported CAM 
modalities, together with massage, herbal medicine and multivitamins. The inclusion or 
exclusion of these individual therapies can potentially impact heavily on estimation of the 
overall prevalence of CAM.19 To avoid confusing survey participants it is also necessary that 
each specific CAM modality be defined. The use of a show-card in a face-to-face personal 
interview or the provision of a detailed list of all forms of CAM in a telephone interview or 
postal questionnaire would gather a more precise measurement on prevalence. In contrast, 
asking participants to voluntarily provide all the names of CAM they have used would be less 
likely to be comprehensive. 
 
Two published reviews provided additional important information on CAM use in some other 
countries.59,60 For example, CAM prevalence data for a number of European countries, such 
as Germany and Austria.18 However, many of the papers cited were published in the local 
language, rather than English and therefore are not included in the current review. In one of 
the reviews, Fisher and Ward60 summarised such European CAM utilisation data and 
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concluded that a high percentage of the general public in Belgium (31%), France (49%), 
Germany (46%), the Netherlands (20%), Denmark (23.2%), and Sweden (25%) were CAM 
users. However, it should be noted that these figures are somewhat higher than those given in 
Figure 2.1. 
 
Since the pioneer research on CAM use published by the Harvard research group in 1993,3 the 
US has been leading the way in investigating CAM utilisation among the general public. More 
recently, employing the most rigorous data collection methods (i.e. computer-assisted personal 
interviews with representative residents), a number of studies were conducted as part of the 
US National Health Surveys.1,4 On the other hand, Australia is one of a few countries that has 
investigated CAM use in sequential surveys.9-11 Yet, these were conducted at a state level, so a 
full picture of Australia’s nationwide utilisation was not available. Thus, the current literature 
review includes CAM utilisation studies only at a national level, with the exception of 
Australian regional studies. 
 
Additional common outcome measurements of these reviewed articles are the characteristics 
of CAM users, concurrent use of CAM and conventional medicine, attitudes towards such use 
and communication between patients, CAM practitioners and Western medicine practitioners. 
Substantial findings on these matters were also collected and are discussed in the relevant 
chapters in this thesis, in comparison with the results of the recently completed CAM 
Australia national study in 2005. In all, the most critical problem in producing the true 
prevalence of the study population is a clear definition of CAM, specifically, the classification 
of CAM modalities. Further high quality research is needed, preferably replicated studies 
supplementary to a national health survey. 
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2.3.3 CAM Utilisation in Australia: A Systematic Review 
This review aimed to systematically examine the current status of use CAM in Australia, in 
particular, the profile of CAM use among the general population, among specific patients 
groups and among the health professionals. 
 
2.3.3.1 Methodology 
 
When identifying worldwide CAM utilisation studies, particular attention was paid to 
Australian literature. A modified version of the search strategy (see Table 2.3) was used to 
identify CAM utilisation studies that had been conducted in Australia with additional search 
limitations (Table 2.6). The two approaches are not mutually exclusive when identifying 
literature on CAM surveys. It was expected that the search limitation on “Australian studies 
only” did not capture all Australian studies. The final search and reference selection process 
took place in December 2005. 
 
Table 2.6 Additional search strategy to identify Australian CAM utilisation studies  
1. exp Australia/  
2. exp South Australia/ 
3. exp Western Australia/  
4. exp Victoria/ 
5. exp New South Wales/ 
6. exp Queensland/  
7. exp Northern Territory/  
8. exp Australian Capital Territory/  
9. exp Tasmania/  
10. (Australia or south Australia or western Australia or Victoria or New South Wales or 
Queensland or Northern territory or Australian Capital Territory or Tasmania).tw. 
11. (Melbourne or Sydney or Brisbane or Adelaide or Perth or Darwin or Canberra or 
Hobart).tw. 
12. or/1-11 
13. 12 and 28 [of Table 2.3] 
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The new-article alert function and a reference cross-check were also included. Most of the 
previously mentioned inclusion and exclusion criteria (see Chapter 2.3.2.1) are applied to 
identify Australian studies, except that studies on CAM use on a subpopulation (e. g. cancer 
patients and the older population) are included in the Australian literature review. Studies on 
the general population and specific populations are presented separately. 
 
2.3.3.2 Results  
 
The initial search identified over 500 articles. After reading titles and abstracts (to clarify 
whether the study was conducted in Australia), a total of 122 articles were included for further 
examination and were read in full. These articles were then sorted in four categories to 
facilitate the article selection process: 1) CAM use in a general population; 2) CAM use in a 
defined population; 3) CAM used by other populations, such as health professionals, and 4) 
articles requiring further clarification, for which opinion from an independent researcher was 
sought. In addition, a study conducted in Western Australia61 and another in Melbourne62 
were also identified. These studies61,62 also reported data on the use of CAM in the general 
population. However, data from both studies were collected from in-street participants; such a 
convenience sampling method did not satisfy the inclusion criteria for the current review. 
 
Six articles were identified by citation tracking of relevant articles. One additional article was 
obtained in 2006 when notified by a new-article alert. Thus, a total of 38 studies were 
included in the current review. These included five studies on CAM use by the Australian 
general population, 9-11,37,38 seven studies on cancer patients,63-69 eight studies on children and 
women (including patients),70-77 12 studies on people with other diseases other than cancer, 78-
89
 and six articles on other (non-clinical) populations.90-95 The key data of included articles are 
summarised in Table 2.7 to Table 2.11 
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Study Design and Methods 
 
The 38 Australian studies represented CAM use by a subtotal of 9,991 of the general 
population, 2,572 cancer patients, 386 children patients, 54,708 women and women patients, 
1,841 other patients (exclude Parslow’s study; see Table 2.10 for the reason) and 2,729 other 
defined populations, in five states and one territory. Six studies were conducted on a 
nationwide basis (and included a total of 56,691 participants), 12 studies in New South Wales 
(NSW); eight in South Australia (SA); six in Victoria (VIC); three in Queensland (QLD), two 
in Western Australia (WA) and one in the Australian Capital Territory (ACT). 
 
In terms of the data collection methods, the majority of these studies (25 in total) used 
traditional questionnaires (13 by mail, two completed by patients in the clinic waiting room 
and 10 completed by clinic patients in their own time). Eleven studies introduced face-to-face 
interviews (including one using a hand-held computer). Two studies employed telephone 
interviews. The use of CAM by General Practitioners (GP) was investigated by analysing 
Health Insurance Commission data (Medicare). 
 
The qualities of sample selection methods varied. Studies on the general population targeted 
randomly selected samples, while studies on clinical or defined populations mainly recruited 
subjects through convenience sampling (e.g. patients attending clinics, and routine 
records/questionnaires for hospital inpatients). Questionnaires were also completed by GPs 
and nurses on their personal use of CAM and also on the CAM used for their patients. Nearly 
half (44%) the studies on a defined population did not state the ages of their subjects. This 
may be partially explained by the fact that no age limitation was applied when recruiting 
patients, particularly cancer patients. The sample size of the majority of the studies on defined 
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populations was less than 1,000, with the exception of two studies on women. The latter were 
supplemental analyses of large-scale national longitudinal studies. 
 
It is not surprising that studies on clinical populations tended to achieve a higher response rate 
than studies on a non-clinical population. This is evidenced by the fact that response rates of 
four patient-based studies were higher than 90%. Thirteen studies, however, did not state their 
response rates. 
 
Results of CAM Use among the General Population 
 
As expected, the major results found in this category were Omnibus Health Surveys in a 
specific state of Australia.9-11 Through extrapolation, these have been frequently quoted to 
represent the use of, and expenditure on, CAM in Australia. Two systematic reviews18,19 on 
CAM utilisation studies considered the methodology employed in the first 1993 survey9 to be 
rigorous. However, the CAM categories used in this survey was somewhat questionable.18 
Such problem has also been observed in two more recent surveys.10,11  
 
Two regional studies in New South Wales were identified, with higher prevalence being 
reported than in the previous South Australian studies (Table 2.7). Kermode’s New South 
Wales study in 199538 was based on nutritional products, including 24 vitamin and other 
supplements, herbal medicine, and homoeopathic medicine (see Table 2.2). Many of these 
items are not universally considered as CAM. It is also worth noting that the Wilkinson’s 
study37 was conducted in a rural community in New South Wales. An extraordinarily high 
prevalence of chiropractic (55.3% of the population had visited chiropractors at least once) 
was reported in this community. It is by far the highest prevalence of chiropractor visits 
documented in the international literature. 
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Common results from the three South Australian9-11 and two New South Wales studies37,38 
suggested that the use of CAM by the Australian general public is not less than 50%, and 
approximately one in four people have visited a CAM practitioner in a 12-month period. 
Wilkinson et al. reported the highest prevalence of both CAM use (70.3%) and CAM 
practitioner visits (62.7%).37 The CAM use was specifically over a 12-month period; however, 
the period is unclear for CAM practitioner visits. A high prevalence in the use of herbal 
medicine and multivitamins was most commonly reported. In a recently published study,11 the 
South Australian-based research team reported that 39.2% used vitamins, and an additional 
13.6% used mineral supplements (excluding calcium, iron or vitamins prescribed by a medical 
doctor). For provider-based therapy, visits to chiropractors and massage therapists represented 
the majority of visits. 11 
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Table 2.7 CAM use among the Australian general population 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
MacLennan 
et al. (1996)9 
South Australia 
(1993) 
Random and 
representative 
samples, aged 15+ 
(3,004) 
South Australian Health 
Omnibus Survey: face-to-
face interview (73%) 
48.5% used one of 11 forms of CAM; 20.3% visited 
CAM practitioners; total CAM expenditure was A$930 
million; 37.6% used vitamins; 9.9% used herbal 
medicine; 14.9% visited chiropractor. 
Kermode 
et al. (1998)38  
North coast of 
New South Wales 
(1995) 
Randomly selected 
adults 
(645) † Telephone interview (44%) 
64% used CAM at the time of being surveyed; 25% 
visited CAM practitioner within the last year; while 75% 
had previously consulted CAM practitioners; 57% used 
nutritional products; 33% used herbal medicine; 50% 
visited chiropractor/osteopath. 
Wilkinson 
et al. (2001)37  
Rural region of 
New South Wales 
(1999) 
Randomly selected 
adults from electoral 
database (300) 
Postal questionnaire 
(31.4%) 
70.3% used one of 14 forms of CAM; 62.7% visited a 
CAM practitioner; 68.7% used vitamins and minerals, 
26.1% used chiropractic; 55.3% had previously visited a 
chiropractor. 
MacLennan 
et al. (2002)10 
South Australia 
(2000) 
Random and 
representative samples 
aged 15+ (3,027) 
South Australian Health 
Omnibus Survey: face-to-
face interview (70.4%) 
52.1 % used one of 9 forms of CAM; 23.3% visited 
CAM practitioners; total CAM expenditure was A$2.3 
billion; 36.4% used vitamins; 13.4% used herbal 
medicine; 16.7% visited chiropractor. 
MacLennan 
et al. (2006)11 
South Australia 
(2004) 
Random and 
representative samples 
aged 15+ (3,015) 
South Australian Health 
Omnibus Survey: face-to-
face interview (71.7%) 
52.2% used one of 8 forms of CAM; 26.5% visited 
CAM practitioners; total CAM expenditure was A$1.8 
billion; 39.2% used vitamins; 20.6% used herbal 
medicine; 16.7% visited chiropractor. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. Key results include two most 
popular forms of CAM and the highest prevalence of visits to CAM practitioner. † Adults: 18 years of age or older 
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General Findings of CAM Use by Children and Women Patients 
 
CAM usage in children and women patients is another area in which the prevalence has 
frequently been investigated. Previous systematic reviews have concluded that there is a 
generally high and possibly increasing prevalence of CAM use among paediatric 
populations.96 A number of national surveys have also consistently found that women are 
more likely to use CAM than men.39 A total of ten studies were identified. Eight were on 
children and women with a medical condition other than cancer (Figure 2.2 and Table 2.8), 
two were on paediatric and women cancer patients68,69 (Table 2.9). 
 
A considerably high prevalence of CAM was also found in Australian studies of children and 
women patients (Figure 2.2). The only study estimates CAM use at the time of study found a 
high prevalence of 35.9% among gastroenterology outpatient children.71 Three studies were 
concerned with the lifetime use of CAM, that is, use of CAM at least once previously. Over 
half (51.7%) of asthmatic children in Sydney73 and approximately half (46%) of South 
Australian children with cancer had previously used CAM.68 A lower lifetime-use rate (33%) 
was reported among non-surgical hospital inpatient children in Victoria.72 However, the above 
findings may need to be interpreted with extreme caution, as the sample size for all the studies 
was rather small (median sample size=106), and the measurement of lifetime use may have a 
higher chance of introducing great recall bias. 
 
Female patients in Australia appeared to favour CAM products the most. A study by 
Gollschewski on 886 randomly selected menopausal women in Queensland found that over 
82.5% had previously used CAM.76 Importantly, and a safety concern, over 73% women used 
CAM products during pregnancy, according to an Adelaide-based study in 2000.70 In this 
study, the most frequently used products were herbal medicine (56%) and aromatherapy oils 
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(40%). Specifically, chamomile, a form of herbal product, and lavender aromatherapy oil were 
most favoured among pregnant women. 
 
CAM prevalence among healthy women was revealed in two large-scale national surveys. A 
1996 study on 41,817 women aged 18-23, 45-50 and 70-75 found that 26.3% had visited 
CAM practitioners within a 12-month period. Later, in 1998, a follow-up study on the same 
group of women aged 45-50 further revealed that over 29% had consulted CAM practitioners 
in the 12 months preceding the survey. 
 
35.9%‡
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77.0%††
73.0%††
26.3%††
24.7%*
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Menopausal women 
Women aged 45-50
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Figure 2.2 Prevalence of CAM use by children and women (patients) in Australia 
 
*  Lifetime use 
†  Used during current pregnancy 
‡  Currently or recently used 
†† Used in the last 12 months 
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Table 2.8 CAM use by children and women (patients) in Australia 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Byrne et al. 
(2002)70 
A teaching hospital in 
Adelaide (2000) 
Inpatients of an antenatal ward 
aged 20-43 (48) 
Interview with a standard 
questionnaire (73%) 
73% used CAM during current 
pregnancy. 
Day et al. 
(2002)71 
South East Sydney 
(2001) 
Gastroenterology outpatient 
children , aged <16 (92) 
Self-completed questionnaire 
(80%) 
35.9% were taking CAM at the 
time of the survey. 
Fong et al. 
(2002)72 
Bendigo base hospital 
in Victoria (1999) 
Non-surgical inpatient children 
(120)† 
Structured questionnaire 
completed by parents (88%) 
33% had previously used one of 15 
forms of CAM. 
Shenfield 
et al. (2002)73 
A teaching hospital in 
Sydney (1998) 
Asthmatic children, aged <19 
(174) Structured questionnaire (92%) 
51.7% used CAM in their lifetime 
and 24.7% visited CAM 
practitioners in their lifetime.  
Adams et al. 
(2003)74 Australia (1996) 
Women aged 18-23, 45-50 and 
70-75 (41,817) 
Australian Longitudinal Study on 
women's health: postal 
questionnaire (n/m)‡ 
Visited CAM practitioners were 
19% (18-23 yo); 28% (45-50 yo), 
and 15% (70-75 yo); overall, 26.3% 
visited CAM practitioners. 
Biddle et al. 
(2003)75 
Wollongong, New 
South Wales (n/m)‡ 
Women attended health 
practitioner services, aged 15-
60 (503) Postal questionnaire (32%) 
77% used CAM; 73% visited CAM 
practitioners. 
Gollschewski 
et al. (2004)76 
Southeast Queensland 
(2001) 
Randomly selected menopausal 
women, aged 47-67 (886) Postal questionnaire (59%) 82.5% had previously used CAM. 
Sibbritt et al. 
(2004)77 Australia (1996-1998) Women aged 45-50 (11,454) 
Australian Longitudinal Study on 
women's health: postal 
questionnaire (87%) 29% consulted CAM practitioners. 
*Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. 
† Age was not state in the study. ‡ n/m: not mentioned
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General Findings on CAM Use for Cancer Treatment 
Studies on the use of CAM by cancer patients have been widely published.97 This is also the 
case for Australian literature, with seven studies published in the last 10 years (Table 2.9). 
With the exceptions of the 1999 women’s health longitudinal study and a study reviewing 
Queensland Cancer Registry records, the remaining five studies recruited patients from 
hospitals and clinics. Such a convenience sampling method is not necessarily a problem for 
studies on clinical patients, provided they are rigorously designed. 
 
Data of CAM prevalence collected on cancer patient studies were varied. Most studies were 
interested in the use of CAM at any time in the past, rather than in its use over the preceding 
year. As shown in Figure 2.3, the prevalence of CAM use ranges from 12% by colorectal 
cancer patients65 to 52% by a mixed group of cancer patients.66 It is interesting to note that 
this highest prevalence was the only study that based on the estimated prevalence after 
diagnosis of cancer. Two studies reported on the prevalence of cancer sufferers seeking 
treatment from CAM practitioners. In one study on those with advanced cancer, 11% sought 
treatment from CAM practitioners,64 and in another, 14.5% of female with cancer sought such 
treatment.69 Unfortunately, more than half the studies failed to investigate individual forms of 
CAM and, importantly, no follow-up studies were conducted to reveal the trend of CAM use 
by cancer patients over time. 
 
Two studies reported the costs related to CAM use. Begbie’s 1996 study63 estimated that the 
median annual cost was $530 per user, with a maximum of $20,000 per annum per user. Two 
out of three (64.3%) users felt they were getting value for their money. Miller66 also found 
that CAM users spent a substantial amount of money over $1,000, on items such as herbal 
medicine, high-dose vitamins and aromatherapy, after being diagnosed with cancer. For most 
therapies, patients would recommend them to others and would take the same therapy again. 
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Table 2.9 CAM use for cancer treatment in Australia 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Sawyer et al. 
(1994)68 
A hospital in South 
Australia (1988-1992) 
Children with cancer 
(48)† 
Questionnaires completed by 
parents (n/m)‡ 46% had previously used CAM. 
Begbie et al. 
(1996)63 
Two clinics at two 
hospitals in Sydney 
(1995) 
Cancer patients, all ages 
(319) 
Self-administered questionnaire 
(62%) 21.9% had previously used CAM. 
Miller et al. 
(1998)66 
A teaching hospital in 
Sydney (1998) 
Cancer patients 
(156) † 
Questionnaire in waiting room 
(90%) 52% used CAM after being diagnosed.  
Correa-Velez 
et al. (2003)64 Queensland (n/m) ‡ 
Advanced cancer 
patients, aged 20+ (111) 
Cancer Registry records: follow 
up interview every four to six 
weeks (88%) 
32% used CAM in one week preceding 
the survey; 11% visited CAM 
practitioners on a regular basis. 
Sibbritt et al. 
(2003)69 Australia (1999) 
A representative sample 
of women, aged 73-78 
(9,375 includes 1,623 
cancer patients) 
Australian longitudinal study on 
women's health: postal 
questionnaire (n/m) ‡ 
14.5% women with cancer consulted 
CAM practitioners; 11.6% women 
without cancer consulted a CAM 
practitioner. 
McGorm 
et al. (2004)65 
Two large public 
hospitals in Adelaide 
(n/m) ‡ 
Patients with colorectal 
cancer (100) † Postal questionnaire (43%) 
12% had previously used CAM for 
colorectal cancer. 
Salminen 
et al. (2004)67 
A cancer institute in 
Melbourne (1999-2001) 
Breast cancer patients 
(215) † 
Questionnaire in waiting room 
(n/m) ‡ 17% had previously used CAM. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. 
† Age was not state in the study. ‡ n/m: not mentioned 
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Figure 2.3 Prevalence of CAM use by Australian cancer patients 
 
 
*  Had previously used CAM 
†  Used after being diagnosed 
‡  Used in last week 
‡‡ Used on a regular basics 
†† Visited practitioners in the last 12 months 
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CAM Use for Treatment of Diseases Other than Cancer 
Twelves studies on CAM use by patients other than cancer patients, children and women 
patients were found (Table 2.10). These represented CAM use by patients with eight different 
clinical conditions: HIV/AIDS,80,84 rheumatoid arthritis (RA),78,82 osteoarthritis,89 
depression,88 chronic obstructive pulmonary disease (COPD),87 diabetes,86 psychiatric 
problems,85 cystic fibrosis,83 and among patients who were attended to two clinical settings: 
emergency department79 and hospital.81 Again, a few studies reported lifetime CAM use (i.e. 
studies on HIV/AIDS, COPD and depression patients). An overview of all prevalence data is 
presented in Figure 2.4. 
 
In seven studies, over 50% of those surveyed had previously used CAM on at least one 
occasion. The highest such prevalence was observed in RA patients in Victoria in 1982 (82% 
used CAM after being diagnosed, and 52% were using it at the time of the study).78 A high 
prevalence among RA patients was further confirmed in a more recent study in 1998.82 Based 
on Melbourne RA patients this study found that 67.3% of patients were CAM users. On the 
other hand, the lowest prevalence (2.9% had previously used CAM) was found in a 2001 
study in Canberra and its enviroment.88 However, this prevalence refers to CAM use by those 
within a sample of the general population who suffered from depression and/or anxiety, the 
number of such users being expressed as a percentage of the entire sample. The true 
prevalence of CAM use by people with depressive or anxiety symptoms remains unclear. 
 
The 1997 and 1999 studies found a similar prevalence of CAM use by HIV/AIDS subjects 
(56% and 55%, respectively). 80,84 These findings can be considered highly reliable, as studies 
were based on large samples of HIV/AIDS subjects in Australia. The authors concluded that 
CAM use was not significantly related to HIV positive individuals having been diagnosed 
with AIDS (p=0.06). 
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Table 2.10 CAM use for treatment of diseases other than cancer in Australia 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Kestin et al. 
(1985)78 
A teaching hospital in 
Victoria (1982) 
Consecutive patients with 
rheumatoid arthritis, aged 15+ 
(90) 
Interview in a structured 
questionnaire (n/m) ‡ 
82% used CAM after being 
diagnosed; 52% were using 
CAM at the time of survey. 
Kristoffersen 
et al. (1997)79 
A Sydney teaching 
hospital (1994) 
Patients presented to an 
emergency department, all ages 
(325) 
Interviews guided by a structured 
questionnaire (98%) 
52% used CAM; 30.5% used 
CAM in one week preceding the 
survey. 
Visser et al. 
(2000)80 
Non-clinical settings in 
Australia (1997) 
Convenience sample of people 
living with HIV/AIDS (925) Postal questionnaire (n/m)‡ 56% had previously used CAM. 
Welch et al. 
(2001)81 
A public hospital in 
Sydney (2000) Hospital inpatients (511) 
Survey as part of the routine 
medication history (n/m) ‡ 
12% were using CAM at the 
time of study.  
Buchbinder 
et al. (2002)82 
A rheumatology clinic 
in Melbourne (1998) 
Community clinic based 
rheumatoid arthritis patients 
(101) 
Telephone administrated 
questionnaire (53%) 
67.3% used CAM for RA and 
31.7% visited CAM practitioners 
for RA.  
Burrows 
et al. (2002)83 
A hospital in 
Queensland (2001) 
Cystic Fibrosis patients, aged 
16+ (83) 
Interview-based questionnaire 
(70%) 
70% had previously used CAM 
and 61% had previously visited 
CAM practitioners; at the time 
of survey, 45% used CAM and 
26% visited CAM practitioners. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. 
† Age was not state in the study. ‡ n/m: not mentioned 
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Table 2.10 CAM use for treatment of diseases other than cancer in Australia (continued) 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Visser et al. 
(2002)84 Australia (1999) 
A total of 8% of total Australian 
who were living with HIV/AIDS, 
aged 18-72 (924) Self -administered survey (n/m)‡ 55% had previously used CAM. 
Alderman 
et al. (2003)85  
A South Australian 
teaching hospital 
(n/m) ‡ Psychiatry patients (52)† Structured interviews (93%) 
51.9% used CAM in the six 
months preceding the survey. 
Clifford et al. 
(2003)86 
Western Australia 
(2001) Patients with diabetes (351) † 
Information obtained a diabetes 
study: interviews (n/m) ‡ 23.6% used CAM. 
George et al. 
(2004)87 Melbourne (n/m) 
Patients with chronic obstructive 
pulmonary disease [COPD] (173) † 
Data obtained through a nested 
survey in a COPD randomised 
controlled trial (n/m) ‡ 41% had previously used CAM. 
Parslow et al. 
(2004)88 
Regional areas in the 
Australian Capital 
Territory (1999-
2001) 
Subjects selected from electoral 
rolls from those aged 20-24 in 
1999, aged 40-44 in 2000 and aged 
60-64 in 2001 (7,485) 
Longitudinal interviews by using a 
hand-held computer (n/m) ‡ 
2.89% had previously used 
CAM to treat depression or 
anxiety (number of people with 
health conditions unclear). 
Zochling 
et al. (2004)89  Sydney (1994-1999) Osteoarthritis patients (341) † 
Three prospective monthly-diaries 
and 12 month follow-up (n/m) ‡ 40% used CAM. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. 
† Age was not state in the study. ‡ n/m: not mentioned 
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COPD: chronic obstructive pulmonary disease 
 
Figure 2.4 Prevalence of CAM use for treatment of diseases other than cancer in 
Australia 
 
*  Had previously used CAM 
†  Used after being diagnosed 
‡  Currently used 
‡‡  Used in the last 6 months 
††  Used in the last 12 months 
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CAM Use by Other Populations 
With the large number of studies having investigated CAM use among the general population 
and clinical patients, researchers have also been interested in the personal use of CAM by 
health professionals and for their patients. With the global trend of increasing use and practice 
of alternative forms of medicine, CAM use by Western medical doctors is of particular 
interests. Studies were also carried out among other health professionals, such as nurses, 
midwives and university health sciences students (Table 2.11) The six studies identified were 
conducted in the states of New South Wales, Victoria, Western Australia, South Australia and 
nationwide by means of postal questionnaires and self-completed questionnaires. 
 
The majority of GPs had referred their patients to a number of common forms of CAM 
practitioners, such as acupuncturists and massage therapists. Based on 488 randomly selected 
GPs in Victoria, Pirotta91 found 93% of them had referred their patients at least once to a 
CAM practitioner, and 82% had referred them at least a few times a year. A recent nationwide 
GP study95 in Australia further revealed that 76% and 72% of GPs had referred their patients 
to acupuncturists or massage therapists, respectively, at least once a month. 
 
The use of CAM by the GPs themselves was also common; 26% had used massage and 21% 
had used acupuncture.95 A high prevalence of personal use was also reported among nurses 
(74% in the past 12 months)93 and university nursing, pharmacy and biomedical sciences 
students (78% in the past 12 months).92 Among the individual forms of CAM that were found 
to be most popular were multivitamins and herbal medicine, a trend similar to CAM use by 
the general population and clinical patients. Moreover, an extremely high prevalence of 
aromatherapy use was found among nurses (44.1%) and students (nursing students: 32.5%, 
pharmacy students: 34.5% and biomedical sciences students: 35.1%).92 
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Table 2.11 CAM use in other populations in Australia 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Hall et al. 
(2000)90 
Perth 
metropolitan 
area (1998) 
Randomly selected 
general practitioners 
[GPs] (282) 
Cross-sectional survey: postal 
questionnaire (74.8%) 
75% formally referred patients to one of 10 CAM 
practitioners in the previous 9 months.  
Pirotta et al. 
(2000)91 Victoria (1997) 
Randomly selected 
GPs (488) Postal questionnaire (64%) 
93% referred at least once and 82% referred at lest a few 
times a year for a CAM therapy. 
Wilkinson 
et al. (2001)92 
New South 
Wales (1999) 
University students in 
nursing, pharmacy and 
biomedical sciences 
(271) 
Self completed questionnaire 
(72%) 78% used CAM. 56.3% visited CAM practitioners. 
Wilkinson 
et al. (2002)93 
New South 
Wales (2000) Nurses (832) Postal questionnaire (n/m)‡ 
74% used CAM for themselves. 38% used CAM for 
patients. 
Gaffney et al. 
(2004)94 
South Australia 
(n/m) 
Obstetricians (75) and 
midwives (145) Postal questionnaire (78%) 
68% obstetricians and 78% midwives had formally 
referred patients to use CAM. 
Cohen et al. 
(2005)95 Australia (2004) GPs (636) Postal questionnaire (33.2%) 
The top three popular forms of CAM used by GP 
themselves were massage (26%), vitamin and mineral 
(13%) and acupuncture (12%). When using in their 
practices, these were acupuncture (18%), meditation 
(18%) and massage (11%). 76% and 72% GP referred 
patients to acupuncturists or massage therapists, 
respectively, at least once a month. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. ‡ n/m: not mentioned 
  
56 
2.3.3.3 Discussion  
 
The use of CAM among the general Australian population had not been comprehensively 
reviewed at the time of writing this thesis. Utilisation studies on clinical conditions, in 
particular, cancer patients, children and women patients were the most popular. 
 
The methodological quality of the Australian studies is varied. In general, there is a lack of a 
standard approach to collect data. As with CAM utilisation studies outside Australia, the 
extent of CAM modalities included in the totality of CAM prevalence is the key challenge for 
a comparable conclusion to be drawn. 
 
Despite these shortcomings, the prevalence of CAM use in Australia, particularly 
aromatherapy, herbal medicine and natural products, is higher than in other Western countries, 
noticeably among cancer patients and those with other defined clinical conditions.  
 
It is important to note that in Australia common forms of CAM therapy are covered, to 
various levels by private health insurance funds. When conventional medicine cannot offer an 
effective cure for a disease, patients are turning to other CAM especially as more scientific 
evidence is becoming available for certain CAM therapies. This is evidenced by the fact that 
over half (58%) of patients with colorectal cancer believed that a hospital should provide 
information about CAM, although they did not necessarily use it.65 In general, there is a lack 
of detailed information on the forms of CAM being used by Australians, and the efficacy of 
these treatments for specific clinical conditions. In this respect, poor communication between 
patients and practitioners,98 is of safety concern.
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2.3.4 Chinese Medicine Utilisation Worldwide: A Systematic Review 
This review aimed to systematically examine published surveys on the use of Chinese 
medicine (CM) by the general population. Specific information about CM was extracted from 
identified CAM surveys (see Chapter 2.3.2.2) that included CM as one of the CAM 
modalities.  
 
2.3.4.1 Methodology 
Chinese medicine (CM) is classified as an alternative medical system by the US National 
Center for Complementary and Alternative Medicine (NCCAM).36 It includes not only the 
commonly known acupuncture, Chinese herbal medicine and Chinese therapeutic massage but 
other modalities, such as Qigong and Chinese medicine dietary therapy. Many Western 
countries, including Australia, have experienced tremendous growth in the use of Chinese 
medicine, particularly acupuncture and some popular herbs, over the past decades. However, 
very few studies have focused exclusively on the totality of all CM modalities. The use of CM 
as a defined health-care system has not been specifically investigated. Thus, the current 
review was aimed to systematically extract CM data from surveys. 
 
For the purpose of this review, CM was categorised into five major domains: 1) acupuncture, 
electro-acupuncture and moxibustion; 2) Chinese herbal medicine; 3) Chinese therapeutic 
massage; 4) Qigong, Tai Chi and martial art; and 5) Chinese medicine dietary therapy. 
 
The database literature search looked for two types of studies: 1) those that explicitly stated 
the prevalence of any one form of CM or CM as a whole [Type I literature], and 2) those in 
which CM information was embedded in utilisation studies on general CAM use among 
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random or representative samples of the general population [Type II literature]. The search 
strategy to identify Type I CM utilisation literature is illustrated below (Table 2.12). This was 
used in combination with the search strategy for general CAM as presented in Table 2.3. 
 
Table 2.12 Search strategy to identify type I literature on Chinese medicine utilisation 
1. exp Medicine, Chinese Traditional/ 
2. exp Drugs, Chinese Herbal/ 
3. exp Medicine, Oriental Traditional/ 
4. exp Plants, Medicinal/ 
5. exp Drugs, Non-Prescription/ 
6. (medicin$ adj05 (chines$ or oriental$ or tibetan$ )).tw. 
7. (herb$ medicin$ or medicin$ herb$).tw. 
8. (plant$ medicin$ or medicin$ plant$).tw. 
9. herb$.tw.  
10. or/1-9 
11. Acupuncture/ 
12. exp Acupuncture Analgesia/ 
13. exp Acupuncture, Ear/ 
14. exp Acupuncture Points/  
15. exp Acupuncture Therapy/  
16. exp Electroacupuncture/  
17. exp Meridians/ 
18. (acupuncture$ or electroacupuncture or electro-acupuncture or acupressure or acupoint$ 
or ((meridian or non-meridian or trigger) adj05 point$)).tw.  
19. or/11-18 
20. exp Moxibustion/ 
21. (moxibustion or moxa or Ai Jiu).tw. 
22. exp Massage/ 
23. (chines$ adj05 massage).tw.  
24. (Tuina or Tui na or An mo).tw. 
25. exp Tai Ji/ 
26. (Tai Ji or Taiji Tai Chi or Taichi).tw. 
27. exp Martial Arts/ 
28. (Gong Fu or Gongfu).tw. 
29. (Qi Gong or Qigong).tw. 
30. (chines$ adj05 (diet$ therap$ or nutrition$ therap$)).tw. 
31. or/20-30 
32. 10 or 19 or 31 
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The language of the publications included was limited to English or Chinese. To qualify for 
inclusion, papers had to use survey methods: either a questionnaire or interview to collect the 
information of CM use, and they had to meet one of the following selection criteria: 
 
1. The study estimated explicitly the prevalence of CM as a whole or any one form of CM 
and, based on a random or representative sample of a national or regional general 
population or a clinical population. 
2. The study was an utilisation study on CAM use among random or representative samples 
of a national population or a regional population, if such a national study was not available, 
and explicit data on the prevalence of CM as a whole or any one form of CM was 
available in the CAM study. 
 
Papers were excluded if one of the following criteria applied: 
1. The study was an utilisation study on CAM use in a clinical population.  
2. The study did not describe the study methods, e.g. a review, an article that did not mention 
how the data of CM prevalence were collected, or a report describing studies elsewhere. 
3. The full publication was not written in English or Chinese. 
4. The study was not published in an academic journal or a formal report document.  
5. Data addressed forms of herbal medicine other than Chinese herbal medicine. 
 
Again, the references of all relevant papers were examined to identify further literature. 
Furthermore, the following publications, which are not available in electronic databases or 
partially admitted to electronic databases, were hand-searched: “Journal of Complementary 
Medicine (Australia, 2002-2006)”; “Journal of Complementary and Integrative Medicine 
(2004-2006); “Journal of Traditional Chinese Medicine (1991-2005)”; “The Journal of 
Chinese Medicine (1991-2005)”; “Chinese Journal of Integrative Medicine (2003-2005)”. A 
search was also conducted on one of the major Chinese literature databases (CQVIP 
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Information, a fee-paying database in China99) and through Google Scholar, using the key 
words listed in Table 2.12 to screen for further literature. Using the same data extraction 
protocol, all identified publications were read in full and searched for substantive information 
that specifically related to CM. 
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2.3.4.2 Results  
 
Methodological Quality and Study Design 
Twelve Type I articles (i.e. exclusively Chinese medicine studies) met the criteria and were 
included in the review. Among these, five articles51,100-103 were based on general populations 
and another seven104-110 were based on defined populations. The key data of these 12 articles 
are summarized in Table 2.13 and Table 2.14.  
 
CM use among the general population was investigated in Taiwan,51,102 Hong Kong101,103 and 
New York City’s Chinatown.100 Except for Chou’s 1991 acupuncture study, all other studies 
investigated CM as a whole.102 Similar to the data collection method for CAM studies on 
clinical patients or a defined population, CM results for a defined population were also based 
on convenience-based participant recruitment (Table 2.14). The sample sizes for all studies 
were large (median size for 11 studies=1,145). Studies on the general population mainly 
comprised data collected through a structured interview or telephone interview, while studies 
on a defined population were predominantly conducted by paper-based questionnaire. 
 
A further 21 Type II literature (i.e. CAM studies with information on CM) met the criteria for 
this review (Table 2.15). The methodological quality of these studies has been discussed 
earlier. Individual forms of CM were available in acupuncture, herbal medicine, moxibustion 
and massage. Data on the use of Qigong and Tai Chi was available only in a US CAM study,1 
while data on Chinese medicine dietary therapy and martial art were not available. 
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Table 2.13 Chinese medicine use in general populations 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Chan et al. 
(1976)100 
New York City's 
Chinatown (n/m)‡ 
Randomly selected 
Chinatown residents aged 
16+ (87) 
Face-to-face interviews using a 
questionnaire (n/m) ‡ 
17.2% had seen Chinese medicine (CM) 
practitioners in the past two years. 
Wong et al. 
(1995)111 
Territory-wide in 
Hong Kong (HK) 
(1989-1990) 
Randomly selected ethnics 
Chinese HK residents aged 
18+ (2,822) Telephone interviews (76%) 
48.9% had previously consulted an 
herbalist; 9% consulted herbalist for their 
most recent illness; 5.8% had previously 
consulted an acupuncturist.  
Chi et al. 
(1997)51 Taiwan (1991-1992) 
Randomly selected adults 
in Taiwan (1,358) 
A 4-week diary and an interview 
(52.9%) 
9.6% used CM as the major source of 
medical care; the top three conditions to 
use CM were diseases of 1) respiratory 
system, 2) musculoskeletal system and 3) 
injuries and poisoning.  
Chou et al. 
(1998)102 Taiwan (1991) 
Randomly selected from 
the voter registration, aged 
20+ (5,805) 
Structured questionnaires used 
during home visits (70.1%) 
12.4% had previously received 
acupuncture treatment. 
Lau et al. 
(2001)103 
A district in HK with 
0.6 million population 
(1995) 
Randomly selected 1,183 
households with 4,339 
participants 
Face-to-face interviews using a 
questionnaire (54.2%) 
3.3% visited a CM practitioner within 3 
months prior to the survey; 13.5% had 
previously used CM. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. ‡ n/m: not mentioned 
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Table 2.14 Chinese medicine use in defined populations 
Author 
(year) 
Place of study 
(year) Sample (n) 
Data collection method 
(response rate, %) General findings* 
Wong et al. 
(1997)104 
A small town in 
Hong Kong (HK) 
(1992-93) 
People reported 
suffering from acute 
illness aged 18+ (847) 
Subgroup analysis of a 
survey with 7,570 subjects: 
telephone interview 
(82.8%) 
14% had previously consulted Chinese medicine (CM) 
practitioners when ill. 
Cassidy 
et al. 
(1998)105 
Six purposively 
selected clinics in 
the US (1995) 
Patients used general 
service clinics and 
Chinese medicine care, 
aged 11+ (575) 
Anonymous self-
completed questionnaire 
(45.9%) 
99% had previously used acupuncture; 59.7% received 
moxibustion and 35.5% used Chinese herbal medicine 
(CHM); the top three reasons of seeking CM were relief 
of pain, unstable mood and, maintaining well being. 
Wong et al. 
(1998)106 
Family practices 
in Vancouver 
(n/m)‡. 
Patients and their 
family members, all 
ages (932) 
Waiting room 
questionnaire (n/m) ‡ 
28% used CHM and 7% used acupuncture in the past 
year, 46% ever used CHM and 15% had previously used 
acupuncture. 
Lau et al. 
(2000)107 
12 randomly 
selected schools 
in HK (1996) 
Secondary school 
students (3,355) 
Structured self-
administrated 
questionnaire (89%) 
8.6% had consulted a CM practitioner over a three 
months period. Injury suffered from falls was the most 
popular reason for seeking CM practitioner (66.5%).  
Hon et al. 
(2004)108 
A school of 
pharmacy in HK 
(2002) Pharmacy students (91) 
Anonymous self-
completed questionnaire 
(100%) 
96% had previously tried CM; 38% had used CM at least 
once in the past year; >40% of CM users had visited a 
CM practitioner; upper respiratory tract infections were 
the most common condition for CM use. 
Ng et al. 
(2004)109 
A community in 
Singapore (1999) 
Non-institutionalised 
elderly aged 65+ 
(2,010)  
Door-to-door residential 
survey by using a 
questionnaire (85%) 
25.3% used CHM in the past year, among whom 12.1% 
used CHM only. The use of CHM was strongly associated 
with arthritis and cancer (odds ratio=2.43 and 2.57). 
Wong et al. 
(2005)110 
A hospital clinic 
in HK (2004) 
Chronic hepatitis B 
patients aged 18+ (362) 
Self-completed 
questionnaire (93%) 
32% had previously used CM and 16% used CM at the 
time of the study. 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. ‡ n/m: not mentioned 
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Table 2.15 Chinese medicine use in general populations (extracted from major CAM utilisation studies) 
Author (year) & country General findings in Chinese medicine 
Eisenberg et al. (1993), USA2 
Chinese medicine (CM) use: acupuncture (0.4%), massage (7%), herbal medicine (3%); 
Visited practitioners: acupuncturist (0.37%); massage therapist (2.9%) herbal therapist (0.3%); 
The mean number of visits to an acupuncturist per user was 38.4 per year. 
Thomas et al. (1993), UK44 0.5% adult populations used acupuncture. 
MacLennan et al. (1996), 
South Australia9 
CM use: herbal medicines (9.9%), Chinese medicine (1.8%), Ginseng (3.0%); 
Visited practitioners: acupuncturist (2.0%), herbal therapist (0.4%). 
Millar et al. (1997), Canada45 N/A 
Paramore et al. (1997), USA15 0.4% visited acupuncturists 
Astin et al. (1998), USA46 CM use: acupuncture (1.4%), massage (5.7%), herbal remedies (4.2%). 
Eisenberg et al. (1998), USA3 
CM use: acupuncture (1.0%), massage (11.1%), herbal medicine (12.1%); 
Visited practitioners: acupuncturist (0.9%); massage therapist (6.8%) herbal therapist (1.8%); 
The mean number of visits to an acupuncturist per user was 3.1 per year. 
Landmark Report (1998), USA41 CM use: acupuncture (2%), massage (14%), herbal medicine (17%), acupressure (5%). 
Druss et al. (1999), USA47 Visited practitioners: acupuncture (0.6%), massage (2.0%), herbal remedies (1.8%). 
Ramsay et al. (1999), Canada6 
CM use: massage (12%), herbal therapies (12%); 
Lifetime use: acupuncture (12%), massage (23%), herbal therapies (17%). 
Ernst et al. (2000), UK17 CM use: acupuncture/acupressure (2.8%), massage (1.2%), herbal medicine (6.8%). 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey.
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Table 2.15 Chinese medicine use in general population (extracted from major CAM population studies, continued) 
Author (year) & country General findings in Chinese medicine 
Millar et al. (2001), Canada48 N/A 
Thomas et al. (2001), UK5 
1.6% visited acupuncturists, 19.8% purchased over-the-counter herbal remedy; 
Over 3 million visits were made to acupuncture providers in 1998; 
The estimated annual out-of-pocket expenditure on acupuncture was 47 million pounds. 
MacLennan et al. (2002), South Australia10 
CM use: herbal medicine (13.4%), Chinese medicine (3.2%), Ginseng (5.0%); 
Visited practitioners: acupuncturist (2.8%), herbal therapist (0.9%). 
Menniti-Ippolito et al. (2002), Italy43 4.8% used herbal medicine, 2.9% used acupuncture during 1997-1999. 
Ni et al. (2002), USA4 CM use: acupuncture (1.4%), massage (6.4%), herbal medicine (9.6%). 
Yamashita et al. (2002), Japan7 
CM use: acupuncture and moxibustion (6.7%), massage and acupressure (14.8%); 
herbs and over-the-counter Kampo (17.2%). 
Barnes et al. (2004), USA1 CM use: acupuncture (1.1%), Tai Chi (1.3%), Qigong (0.3%), Ginseng (24.1%). 
Thomas et al. (2004), UK16 
Visited practitioners: acupuncturist (1.6%), herbal therapist (0.8%), massage therapist (2.1%); 
traditional Chinese medicine (0.4%). 
Nielsen et al. (2005), Denmark42 N/A 
MacLennan et .al. (2006), South Australia112 
CM use: herbal medicine (20.6%), Chinese medicine (2.3%), Ginseng (5.0%); 
Visited practitioners: acupuncturist (2.1%), herbal therapist (1.9%). 
* Unless otherwise defined, use, practitioner visit and expenditure were in the 12-month period preceding the survey. 
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Prevalence of Chinese Medicine Use in General Populations of Countries and Regions 
CM prevalence was first described in a 1976 study in New York City’s Chinatown.100 It found 
that 17.2% of the population had seen CM practitioners in the previous two years. However, 
the sample size was rather small (87 participants) and the survey did not differentiate between 
visits for acupuncture, massage or other services. Studies in Hong Kong (HK)101,103 and 
Taiwan51 were based on data over 10-15 years ago, the representation of the current status of 
CM use is not clear. 
 
The highest prevalence (48.9% had previously consulted an herbalist) was reported in a Hong 
Kong territory-wide survey conducted by Wong et al. in 1990.101 In contrast, a low prevalence 
of previous use of CM (13.5%) was reported in another Hong Kong survey in 1995,103 based 
on randomly selected household residents. Study subjects for the latter survey were selected in 
the Kwun Tong district of Hong Kong, and females in the households were chosen to answer 
questions on behalf of all family members. Thus, this 1995 survey included utilisation data 
from all age ranges and may influence the overall prevalence. 
 
A study in Taiwan employed an unusual data collection method.51 Based on a four-week diary 
and a retrospective interview, the researcher found that nearly one in 10 people used CM as 
their major form of medical care. Moreover, a large-scale study on acupuncture conducted at 
the same time also found just over one tenth (12.4%) of the Taiwanese population had ever 
received acupuncture treatment.102 
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Prevalence of Chinese Medicine Use in Defined Populations 
 
Seven studies on CM use by patients, students or other defined populations were found (Table 
2.14). These studies were conducted in the US,105 Canada,106 Singapore109 and Hong 
Kong.104,107,108,110 Similar to the findings on CM use by the general population, CM 
prevalence in defined populations varied markedly.  
 
The first in-depth, large-scale survey of Chinese medicine use in the US105 found that 99% of 
the survey participants had previously received acupuncture. The use of Chinese herbal 
medicine and moxibusion by the study’s participants was also substantial. However, the study 
was conducted in six selected clinics, including Chinese medicine clinics. It is highly likely 
that study participants attended these clinics for the purpose of a specialised Chinese medicine 
service. Thus, the results of this study on CM use have highly to be much higher than its 
actual use by the general population (Table 2.14). 
 
A Canadian study by Wong et al.106 recruited patients who had visited medical practitioners 
without Chinese medicine expertise. The prevalence of 28% of patients and their family 
members who had used Chinese herbal medicine in the past year was similar to a Singapore 
study109 (25.3%) on elderly people aged 65 or older.  
 
The use of CM in Hong Kong, a specially administrated region of China, had been considered 
more popular than in most, if not all, Western countries. However, this was not clearly 
confirmed by four Hong Kong studies. 104,107,108,110 A relatively low prevalence was reported 
for secondary school students (8.6% consulted CM practitioners over a three-month 
period),107 for people suffering from acute illness (14% lifetime consulting rate),104 and for 
chronic hepatitis B patients (16% at the time of the survey).110 
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Prevalence of Chinese Medicine Use (Extracted from CAM Studies) 
 
Acupuncture and herbal medicine are popular forms of CAM in many countries. Although 
very few studies have been conducted to collect data exclusively on acupuncture and other 
forms of CM, promising data are available from well-designed CAM studies. Such relevant 
data were extracted and are discussed below. With a lack of specific studies on CM use in 
Western countries, the extracted data are of particular value. 
 
Of 21 identified CAM studies, three did not provide information on Chinese medicine in any 
form. Information on acupuncture was specifically investigated in the majority of studies, 
however, limited information is available concerning overall CM prevalence. Moreover, no 
studies included a classification of Chinese-style massage and herbal medicine. Prevalence 
data on acupressure and moxibusion have been occasionally reported (Figure 2.5). 
 
Overall CM prevalence was determined in three Australian studies9-11 and a UK study.16 In 
Australia, the prevalence increased markedly from 1993 to 2000, from 1.8% to 3.2%, but then 
deceased to 2.3% in 2004. The prevalence of visits to CM practitioners was estimated in a UK 
study. 16 It was estimated that 0.4% of the total population had consulted CM practitioners in a 
12-month period but this excluded visits to acupuncturists, herbalists and massage 
practitioners. 
 
The prevalence of herbal medicine use in the US ranged between 3.0% in 19902 and 17% in 
1997.3 Based on four studies between 1997 and 1999, the average prevalence of herbal 
medicine use was 10.8%.3,4,41,46 A high prevalence of herbal medicine use was also reported 
by studies in the UK (19.8%),5 Australia (20.6%)11 and Japan (17.2%).7 Similar to the 
prevalence of herbal medicine use, approximately one in ten Americans used massage 
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therapy.3,41 This prevalence was similar to that in Canada and Japan. However, a 1999 UK 
study suggested that only 1.2% of the population used massage.17 For acupuncture, except for 
a higher rate (6.7%) reported in Japan,7 most studies estimated the prevalence at less than 3%. 
 
In terms of practitioner visits, the prevalence of visits to acupuncturists, massage therapists 
and herbal medicine practitioners was reported in the US, the UK and Australia (Figure 2.6). 
Although the use of acupuncture treatment was frequently reported, less than 3% of the 
populations was estimated to have visited such a practitioner in the previous 12 months, based 
on the utilisation studies in six countries (Figure 2.6). These studies also estimated that less 
than 2% had consulted herbal medicine practitioners.
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Figure 2.5 Prevalence of Chinese medicine use in six countries 
CM: Chinese medicine; HM: Herbal medicine 
Note: Years were at the time of conducting studies which are different from the dates of publication. 
US90, US97A (Eisenberg et al.2,3); US97B (Landmark report41); US98 (Astin46); US99 (Ni et al.4); US02 (Barnes et al.1); 
UK93, UK98 (Thomas et al.5,44); UK99 (Ernst et al.17); Canada99 (Millar et al.48); AUS93, AUS00, AUS04 (MacLennan et al.9-11); 
Italy99 (Menniti et al.43); Japan01 (Yamashita et al.7). 
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Figure 2.6 Prevalence of visits to Chinese medicine practitioners in three countries 
CM: Chinese medicine; HM: Herbal medicine 
Note: Years were at the time of conducting studies which are different from the dates of publication. 
US90, US97A (Eisenberg et al. 2,3); US94: (Paramore et al.15), US96 (Druss et al.47); UK98, UK01 (Thomas et al.5,16); 
AUS93, AUS00, AUS04 (MacLennan et al.9-11). 
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2.3.4.3 Discussion  
 
In the US, Chinese medicine (CM) is an integral part of the growing field of CAM.28 The 
results of studies drawn from the past three decades also suggest that CM has been used by a 
large part of the population of several countries, and that it is one of the most popular forms of 
alternative treatment to deal with diseases and maintain general health. Based on the current 
review, the prevalence of CM use may not be conclusive for most countries. In addition, in 
some countries, at least in China, CM utilisation, including public use and practices, may have 
been investigated and reported in some other forms, such as government reports. 
 
Although an eligible CM utilisation study has not been identified in Mainland China in the 
current review, data on Chinese medicine services, including specialised Chinese medicine 
hospitals and clinics are widely available in China. An examination of data from the State 
Administration of Traditional Chinese Medicine, P. R. China (SATCM)113 suggested that, in 
2004, there were 3,716 Chinese medicine hospitals in China, including hospitals where CM 
was integrated with Western medicine (WM) and hospitals of national minority medicine. The 
SATCM also estimated that, in 2003, in China, nationwide, there were more than 171,419 CM 
physicians and 30,934 assistant CM physicians.113 As such, if rigorous utilisation study was 
designed to estimate the total prevalence of CM in China, substantial proportion of CM usage 
is highly to be estimated. 
 
When conducting the literature search for CM, a considerable number of studies on general 
herbal medicine, rather than specific Chinese herbal medicine, were also identified. However, 
herbal medicine/products presented in such studies were mainly Western-type medicines (e.g. 
St. John’s Wort, evening primrose and Echinacea). Detailed analyses of the extremely broad 
range of herbal medicine modalities are considered beyond the scope of the current thesis.
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2.4 Summary of the Literature Review 
These three systematic reviews considered to provide a comprehensive overview of current 
CAM utilisation in general populations around the world. CAM use in different regional and 
clinical populations in Australia, as well as the use of all forms of Chinese medicine around 
the world, have been systematically summarised. Due to the heterogeneity of the studies 
included, data from these reviews should be interpreted with caution, despite the fact that the 
reviews have been completed adhering to rigorous methodology. Nevertheless, the researcher 
performed these tasks through an objective protocol: an explicit statement of the literature 
search strategy (see Table 2.3), a detailed inclusion and exclusion criteria (see Chapter 
2.3.2.1) and critically, a standardised, predefined data extraction form (see Table 2.4). 
 
As expressed in Chapters 2.1 and 2.2, it appeared that there was little capacity to compare 
international literature in CAM utilisation surveys due to the substantive differences in its 
definition and the totality of CAM modalities. As might be expected, similar obstacles were 
encountered in the current review, particularly with respect to the systemic comparison 
between countries/regions. Nevertheless, the important function of these reviews was to 
summarise the existing literature to assist the design of a population-based CAM survey in 
Australia. The methodological issues identified were discussed in details (see Chapter 8.2). 
 
Although there are considerable uncertainties about the true prevalence of overall CAM and 
CM use, the prevalence of most forms of CAM (e.g. herbal medicine) in many countries was 
found to be increasing markedly. On the basis of the data outlined for Australia, it is apparent 
that overall CAM prevalence is generally higher than in most other Western countries. 
Specifically, the highest prevalence of a single form of CAM (aromatherapy) was found in 
Australia amongst the majority (if not all) Western countries.10,11 This therapy, surprisingly, 
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was not included in previous US national health interviews,1,4 nor has it been reported as part 
of overall CAM prevalence in the US.2,3 
 
In 2005, the Kobe Centre for Health Development of the World Health Organisation (WHO) 
published a comprehensive global atlas of CAM use.114 It was designed to record details of 
policy, regulation, education, research practices and use of CAM around the world. CAM use 
in six WHO regional areas was outlined. 
 
In the WHO African region, it has been suggested that CAM, also known as African 
Traditional Medicine (ATRM) is still the only form of health care in some communities.115 In 
addition, it has been estimated that more than 80% of Africans used ATRM, whereas only 
about 50% of the African population had regular access to essential pharmaceuticals.116  
 
In the WHO region of the Americas, a review was conducted across 35 member 
states/countries. Apart from the US and Canada (see Table 2.4), a CAM survey was only 
available for the Argentine Republic.117 It revealed that more than half (54.4%) of the 
population of Argentina used CAM, among which homeopathy (40%), herbal medicine 
(36.7%), chiropractic (21.4%), acupuncture (12.9%) and bath flowers (11.6%) were most 
popular. 
 
No consolidated data are available on utilisation and practices of CAM in South-East Asian 
region and the Eastern Mediterranean region, despite the belief that various modalities of 
CAM are being used in this region.118,119 Other than some general data on the use of Ayurveda 
and Unani in India, Bangladesh and Nepal; Thai therapy in Thailand; and Jamu in Indonesia, 
other forms of CAM have rarely been investigated. 
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There is a wide range of CAM within the European region, particularly in Western European 
countries, such as Germany, Denmark and the UK. More importantly, nearly all countries in 
this region have some form of government subsidisation of CAM.120 Population surveys are 
available in the UK and Denmark to show that the trend of CAM use by the general public is 
increasing over time (see Table 2.4).  
 
Perhaps, more comprehensive results are available in the Western Pacific region.121 
Traditional Chinese medicine (including acupuncture, herbal medicines and massage therapy) 
is officially recognised in a number of countries, for example, China, Japan, Singapore and the 
Philippines. As mentioned in Chapter 2.3.4 (a systematic review of the specific prevalence of 
Chinese medicine), information available for these countries is mainly on the profile of CAM 
services and practices, other than the use by the general population. A profile of CAM usage 
in Australia was not included in the WHO report. 
 
In summary, as discussed in most published CAM surveys, rigorous survey research is 
required to exclude the drawbacks of all aspects of CAM research, in particular the 
classification and definition. In addition, future research should focus on the use of listed, 
commonly used forms of CAM over a defined period, preferably the previous year. Other 
critical matters related to CAM use, are why people use CAM, and what are the perceived and 
actual benefits and risks of using CAM. Presented below is the methodology and results of a 
recently completed CAM national study in Australia, in which considerable efforts were made 
to answer the research questions and objectives according to rigorous standards. 
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CHAPTER 3. METHODOLOGY  
 
3.1 Foreword  
In general, a clear CAM definition, a reliable survey instrument, as well as rigorous sampling 
and data collection methods are vital in designing a reliable CAM survey. Based on the 
existing literature, with specific consideration to the Australian health-care context, the 
identified methodological concerns in conducting a national population CAM study in 
Australia are discussed below. 
 
Extensive consultations were conducted with experienced CAM researchers, CAM academics 
and population health researchers to assist in the survey design. These consultations were 
extremely helpful in confirming the issues faced by researchers conducting CAM surveys. 
Data collected through computer-assisted telephone interviews (CATI) with randomly 
selected individuals using random-digit dialling (RDD) seem to be the most appropriate 
methods in the Australian context. Seventeen (17) forms of CAM were included in the survey 
on the basis of a review of existing literature on CAM utilisation, in Australia and overseas. 
Since a comprehensive list of CAM modalities used by the Australian population is not 
readily available, a pilot study was conducted. The initial draft of the survey instrument was 
developed from similar considerations. 
 
The detailed sampling methods, the process of developing an appropriate survey instrument, 
the data collection protocol, the quality assurance process and the data analyses approaches 
are presented in this chapter. 
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3.2 Sampling Methods 
3.2.1 Sample Size 
In general, the sample size required to represent a population depends on the size of the 
population, the desired level of statistical significance and the acceptable level of margin of 
error. The Australian adult population at the time of conducting this study was approximately 
15.3 million.122 CAM prevalence estimation in South Australia in 2000 was 52.1%10 
(confirmed in 2004 with 52.2%11). With 95 percent confidence intervals of plus/minus 3%, it 
was determined that 1,067 interviews would be appropriate for the proposed study (Figure 
3.1,calculated by Epi Info 6.0 package, Centers for Disease Control and Prevention, USA).123  
 
 
Figure 3.1 Sample size calculation using Epi Info 6.0 software package 
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The appropriate sample size can also be calculated through the modification of a common 
statistical formula: 
Because an estimated margin of error can be calculated as: e =
n
pp
z
)1( −
 
The estimated number of interviews: n= 2
2 )1(
e
ppz −
= 2
2
03.0
)5.01(*5.0*96.1 −
=1,067 
Where p = Value used to represent the population proportion (prevalence of outcome 
measurement, when p=0.5 it maximises the required sample size) 
 e = Desired margin of error 
 z = Critical value from the standard normal distribution table 
n = Target population 
 
This calculation is based on the assumption that random samples will be drawn from an 
extremely large general population. In the current case, samples will be drawn from 15.3 
million adult Australians, which can be considered as infinitely large in statistical terms. 
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3.2.2 Sample Selection 
Target Population 
 
The participants of the study were adults aged 18 years or older who were randomly selected 
from all states and territories around Australia. As all interviews were conducted in English 
only, only participants who were fluent in English were recruited. In addition, household 
members who had physical or mental handicaps, and those had not given oral consent to 
interviewers were excluded. 
 
Stratified Household Sampling Frames 
 
This study was conducted concurrently in six states and two territories: New South Wales, 
Victoria, Queensland, South Australia, West Australia, Tasmania, Australian Capital Territory 
and Northern Territory. Sample distributions were allocated at state level (Table 3.1). The 
populations of Tasmania, Northern Territory and the Australian Capital Territory are rather 
small. Thus, although representative proportions of interviews were achieved for all 
states/territories, it was decided that state-level comparisons would only be done for New 
South Wales, Victoria, Queensland, South Australia and Western Australia. 
 
Table 3.1 Allocation of study samples in accordance with state and territory populations 
State/Territory ABS (%) Targeted sample size (n) 
New South Wales 33.5 358 
Victoria 24.9 266 
Queensland 19.1 204 
South Australia 7.8 83 
Western Australia 9.8 104 
Tasmania 2.4 25 
Northern Territory 0.9 10 
Australian Capital Territory 1.6 17 
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Quota Set with the Interviews 
 
In an effort to achieve a representative sample through the random dialling process, using the 
2004 ABS population data percentages on age and gender,124 interviews for each gender and 
each age range were then allocated (i.e. 18-24, 25-34, 35-44, 45-54, 55-64 and 65+) (Table 
3.2). The percentages of interviews in the various age groups for each gender in the current 
samples matched the Australian population data. Participants were accepted in each defined 
category until the quotas were full. These protocols were to ensure the random digit dialling 
process (see below) and stratified sampling frames were practical. However, the use of quotas 
limited the randomised selection process, and the need to overcome this possible limitation 
will be discussed in this chapter. 
 
Table 3.2 Gender and age quotas set in the study 
Male Female  
Age range ABS (%) 
Quota set in 
the study ABS (%) 
Quota set in 
the study 
18-24 6.57% 60-70 6.29% 60-70 
25-34 9.39% 90-100 9.40% 90-100 
35-44 9.75% 100-110 9.85% 100-110 
45-54 8.94% 90-100 9.04% 90-100 
55-64 6.94% 70-80 6.82% 70-80 
65+ 7.61% 75-85 9.40% 95-105 
 
Selection of Participants within Households 
The methodology used to select participants within households was the “next birthday” 
technique to minimise volunteer bias. Only one participant was selected from each household. 
Once identified, the participant would not be substituted with another member of the 
household. 
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3.3 Development of Survey Instrument 
A definite CAM definition is not possible, yet CAM usually refers to therapies/products that 
purport to offer diagnostic and therapeutic alternatives or to complement conventional 
medicine. Due to the complexity of CAM modalities, it was decided to include a list of 
therapies based on the previously discussed systematic reviews of the literature (Chapter 2), 
which were commonly being used in Australia. 
 
To address the issue of a potential overlap of CAM modalities, and to provide an appropriate 
classification of CAM, with consideration of the Australian health-care context and previous 
CAM utilisation studies nationally and internationally,1-5,9-11 17 forms of CAM were included 
in the main survey (Table 3.3) (Appendix A). In addition, based on a previous study from our 
research group,62 it was decided to include the specific forms of Chinese medicine: Chinese 
herbal medicine, acupuncture, Chinese therapeutic massage, Chinese dietary therapy, Qigong, 
martial art and Tai Chi. This was done to ensure that all major forms of Chinese medicine 
were covered by the survey, and to produce explicit utilisation information on Chinese 
medicine as a whole within a general CAM study. This will allow comparison with previous 
Australian regional studies,10,11 which collected CAM prevalence by using different terms of 
individual CAM modalities, for example, “Chinese medicine” and “herbal medicine” were 
researched independently. 
 
In addition to the 17 selected forms of CAM, the contracted professional survey company 
suggested that a list of “other CAM” should be included in the survey. This was to assist the 
interviewers when a participant indicated that they had used CAM other than, or in addition to 
any of the 17 selected forms of CAM. The list of “other CAM” modalities was available to 
interviewers through an auto-dropdown list on the computer interview screen (Table 3.4). 
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Table 3.3 NCCAM classifications of the 17 selected forms of CAM in the survey 
NCCAM Classifications* 17 CAM therapies 
Alternative medical 
systems 
1.  Acupuncture 
2.  Homeopathy 
3.  Naturopathy 
Mind-body interventions 4.  Meditation 
5.  Yoga 
Biologically based 
therapies 
6.  Aromatherapy 
7.  Chinese herbal medicine 
8.  Chinese medicine dietary therapy 
9.  Clinical nutrition (e.g. multivitamins and minerals) 
10.  Western herbal medicine 
Manipulative and body-
based methods 
11.  Chinese therapeutic massage 
12.  Chiropractic 
13.  Osteopathy  
14.  Reflexology 
15.  Western therapeutic massage 
Energy therapies 16.  Energy healing (e.g. reiki and therapeutic touch) 
17.  Qigong, martial art and Tai Chi 
* NCCAM: National Center for Complementary and Alternative medicine (US) 
 
Table 3.4 List of “other forms of CAM” included in the survey 
Alexander technique 
Art/music/dance therapy 
Ayurveda  
Bowen technique 
Hypnotherapy 
Iridology 
Kinesiology 
Magnetic field therapy 
Myotherapy 
Prayer 
Other forms of relaxation techniques (eg. Pilates) 
Shiatsu 
Other--specify 
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A questionnaire was developed to answer the research questions which were designed to be 
completed in an average of 15 minutes. The questionnaire was divided into six sections (Table 
3.5) and contained some 60 questions: 40 yes/no questions, 15 multiple-choice questions and 
five open-ended questions. In addition, groups of questions on four specific forms of CAM: 
acupuncture, CHM, chiropractic and osteopathy were developed by relevant experts in these 
fields, with particular emphasis on the benefits and risks, insurance coverage and regulation 
matters. These questions were later re-formatted in a coherent manner. 
 
Table 3.5 Structure of the computer-assisted telephone interview questionnaire 
• Section 1: General health and the use of conventional medical services 
• Section 2: Prevalence and frequency of use, and expenditure on CAM 
• Section 3: Rationales for CAM use and attitudes toward CAM regulation  
• Section 4: CAM and private health insurance reimbursement and Medicare coverage 
• Section 5: Questions on four CAM therapies that are regulated at national or state level 
• Section 6: Socio-demographic information on participants 
 
A total of eight revisions were made to the instrument between December 2004 and April 
2005. The instrument was then programmed for use in a CATI telephone interviewing system. 
A sample of the final version of the questionnaire and a sample of the CATI programming 
script are attached (Appendix B C). Finalisation of the instrument was achieved after 
conducting the pilot study. 
 
Participants were first asked about their use of the 17 CAM therapies and any other forms of 
CAM over the 12 months preceding the survey. Thus were asked whether or not they had 
visited a practitioner for any of the 17 forms of CAM. Participants were not required to 
answer all questions. Depending on each participant’s historical CAM use, specific questions 
were customised by the CATI system. In an attempt to enhance the validity, the sequence of 
the 17 forms of CAM therapies was offered randomly for each interview session. 
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3.4 Computer-Assisted Telephone Interview 
When determining whether to use a mail or telephone survey to collect information, it is 
important to evaluate the advantages and disadvantages of each method in relation to the 
research objectives. Mail surveys are frequently used and are relatively inexpensive. However, 
they tend to have a low response rate and are time-consuming to implement. Mail surveys are 
suitable for the investigation of sensitive issues, such as illicit drug use, or for surveys 
requiring participants to fill in complex and lengthy questionnaires. However, unlike 
telephone surveys, there is less opportunity for mail survey participants to provide 
explanations of their perceptions, beliefs and attitudes towards the research questions. 
 
Computer-assisted telephone interview (CATI) involves electronic data collection, capture, 
and associated tasks.125 It is commonly used in large-scale health surveys, such as the 
Victorian Population Health Surveys and the New South Wales Health Surveys. In Australia, 
the percentage of households with fixed telephones is 97.5%,126 hence the CATI surveys 
methodology is feasible. The advantage of using CATI for a survey such as the one proposed, 
is that it is relatively cost effective, providing standardised prompts, thereby ensuring data 
consistency. It also offers direct data input and data output.127,128 For the reasons outlined 
above, it was decided that the study would employ the CATI method of data collection. 
 
A CATI facility is currently not available at RMIT University, and the cost of setting up a 
CATI centre is substantial. State health authorities in Australia conduct CATI surveys, either 
through their own call rooms or by contracting with commercial providers. Thus, a survey 
research company was contracted to conduct the telephone interviews. The use of professional 
trained telephone interviewers also ensured that reliable data would be obtained. A similar 
approach has been used by other researchers for well cited reports.2,3  
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3.4.1 Random Digit Dialling 
 
Telephone surveys, based on the selection of random telephone numbers, were used in the 
early 1960s.129 Most importantly, telephone numbers should be generated by a random digit-
dialling (RDD) method. Such a method had been used in previous similar CAM utilisation 
studies in the US.2,3 Unlike drawing numbers from the phone book listings, RDD allows for 
the inclusion of silent, unlisted and recently allocated telephone numbers. Thus, telephone 
numbers used in the interviews did not come from any specific source but were randomly 
generated by computer to ensure all household members had an equal probability of being 
contacted. 
 
In an attempt to minimise company or other business numbers, existing residential-prefix 
telephone numbers was used. For the current study, the first step of the RDD sampling was to 
select telephone numbers from the current available Telstra (a national telephone company) 
telephone exchanges. Randomly generated telephone numbers with six-digit prefixes for each 
study area in different states/territories were produced. Two digit suffixes were then randomly 
appended at the end of the prefixes (e.g. 9666 55** might become a telephone number 
between 9666 5501 and 9666 5599).  
 
A total of 20,000 telephone numbers was initially generated; the CATI computer system then 
screened out calls to facsimile machines, data lines, and unassigned and disconnected 
numbers, which meant only live calls were assigned to interviewers. Additional random 
telephone numbers were generated to recruit sufficient participants. A minimum of five call 
attempts was made to contact the household member. Calling proceeded, and a record of all 
calls was made, including non-reachable numbers, confirmed call-back numbers and 
household members who declined to participate. 
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3.4.2 Interviewer Training 
 
In an effort to produce the precise prevalence of CAM users and non-users, interviewers with 
experience in health surveys were selected from the survey company to conduct the interviews 
for the current survey. All interviewers attended a four-hour training and debriefing session in 
which the fieldwork manager and study investigator went through each interview question. 
Interviewers were given explanations of survey background information and all listed CAM 
modalities to be investigated. 
 
In addition, a brief interview memorandum with a short definition of each form of CAM was 
also provided to all interviewers, and used during interview sessions. Samples of common 
forms of CAM were highlighted on the computer interview screen, and were provided to the 
survey participants if requested. Other interviewer instructions included, “Australian common 
allied health professions such as physiotherapy and occupational therapy are not considered as 
CAM in this study”, “please distinguish between CAM use under the supervision of a 
practitioner and use without such supervision”; “please confirm it was out-of-pocket 
expenditure excluding money you [the survey participant] have obtained rebates from any 
source”, “please only provide expenditure and frequency of visits to CAM practitioners in the 
past 12 months”; “please differentiate the use of Chinese herbal medicine and Western herbal 
medicine, and Chinese therapeutic massage in compared to other massage therapies (i.e. 
Western therapeutic massage)”. 
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3.4.3 Quality Control Procedures 
 
For quality control purposes, two interview fieldwork supervisors randomly checked interview 
conversations simultaneously. The researcher was also on site, and randomly listened to most 
of the interview sessions. Interviewers had the opportunity to refer any questions from 
participants to the researchers during the interview sessions. The researchers also had the 
opportunity to correct or make comments on participants’ responses. The detailed survey 
development process, including the quality assurance strategy, is summarised in the following 
flowchart (Figure 3.2). 
 
 
Pilot Study (30 CATI Interviews)
Commissioned to a commercial survey company
Research Proposal and ethics 
Approved by RMIT University
Survey Design (RDD &CATI)
Questionnaire Development
Questionnaire Revised and Re-Programmed
CATI Field Work
Nationwide, 1067 telephone interviews
Data Recorded Simultaneously 
by Interviewers
Researchers & field managers 
monitoring and supervising
Quality Assurance 
In-house checking by a programmer, 
double-checked by a researcher
Data Auditing, Merging
& Reformatting
Dataset Produced 
For In-depth Analysis
 
Figure 3.2 Survey development-process and quality-assurance protocols 
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3.4.4 Interview Procedures 
 
The procedure of conducting the CATI telephone interview is described below. The 
automated dialling CATI system makes the initial phone calls from the monitoring stations; 
all working telephones then transfer to the interviewers. The interviewers then initiate the 
interview procedures, and the computer program controls questions branching or skipping. 
The interviewers then conduct the tasks of interviewing and entering the data into the 
computer system simultaneously. Where appropriate, the CATI system will also perform data 
checking while an interview is in progress. The subjects’ responses are then transferred 
directly into a CATI program linked to a database. These procedures ensured accurate and 
consistent answers were given by the participants. 
 
The interactive statistical software in the CATI system permits rapid preliminary analysis of 
the survey data. The final output of the data will be produced in different formats: raw, 
uncoded preliminary data files, Excel and SPSS data files and partially coded qualitative data 
files. The project managers in the research company will also audit a minimum of 10% of the 
interviews. 
 
The process of CATI auto branching is very important to collect reliable information. For 
instance, if a participant responded that they had never used any form of CAM, the CATI 
system would skip to the relevant questions instead of asking them specific questions on using 
CAM. Similarly, if a participant had used a specific form of CAM, the CATI system would 
continue to ask questions relevant to that type of CAM (e.g. practitioner visits and frequency). 
As a result of this automatic branching or skipping of questions, interview time was 
minimised. 
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Having complied with the ethical requirements, potential participants were given an 
abbreviated statement in plain language with background information about the survey to 
obtain their consent to participate (Appendix D). A full, printed version of the statement was 
provided if a potential participant requested one (Appendix E). Participants were informed 
prior to participating in the interview that this survey was intended to obtain accurate 
information about CAM utilisation to determine national prevalence data.  
 
The CATI interviews were conducted in May and June 2005. A maximum of 15 attempts 
were made to establish contact with an individual. People who normally stay at home during 
the day may have different characteristics, compared to those normally at work during the day. 
Thus, the telephone calls were made from nine o’clock in the morning to nine o’clock in the 
evening, seven days a week, to get a balance of different groups of participants. Appointments 
were made during the duration of the survey period, and an additional 10 attempts were made 
to contact each identified individual with an appointment. No financial incentive was 
provided. 
 
In order to obtain accurate information on CAM prevalence, the following questions were 
asked: “In the past 12 months, have you used any one of the following types of 
complementary medicine? Please say yes or no when it is named”. If a participant used one 
specific form of CAM, the following questions were asked: “Have you visited a practitioner 
for [name of automated CAM appeared in the screen based on previous question] in the past 
12 months?” and “how many times in total did you visit a practitioner for [name of CAM] in 
the past 12 months?” Due to the limitation on the time of interviews, the frequency question 
was asked only if a participant used one of ten types of CAM (mainly provider-based CAM 
therapies, see result section Table 4.9). The flowchart below summarises the process of the 
interview (Figure 3.3). 
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Initial contact
Have used at least one of 17 forms
of CAM in past 12 months (prevalence)
Establish eligibility
(eg. age and, language proficiency)
End of survey
(Re-affirm this survey is fully comply 
with relevant privacy Acts and ethics requirements)
Frequency of use and 
expenditure on CAM in past 12 months
Rationale, perceptions,
attitudes & concerns of using CAM
Additional questions on:
(acupuncture, chiropractic, 
Chinese herbal medicine, osteopathy) 
Health insurance and CAM
(Coverage and reimbursement)
Regulation and CAM
Demographic information
(eg. education, income, employment)
Selected questions in each section 
(rationale, attitudes, 
insurance coverage and regulation) 
Used prayer or other forms of CAM?
Lifetime use of CAM?
Have never used at least one of 
17 forms of CAM in past 12 months
Yes No
 
Figure 3.3 Flowchart of computer-assisted telephone interview questions 
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3.5 Pilot Study  
3.5.1 Foreword 
Ethics approval (Appendix F) was obtained for the study from RMIT University’s Human 
Research Ethics Committee. A pilot survey with 30 randomly selected individuals in the state 
of Victoria was conducted in April 2005. The responses from the pilot study helped to clarify 
the understanding on the 17 CAM therapies to be included in the main study. The pilot study 
was also used to validate and refine the survey questions, the flow of the interview, and to 
assess the quality assurance procedures of the research company contracted to conduct the 
fieldwork. As a result of the pilot study, changes were made to the questionnaire 
programming, the final version of the questionnaire and the interview schedules. Interview 
notes were provided to interviewers to clarify some frequently asked questions that arose from 
the pilot study. 
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3.5.2 Results of the Pilot Study 
 
Telephone interviews were successfully conducted with 30 randomly selected Victorians. 
Their age ranges, gender and country of birth are presented in Table 3.6 below, and are 
compared with the 2001 Victorian population data. 
 
Table 3.6 Basic demographic information on pilot study participants 
Characteristic Results of pilot study % 
ABS 2001 Victoria 
% 
18-24 16.7 12.7 
25-34 20.0 19.8 
35-44 30.0 20.4 
45-54 10.0 18.0 
55-64 13.3 12.2 
 
 
 
 
 
 
Age range 65+ 10.0 16.9 
Male 33.3 49.1  
Gender Female 66.7 50.9 
Australia 80.0 71.1  
Birthplace Overseas 20.0 28.9 
 
 
In relation to CAM utilisation, 22 out of 30 (73.3%, unweighted percentage) participants had 
used at least one of the 17 forms of CAM in the 12 months preceding the survey, while 86.7% 
participants had visited a medical doctor in the same period. The most popular forms of CAM 
were: aromatherapy, multivitamins or nutritional supplements, and yoga (each modality, 
>20%). Other interesting findings include: 
 
1. Fifty-nine percent considered Western medicine has a relatively higher risk of side effects, 
while 77% considered CAM to be relatively safe. 
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2. One in four participants who used CAM had never informed their medical doctors. 
3. Out-of-pocket expenditure on CAM products was between $0 and $350 per annum. 
4. Out-of-pocket expenditure on CAM consultations was between $0 and $1,000 per annum. 
5. Additional out-of-pocket expenditure on CAM-related items was between $15 and $1,500 
per annum. 
6. If a private health insurance offered CAM for no or little additional cost, 60% participants 
would buy insurance from that company. 
7. Medicare should or should not cover visits to practitioners of selected forms of CAM: 
• 80% suggested it should cover visits to an acupuncturist in addition to a registered GP 
who provided acupuncture treatment. 
• 63.3% suggested it should cover visits to Chinese herbal medicine practitioners 
• 66.7% suggested it should cover visits to chiropractors 
• 70% suggested it should cover visits to osteopaths 
 
Due to the small size of the pilot sample, the above data were collected to assist the design of 
the main survey only and must not be generalised. 
 
In the pilot study, the researcher randomly listened to some interview sessions, and established 
that the vast majority of participants were able to follow the sequence of the interview 
questions. However, participants commented that the interview was lengthy and that some 
questions were repetitive (specific research questions on four forms of CAM: acupuncture, 
etc). Importantly, some participants were unsure about some forms of CAM and queried them. 
A clear explanation was desirable. In addition, two interviewers mentioned that they were 
unable to inform survey participants what homeopathy and osteopathy were. These matters 
were resolved before the main survey. 
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3.5.3 Discussions and Finalisation of the Survey Instrument 
 
Perhaps the most important outcome of the pilot study was that it indicated that over 70% of 
the participants had used at least one form of complementary medicine in the past 12 months; 
this provided further confirmation of the adequacy of the target sample size (i.e. 1,067). 
 
All participants were also asked whether they had used any other forms of CAM other than 
the 17 surveyed. Only three mentioned such use, with none of them saying they had used other 
CAM but not any of the 17 forms of CAM. Thus, the pilot study also indicated that these 17 
forms of CAM therapies are likely to be the most commonly used CAM in Australia. 
Therefore, the pilot study to test CAM modalities used in Australia was most valuable for 
finalising the survey instrument. 
 
Other problems encountered during the pilot study included the definition of multivitamins 
and minerals. This was expected and has been commented by researchers in CAM utilisation 
studies.1 However, there is no easy way for the general public to define “non-CAM vitamins” 
and “CAM vitamins”. It was decided, therefore, for the purpose of this survey, the term 
“clinical nutrition” would include multivitamins and minerals. The term clinical nutrition is 
more commonly known in Australia. The use of the prefix “multi-” also indicated that the 
current study was not referring to a single vitamin consumed daily. Interviewers were 
expected to clarify this with participants while conducting the main survey. 
 
In addition, a few questions were designed to capture the reason(s) why participants used a 
particular form of complementary medicine. For instance, the original question on chiropractic 
was: “you mentioned earlier that you have sought chiropractic treatment in the last 12 months. 
Would you say the main reasons were: [read out by interviewers] 1) To improve general 
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health and well-being; 2) To improve sporting performance; 3) To improve [the] ability to 
undertake normal daily activities; 4) For relief of symptoms; 5) None of above–other specify.” 
The question was designed with multiple choices, as participants may have been using 
chiropractic for multiple purposes. The computer program, however, captured only one 
answer then skipped to the next question, so interviewers lost the opportunity to gather 
additional answers. Similar programming problems also occurred with another three 
questions. Such problems were resolved in consultation with the CATI script programmer 
before the main survey. 
 
Finally, as would have been anticipated, the recruitment from certain cohorts of participants 
was difficult. This was particularly observed in young males aged 18-34. This reinforces that 
the use of a national quota (see Table 3.2) in the main survey is necessary to recruit a 
nationally representative study population. 
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3.6 Data Analysis 
3.6.1 Data Consolidation and Missing Data 
Abandoned interviews (four in total) did not count toward the total of 1,067 successful 
interviews. Information on them is not available, even though the interviews were partially 
completed, as the temporary records were deleted immediately after the interviews had been 
discarded. 
 
The final dataset produced by the survey company was a SPSS (Statistical Package for Social 
Sciences130) data file. Because of the abovementioned quality assurance protocol, and the fact 
that the information was recorded by using a computer-assisted telephone interview system, 
missing data was minimal throughout the data set. The number of missing data in each 
research question is no more than 5%; thus, according to Korn and Graubard, this is fully 
acceptable.131 
 
There are two types of missing data: the purposively designed non-relevant items and items to 
which participants did not respond. Non-relevant items are those that were not relevant to a 
particular participant; for example, a question about expenditure on CAM was not put to a 
non-CAM user. A negative value “-1” was assigned to these responses. Such results do not 
have any impact on the data analyses. While the “real” missing data (e.g. a CAM user who did 
not state CAM expenditure for no given reason), was assigned an extreme value of “99999” 
and was clearly defined in the data property in the SPSS file.  
 
The task of identifying missing data and distinguishing it from non-relevant data was carried 
out in two steps. Firstly, all data were exported to a Microsoft ACCESS database, using 
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purposively designed queries, those participants who stated “don’t know” or “refused to 
answer” were identified. These mainly occurred in questions about CAM expenditure, number 
of visits to CAM practitioners, participants’ age, income and personal demographic 
information. In the second step, a new function available from the SPSS software 14.0132 was 
employed. The “data validation” function was particularly useful in customising a particular 
rule to check whether an individual value was within a valid range and to check the minimum 
and maximum data values in each data cell. It also flagged the identification of invalid cases 
for further investigation. A number of outliers of particular values had been flagged in this 
step for future notice. The overall cases of missing data in any variable are small. Thus, a 
missing value analysis was not conducted. 
 
The original dataset consists of 236 variables (Appendix G1). However, qualitative data (e.g. 
medical conditions for which a form of CAM was used) and “other-specify” questions (e.g. 
other forms of CAM and country of birth) were recorded in a separate Excel file. Such data 
were merged with the original dataset. More importantly, before any analysis could be carried 
out, a series of variables was created. These included “CAM user”, “those who visited CAM 
practitioners”, “acupuncture user”, “chiropractic user” etc. Questions with multiple responses 
were defined as a separate set of data in order to produce multiple-response frequency tables. 
Finally, most demographic data were recoded in accordance with relevant classifications used 
in government reports.  
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3.6.2 Reliability and Validity of Survey Instrument 
 
Although questions contained in the current survey had been tested by a group of researchers 
and re-tested in a pilot study, it should be noted that the newly developed instrument has not 
been widely tested and its reliability has not been formally and statistically evaluated. Also, 
little information is known about its validity.  
 
The relationship between reliability and validity requires further consideration. Outcome data 
can be valid but not reliable. Also, a measure can be reliable but invalid.133-135 Very often, the 
reliability, which measures the consistency of obtaining data from a scale, can be measured by 
examining how people answer each item of a set of questions. Mathematically, Cronbach’s 
alpha (α) value can be calculated for each section of the questionnaire with a value that ranges 
from 0 to 1. In general, an alpha coefficient of 0.70 or higher is considered acceptable for 
most instrumental design purpose.136 Unfortunately, for validity, a conclusive method of 
assessment is not readily available. Most social science analyses rely on a scale that produces 
results that are expected on the basis of well-established theories. 136 Most often face validity 
is ascertained via experts within the particular area that is researched. 
 
Therefore, scale reliability analyses (through SPSS) were carried out for different sections 
within the instrument to assess internal consistency of items measured by the scale. This is to 
ensure that answers from participants will not differ because the survey is confusing or has 
multiple interpretations.  
 
In the current survey, prevalence questions and attitudes towards a series of pre-defined 
questions on CAM-related matters are of major concern from a reliability perspective. The key 
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results of the reliability test on the 17 CAM prevalence questions confirm that the scale is 
reliable. The Cronbach’s alpha value is calculated as 0.759, which suggests that the scale is 
reliable (i.e. a value higher than 0.7).137 More specifically, Table 3.7 shows the item-total 
correlation of these 17 questions. It indicates that when removing any of the items, the 
Cronbach’s alpha value would not increase markedly, from the calculated reliability of the 
entire scale, 0.759. Therefore, the reliability coefficient for all items may be considered 
appropriate. In addition, Table 3.8 shows the inter-item correlation for the 17 CAM 
prevalence questions; the average correlation value is 0.163 (standard deviation (SD)=0.08) 
with a maximum of 0.404. It reveals that responses to these questions are not highly 
correlated. In addition, the item-total correlations of these questions range between 0.199 to 
0.456 (Mean=0.354, SD=0.07). According to Briggs and Cheek,137 this falls within the 
optimal range for the inter-item correlation (0.2-0.4). 
 
Similarly, when examining the questions on whether or not participants visited a CAM 
practitioner, Cronbach’s alpha value of 0.760 and an average inter-item correlation of 0.171 
(SD=0.09) were obtained. Moreover, considerably high Cronbach’s alpha values were also 
achieved for the items on attitudes towards CAM and Western medicine (α=0.954); the 
reasons for informing medical practitioners about CAM use (α=0.893); the reasons for not 
informing medical practitioners about CAM use (α=0.970); the reasons for using acupuncture, 
Chinese herbal medicine, chiropractic or osteopathy (α=0.924); the recommendations received 
for using these four therapies (α=0.908); and questions on regulations and private health 
insurance related to CAM use (α=0.763).
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Item-Total Statistics
2.07 5.422 .340 .748
2.09 5.415 .406 .744
2.11 5.554 .349 .748
2.14 5.724 .290 .753
2.10 5.612 .269 .753
1.99 5.150 .398 .742
1.89 4.876 .456 .737
2.00 5.488 .199 .762
2.12 5.678 .244 .755
2.10 5.437 .417 .743
2.06 5.266 .428 .740
1.99 5.131 .400 .742
2.00 5.138 .417 .740
1.71 5.033 .309 .757
2.09 5.434 .393 .745
2.12 5.609 .338 .750
2.04 5.311 .370 .745
1 Use ACU
2 Use CHM
3 Use CTM
4 Use CMDT
5 Use QG MA TC
6 Use WHM
7 Use WTM
8 Use Chiropractic
9 Use Osteopathy
10 Use Homeopathy
11 Use Naturopathy
12 Use Meditation
13 Use Aromatherapy
14 Use Clinical Nutrition
15 Use Energy Healing
16 Use Reflexology
17 Use Yoga
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected
Item-Total
Correlation
Cronbach's
Alpha if Item
Deleted
 
Table 3.7 Item-total correlation matrix of the prevalence questions on 17 forms of 
CAM 
Inter-Item Correlation Matrix
1.000
.318 1.00
.355 .324 1.000
.207 .385 .303 1.000
.067 .143 .153 .107 1.00
.160 .239 .139 .159 .074 1.00
.219 .187 .214 .110 .147 .175 1.000
.175 .052 .043 .022 .047 .080 .232 1.00
.153 .158 .125 .101 .073 .120 .159 .054 1.00
.230 .313 .197 .245 .063 .269 .159 .101 .193 1.00
.115 .218 .162 .132 .103 .324 .215 .147 .177 .404 1.00
.134 .145 .099 .107 .244 .219 .216 .051 .125 .210 .178 1.00
.136 .143 .159 .087 .199 .206 .313 .085 .068 .135 .216 .261 1.000
.070 .137 .063 .061 .062 .275 .220 .140 .077 .169 .215 .169 .194 1.00
.147 .176 .196 .137 .252 .155 .248 .083 .092 .181 .174 .290 .323 .068 1.000
.123 .230 .222 .170 .124 .116 .248 .083 .084 .174 .153 .158 .211 .098 .304 1.00
.107 .142 .120 .084 .210 .185 .247 .007 .134 .163 .216 .356 .268 .142 .178 .123 1.00
1 Use ACU
2 Use CHM
3 Use CTM
4 Use CMDT
5 Use QG MA TC
6 Use WHM
7 Use WTM
8 Use Chiropractic
9 Use Osteopathy
10 Use Homeopathy
11 Use Naturopathy
12 Use Meditation
13 Use Aromatherapy
14 Use Clinical Nutrition
15 Use Energy Healing
16 Use Reflexology
17 Use Yoga
        
1      2     3  4   5 6 7 8 9 10 11 12 13 14 15 16 17
 
 
Table 3.8 Item-item correlation matrix of the prevalence questions on 17 forms of CAM 
ACU: Acupuncture, CHM: Chinese herbal medicine, CTM: Chinese therapeutic massage, 
CMDT: Chinese medicine dietary therapy, QGMATC: Qigong, martial art and Tai Chi, WHM: 
Western herbal medicine, WTM: Western therapeutic massage.
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3.6.3 Data Weighting Procedures  
 
The purpose of the data weighting process was to adjust for representativeness with the 
national population. The weighting procedure used in this thesis is the most conventional, 
post-stratified direct weighting method.138 The quota used in the CATI interview was based 
on nationwide statistics; a reasonable distribution of the study population was achieved at the 
end of the recruitment to represent Australia’s overall population. However, the final make-up 
of the study population does not match the national population distribution exactly, 
particularly on a state/territory level. In addition, at the time of developing the national quota, 
the available ABS population data were for June 2004, while the study participants were 
recruited between May and June 2005. A post-stratified weighting process was required. 
 
As a result of the age/gender/region weighting process, a total of 89 weighting values were 
applied to the original dataset (Table 3.9). The method used to calculate the weighting value is 
in accordance with the number of interviews in this survey and the proportion of sample 
required to represent corresponding adult Australians.138 For instance, a total of 28 interviews 
were conducted with male participants aged 18-24 in New South Wales; this represented 
2.63% of the total 1,067 interviews in the current survey (three participants who did not state 
their ages were weighted differently, see Table 3.9). Based on the ABS data, there was a 
population of 330,628 adults in this division, or 2.15% of the total adult Australian 
population. The actual interview numbers exceeded the total number of people required to 
represent the overall national population. Thus, the assigned weighting value for people 
within this division is less than 1.0. This can be calculated as a ratio of approximately 2.15% 
over approximately 2.63%, which equals 0.81620. The sum of the total weights equals the 
total number of adult Australians interviewed (1,067). 
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Table 3.9 Data weighting values applied in the data analyses 
Weighting values* 
Regions/age 18-24 25-34 35-44 45-54 45-54 65+ 
Male 
New South Wales 0.81620 0.83725 0.88032 1.09447 1.40855 0.75336 
Victoria 1.44342 1.77789 1.42955 0.83317 0.87099 1.88991 
Queensland 1.00671 0.83976 1.04984 0.93082 0.72145 1.17948 
South Australia 1.73776 1.39896 0.97004 0.93170 2.01745 3.56656 
Western Australia 1.20118 1.40761 0.87729 1.09573 0.94109 0.93408 
Tasmania 0.79241 1.92156 0.57844 1.20164 0.49743 0.72875 
Northern Territory 0.82503 1.24432 0.60585 0.48744 0.63889 0.35148 
ACT N/A† 0.88589 0.33046 0.77136 0.57426 0.96805 
Female 
New South Wales 1.55654 1.07618 0.97995 1.27818 0.92574 1.26370 
Victoria 0.83665 1.25713 0.82253 0.85538 0.80423 0.74546 
Queensland 1.33450 0.76631 1.57041 0.81622 1.33693 1.27532 
South Australia 0.70255 1.66628 0.70077 0.54470 0.68234 0.69950 
Western Australia 1.13337 1.06591 1.04641 1.41271 1.20283 1.11831 
Tasmania 0.49671 1.00738 1.21232 1.22504 N/A† 2.68163 
Northern Territory N/A† N/A† N/A† N/A† 0.50673 N/A† 
ACT 1.29250 0.43840 0.28479 1.65587 N/A† 0.59783 
ACT: Australian Capital Territory 
*Three participants did not state their age, a weighting value of 1.00000 was applied. 
† N/A: Interviews did not conduct in that regional areas, a weighting value was not applicable. 
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The method used to define the weighting values for each participant was through the SPSS 
syntax technique (Table 3.10). 
 
 
Table 3.10 An example of SPSS syntax for data weighting protocol 
COMPUTE Wgt=0. 
IF ((Region=NSW) and (Age=18-24) and (Gender=Male)) Wgt=0.81620. 
IF ((Region=VIC) and (Age=18-24) and (Gender=Male)) Wgt=1.44342. 
IF ((Region=OLD) and (Age=18-24) and (Gender=Male)) Wgt=1.00671. 
IF ((Region=SA) and (Age=18-24) and (Gender=Male)) Wgt=1.73776. 
IF ((Region=WA) and (Age=18-24) and (Gender=Male)) Wgt=1.20118. 
IF ((Region=TAS) and (Age=18-24) and (Gender=Male)) Wgt=0.79241. 
EXECUTE . 
 
 
Alternatively, a weight can also be based on how many Australian each participant represents. 
On average, each of the 1,067 participants in the current survey represented a total of 
14,544.37 adult Australians (based on the ABS June 2005 data,122 the total number of adult 
Australians was 15,518,843). More specifically, for the abovementioned 28 male adults aged 
18-24 in New South Wales, each participant will represent a total of 11,808.11 persons (the 
total adult population in that division was 330,628122). When applying these weighting 
factors, the sum of the weights was the total number of adult Australians aged 18 or over at 
the time of the survey, which was approximately 15.5 million people. However, this method 
produces large weighting values and is more difficult to manage when performing SPSS data 
analyses. Consequently, the method mentioned earlier (direct weighing method), with much 
smaller weighting values, was used in this study. 
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3.6.4 Statistical Analyses 
 
3.6.4.1 Descriptive Analyses  
 
A general descriptive analysis was initially carried out to examine the distribution of the data 
in terms of their central tendency and spread, such as mean, median, standard deviation, 
skewness and kurtosis. A symmetric distribution of a number of variables (e.g. the CAM cost 
and number of visits to CAM practitioners) is of particular importance before conducting 
correlations or regressions analyses (see below). When calculating prevalence and other major 
results, 95% confidence intervals are also calculated and, where appropriate, the exact level of 
statistical significance and the corresponding numbers are also provided. 
 
Standard errors (SE) for all proportions are calculated as: SE= npp /)1(* −  where p is the 
proportion, and n is the total number of participants investigated. Consistent with some ABS 
reports, relative standard error (RSE) is also calculated with major prevalence. The formula is: 
RSE (as a percentage) = (Standard error of the percentage/actual estimation)*100. All 
estimations with a RSE greater than 25% are recommended to be used with caution, while a 
RSE greater than 50% is considered unreliable, as it does not meet the standard of reliability. 
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3.6.4.2 Inferential Analyses 
 
The independent t-test, and one-way and two-way ANOVA tests were used to test for 
differences between groups. These were conducted via the SPSS program. Importantly, for 
prevalence data, the Z-test was used to determine the significance of differences between two 
percentages (through the statistical formula below (calculated in Microsoft Excel) and also 
confirmed in the MINITAB–a specialised statistical software package). 
Z=
SS ba
ba XX
22
−
−
=
bbbaaa
ba
NXXNXX
XX
/)1(/)1( −−−
−
 
Where  aX  and bX  are two percentages being compared 
S a  and S b  are the standard errors of those percentages  
aN  and bN  are the total number of participants investigated  
The critical z value at the 0.05 significance level is ±1.96 
 
Cross-tabulation analysis was used to reveal the frequency and common characteristics of the 
outcome measurements: CAM users and related variables. Because participants’ demographic 
information is mainly in the form of categorical variables, the results can be displayed in 
customised multi-way frequency tables. The chi-square-based statistics (phi, Cramér's V, and 
contingency coefficient) are obtained depending on the nature of the variables (nominal, 
ordinal or interval). In the result section, the weighted percentages are presented rather than 
the actual frequencies of cases together with their chi-square value and probability (p). 
 
Evidence exists to explain the characteristics that account for the use of CAM and visits to 
CAM practitioners. These include being female, having a better socio-economic status, 
holistic personal beliefs and experiences with conventional medicine. Thus, hypotheses on 
factors that contribute to the use of CAM were tested to confirm whether an association exists. 
These hypotheses will be discussed in the logistic regression model section. 
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3.6.4.3 Multivariate Logistic Regression 
 
A regression model is commonly used to assess the relationship between a dependent variable 
and a set of independent variables (predictors). In the case of the current study, the dependent 
variables of interest are mainly dichotomous, (e.g. whether or not CAM was used) with more 
than one explanatory independent variable. According to the principles of correlation and 
regression, a binary logistic regression is most appropriate.139 Mathematically, in general, the 
overall effect of the independent variables (known as predictors in the regression) on the 
dependent variable (the outcome measure) is expressed by the square of the correlation 
coefficient (r2), which can be used to predict the proportion of the variance in the dependent 
variable which is explained by its relationship with the independent variables.140 
 
In the current study, the major dependent variables are “CAM user” and “visited CAM 
practitioners” which represents the use of any of the 17 forms of CAM and visits to a 
practitioner for any one of the 17 forms of CAM, respectively. Separate regression analyses 
incorporating predictor variables were carried out within four specific forms of CAM. Guided 
by a previous US national study on why people use CAM,46 a list of the hypothesised 
predictor variables that used to assess the potential correlation with CAM use are generated 
(details below). However, the use of the existing classification may eliminate and/or include 
potential factors, both unintentionally and intentionally. Thus, the maximum number of 
independent variables was included in the initial model-developing stage. Final regression 
outputs presented in this dissertation are variables that had been entered via a step-wise 
method and which contributed significantly to the model. 
 
Although logistic regression does not assume a linear relationship between the dependent and 
independent variables, and the dependent variables need not be normally distributed, there are 
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a few assumptions for the data that may restrict the application of logistic regression analysis. 
As logistic regression is based on the principle of maximum likelihood estimation (MLE), a 
considerably large sample is required. Peduzzi et al. suggested that a minimum of 10 
observations per parameter should be included in the model.141 
 
As with most statistical procedures, outliers can substantially affect all results. As discussed in 
the data consolidation process above, a thorough data check was conducted before performing 
data analysis. In addition, for the purpose of logistic regression, the residuals produced 
alongside the regression model were inspected to identify outlying cases that may have 
affected the model.  
 
Moreover, as required for general multiple regression, logistic regression also requires no 
multicollinearity between variables.142 In simple terms, this means that high inter-correlations 
among independent variables will change the estimation of the coefficient and will be a 
problem. As Pallant suggested, ideally the predictor variables should be strongly related to the 
dependent variables but not strongly related to each other.142 In the current study, a 
collinearity diagnostic was conducted, and variables with the problem of multicollinearity was 
detected by examining the correlation matrix and tolerance value. For example, a variable 
with a tolerance value less than 0.1 was not included in the regression model. 
 
A few technical terms that are presented in the SPSS output format should be noted, as they 
are not exactly the same as conventional regression values. First, as stated in the SPSS 
Regression Models 12.0 Manual,143 the Hosmer and Lemeshow Test provides the most 
reliable test on a model performance (to support the model, the p value should be greater than 
0.05). The significance value is in contrast to the significant results in the Omnibus Tests of 
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Model Coefficients. In the latter case, a p value less than 0.05 indicates the final model is 
better than the original guessing model in Block 0.142 
 
For easy interpretation, the original beta coefficients in the logistic regression are in a log 
format, and have been transformed into an odds ratio by taking the exponential (presented as 
Exp (B) in the SPSS output). According to Tabachnick and Fidell,144 the odds ratio is “the 
increase (or decrease if the odds ratio is less than one) in odds of being in one outcome 
category when the value of the predictor increases by one unit” while keeping all the other 
predictors constant. For example, in the current study, this may refer to the odds of a 
participant with a particular characteristic using CAM a greater or lesser number times than 
someone who does not have that particular characteristic, all other factors being equal. All 
analyses in this thesis used SPSS to compute regression statistics, and will be presented in 
comparison to a reference category for all categorical variables. 
 
A Classification Table is also provided in the SPSS output as an indication of how well the 
model predicted the correct category (CAM use or visits to CAM practitioner). Values in the 
table correspond to the conventional statistics of sensitivity (the true positives) and specificity 
(true negatives) of the model.143 Thus, the summarised statistics of the classification table (the 
percentage accurate in classification (PAC) statistics) are presented in the current thesis. 
 
Lastly, regression results presented in the current thesis were based on the original unweighted 
data. This is on the basis of the recommendation by Winship and Radbill that population 
weights do not make a difference in the results and therefore are not necessary for the 
regression model.145 It is important to note that this method was also employed in a previous 
CAM utilisation study in South Australia.9 Thus, comparison of results between the current 
study and those previous studies can be much more straightforward. 
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CHAPTER 4. NATIONAL PROFILE OF CAM UTILISATION  
 
4.1 Results 
4.1.1 Foreword 
The intended number of participants (1,067) completed the survey interview. Ninety percent 
of the interviews ranged between 7.5 and 22.5 minutes, with an average of 13.5 minutes. 
When considering the downtime in filling appointments, the total average time taken to 
complete the whole interview was just over 22 minutes. The minimum interview time was 
four minutes, and the maximum was 37 minutes.  
 
The representativeness of the study population can be evaluated through a comparison with 
existing independent sources (e.g. the ABS data and recent government surveys), although 
some data collected from other sources are not readily available for comparison (e.g. some 
ABS data are only applicable to people aged 15 years and older). Nevertheless, after 
comparing with a variety of publications (details below), the study population can be 
considered as a representative sample of the entire Australian adult populations. 
 
Detailed results of national profile of CAM use are presented in this chapter. A regional (state) 
profile of CAM utilisation is presented in Chapter 5, while Chapter 6 presents specific 
analyses on some popular forms of CAM in Australia, such as acupuncture, Chinese herbal 
medicine, chiropractic and osteopathy. Matters related to CAM use, such as rationale for using 
CAM, insurance coverage and regulation are presented in Chapter 7. 
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4.1.2 Survey Response Rate 
 
For the main survey 26,367 telephone numbers were generated for dialling. Of these, 28% 
were not functioning, 10% were not assigned to households or were facsimile/modem 
numbers, 15% did not answer after a maximum of 18 call attempts. Among the remaining 
7,260 participants (the eligibility of most of whom has not been established), 1,067 completed 
the interview. This corresponds to a 14.7% overall response rate. The response rate was 
calculated using the formula in the flowchart below (Figure 4.1), which is comparable to the 
method suggested by the American Association for Public Opinion Research.146 
 
Due to the relatively short period of the survey (two months), 320 participants were not 
available during the study period, and 76 interview appointments remained unsolved at the 
end of the survey. These figures were not taken into consideration when calculating the 
response rate. On the other hand, the estimated proportion of cases of unknown eligibility was 
not reported by the survey company. Thus, an adjusted response rate may be reasonably higher 
than the current estimation. The majority of people who refused to participate did not provide 
a reason. Of those who gave a detailed explanation, “don’t have time” and “never do surveys” 
were the most common responses. 
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Initial household contacts
(26,367)
Completed & valid interviews
(1,067)
Households contacted
(12,157)
Agreed to participate
(1,147)
Contacts were not 
established*
(14,210)
*Telephone numbers not functioning (7,241), fax/internet/data numbers (1,308),
Business and other non-households numbers (1,258), 
Phone did not answer, engaged after five attempts or was an answering machining (4,403).
Unresolved 
appointments
(76)
Terminated
interview 
(4)
Refusals
(6,189)
Not available during
the survey period (421)
Ineligible/quota full
(4,400)
 
Figure 4.1 Flowchart of the final interview outcome 
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4.1.3 Characteristics and Representativeness of Survey Participants 
 
Every effort was made to ensure that the survey participants were representative of the 
Australian national population. National aggregated quotas for gender, age ranges, and 
state/territory were set on the basis of 2004 ABS data,124 and the proportions recruited for 
each of these did not differ significantly from the relevant ABS data for 2005122 (p>0.05) 
(Table 4.1). The survey sample was also representative of the Australian population in terms 
of self-reported health status,147 place of birth (born in Australia or overseas), educational 
status, employment status and household income range148 (Table 4.1). 
 
The sample representativeness in this survey was extended when examining the details of 
participants’ country of birth (Table 4.2 shows the top 10 countries of birth of survey 
participants). It suggested that participants’ countries of birth were reasonably distributed 
across a wide range of different nations similar to the Australian national data,149 although the 
population of the state of Tasmania, the Northern Territory and the Australian Capital 
Territory are relatively small, and the corresponding numbers of interviews were small. 
 
In most cases, participants were asked about their detailed demographic information rather 
than the combined categories presented in Table 4.1. For example, educational background 
was categorised as “did not complete high school, completed high school, enrolled at TAFE or 
university, TAFE or university degree, postgraduate degree” (Table 4.3). These categorical 
data were merged for easy interpretation, and enhance the statistical power when performing 
sub-group analyses. In addition to the characteristics presented in Table 4.1, participants were 
also asked about their status of health insurance coverage. Overall, more than half (55.6%) of 
the participants were covered by a private health insurance. 
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Table 4.1 Comparison of socio-demographic characteristics on survey participants and 
the Australian population 
Characteristic* Survey participants (%**) 
Australian 
population (%) 
p value† 
(chi square) 
Gender    
Male 49.0 49.7 0.65 (0.20) 
Female 51.0 50.3  
Age range (year)    
18-24 11.9 12.8 0.83 (2.14) 
25-34 17.7 18.5  
35-44 20.3 19.4  
45-54 18.8 18.0  
55-64 14.6 14.1  
65+ 16.7 17.2  
Region     
New South Wales 33.1 33.4 0.57 (5.74) 
Victoria 24.7 24.9  
Queensland 19.3 19.3  
South Australia 8.2 7.7  
Western Australia 9.0 9.8  
Tasmania 2.4 2.4  
Northern Territory  0.8 0.9  
Australian Capital Territory 2.4 1.6  
Self-reported health    
Excellent 18.2 17.7 0.06 (9.16) 
Very good 35.2 32.6  
Good 31.2 30.9  
Fair 11.5 13.8  
Poor 3.8 5.0  
Country of birth‡    
Australia 76.2 76.8 n/a 
Overseas 23.8 23.2  
Post-secondary education‡    
No 43.8 49.1 n/a 
Yes 56.2 50.9  
Employment‡    
Employed 65.7 61.4 n/a 
Not in labour force 34.3 38.6  
Annual household income A$‡    
<20,000 17.7 20.0 n/a 
20,001-40,000 21.1 24.1  
40,001-60,000 21.5 19.2  
60,001+ 39.7 36.7  
*  Except for self-reported health, population data are from the ABS 2005 collection. 
Self-reported health data are from the AIHW Health Report 2004. 
** Percentages are of those who provided characteristic information in each category. 
†  Probability of a difference in the frequency of each categorical variable between the 
survey and ABS data (chi square). 
‡  n/a: Data not directly comparable; survey sample data are for 18 years and older, while  
corresponding population data are for 15 years and older. 
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Table 4.2 The top ten countries of birth of survey participants 
2005 CAM Survey 
Country of Birth 
N %* 
Australian Bureau of 
Statistics† (%) 
Australia 808 76.2% 76.8% 
UK & Ireland 91 8.6% 6.0% 
New Zealand  25 2.4% 2.1% 
Germany 11 1.0% 0.6% 
USA 9 0.8% 0.3% 
India 9 0.8% 0.6% 
Indonesia 7 0.7% n/a 
South Africa 7 0.7% 0.5% 
Netherlands 6 0.6% 0.5% 
Poland 5 0.5% 0.3% 
Others 82 7.7% 12.4% 
* Exclude seven participants who refused to provide information on country of birth 
† Source: Australian Year Book 2005 Page 122 
 
Table 4.3 Detailed education and employment background of survey participants 
Characteristics N % 
Post-secondary education*   
<High school 204 19.2% 
Completed high school 260 24.5% 
Enrolled at TAFE or university 72 6.8% 
TAFE or university degree 341 32.2% 
Postgraduate 183 17.3% 
Employment†   
Full time 435 41.3% 
Part time or casual 181 17.2% 
Self employed 75 7.1% 
Home duties 68 6.5% 
Student 36 3.4% 
Retired or pensioner 221 21.0% 
Unemployed 36 3.4% 
* Exclude seven participants who refused to provide information on education 
† Exclude 15 participants who refused to provide information on employment 
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4.1.4 Use of Common Forms of CAM 
 
4.1.4.1 Prevalence of CAM Use 
Unless otherwise indicated, the results shown in this chapter were obtained by weighting the 
sample data to reflect population norms. Table 4.4 shows the prevalence of use of the 17 
forms of CAM included in the survey. Over two thirds (68.9%, 95% CI: 66.1% – 71.7%) of 
participants had used at least one of the 17 CAM therapies in the previous 12 months.  
 
Of the total 17 forms of CAM, the use of clinical nutrition (including multivitamins and 
minerals) was found to be the most popular (45.8%, 95%CI: 42.8% – 48.8%), while Chinese 
medicine dietary therapy had the smallest following at 2.3% (95%CI: 1.4% – 3.2%). Low 
prevalence was also observed in the use of reflexology (4.1%, 95%CI: 2.9% – 5.3%) and of 
osteopathy (4.6%, 95%CI: 3.3% – 5.9%). In summary, the 10 most popular forms of CAM, in 
decreasing order, were clinical nutrition (including multivitamins and minerals), Western 
massage therapy, meditation, Western herbal medicine, aromatherapy, chiropractic, yoga, 
naturopathy, acupuncture and Chinese herbal medicine. None of the relative standard errors of 
the prevalence was higher than 25%. 
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Table 4.4 Prevalence of the 17 investigated forms of CAM 
Prevalence 
Type of CAM 
% 95% CI RSE* (%) 
Clinical nutrition 45.8 (42.8 – 48.8) 3.3 
Western massage therapy 27.2 (24.5 – 29.9) 5.0 
Meditation 17.5 (15.2 – 19.8) 6.6 
Western herbal medicine  16.3 (14.1 – 18.5) 6.9 
Aromatherapy 16.1 (13.9 – 18.3) 7.0 
Chiropractic 16.1 (13.9 – 18.3) 7.0 
Yoga 12.0 (10.1 – 13.9) 8.3 
Naturopathy 10.7 (8.8 – 12.6) 8.8 
Acupuncture 9.2 (7.5 – 10.9) 9.6 
Chinese herbal medicine 7.0 (5.5 – 8.5) 11.2 
Energy healing 7.0 (5.5 – 8.5) 11.2 
Homeopathy 6.0 (4.6 – 7.4) 12.1 
Qigong, martial art and Tai Chi 6.0 (4.6 – 7.4) 12.1 
Chinese therapeutic massage 5.1 (3.8 – 6.4) 13.2 
Osteopathy 4.6 (3.3 – 5.9) 13.9 
Reflexology 4.1 (2.9 – 5.3) 14.8 
Chinese medicine dietary therapy 2.3 (1.4 – 3.2) 20.0 
At least 1 of the above forms of CAM 68.9 (66.1 – 71.7) 2.1 
* RSE: relative standard error = (standard error/estimated prevalence)*100 
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4.1.4.2 Characteristics of CAM Users 
 
A total of 737 participants were classified as CAM users, 45.5% of whom were male, and 
54.5% female. Key socio-demographic characteristics of the CAM users are summarised in 
Table 4.5. A higher proportion of females were CAM users than males, and fewer of those 
aged 65 and above were users than were younger adults. However, it is worth noting that 60% 
of those aged 65 and above used CAM (Table 4.5). It appears that CAM users are more likely 
to have higher levels of education, to have private health insurance, and to be in households 
with higher than average incomes (Table 4.5). There was little difference in the use of CAM 
between those born in Australia and those born overseas. In contrast, there was considerable 
variation in the prevalence of the use of CAM between Australian states (details Chapter 5). 
 
Table 4.6 is the detailed cross-tabulation analysis that reveals the proportions of survey 
participants who had used each of the 17 forms of CAM, and the participants’ specified socio-
demographic characteristics. The largest gender differentials were in the use of aromatherapy, 
Western herbal medicine, Western massage, naturopathy, energy healing and yoga (all 
modalities with female users being higher than male users, p<0.001). In particular, the use of 
aromatherapy by females (24.0%) was almost three times that by males (8.1%) (p<0.0001). 
Gender differences were also observed in osteopathy and reflexology users, but less 
significant (p<0.05). 
 
As mentioned earlier, the youngest group (18 to 34 years of age) was more likely to use CAM 
therapies than the older cohorts. However, this may be largely due to the relatively high 
prevalence of use of yoga, Qigong, martial art, Tai Chi and clinical nutrition by the youngest 
group (18-34 age group, compared with the 35-64 and 65 and older age groups, p<0.05). Not 
surprisingly, older people also had a low prevalence of use of Chinese herbal medicine, 
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Table 4.5 Socio-demographic characteristics on CAM users 
Were CAM users 
Characteristics % (95%CI) p value† 
Gender   
Male 63.4 (59.3 – 67.5)  
Female 74.4 (70.7 – 78.1) <0.001 
Age (year)   
18-34 75.3 (70.7 – 79.9)  
35-64 69.0 (65.1 – 72.9) <0.05 
65+ 57.8 (50.7 – 64.9) <0.001 
Country of birth   
Australia 70.2 (67.1 – 73.3)  
Other 65.0 (59.1 – 70.9) >0.05 
Region    
New South Wales 72.1 (67.5 – 76.7)  
Victoria 69.8 (64.3 – 75.3) >0.05 
Queensland 71.0 (64.8 – 77.2) >0.05 
South Australia 60.8 (50.3 – 71.3) >0.05 
Western Australia 66.6 (57.6 – 75.6) >0.05 
Self-reported health status   
Excellent/very good/good 68.4 (65.4 – 71.4)  
Fair/poor 71.7 (64.7 – 78.7) >0.05 
Post-secondary education   
No 61.6 (57.1 – 66.1)  
Yes 74.7 (71.2 – 78.2) <0.001 
Employment   
Employed 72.5 (69.2 – 75.8)  
Unemployed or not in labour force 62.9 (57.9 – 67.9) <0.005 
Private health insurance   
Yes 72.2 (68.6 – 75.8)  
No 64.9 (60.6 – 69.2) <0.05 
Annual household income (A$)   
<20,000 60.1 (52.5 – 67.7)  
$20,000 - 40,000 65.5 (59.0 – 72.0) >0.05 
>40,000 72.8 (69.1 – 76.5) <0.005 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†    Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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aromatherapy, Western herbal medicine, (all modalities, 65 and above age group, compared 
with 18-34 age group, p<0.01), and Chinese therapeutic massage (p<0.05). In contrast, the 
highest proportions of users of osteopathy and reflexology were those over 65 years of age. 
 
When examining participants’ country of birth, it is clear that a higher prevalence in the use of 
Chinese herbal medicine (p<0.01), acupuncture (p<0.05), Chinese medicine dietary therapy 
(p<0.05) and reflexology (p<0.05) was observed in those born overseas than those born in 
Australia. However, the use of chiropractic by those people born in Australia (18.1%) was 
almost twice that of those born overseas (9.7 %) (p<0.001). 
 
Similar to the finding of overall CAM use, self-reported health status did not seem to 
significantly affect the use of any specific form of CAM. However, a clearly higher use of 
some forms of CAM (yoga, Western herbal medicine, aromatherapy and naturopathy) was 
observed in those with an excellent/very good or good health status. In addition, those who 
rated their health status as fair or poor tended to have a higher (but not statistically significant) 
use of acupuncture, Qigong, martial art, Tai Chi, chiropractic, osteopathy, meditation, clinical 
nutrition and energy healing. 
 
With respect to educational background, for each of the 17 forms of CAM higher use was 
observed in those with post-secondary education, although a statistically significant difference 
was only observed in the use of acupuncture, Chinese herbal medicine, Western herbal 
medicine, Western therapeutic massage, homeopathy, naturopathy, meditation, aromatherapy, 
clinical nutrition and yoga. Very similar findings were found in participants’ employment 
status, that is, people who were employed at the time of the survey also had a higher rate of 
CAM use, except for osteopathy and energy healing. For the latter two categories of users, 
those unemployed or not in the labour force, had a slightly higher rate of CAM use (p>0.05).  
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Private health insurance funds in Australia provide limited coverage of a number of CAM 
therapies, such as acupuncture, chiropractic and massage therapy. The common view of the 
correlation between CAM use and insurance cover is that those covered by private health 
insurance would be more likely to choose some specific forms of CAM, as they can claim for 
limited reimbursements for those types of CAM therapies. This hypothesis was confirmed by 
most users but not users of aromatherapy, Chinese medicine dietary therapy, as well as 
Qigong, Tai Chi and martial art. Among all CAM therapies, there was a statistically 
significant difference between those covered by private health insurance and those who are 
not on the use of chiropractic (p<0.01) and Western massage therapy (p<0.01). 
 
As for most Western countries, the cost related to seeing a CAM practitioner and/or the use of 
CAM products are mainly borne by the consumers themselves. Thus, the use of CAM may be 
partially determined by the affordability of that CAM therapy/product. This hypothesis is 
generally acceptable for most forms of CAM used by the current survey participants. The most 
significant income differential was for chiropractic and aromatherapy users. Only 
approximately one tenth of the survey participants with an overall household income of less 
than $20,000 had used chiropractic (7.5%) or aromatherapy (10.1%), whereas the prevalence 
of use of these therapies doubled to approximately 20% among those with an income between 
$20,000 and $40,000, and among those with incomes exceeding $40,000. 
 
The tests of significance mentioned above between categories were conducted without 
controlling the potential cross-effects (referred to as interaction in statistical analyses) among 
predictor variables. For example, those employed may also have higher household incomes 
and be covered by private health insurance. Due to this, a multivariate logistic regression 
analysis that considers the correlation between variables was also carried out. 
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Table 4.6 Socio-demographic characteristics on users of each of the 17 forms of CAM 
Percents (standard error) of use of –  
 Characteristics Acupuncture CHM CTM CMDT QGMATC WHM WTM Chiropractic Osteopathy 
Gender          
Female 9.6 (1.27) 7.7 (1.15) 5.8 (1.01) 3.0 (0.73) 7.2 (1.12) 20.2 (1.73) 33.3 (2.03) 17.1 (1.62) 5.8 (1.01) 
Male 8.9 (1.24) 6.1 (1.04) 4.3 (0.89) 1.7 (0.57) 4.6 (0.91) 12.3 (1.43)** 21.0 (1.77)** 15.0 (1.55) 3.3 (0.78)* 
Age (year)          
18-34 7.6 (1.46) 8.1 (1.49) 5.7 (1.27) 2.3 (0.82) 9.5 (1.61) 16.3 (2.03) 33.8 (2.59) 15.0 (1.96) 3.1 (0.96) 
35-64 10.3 (1.30) 7.8 (1.15) 5.6 (0.98) 2.8 (0.71) 4.7 (0.90)** 17.7 (1.63) 27.7 (1.91) 16.7 (1.60) 5.0 (0.93) 
65+ 9.2 (2.13) 2.6 (1.16)** 2.4 (1.12)* 1.1 (0.78) 2.9 (1.23)** 12.3 (2.42) 13.9 (2.55)** 15.7 (2.68) 5.9 (1.74) 
Country of birth          
Australia 10.2 (1.06) 5.5 (0.80) 4.7 (0.74) 1.7 (0.45) 6.2 (0.84) 15.9 (1.28) 28.2 (1.58) 18.1 (1.35) 4.8 (0.75) 
Overseas 6.5 (1.56)* 11.1(2.00)** 6.4 (1.55) 4.7 (1.34)* 5.2 (1.40) 17.7 (2.42) 25.0 (2.75) 9.8 (1.89)** 3.8 (1.21) 
Self-reported health status          
Excellent/very good/good 8.6 (0.93) 6.9 (0.85) 5.1 (0.73) 2.8 (0.55) 5.8 (0.78) 17.1 (1.25) 27.3 (1.48) 15.2 (1.19) 4.5 (0.69) 
Fair/poor 12.1 (2.57) 6.4 (1.93) 4.9 (1.70) 0.0 (0.00)** 6.4 (1.93) 11.8 (2.54) 26.3 (3.47) 20.6 (3.19) 4.8 (1.68) 
Post-secondary education          
No 6.4 (1.15) 4.7 (0.99) 4.7 (0.99) 1.9 (0.64) 4.9 (1.01) 13.0 (1.58) 20.8 (1.90) 15.4 (1.70) 3.6 (0.87) 
Yes 11.3 (1.29)** 8.7 (1.15)** 5.4 (0.92) 2.7 (0.66) 6.8 (1.03) 18.8 (1.59)** 32.2 (1.90)** 16.7 (1.52) 5.3 (0.91) 
Employment          
Employed 9.8 (1.13) 8.1 (1.04) 6.0 (0.90) 2.9 (0.64) 6.4 (0.93) 17.4 (1.45) 29.7 (1.74) 16.8 (1.42) 4.5 (0.79) 
Unemployed/not in labour force 7.8 (1.40) 4.6 (1.10)* 3.5 (0.97) 1.3 (0.60) 5.1 (1.16) 14.4 (1.84) 22.5 (2.19)** 14.5 (1.85) 4.7 (1.11) 
Private health insurance          
Yes 10.8 (1.27) 7.3 (1.07) 5.7 (0.95) 2.3 (0.62) 5.8 (0.96) 17.2 (1.55) 32.5 (1.92) 19.0 (1.61) 5.6 (0.94) 
No 7.4 (1.21) 6.6 (1.15) 4.3 (0.94) 2.4 (0.71) 6.3 (1.12) 14.8 (1.65) 20.9 (1.88)** 12.4 (1.53)** 3.3 (0.83) 
Annual household income          
<A$20,000 8.1 (2.16) 5.9 (1.88) 3.7 (1.49) 2.8 (1.32) 6.2 (1.91) 12.1 (2.59) 18.3 (3.07) 7.3 (2.07) 6.7 (1.99) 
A$20,000 – A$40,000 7.0 (1.79) 7.6 (1.85) 4.0 (1.37) 2.0 (0.98) 7.0 (1.78) 19.3 (2.76) 23.6 (2.97) 19.0 (2.74)** 1.3 (0.79)* 
>A$40,000 10.1 (1.27) 6.9 (1.07) 5.5 (0.96) 2.2 (0.62) 5.3 (0.94) 17.2 (1.59) 32.2 (1.97)** 18.4 (1.63)** 5.5 (0.96) 
Note 1: probability of proportion being significantly different from the first value in each demographic category * p<0.05, ** p<0.01; significance levels were adjusted to allow for 
multiple comparisons. Note 2: CHM: Chinese herbal medicine; CTM: Chinese therapeutic massage; CMDT: Chinese medicine dietary therapy; QGMATC: Qigong, Martial art and 
Tai Chi; WHM: Western herbal medicine, WTM: Western therapeutic massage.
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Table 4.6 Socio-demographic characteristics on users of each of the 17 forms of CAM (continued) 
Percents % (standard error) of use of –  
Characteristic  
Homeopathy 
 
Naturopathy 
 
Meditation 
 
Aromatherapy 
Clinical 
nutrition 
Energy 
healing 
 
Reflexology 
 
Yoga 
Gender         
Female 6.6 (1.07) 14.2 (1.50) 19.3 (1.70) 24.0 (1.84) 51.5 (2.15) 9.9 (1.29) 5.5 (0.98) 16.6 (1.61) 
Male 5.5 (0.99) 7.1 (1.11)** 15.6 (1.58) 8.1 (1.19)* 40.1 (2.13)** 4.0 (0.85)** 2.7 (0.71)* 7.3 (1.13)** 
Age (year)         
18-34 5.9 (1.30) 11.1 (1.72) 18.1 (2.11) 19.9 (2.19) 53.6 (2.73) 7.2 (1.42) 3.2 (0.97) 20.4 (2.21) 
35-64 6.6 (1.06) 11.5 (1.36) 18.3 (1.65) 17.8 (1.63) 44.9 (2.13)* 7.3 (1.11) 3.9 (0.83) 8.4 (1.18)** 
65+ 4.6 (1.55) 7.5 (1.94) 13.6 (2.53) 4.2 (1.48)* 35.4 (3.52)** 5.0 (1.61) 5.7 (1.71) 7.9 (1.99)** 
Country of birth         
Australia 5.0 (0.76) 10.6 (1.08) 17.0 (1.32) 17.2 (1.32) 45.4 (1.75) 7.5 (0.92) 3.3 (0.63) 11.7 (1.13) 
Overseas 8.8 (1.80) 11.0 (1.99) 18.4 (2.46) 13.2 (2.15) 47.3 (3.17) 5.5 (1.45) 7.0 (1.62)* 13.5 (2.16) 
Self-reported health status         
Excellent/very good/good 6.0 (0.79) 10.9 (1.04) 16.7 (1.24) 16.6 (1.24) 45.6 (1.66) 6.1 (0.80) 4.1 (0.66) 12.9 (1.11) 
Fair/poor 5.9 (1.85) 9.4 (2.30) 21.1 (3.21) 13.5 (2.69) 46.7 (3.93) 11.2 (2.48) 3.8 (1.51) 6.8 (1.98)** 
Post-secondary education         
No 4.0 (0.92) 8.2 (1.29) 11.9 (1.52) 12.7 (1.56) 38.1 (2.28) 5.7 (1.09) 3.6 (0.87) 7.4 (1.23) 
Yes 7.4 (1.07)* 12.5 (1.34)* 21.7 (1.67)** 18.9 (1.59)** 52.0 (2.03)** 8.0 (1.10) 4.6 (0.85) 15.6 (1.48)** 
Employment         
Employed 6.9 (0.96) 12.4 (1.25) 17.8 (1.46) 18.4 (1.48) 50.2 (1.91) 6.8 (0.96) 4.1 (0.75) 13.1 (1.28) 
Unemployed or not in labour force 4.7 (1.11) 7.5 (1.38)** 15.7 (1.91) 12.1 (1.71)** 39.1 (2.56)** 6.8 (1.32) 4.1 (1.04) 10.6 (1.61) 
Private health insurance         
Yes 6.5 (1.01) 11.3 (1.30) 18.0 (1.58) 15.7 (1.49) 48.5 (2.05) 7.0 (1.04) 4.5 (0.85) 12.6 (1.36) 
No 5.4 (1.04) 9.8 (1.38) 16.8 (1.73) 16.9 (1.73) 42.8 (2.29) 7.0 (1.18) 3.7 (0.88) 11.4 (1.47) 
Annual household income         
<A$20,000 4.8 (1.69) 6.9 (2.01) 17.5 (3.01) 10.1 (2.40) 36.3 (3.81) 6.5 (1.96) 2.5 (1.25) 6.9 (2.01) 
A$20,000 – A$40,000 6.3 (1.70) 11.7 (2.25) 16.9 (2.62) 20.4 (2.82)** 42.9 (3.46) 7.8 (1.87) 7.0 (1.79)* 9.9 (2.09) 
>A$40,000 5.9 (0.99) 11.0 (1.32) 18.6 (1.64) 17.2 (1.59)* 49.7 (2.11)** 7.2 (1.09) 3.7 (0.79) 14.2 (1.47)** 
Note 1: probability of proportion being significantly different from the first value in each demographic category * p<0.05, ** p<0.01 
Note 2: significance levels were adjusted to allow for multiple comparisons. 
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4.1.5 Visits to CAM Practitioners 
 
4.1.5.1 Prevalence of Visiting CAM Practitioners 
 
Almost two thirds (64.0%, 95%CI: 60.5% – 67.5%) of CAM users had visited a CAM 
practitioner in the previous 12 months (Table 4.7). Not surprisingly, there were considerable 
differences between the 17 forms of CAM in the proportions of practitioner visits. For 
example, in the 12 months preceding the survey, only about one sixth (16.4%) of clinical 
nutrition users had consulted a practitioner, whereas about one third (32.9%) of Chinese 
herbal medicine users and 29.1% of Western herbal medicine users had visited a practitioner. 
As might have been expected, the highest proportions of practitioner visits were by users of 
provider-based CAM therapies, such as chiropractic (90.6%), acupuncture (81.1%), 
osteopathy (76.4%) and Western massage therapy (73.7%) (Table 4.7). It is a safety concern 
and perhaps somewhat puzzling that nearly one in 10 chiropractic users and approximately 
one in five users of acupuncture, osteopathy or Western massage therapy did not visit a 
relevant practitioner. 
 
The actual proportion of participants who had visited a CAM practitioner in the preceding 12 
months was 44.1% (95%CI: 41.1% – 47.1%) of the total survey participants (Table 4.8). Of 
the total practitioner visits, Western massage therapist visits was found to be the most popular 
(20.1%, 95%CI: 17.7% – 22.5%); high prevalence was also observed in visits to chiropractors 
(14.6, 95%CI: 12.4% – 16.7%) and acupuncturists (7.5%, 95%CI: 5.9% – 9.15). 
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Table 4.7 Percentage of CAM users that visited practitioners for 17 forms of CAM 
Percentage** 
Type of CAM* 
% 95% CI RSE† (%) 
Clinical nutrition 16.4 (13.1 – 19.7) 10.2 
Western massage therapy 73.7 (68.6 – 78.8) 3.5 
Meditation 23.7 (17.6 – 29.8) 13.2 
Western herbal medicine 29.1 (22.4 – 35.8) 11.8 
Aromatherapy 19.3 (13.4 – 25.2) 15.6 
Chiropractic 90.6 (86.2 – 95.0) 2.5 
Yoga 56.9 (48.3 – 65.5) 7.7 
Naturopathy 55.8 (46.7 – 64.9) 8.3 
Acupuncture 81.1 (73.4 – 88.8) 4.9 
Chinese herbal medicine 32.9 (22.2 – 43.6) 16.6 
Energy healing 46.7 (35.3 – 58.1) 12.4 
Homeopathy 47.7 (35.5 – 59.9) 13.1 
Qigong, martial art and Tai Chi 53.3 (41.1 – 65.5) 11.7 
Chinese therapeutic massage 62.2 (49.3 – 75.1) 10.6 
Osteopathy 76.4 (64.5 – 88.3) 7.9 
Reflexology 51.5 (36.7 – 66.3) 14.6 
Chinese medicine dietary therapy 24.8 (7.9 – 41.7) 34.8†† 
At least 1 of the above forms of CAM 64.0 (60.5 – 67.5) 2.8 
*  Types of CAM are listed in descending order of the type of CAM prevalence 
** Percentages are of users that visited a practitioner of a specific type of CAM 
†  RSE: relative standard error = (standard error/estimated prevalence)*100 
††
  Relative standard error >25%, results to be interpreted with caution 
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Table 4.8 Percentage of participants that visited practitioners for 17 forms of CAM 
Percentage** 
Type of CAM* 
% 95% CI RSE† (%) 
Western massage therapy 20.1 (17.7 – 22.5) 6.1 
Chiropractic 14.6 (12.4 – 16.7) 7.4 
Acupuncture 7.5 (5.9 – 9.1) 10.8 
Clinical nutrition 7.5 (5.9 – 9.1) 10.8 
Yoga 6.8 (5.3 – 8.4) 11.3 
Naturopathy 5.9 (4.5 – 7.4) 12.2 
Western herbal medicine 4.7 (3.5 – 6.0) 13.7 
Meditation 4.1 (2.9 – 5.3) 14.7 
Osteopathy 3.5 (2.4 – 4.6) 16.1 
Energy healing 3.2 (2.2 – 4.3) 16.7 
Qigong, martial art and Tai Chi 3.2 (2.1 – 4.2) 16.9 
Chinese therapeutic massage 3.2 (2.1 – 4.2) 17.0 
Aromatherapy 3.1 (2.1 – 4.2) 17.1 
Homeopathy 2.9 (1.9 – 3.9) 17.8 
Chinese herbal medicine 2.3 (1.4 – 3.2) 20.0 
Reflexology 2.1 (1.3 – 3.0) 20.8 
Chinese medicine dietary therapy 0.6 (0.1 – 1.0) 40.1†† 
At least 1 of the above forms of CAM 44.1 (41.1 – 47.1) 3.5 
* Types of CAM are listed in descending order of the prevalence of CAM practitioner visits 
** Percentages are of survey participants that visited a practitioner of a specific type of 
CAM 
† RSE: relative standard error = (standard error /estimated prevalence)*100 
††
 Relative standard error >25%, results to be interpreted with caution 
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4.1.5.2 Frequency of CAM Practitioners Visits 
 
The number of practitioner visits by survey participants during the 12 months preceding the 
survey was determined for the 10 most common provider-based CAM therapies (Table 4.9). 
Thirty seven percent (37.0%, 95%CI: 34.2% – 40.0%) of the participants had visited a 
practitioner of at least one of the 10 forms of CAM listed in Table 4.9, on at least one 
occasion in the 12-month period. The highest mean number of visits was for users of 
acupuncture (8.8), closely followed by users of chiropractic (8.4) (see Appendix G2 for the 
original unweighted data and Appendix G3, statistical summary of weighted data). 
 
The average number of visits to one or more of the types of CAM practitioners in Table 4.9, 
over the 12-month period was 12.1, which when extrapolated to the national adult population, 
equates to 69.2 million visits. Almost one third of these (32.1%) were to a massage therapist 
(Western and Chinese therapeutic massage) and over one quarter (27.5%) were to 
chiropractors, that is, adult Australians made 22.2 million visits to massage therapists and 
19.0 million visits to chiropractors in the 12-month period. 
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Table 4.9 Frequency of visits to practitioners for 10 forms of CAM 
Survey participants 
Estimate for national 
population* 
Type of CAM 
Mean (95%CI) Million (95%CI) 
Acupuncture 8.75 (5.2 – 12.3) 10.16 (6.0 – 14.3) 
Chiropractic 8.44 (6.5 – 10.4) 19.05 (14.6 – 23.5) 
Homeopathy 6.65 (1.9 – 11.4) 2.97 (0.8 – 5.1) 
Western massage 6.29 (5.1 – 7.5) 19.55 (15.9 – 23.2) 
Chinese herbal medicine 5.98 (3.5 – 8.5) 2.12 (1.2 – 3.0) 
Osteopathy 5.69 (3.8 – 7.6) 3.08 (2.0 – 4.1) 
Chinese therapeutic massage 5.43 (3.2 – 7.7) 2.66 (1.6 – 3.8) 
Naturopathy 5.32 (2.9 – 7.7) 4.87 (2.7 – 7.0) 
Aromatherapy† 3.98 (1.8 – 6.2) 1.93 (0.9 – 3.0) 
Western herbal medicine 3.75 (2.7 – 4.8) 2.76 (2.0 – 3.5) 
Visits to one or more of the above 
CAM practitioners 12.1 (10.0 –14.2) 69.15 (57.6 – 81.4) 
* Based on an adult Australian population of 15.5 million and corresponding prevalence of 
CAM practitioner visits as estimated in the current study (see Table 4.8). 
†
 Adjusted mean after excluding two obvious outliers 
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4.1.5.3 Characteristics of People Visiting CAM Practitioners 
 
Table 4.10 shows the socio-demographic profiles of survey participants who had visited a 
CAM practitioner during the preceding 12 months. In general, the findings for practitioner 
visits were in accord with those for CAM users. That is, higher proportions of those who 
visited CAM practitioners were female, younger adults, people with higher levels of 
education, those with private health insurance, and those who had higher household incomes. 
However, it is of interest that there was less variation between Australian states in the 
proportions of participants who had visited a CAM practitioner than in the proportions of 
CAM users. Detailed analyses of the possible regional differences are presented in Chapter 5. 
 
Despite the similarities in the socio-demographic profiles of CAM users and those who had 
visited CAM practitioners, there were some differences. Thus, there was no statistically 
significant difference between the proportions of employed and unemployed participants that 
visited CAM practitioners or in the proportions in the two younger age ranges (Table 4.11). 
On the other hand, unlike the findings for CAM users, significantly more participants who 
visited CAM practitioners were born in Australia than born overseas and a higher proportion 
had household incomes of $20,000-$40,000 than less than $20,000 (Table 4.11). 
 
Table 4.11 presents a detailed cross-tabulation analyses that reveals the proportions of survey 
participants with the specified socio-demographic characteristics who had visited practitioners 
for each of the 17 forms of CAM. The overall pattern of the characteristics’ differentials was 
similar to the findings discussed above relating to the users of each of the 17 forms of CAM, 
although a statistically significant difference was more commonly detected in visiting 
provider-based CAM practitioner, such as acupuncture, massage therapy and osteopathy. 
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Table 4.10 Characteristics of people who had visited CAM practitioners 
Visited CAM practitioners 
Socio-demographic characteristic 
% (95%CI) p value† 
Gender   
Male 38.9 (34.7 – 43.1)  
Female 49.2 (45.0 – 53.4) <0.001 
Age range (year)   
18-34 48.1 (42.7 – 53.5)  
35-64 45.0 (40.8 – 49.2) >0.05 
65+ 34.9 (28.0 – 41.8) <0.01 
Country of birth   
Australia 46.5 (43.1 – 49.9)  
Other 36.7 (30.7 – 42.7) <0.01 
Region    
New South Wales 45.0 (39.9 – 50.1)  
Victoria 48.0 (42.0 – 54.0) >0.05 
Queensland 41.4 (34.7 – 48.1) >0.05 
South Australia 44.5 (33.8 – 55.2) >0.05 
Western Australia 42.0 (32.6 – 51.4) >0.05 
Self-reported health status   
Excellent/very good/good 43.6 (40.4 – 46.8)  
Fair/poor 46.7 (39.0 – 54.4) >0.05 
Post-secondary education   
No 35.7 (31.3 – 40.1)  
Yes 50.8 (46.8 – 54.8) <0.001 
Employment   
Employed 46.3 (42.6 – 50.0)  
Unemployed or not in labour force 40.1 (35.1 – 45.1) >0.05 
Private health insurance   
Yes 49.3 (45.3 – 53.3)  
No 37.9 (33.5 – 42.3) <0.001 
Annual household income (A$)   
<20,000 30.3 (23.2 – 37.4)  
$20,000 - 40,000 43.2 (36.4 – 50.0) <0.05 
>40,000 49.0 (44.9 – 53.1) <0.001 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†      Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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Table 4.11 Characteristics of people who had visited practitioners for each of the 17 forms of CAM  
Percentages (standard error) of people of visiting a practitioner for – 
Characteristic ACU CHM CTM CMDT QGMATC WHM WTM Chiropractic Osteopathy 
Gender 
         
Female 6.9 (1.09) 2.1 (0.62) 3.6 (0.81) 0.6 (0.34) 3.3 (0.77) 5.9 (1.02) 23.0 (1.81) 15.3 (1.55) 4.0 (0.84) 
Male 8.1 (1.18) 2.5 (0.67) 2.6 (0.70) 0.5 (0.32) 3.1 (0.75) 3.5 (0.80) 17.1 (1.64)* 13.8 (1.50) 3.0 (0.74) 
Age (year) 
         
18-34 6.2 (1.32) 2.6 (0.87) 3.9 (1.06) 0.2 (0.26) 5.9 (1.29) 5.7 (1.27) 26.0 (2.40) 13.7 (1.88) 2.7 (0.90) 
35-64 8.6 (1.20) 2.7 (0.69) 3.1 (0.74) 0.9 (0.39) 2.1 (0.62)** 5.0 (0.93) 20.2 (1.72) 15.1 (1.53) 4.1 (0.84) 
65+ 6.7 (1.84) 0.7 (0.61) 2.0 (1.03) 0.4 (0.47) 1.5 (0.90)** 2.2 (1.09)* 9.5 (2.16)** 14.6 (2.60) 3.1 (1.28) 
Country of birth 
         
Australia 8.1 (0.96) 2.2 (0.52) 3.2 (0.62) 0.5 (0.24) 3.7 (0.66) 4.2 (0.70) 21.1 (1.43) 16.2 (1.30) 3.7 (0.67) 
Other 5.8 (1.49) 2.6 (1.01) 3.2 (1.11) 0.9 (0.60) 1.7 (0.82) 6.8 (1.59) 17.2 (2.40) 9.5 (1.86)** 2.7 (1.04) 
Self-reported health status 
         
Excellent/very good/good 7.1 (0.85) 2.3 (0.50) 2.8 (0.55) 0.7 (0.27) 3.2 (0.58) 4.9 (0.72) 19.9 (1.33) 14.1 (1.16) 3.6 (0.62) 
Fair/poor 9.2 (2.28) 2.2 (1.14) 4.9 (1.70) 0.0 (0.00)** 2.5 (1.23) 3.9 (1.53) 20.6 (3.19) 16.5 (2.92) 3.0 (1.34) 
Post-secondary education 
         
No 4.7 (0.99) 1.5 (0.57) 2.8 (0.78) 0.4 (0.30) 1.9 (0.63) 3.3 (0.84) 12.8 (1.57) 13.4 (1.60) 2.2 (0.69) 
Yes 9.5 (1.19)** 2.9 (0.68) 3.4 (0.74) 0.7 (0.34) 4.2 (0.81)* 5.8 (0.95)* 25.7(1.78)** 15.6 (1.48) 4.5 (0.84)* 
Employment 
         
Employed 8.4 (1.06) 2.7 (0.62) 3.6 (0.71) 0.7 (0.31) 3.6 (0.71) 5.4 (0.86) 22.0 (1.58) 15.3 (1.37) 4.0 (0.74) 
Unemployed or not in labour force 5.3 (1.17) 1.5 (0.64) 2.5 (0.81) 0.4 (0.35) 2.5 (0.82) 3.8 (1.00) 16.6 (1.95)* 13.4 (1.78) 2.7 (0.85) 
Private health insurance 
         
Yes 9.3 (1.19) 2.9 (0.69) 3.6 (0.76) 0.6 (0.32) 3.2 (0.72) 4.4 (0.84) 24.9 (1.77) 17.7 (1.57) 4.9 (0.89) 
No 5.3 (1.03)** 1.5 (0.57) 2.7 (0.75) 0.6 (0.35) 3.2 (0.81) 5.2 (1.03) 14.2 (1.62)** 10.6 (1.43)** 1.7 (0.60)** 
Annual household income (A$) 
         
<20,000 4.4 (1.64) 1.0 (0.80) 1.5 (0.95) 1.5 (0.97) 3.0 (1.36) 4.3 (1.61) 9.3 (2.30) 6.3 (1.93) 4.3 (1.61) 
$20,000 - 40,000 6.3 (1.69) 2.9 (1.18) 3.2 (1.23) 0.4 (0.45) 3.3 (1.25) 7.2 (1.80) 15.1 (2.50) 17.2 (2.64)** 0.9 (0.65)* 
>40,000 8.7 (1.19)* 2.1 (0.60) 3.7 (0.79) 0.4 (0.26) 3.0 (0.72) 4.6 (0.88) 26.2 (1.85)** 17.3 (1.59)** 4.7 (0.89) 
Note 1: probability of proportion being significantly different from the first value in each demographic category (Z test) * p<0.05, ** p<0.01; Note 2: significance 
levels were adjusted to allow for multiple comparisons; Note3: CHM: Chinese herbal medicine; CTM: Chinese therapeutic massage; CMDT: Chinese medicine dietary 
therapy; QGMATC: Qigong, Martial art and Tai Chi; WHM: Western herbal medicine, WTM: Western therapeutic massage. 
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Table 4.11 Socio-demographic characteristics and visits to practitioners of each of the 17 forms of CAM (continued) 
 
Percentages (standard error) of people of visiting a practitioner for – 
Characteristic 
Homeopathy Naturopathy Meditation Aromatherapy Clinical nutrition Energy healing Reflexology Yoga 
Gender         
Female 3.9 (0.83) 9.0 (1.23) 3.8 (0.82) 4.5 (0.89) 10.1 (1.30) 4.6 (0.91) 2.6 (0.69) 9.2 (1.25) 
Male 1.9 (0.59)* 2.9 (0.73)** 4.5 (0.90) 1.7 (0.56)** 4.9 (0.94)** 1.8 (0.58)** 1.6 (0.55) 4.4 (0.90)** 
Age (year) 
        
18-34 2.1 (0.78) 6.2 (1.32) 6.3 (1.34) 4.3 (1.11) 9.7 (1.62) 4.5 (1.13) 3.2 (0.97) 12.5 (1.81) 
35-64 3.5 (0.78) 6.5 (1.05) 3.5 (0.79) 3.5 (0.78) 6.5 (1.06) 3.3 (0.76) 1.8 (0.57) 4.4 (0.88)** 
65+ 2.6 (1.17) 4.0 (1.44) 2.0 (1.04)* 0.0 (0.00)** 6.5 (1.81) 1.1 (0.77)* 1.1 (0.77) 4.1 (1.46)** 
Country of birth 
        
Australia 2.4 (0.53) 5.6 (0.81) 4.5 (0.73) 3.0 (0.60) 7.4 (0.92) 3.0 (0.60) 1.5 (0.43) 6.4 (0.86) 
Overseas 3.8 (1.21) 7.3 (1.65) 3.1 (1.10) 3.5 (1.17) 7.1 (1.63) 4.1 (1.26) 4.2 (1.27)* 8.4 (1.76) 
Self-reported health status 
        
Excellent/very good/good 2.7 (0.54) 6.0 (0.79) 4.2 (0.67) 3.4 (0.60) 6.8 (0.84) 2.9 (0.56) 2.2 (0.49) 7.8 (0.89) 
Fair/poor 4.0 (1.55) 5.7 (1.82) 4.0 (1.54) 1.7 (1.01) 11.5 (2.51) 4.4 (1.61) 0.8 (0.72) 1.1 (0.83)** 
Post-secondary education 
        
No 1.9 (0.64) 4.8 (1.01) 2.6 (0.75) 2.4 (0.71) 6.0 (1.12) 2.1 (0.68) 1.2 (0.52) 4.0 (0.92) 
Yes 3.7 (0.76) 6.8 (1.03) 5.4 (0.92)* 3.7 (0.77) 8.7 (1.14) 4.1 (0.81) 2.8 (0.67) 9.0 (1.17)** 
Employment 
        
Employed 3.1 (0.66) 7.2 (0.99) 4.5 (0.79) 3.4 (0.69) 8.8 (1.08) 3.2 (0.67) 2.3 (0.57) 7.4 (1.00) 
Unemployed or not in labour force 2.6 (0.83) 3.8 (1.00)* 2.5 (0.82) 2.5 (0.81) 5.4 (1.18)* 3.5 (0.97) 1.8 (0.70) 6.1 (1.25) 
Private health insurance 
        
Yes 3.3 (0.74) 6.7 (1.02) 4.0 (0.81) 3.4 (0.75) 8.8 (1.16) 3.4 (0.74) 2.4 (0.62) 7.8 (1.10) 
No 2.1 (0.67) 4.9 (1.00) 4.4 (0.95) 2.7 (0.76) 5.8 (1.08) 3.1 (0.81) 1.8 (0.62) 5.7 (1.07) 
Annual household income (A$) 
        
<20,000 2.5 (1.23) 2.3 (1.19) 3.0 (1.34) 2.4 (1.22) 5.4 (1.79) 3.3 (1.42) 0.0 (0.00) 2.7 (1.30) 
$20,000 - 40,000 3.3 (1.24) 6.8 (1.75)* 3.0 (1.19) 2.2 (1.02) 7.7 (1.87) 4.0 (1.36) 3.0 (1.20)* 5.1 (1.54) 
>40,000 2.7 (0.68) 6.4 (1.03)** 5.4 (0.95) 4.1 (0.83) 7.0 (1.07) 3.4 (0.76) 2.4 (0.65)** 9.2 (1.22)** 
Note 1: probability of proportion being significantly different from the first value in each demographic category (Z test) * p<0.05, ** p<0.01 
Note 2: significance levels were adjusted to allow for multiple comparisons 
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4.1.6 Use of Other Forms of CAM 
 
4.1.6.1 Prayer 
 
In addition to the 17 major forms of CAM investigated, participants were asked about their 
use of prayer and “other forms of CAM not mentioned elsewhere in the survey”. In total, one 
in five (20.8%, 95%CI: 18.4% – 23.2%) surveyed participants had prayed in the 12 months 
prior to the survey. Of these, over a quarter (25.7%, 95%CI: 20.0% – 31.4%) had visited a 
prayer practitioner, such as a priest, in the 12-month period. A proportion of participants also 
mentioned that they prayed or visited a professional to pray for their health or someone else’s 
health. Detailed percentages of such use, however, were not recorded. 
 
Presented in Table 4.12 is the demographic information related to prayer users and people 
who had visited a practitioner for the purpose of praying. Importantly, the answers recorded 
on prayer did not differentiate between “prayer for personal health purposes” and “prayer for 
religious purposes”. The latter is not normally regarded as complementary or alternative 
health care. 
 
As opposed to the overall use of the 17 specific forms of CAM, the proportion (26.7%) of 
adults aged 65 or older who had prayed for any reason was much higher than the proportion 
among younger adults aged 18-34 (17.9%, p<0.05) who had prayed. It is interesting to note 
that a statistically significant difference was found between those having a lower household 
income (less than $20,000, with a prevalence of 26.7%) and those having a relatively high 
household income (more than $40,000, with a prevalence of 17.2%, p<0.05). 
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Table 4.12 Socio-demographic characteristics on users of prayer 
Prayer 
Visited prayer 
practitioner 
  
Characteristic* 
% (SE %) P value† % (SE %) p value† 
Gender       
Female 25.3 (1.87)  6.1 (1.03)  
Male 16.1 (1.60) <0.001 4.5 (0.90) >0.05 
Age (year)     
18-34 17.9 (2.10)  3.7 (1.04)  
35-64 20.2 (1.72) >0.05 5.4 (0.97) >0.05 
65+ 26.7 (3.26) <0.05 7.4 (1.93) >0.05 
Country of Birth     
Australia 20.1 (1.41)  5.3 (0.79)  
Non-Australia 21.9 (2.62) >0.05 4.7 (1.35) >0.05 
Region      
New South Wales 19.2 (2.08)  4.9 (1.14)  
Victoria 22.3 (2.54) >0.05 6.3 (1.48) >0.05 
Queensland 23.4 (2.95) >0.05 6.7 (1.73) >0.05 
South Australia 19.6 (4.36) >0.05 5.3 (2.46) >0.05 
Western Australia 15.7 (3.54) >0.05 2.9 (1.65) >0.05 
Self-reported health status     
Excellent/very good/good 19.5 (1.32)  5.0 (0.73)  
Fair/poor 27.9 (3.53) <0.05 6.9 (2.00) >0.05 
Post-secondary education     
No 18.3 (1.81)  4.2 (0.94)  
Yes 22.6 (1.70) >0.05 6.2 (0.98) >0.05 
Employment     
Employed 19.4 (1.51)  5.4 (0.86)  
Unemployed or not in labour force 24.0 (2.24) >0.05 5.4 (1.18) >0.05 
Private health insurance     
Yes 20.1 (1.64)  6.5 (1.01)  
No 20.9 (1.88) >0.05 3.7 (0.87) <0.05 
Annual household income     
<A$20,000 26.7 (3.51)  4.7 (1.68)  
A$20,000-A$40,000 22.8 (2.93) >0.05 5.6 (1.61) >0.05 
>A$40,000 17.2 (1.59) <0.05 5.3 (0.94) >0.05 
SE:  standard error 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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4.1.6.2 Other Forms of CAM 
Among all survey participants, less than 5% mentioned the use of forms of other CAM than 
the 17 named forms of CAM or prayer. Only three participants mentioned that they used other 
forms of CAM but did not use any of the 17 named CAM therapies or prayer. Diverse answers 
were provided and none of these therapies had a prevalence of higher than 2% among all 
participants (Table 4.13). 
 
Table 4.13 The use of other forms of CAM 
Used in Past 12 Months 
Type of CAM 
Original (N) Weighted (%) RSE (%)* 
Other forms of relaxation techniques† 13 1.24 27.3 
kinesiology 6 0.60 39.5 
Iridology 4 0.36 51.0 
Bowen technique 4 0.33 53.2 
Bioelectromagnetic-based therapies 3 0.32 54.2 
Shiatsu 3 0.25 60.6 
Exercise 2 0.22 64.8 
Cranio sacral therapy 2 0.17 75.0 
Indigenous and aboriginal medicine 2 0.16 76.8 
Hypnotherapy 2 0.15 80.2 
Ayuveda 1 0.07 119.4 
Colonic irrigation 1 0.12 88.2 
Ear candling 1 0.11 91.5 
Hot bath 1 0.07 113.0 
Juice therapy 1 0.08 105.5 
Level three reconnection therapy 1 0.07 116.1 
Silver clove 1 0.08 105.1 
Tae Bo 1 0.07 113.6 
Other†† 5 0.44 46.0 
Total other CAM other than the 17 major 
CAM and prayer 51 4.6 14.0 
*  RSE: relative standard error = (standard error /estimated prevalence)*100; a relative 
standard error >25% indicates that result should be interpreted with caution 
†  Examples include Pilates and weight-loss exercise 
†† Participants did not remember the actual name of the CAM or had stated other forms of 
CAM, but the interviewers were not able to record the names. 
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4.1.7 Economic Considerations of CAM Use  
 
4.1.7.1 Overview 
CAM users were asked about their “out-of-pocket” annual expenditure on CAM (products, 
practitioner visits and other related items). Thirty-five CAM users, who did not respond to one 
or more of the three questions on expenditure, were excluded from the expenditure analysis. 
The crude expenditure estimations on CAM were skewed toward the lower values (Figure 4.2, 
raw data). The maximum expenditure reported by CAM users was $10,000, either on CAM 
products or on CAM practitioners, and $6,000 on other related CAM. Some of the high 
amounts (e.g. $5,000 spent on visiting CAM practitioners) were recorded by interviewers and 
verified by the researchers during the CATI telephone interviews. Such values may be 
considered as the actual expenditure of the users. However, when examining the raw data, a 
total of 95% users provided an amount of less than $1,500 (see Appendix G4-G6 for the 
original data and G7 for a statistical summary). Thus, there is a need to adjust for the average 
expenditure among all CAM users, in order to extrapolate these values to a national level. 
 
Figure 4.2 Frequency distribution of CAM expenditure data 
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Since the expenditure reported by a small number of participants appeared to be 
extraordinarily high, in an attempt to exclude aberrant values in total expenditure estimates, 
those extremely high values (e.g. in general, a value that is higher than the mean±2SD can be 
considered as a potential outlier) and the same numbers of the lowest value were excluded. To 
be consistent, these numbers, corresponding approximately to 2.5 % of the highest and the 
lowest expenditure values were ignored. (presented as adjusted means below). 
 
Using this correction, the estimated annual expenditure by survey participants on CAM 
products, CAM practitioners and other CAM-related items is summarised in Table 4.14. Thus, 
based on a total of 15.5 million adult Australians in 2005, together with the estimated CAM 
prevalence arising from the survey, the Australian national extrapolated total expenditure in 
the 12 months preceding the survey is estimated as A$4.13 billion (Table 4.14) (see Appendix 
G8 for the detailed statistics). On the other hand, as mentioned above, it was estimated that 
adult Australians had made a total of 69.15 million CAM practitioner visits (see Chapter 
4.1.5.2). This suggests that the average out-of-pocket expenditure to CAM practitioner visits 
is estimated at A$25 per visit (i.e. A$1.73 billion divided by 69.15 million visits). 
 
Table 4.14 National out-of-pocket expenditure on CAM 
Expenditure by survey 
participants 
CAM products 
(65.8%)* 
CAM 
practitioners 
(42.3%)* 
Other items 
related to CAM 
(16.3%)* 
Adjusted mean (SE)† 182.3 (9.3) 263.6 (15.4) 212.3 (23.6) 
95% CI 164-200 233-294 166-259 
Median 100 150 100 
Range 0-1400 0-2000 12-2000 
Estimated national expenditure# 1.86 billion 1.73 billion 0.54 billion 
*  % of participants that provided estimates 
†
  Lowest and highest 2.5% of estimates ignored (see text) 
#
  Based on an adult Australian population of 15.5 million 
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4.1.7.2 Regional Differences in CAM Expenditure 
 
While CAM prevalence and the prevalence of visiting CAM practitioners in each state in 
Australia varied considerably, it is also of interest to compare the average expenditure in 
different regions. Presented in Table 4.15 are adjusted means expenditure for CAM products, 
CAM practitioners and CAM-related items (weighted), as well as state estimations based on 
the corresponding state population. 
 
Table 4.15 Regional differences of out-of-pocket expenditure on CAM 
 State expenditure (A$) 
Products NSW VIC QLD SA WA 
Adjusted mean 186.7 172.7 187.1 187.4 163.2 
SE 16.2 18.7 19.8 33.5 28.6 
State estimation (million) 664.0 449.4 382.6 128.2 150.9 
Test for significant difference via ANOVA:  F (4, 638)=0.20, p=0.938 
Practitioners NSW VIC QLD SA WA 
Adjusted mean 285.9 258.6 281.1 204.1 200.3 
SE 27.5 28.9 39.9 39.0 38.8 
State estimation (million) 644.9 449.2 344.7 106.8 121.7 
Test for significant difference via ANOVA:  F (4, 410)=0.952, p=0.434 
Other items related to CAM NSW VIC QLD SA WA 
Adjusted mean 211.1 176.0 321.4 235.9 171.3 
SE 26.1 45.3 90.2 83.5 51.8 
State estimation (million) 181.5 122.7 111.0 52.5 48.0 
Test for significant difference via ANOVA:  F (4, 156)=0.964, p=0.429 
SE: standard error; NSW: New South Wales; VIC: Victoria; QLD: Queensland; SA: South 
Australia; WA: Western Australia.
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For CAM products, it appeared that the average expenditure per user in each state is similar 
(ANOVA, F (4, 638)=0.20, p>0.05). In addition, the average amount spent on CAM products 
in most states is similar to the national expenditure level (A$182.3), although Western 
Australia users reported a relatively lower average expenditure (A$163.2). 
 
On average, South Australia and Western Australia users appeared to spend less on visiting 
CAM practitioners than the estimated national average (approximately A$60 less per person 
per year), although, again, the differences between states were not found to be statistically 
significant (ANOVA, F (4,410)=0.952, p>0.05). 
 
A much bigger variation (although not significantly different, ANOVA, F (4, 156)=0.964, 
p>0.05) was found between the costs related to CAM use, such as books, equipment and 
classes. That is, New South Wales and South Australia users had similar costs to the national 
average; Queensland users had a higher cost, whereas the costs estimated by Victoria and 
Western Australia users appeared to be relatively low (Table 4.15). 
 
In all, at least one third (36.1%) of the total CAM costs in Australia was spent in New South 
Wales, a further quarter (24.7%) was spent in Victoria, 20.3% in Queensland, 7.0% in South 
Australia, 7.8% in Western Australia, and only approximately 4.2% was spent in the 
remaining states and territories. Rather than the proportions distributed to each state for total 
CAM costs, individual state expenditure on the costs of each of the CAM products, CAM 
practitioners or other related CAM items also had similar distributions. For example, at least 
one third (35.7%) of the total national costs on CAM products was spent in New South Wales, 
and approximately a quarter (24.2%) was spent in Victoria (Table 4.15). 
  
139 
4.2 Discussion 
4.2.1 Prevalence of CAM Use 
4.2.1.1 Comparison with Other Australian Studies 
 
Perhaps the most important finding of the present study is that the prevalence of CAM use in 
Australia is considerably higher than previously estimated. The current study indicates that 
68.9% of the Australian population are CAM users, whereas the figure usually quoted is 
52.2%.11 The previous estimate is, in fact, an extrapolation from the findings of a survey 
conducted within a single Australian state, South Australia, in 2004.11 Although the types of 
CAM included in this national study were not identical to those in the previous regional study, 
it is probable that regional differences account for the higher national estimate of CAM use. 
Unfortunately, within the national quota, the regional quotas were insufficient to demonstrate 
what might be real differences in the prevalence of CAM use between Australian states. The 
current study suggests that only 60.8% of the South Australian cohort were CAM users, 
whereas for the most populous state, New South Wales, the prevalence of use was 72.1%, and 
only slightly lower in Queensland (71.0%) and Victoria (69.8%). However, as noted above, 
statistically significant differences between these regional figures were not demonstrated in 
the current study. 
 
The findings of the high prevalence of CAM use in several defined states are consistent with 
previous small-scale regional studies, which were based on randomly selected participants in 
New South Wales. It was suggested that between 67% and 70.3% of participants used CAM 
during a 12-month period.37,38 In line with the current global trend of an increase in the use of 
CAM over the past decade, the relatively higher prevalence of CAM use as estimated in the 
present study appears accurate. 
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It is worth noting that CAM modalities investigated in the current and previous studies varied 
greatly. Thus, comparisons of the prevalence of individual forms of CAM can only be made 
with limited forms of CAM. In addition, the previous surveys were conducted in the states of 
South Australia and New South Wales. Thus, state and national prevalence of CAM use in the 
current survey are presented (Table 4.16). 
 
Table 4.16 Comparison of CAM prevalence with previous Australian surveys 
Current survey prevalence Regional survey prevalence  
CAM National NSW SA NSW 9538 NSW 9937 SA 0411 
Overall 68.9% 72.1% 60.8% 67.0% 70.3% 52.2% 
Clinical nutrition* 45.8% 47.3% 43.6% 57.0%† 68.7% 39.2%** 
Herbal medicine# 19.8% 20.3% 14.2% 32.0%†† … 20.6% 
Chiropractic 16.1% 17.0% 17.0% … 26.1% … 
Massage therapy# 28.8% 28.7% 25.3% … 25.1% … 
Homeopathy 6.0% 5.0% 8.9% 3.0-8.0%‡ … 2.2% 
Aromatherapy 16.1% 13.8% 10.0% … … 11.2%‡‡ 
Soy products … … … … … 3.8% 
Chinese medicine 19.3% 17.1% 17.2% … …# # 2.3% 
NSW: New South Wales; SA: South Australia 
…  Indicates prevalence was not provided in that survey 
*   Including multivitamins and mineral supplements 
#   Includes different forms of massage therapy or herbal medicine 
**  Prevalence was for vitamins only; the prevalence for mineral supplement was 13.6%, 
combined prevalence was not presented in the article. 
†   Includes 18 different nutritional items 
††  Western herbal medicine only; total herbal medicine was 33.0% 
‡   General homeopathies, 3%, when including other homeopathic remedies, 8.0% 
‡‡  Refers to aromatherapy oil 
##  Categories of acupuncture and Chinese medicine were used in the survey, details did 
not present. 
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In general, previous regional surveys appear to show a higher individual prevalence of CAM 
use. For example, the use of clinical nutrition in New South Wales, estimated in the current 
survey, was 47.3%, while the prevalence in the 199538 and 199937 New South Wales surveys 
was higher. However, these regional surveys included a broader range of vitamins and 
minerals, whereas the current survey specified multivitamins and minerals, rather than daily 
consumer vitamin (e.g. vitamin A prescribed by a medical doctor). On the other hand, the 
39.2% of vitamin prevalence in South Australia was estimated separately from mineral 
supplements use (13.6%).11 The combined prevalence is considered no less than the South 
Australia prevalence as estimated in the current study (43.6%). Similarly, the previously 
estimated prevalence of chiropractic and herbal medicine in New South Wales37,38 and the 
prevalence of herbal medicine in South Australia11 were also higher than the current estimated 
prevalence in each of these corresponding states (Table 4.16). 
 
The prevalence of massage therapy use in New South Wales37,38 and aromatherapy use in 
South Australia11 were similar to estimations in the current survey. However, a great variation 
in the prevalence of homeopathy has been reported. The New South Wales prevalence (5.0%) 
estimated in the current survey was within the broad range of that from the New South Wales 
survey in 1995 (3.0%-8.0%).38 However, a significantly lower prevalence was estimated in 
South Australia (2.2% in 2004), 11 compared to the current estimation for the state of South 
Australia (8.9%). These are in contrast to the abovementioned regional differences in the 
prevalence of individual forms of CAM, where the prevalence of homeopathy in South 
Australia, as estimated in the current survey was highest, compared to any other state or 
territory of Australia. Furthermore, after examining the South Australia surveys in 1993,9 
200010 and 2004,11 it is very surprising that the prevalence of homeopathy decreased 
substantially from 4.4% in 1993, and 4.3% in 2000 to the most recent estimate of 2.2% in 
2004. The large discrepancy in estimated homeopathy use requires further investigation. 
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Variations in the prevalence of CAM practitioner visits between Australian states were 
somewhat less than variations in the overall prevalence of CAM use. Based on the current 
findings, the proportion of the Australian adults that consulted at least one CAM practitioner 
over a 12-month period was 44.1%. This is again much higher than the prevalence of CAM 
practitioner visits estimated in the 2004 South Australian study (26.5%).11 Again, regional 
differences may, at least in part, explain the difference, although, it is also likely that different 
CAM modalities in the two studies are a factor. For example, importantly, massage therapy 
was not included in any one of the recent South Australian CAM surveys,9-11 whereas a 
substantial proportion of the current survey participants had visited massage therapists. 
 
Figure 4.3 presents the prevalence of visits to practitioners of eight individual forms of CAM, 
that were estimated by the 2004 South Australia survey,11 by the current survey for the State 
of South Australia, and by the current survey for the whole nation. As noted above, the current 
survey provides a higher overall prevalence of CAM practitioner visits in South Australia, 
compared to the estimated prevalence in previous South Australia surveys; this seems to be 
the same for visits to practitioners of most individual forms of CAM, except naturopaths, 
herbal therapists, reflexologists and chiropractors.  
 
For visits to reflexologists and chiropractors, the South Australia estimates and the current 
survey estimates for South Australia were similar. Surprisingly, based on the current survey, 
none of the herbal medicine users from South Australia had visited practitioners; and the 
South Australia survey estimated that only 1.9% had visited such practitioners.11 A low 
prevalence of visiting herbal medicine practitioners was also observed in both studies. It is 
also important to note the limitations of the current study in drawing conclusions at a state 
level. In particular, the relatively small number of interviews that were conducted in South 
Australia. 
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Overall CAMP: visits to any one type of CAM practitioners 
SA: South Australia 
Figure 4.3 Prevalence of visits to CAM practitioners in the current survey and a recent 
South Australia survey 
 
 
The prevalence of visits to naturopaths estimated by the South Australia survey11 (5.7%) was 
much higher than the current survey estimate for South Australian adults (1.3%) but was 
similar to the national estimation (5.9%). In the 2004 South Australia study,11 however, a 
prevalence of 5.7% was estimated for visits to a naturopath or a natural therapist. The 
definition of natural therapist is generally broader than the definition of a defined naturopath, 
and may have contributed to the different finding. 
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4.2.1.2 Comparison with Overseas Studies 
 
It is of interest to compare the current estimated prevalence of CAM use in Australia with the 
most recent estimates for the United States (62%),1 Canada (50%),6 the United Kingdom 
(28.3%)5 and Japan (76.0%).7 The data were collected through the computer-assisted 
telephone interview (CATI) method, with the exceptions of the US data, which were through 
computer-assisted personal interview (CAPI), and the UK data, which were through postal 
questionnaire. Detailed data collection methods were discussed in Chapter 2.3.2.2. 
 
The comparisons of CAM as a whole among these countries would be less meaningful 
without the recognition of the limitations of different forms of CAM being included in these 
surveys. For example, the 62% CAM prevalence as estimated in the 2002 US survey included 
prayer specifically for health reasons.1 When prayer for health reasons was excluded from the 
definition of CAM, only 36% of US adults used CAM in the past 12 months, which is lower 
than a 1997 US survey conducted by the Harvard Medical School (42.1%).3 
 
The 1998 UK study found a 28.3% CAM prevalence.5 However, the definition of CAM in this 
study included only eight forms of CAM. The number of CAM investigated was markedly 
less than the number investigated by most CAM surveys in other countries. In addition, in this 
UK study, except for over-the-counter homeopathic remedies and herbal remedies, the 
prevalence of other CAM was based on visits to practitioners rather than actual CAM use. 
These may have impacted considerably on the overall prevalence of CAM use in the UK. 
Surprisingly, a more recent survey conducted by the same group of researchers in 2001 found 
that only an estimated 10.0% of the UK population had received any one of the 23 forms of 
CAM from practitioners in the past 12 months.16 Again, this prevalence was for practitioner 
visits only; the overall prevalence of CAM use in the UK remains unclear. 
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With respect to the prevalence of specific forms of CAM, this would be clear only if 
comparisons were made with several common forms of CAM. Again, as noted above, this is 
due to the names and classifications of individual forms of CAM varying between different 
surveys in different countries and even within a country. For example, the modality of herbal 
medicine was not singled out in a recent US survey in 2002, thus creating a difficulty in 
making comparisons with other studies.1 Nevertheless, presented in Table 4.17 are the 
common CAM modalities that were investigated in the current survey, the 1997 and 2002 US 
surveys,1,3 the 1998 UK survey,5 the 1999 Canadian survey6 and the 2001 Japanese survey.7 
 
A high prevalence of the use of herbal medicine, massage therapy and chiropractic was 
observed in the current survey, the 1997 US survey and the 1999 Canadian survey. A 
minimum of 11% of the adult population of these countries had used these therapies during a 
12-month period. On the other hand, with the exception of the extremely popular use of 
homeopathy as estimated in the UK in 1998 (8.6%), for most individual forms of CAM, its 
use among Australians was more prevalent than most other countries. 
 
Existing evidence indicates that the practice of, and training in, acupuncture is common in the 
US and the UK. For example, it has been estimated that over 10,000 non-physician 
acupuncturists and nearly 3,000 physicians practised acupuncture in the US in 1998.150 In 
addition, according to the Accreditation Commission for Acupuncture and Oriental Medicine, 
a national accrediting agency recognized by the U.S. Department of Education, there were 
over 50 schools and colleges of acupuncture with accredited or candidacy status.151 However, 
it is surprising to find out that less than 2% of adults from the US and the UK had used 
acupuncture, whereas nearly 10% of Australians had done so. In all, the biggest distinction 
between the prevalence of CAM use in Australia and other countries is in the use of 
acupuncture, aromatherapy and naturopathy. 
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Table 4.17 Comparison of CAM prevalence with selected overseas CAM surveys 
Prevalence (%) 
CAM 
AUS 05* US 021 US 973 UK 985 CAN 975 JPN 017 
Acupuncture 9.2 1.1 1.0 1.6‡ … 6.7 
Chiropractic 16.1 7.5 11.0 3.6‡ 13.0 7.1‡‡ 
Massage therapy 28.8** 5.0 11.1 … 12.0 14.8 
Osteopathy 4.6 … … 4.3‡ … 7.1‡‡ 
Reflexology 4.1 … … 2.4‡ … … 
Herbal medicine 19.8** …*** 12.1 19.8 12.0 17.2 
Homeopathy 6.0 1.7 3.4 8.6 4.0 0.3 
Aromatherapy 16.1 … 5.6†† 3.5‡ 5.0 9.3 
Naturopathy 10.7 0.2 0.7†† … … … 
Any CAM 68.9 62.0† 42.1 28.3 50.0 76.0 
AUS: Australia; US: United States; UK: United Kingdom; JPN: Japan; CAN: Canada. 
…  Indicates prevalence was not provided in that survey 
*   Refers to the current survey that conducted in 2005 
**  Prevalence includes different forms of massage therapy or herbal medicine 
*** The category of “non-vitamin, non-mineral, natural products” included common herbal 
medicine, such as Ginseng and Ginkgo biloba. The total prevalence was 18.9%. 
†   Prevalence included prayer specifically for health reasons. 
††  Use of these CAM was not part of the total 42.1% CAM prevalence. 
‡   Prevalence was visits to practitioners for named CAM therapy rather than the actual 
use. Use of each of the CAM therapies was not estimated in any UK study. 
‡‡  A combined prevalence of chiropractic and osteopathy was estimated (total, 7.1%) 
 
 
Anecdotally, aromatherapy and naturopathy are commonly practiced in Australia. Thus, the 
current survey estimated that nearly one in six Australians had used aromatherapy in the 12 
months preceding the survey. The high prevalence was also estimated in an Australian 
regional study.11 On the other hand, only approximately 5% of Canadians and Americans 
reported the use of aromatherapy.3,5 Surprisingly, in the 1997 US study the use of 
aromatherapy was not counted toward the total CAM prevalence.3 Efforts to ensure the CAM 
modalities were comparable to a previous 1990 study conducted by the same group of 
researchers seemed to be the main rationale for excluding additional, newly investigated 
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therapies in 1997.2,3 Thus, the total estimated CAM prevalence would be higher in the US if 
the CAM definition included aromatherapy and naturopathy. 
 
It is also of interest to compare the findings arising from the current survey with data for 
Japan. The prevalence of overall CAM use in Japan is much higher than most countries, 
including Australia (Table 4.17). It is not surprising that some forms of CAM, including 
Kampo and acupuncture, are widely accepted in Japan.7 For example, in addition to the 17.2% 
adults who used herbs or over-the-counter (OTC) Kampo (Table 4.17), 10% of adults also 
used ethical Kampo and nearly half (43.1%) of Japanese adults used a dietary supplement. 
However, the use of other individual forms of CAM was relatively lower in Japan than in 
Australia. Thus, despite the overwhelming number of licensed acupuncturists in Japan 
(113,000 in 2001),152 the total prevalence of using acupuncture and moxibustion in 2001 was 
only 6.7%, which was lower than the Australian prevalence (9.2%) in 2005. 
 
The findings of the current study provide strong evidence that complementary and alternative 
medicine forms an integral part of Australia’s health care system. The popularity of CAM in 
Australia is not only evidenced by the high prevalence of common forms of CAM, such as 
chiropractic and acupuncture. But also by forms of CAM that are not common in other 
countries, such as aromatherapy and naturopathy. Concerning the efficacy and safety of use, 
further rigorous research in the CAM field in Australia is necessary and critical. 
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4.2.2 Characteristics of CAM Users 
 
Most commonly, survey studies on CAM prevalence have also investigated the use of CAM 
by different socio-demographic groups. Common characteristics related to a higher prevalence 
of CAM, such as age, educational background, and income range were first reported in a 1990 
US study.2 The current study suggests a higher prevalence of CAM use by females, by the 
better educated, by those with higher incomes, by those in employment, and by those with 
private health insurance cover. These findings are generally consistent with reports of similar 
studies from other countries1,3 and those of previous Australian studies.10,11 However, in terms 
of age difference, the current survey found the highest prevalence was among the youngest 
adults (18-34 years old), rather than by middle-aged adults. Some findings in regard to the 
characteristics of users may differ between studies. For example, the gender differential in the 
use of CAM was not observed in two US studies2,46 and a recent UK study.16  
 
It is of interest to examine the ethnicity of CAM users, as the conclusion drawn from a large 
population survey suggested that the use of different CAM modalities for treatment versus 
illness varied across race and ethnicity categories.153 Although differences in CAM use 
between Australian residents born in different countries were not explored, or between those 
in different ethnic groups, the findings indicate that, in general, individuals who were not born 
in Australia were less likely to visit a CAM practitioner than those born in Australia. This 
finding was similar to the 2004 South Australian study, which found that Australian-born 
residents had used CAM more than those born elsewhere.11  
 
The difference of CAM use among different ethnic groups was also commonly reported in the 
US surveys. However, the findings were somewhat contradictory between studies. For 
example, both of the Harvard surveys2,3 found the use of CAM was significantly less common 
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among African Americans (defined as black adults) than among members of other racial 
groups. However, a more recently published article suggested that black adults were more 
likely to use CAM overall, when the definition of CAM included prayer specifically for health 
purposes. The authors further revealed that the high prevalence among black adults was 
mainly in the use of the mind-body therapies, including prayer, whereas the use of biological-
based therapies, such as multivitamins, was less common.1 
 
Limited CAM surveys have also explored the association between the use of CAM and users’ 
status of health insurance coverage. Again, commonly, people with private health insurance 
were more likely to use CAM.1,4 This finding is not surprising. However, detailed information 
on what forms of CAM people with private health insurance were more likely to use was 
limited. The current survey has also confirmed high use among those with private health 
insurance. In addition, the current survey revealed that the common forms of CAM that 
participants had used, such as chiropractic, acupuncture and remedial massage were usually 
covered by private health insurance. Thus, for those who were less commonly covered by 
private health insurance, for CAM such as aromatherapy, a significant variation of prevalence 
between people with and without private health insurance was not observed. In this case, 
aromatherapy used by those without private health insurance was even higher than the use 
among those with insurance coverage. 
 
In terms of regional differences within countries, the trend is obvious that American people 
who reside in the West of the country are much more likely to use CAM than residents from 
other regions.1-4 In addition, in the UK, a relatively high prevalence was found in the 
Midlands and East Anglia, while in the North of England it was lower.16 In Canada, the 
highest rate was reported in British Columbia and Alberta.45,48In Australia, potential regional 
differences had not been investigated in the past, as each of the previous surveys was 
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conducted in a single state. Thus, the current survey suggests that there are marked regional 
differences within Australia. The CAM prevalence on the East coast, including New South 
Wales, Victoria and Queensland was considerably higher than other states/territories.  
 
Another frequently reported characteristic associated with CAM use is the health status of the 
participants, either self-rated general health or some specific health conditions. Commonly, 
people with chronic health conditions are more likely to use CAM.45 More specifically, people 
with conditions such as back pain, allergy and fatigue are frequently found to be associated 
with a high prevalence of CAM use.3,46 In the current survey, overall CAM prevalence 
between people with relatively poor health and those in better health was less significant. 
However, for certain forms of CAM, such as acupuncture, chiropractic and energy healing, 
people in poor health were more likely to have used these therapies. Unfortunately, detailed 
health conditions associated with specific forms of CAM use in Australia’s general population 
were not collected in the current survey, nor in any previous surveys in Australia.  
 
In summary, the common characteristics associated with CAM use in Australia are reasonably 
consistent with the literature in other countries. The current survey better comprehends these 
general findings in the Australia health context, notably in the regional differences and the 
status of health insurance and CAM use among adult Australians. 
.
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4.2.3 Economic Considerations of CAM Use 
 
The Australian Government’s Department of Health and Ageing estimates that the average 
number of services provided per patient by medical practitioners in the year ending June 30, 
2005 was 5.5.154 The estimate from the current study is similar, being 5.53 visits over a 12-
month period. For an adult population of 15.5 million (with an estimated 80.8% of them 
visiting medical practitioners), taking the average number of visits to a medical practitioner 
per annum as 5.5, the total number of consultations by the adult Australian population in a 12- 
month period can be estimated as 68.9 million. Again, this figure is similar to the current 
estimate of the total number of visits to CAM practitioners over a 12-month period (69.2 
million). The similar number of practitioner visits for conventional medical services and 
CAM services is all the more surprising considering that generally, most of the cost of CAM 
practitioner visits would be borne by users, whereas medical practitioner consultations are 
subsidised by the national health system. 
 
The Australian Institute of Health and Welfare (AIHW) estimated that, between 2003 and 
2004, “out-of-pocket” expenditure by Australians on all over-the-counter health care products 
not subsidised by the national Pharmaceutical Benefits Scheme (PBS) was A$4.05 billion.155 
It is of interest to compare this figure with the current estimate of A$1.86 billion spent by 
Australians on CAM products in the 12-month period. It appears that the annual national 
expenditure on CAM products accounts for almost half the expenditure on non-subsidised 
health care products. With regard to practitioner services, the AIHW estimated that 
Australians spent over A$1.6 billion on medical services. The current findings indicate that 
they spend a similar amount (A$1.73 billion) on CAM practitioner visits.
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It is of interest to note the CAM expenditure estimated in two South Australia studies.10,11 
One, conducted in 2000, estimated that over A$2.3 billion would had been spent by the all 
Australians, whereas another, more recent, South Australia study in 2004 estimated that the 
cost of CAM had decreased to A$1.8 billion. The adverse publicity of the Pan Pharmaceutical 
crisis in 2003 could have contributed to the decline of the cost, as researchers have 
mentioned.11 In contrast, the current survey estimated a much higher CAM cost incurred by 
Australians, based on the responses from participants nationwide in 2005. It was estimated 
that the national expenditure on CAM was 4.13 billion per annum. This was higher than that 
any previous Australian studies. The amount included additional expenditure related to CAM 
use, such as books and audio-visual materials (A$0.54 billion); this category was not included 
in any of the previous Australian regional surveys. Whether the current estimation better 
reflects current utilisation in Australia would need to be confirmed in a future well-designed 
follow-up study with a consistent research protocol. 
 
It is also worth noting that the mean expenditure on CAM practitioners was relatively low in 
South Australia and Western Australia, compared to the mean expenditure in New South 
Wales, Queensland and Victoria and to the national average. Although not statistically 
significant, the variations were notable. For example, the mean expenditure among South 
Australian adults was A$80 less than the amount spent by New South Wales adults (A$204.1 
and A$285.9, respectively) and about A$60 less than the national average (A$263.6). The 
average expenditure spent on CAM products in different states was reasonably comparable. 
As noted, the current survey suggests a lower CAM prevalence in the state of South Australia 
as well as a lower mean expenditure on CAM in South Australia. The above-noted 
discrepancy between the estimated national CAM expenditure in the current survey and the 
extrapolated national expenditure generated from a single state (South Australia) 10,11 requires 
further consideration. 
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Internationally, out-of-pocket expenditure on CAM was also estimated in studies conducted in 
the US, the UK and Canada. The highest expenditure was estimated in the US in 1997, when 
over $US27 billion was spent by the Americans. Notably, expenditure on herbal products 
alone amounted to $US5.1 billion, and out-of-pocket expenditure on high-dose vitamins more 
than tripled from US$0.9 billion in 1990 to US$3.3 billion in 1997.3 A relatively moderate 
out-of-pocket expenditure on CAM was estimated in a 1997 Canadian study (3.8 billion 
Canadian dollars).6 On the other hand, Ernst and Write estimated a total of £1.6 billion was 
spent by UK adults in 1999, based on the average cost of a pre-categorised range of 
estimations.17 Thomas and her colleagues estimated the CAM cost of six “more established” 
therapies, and the annual out-of-pocket expenditure was estimated as £450 million in UK.5 
Thus, the estimated CAM expenditure in the UK studies may need to be interpreted with 
caution, as suggested by the researchers. 
 
In summary, the estimation of CAM expenditure is subject to a number of problems. The 
potential inaccuracies of recall bias (generally, for a one-year period) are the major concern 
for the accuracy of extrapolation. Moreover, the greater variation of cost estimations by 
individual CAM users restricts the precision of extrapolation from a survey population to a 
national level. As observed in the current survey, a small proportion of participants spent a 
relatively large amount on CAM, due to their specific chronic health conditions, such as 
trauma. The estimations made from information provided by such participants do not 
necessarily violate the accuracy of such cost estimation. However, the extreme values may 
impact substantially on the overall average. Finally, the totality of the CAM expenditure is 
also subject to the same weakness of current uncertainty over the definition and classification 
of CAM modalities in different social contexts among literature. 
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CHAPTER 5. REGIONAL DIFFERENCES IN CAM USE  
 
As mentioned earlier, regional difference in overall CAM use in Australia may contribute to 
the relatively high prevalence found in the current study. It is of particular interest to explore 
the use of specific forms of CAM and investigate the characteristics of CAM users in different 
states and territories in Australia. The findings and discussions are presented in this Chapter. 
 
5.1 Results 
5.1.1 Overview 
When interpreting the findings presented in this Chapter, it is important to note the sample of 
interviews that were conducted in each state and territory. As outlined in Table 3.1, the 
number of interviews was allocated at a state level based on the recent Australian Bureau of 
Statistics data. Thus, the final completed interviews were: New South Wales (353), Victoria 
(264), Queensland (206), South Australia (87), Western Australia (96), other states and 
territories (61). 
 
Overall, the state of New South Wales had the highest prevalence of CAM use (72.1%), 
closely followed by Queensland (71.0 %), then Victoria (69.8%), with South Australia having 
the lowest rate (60.8%). In terms of visiting a CAM practitioner, the highest prevalence was 
found in Victoria (48.0%), with Queensland (41.4%) and Western Australia (42.0%) having a 
lower rate. However, these regional differences were not statistically significant (Table 5.1 
and Table 5.2).
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When examining the use of each of the 17 forms of CAM specifically, the significant regional 
differentials were identified in several modalities between states. As shown in Table 5.2, a 
substantially low rate of acupuncture use was reported in Western Australia (2.7%), whereas 
the rate was at least three times higher in New South Wales (9.9%, p<0.01), Victoria (10.9%, 
p<0.01) and Queensland (11.6%, p<0.01). Similarly, significantly low rates were also found in 
the use of osteopathy in South Australia (1.2%) and Western Australia (2.2%), and the use of 
naturopathy in Queensland (6.2%) and South Australia (5.5%). In contrast, Victorian adults 
favoured the use of aromatherapy the most (20.9%) − more than double the use in South 
Australia (10.0%) and 1.5 times higher than the use in New South Wales (13.8%) and 
Western Australia (13.7%, p<0.05). 
 
Anecdotally, some types of CAM practitioners are more popular in some states of Australia 
than in others. Thus, similar to the findings of the regional differences of CAM use in 
Australia, as shown in Table 5.2, it is of interest to see that visits to an acupuncturist were 
much higher in New South Wales (8.3%) and Victoria (10.1%) than in South Australia (3.2%, 
p<0.05) and Western Australia (2.7%, p<0.01). Surprisingly, in South Australia, none of the 
survey participants had visited practitioners for Chinese herbal medicine, Western herbal 
medicine or Chinese medicine dietary therapy. 
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Table 5.1 Regional differences of use of 17 forms of CAM 
Percent (standard error) of CAM use 
Regions Any CAM Acupuncture CHM CTM CMDT QGMATC WHM WTM Chiropractic 
NSW 72.1 (2.37) 9.9 (1.57) 6.3 (1.29) 4.8 (1.13) 2.2 (0.77) 3.7 (1.00) 16.9 (1.98) 27.1 (2.35) 17.0 (1.98) 
VIC 69.8 (2.80) 10.9 (1.90) 8.8 (1.73) 8.3 (1.68) 3.3 (1.09) 7.7 (1.63)* 17.3 (2.31) 27.2 (2.71) 17.4 (2.31) 
QLD 71.0 (3.15) 11.6 (2.23) 8.2 (1.91) 3.4 (1.27) 1.7 (0.89) 8.5 (1.94)* 15.0 (2.49) 32.2 (3.25) 14.9 (2.47) 
SA 60.8 (5.37) 6.9 (2.78) 5.8 (2.57) 2.3 (1.66) 1.7 (1.41) 5.4 (2.48) 10.1 (3.31) 25.3 (4.78) 17.0 (4.13) 
WA 66.6 (4.60) 2.7 (1.58)** 3.6 (1.80) 4.4 (2.00) 2.5 (1.52) 3.0 (1.66) 15.5 (3.53) 20.4 (3.93) 14.4 (3.42) 
Regions Osteopathy Homeopathy Naturopathy Meditation Aromatherapy Clinical 
nutrition 
Energy 
healing 
Reflexology Yoga 
NSW 6.0 (1.25) 5.0 (1.16) 11.8 (1.70) 16.7 (1.97) 13.8 (1.82) 47.3 (2.63) 5.6 (1.21) 4.0 (1.04) 12.7 (1.76) 
VIC 5.2 (1.36) 8.0 (1.66) 14.7 (2.16) 18.3 (2.36) 20.9 (2.48)* 43.0 (3.02) 9.1 (1.75) 5.3 (1.36) 12.4 (2.01) 
QLD 3.8 (1.34) 4.2 (1.40) 6.2 (1.67)* 19.0 (2.73) 16.7 (2.60) 49.9 (3.48) 6.0 (1.66) 4.0 (1.36) 13.0 (2.34) 
SA 1.2 (1.18)** 8.9 (3.13) 5.5 (2.52)* 13.0 (3.70) 10.0 (3.30) 43.6 (5.45) 5.3 (2.46) 2.0 (1.55) 8.5 (3.06) 
WA 2.2 (1.43)* 6.4 (2.39) 11.4 (3.10) 17.8 (3.72) 13.7 (3.35) 46.8 (4.86) 9.7 (2.89) 3.8 (1.87) 8.6 (2.73) 
Note 1: probability of proportion being significantly different from prevalence in first category (NSW) (Z-test, *: p<0.05, **: p<0.01) 
Note 2: NSW: New South Wales, VIC: Victoria, QLD: Queensland, SA: South Australia, WA: Western Australia 
Note 3: CHM: Chinese herbal medicine, CTM: Chinese therapeutic massage, CMDT: Chinese medicine dietary therapy, 
QGMATC: Qigong, martial art and Tai Chi, WHM: Western herbal medicine, WTM: Western therapeutic massage 
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Table 5.2 Regional differences of visits to practitioners for 17 forms of CAM 
Percent (standard error) of visits to CAM practitioners 
Regions Any CAM Acupuncture CHM CTM CMDT QGMATC WHM WTM Chiropractic 
NSW 45.0 (2.63) 8.3 (1.46) 2.4 (0.81) 3.1 (0.92) 0.5 (0.39) 2.2 (0.77) 6.0 (1.25) 21.9 (2.18) 15.0 (1.89) 
VIC 48.0 (3.05) 10.1 (1.84) 3.7 (1.14) 5.0 (1.33) 1.2 (0.66) 3.9 (1.18) 6.0 (1.44) 22.0 (2.53) 15.9 (2.23) 
QLD 41.4 (3.43) 7.7 (1.85) 2.0 (0.96) 2.3 (1.04) 0.4 (0.42) 5.3 (1.56) 2.1 (1.00)* 19.3 (2.75) 12.8 (2.32) 
SA 44.5 (5.46) 3.2 (1.93)* 0.0 (0.00)** 2.3 (1.66) 0.0 (0.00) 1.7 (1.41) 0.0 (0.00)** 19.6 (4.37) 16.1 (4.04) 
WA 42.0 (4.81) 2.7 (1.58)** 1.1 (1.03) 1.3 (1.12) 0.0 (0.00) 0.8 (0.89) 6.7 (2.44) 12.6 (3.23)* 14.4 (3.42) 
Regions Osteopathy Homeopathy Naturopathy Meditation Aromatherapy Clinical 
nutrition 
Energy 
healing 
Reflexology Yoga 
NSW 4.9 (1.14) 3.0 (0.90) 7.2 (1.36) 3.6 (0.98) 2.9 (0.88) 9.2 (1.53) 4.0 (1.04) 1.5 (0.65) 5.8 (1.23) 
VIC 4.3 (1.24) 3.9 (1.18) 8.7 (1.72) 3.8 (1.16) 4.5 (1.26) 7.8 (1.63) 3.1 (1.05) 3.4 (1.11) 8.8 (1.73) 
QLD 2.2 (1.02) 1.5 (0.86) 2.3 (1.04)** 5.9 (1.64) 1.2 (0.76) 5.2 (1.55) 1.5 (0.86) 1.6 (0.87) 7.3 (1.81) 
SA 1.2 (1.18)* 4.9 (2.37) 1.3 (1.25)** 4.4 (2.25) 2.8 (1.82) 6.6 (2.73) 4.2 (2.19) 0.8 (1.01) 5.1 (2.42) 
WA 1.1 (1.00)* 1.3 (1.12) 6.8 (2.46) 4.0 (1.90) 4.0 (1.91) 6.6 (2.42) 4.2 (1.96) 2.5 (1.52) 4.4 (2.00) 
Note 1: probability of proportion being significantly different from prevalence in first category (NSW) (Z-test, *: p<0.05, **: p<0.01) 
Note 2: NSW: New South Wales, VIC: Victoria, QLD: Queensland, SA: South Australia, WA: Western Australia 
Note 3: CHM: Chinese herbal medicine, CTM: Chinese therapeutic massage, CMDT: Chinese medicine dietary therapy, 
QGMATC: Qigong, martial art and Tai Chi, WHM: Western herbal medicine, WTM: Western therapeutic massage 
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5.1.2 Profile of CAM Users in New South Wales  
 
More people live in New South Wales (NSW) than any other state or territory of Australia. As 
noted above, the proportions of CAM users and people visits to CAM practitioners in New 
South Wales were considerably higher than most other states/territories. A sub-group analysis 
on socio-demographic characteristics that related to CAM users and people visits to CAM 
practitioners in New South Wales is summarised in Table 5.3. It is worth noting that when 
conducting sub-group analyses in all states and territories, the sample sizes become smaller 
and, consequently, the statistical power of the test to detect differences in each region is 
reduced. Thus, statistically significant differences are less likely to be observed at a state level. 
 
In New South Wales, those participants who considered their health as poor or fair were more 
likely to use CAM (82.8%) than those in better health (70.1%, p<0.05). Such a difference, 
however, was not observed in the national prevalence. In addition, New South Wales appeared 
to be the only state in which such a difference was found. A few national significant findings 
of people visits to CAM practitioners are also observed in New South Wales, such as a higher 
prevalence among those with a post-secondary education, who have private health insurance, 
and those with relatively higher income ranges (Table 5.3). 
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Table 5.3 Socio-demographic characteristics of CAM users in New South Wales 
Users Visited practitioners   
Characteristics* 
 % (95% CI) p†   % (95% CI) p† 
Gender     
Female 74.6 (68.2 – 80.9)  46.0 (38.8 – 53.2)  
Male 69.5 (62.7 – 76.3) >0.05 44.1 (36.8 – 51.4) >0.05 
Age (year)     
18-34 75.5 (67.5 – 83.4)  45.1 (35.8 – 54.3)  
35-64 72.2 (65.7 – 78.7) >0.05 46.2 (38.9 – 53.4) >0.05 
65+ 66.9 (55.4 – 78.5) >0.05 42.5 (30.4 – 54.6) >0.05 
Country of Birth     
Australia 72.2 (66.9 – 77.6)  46.9 (41.0 – 52.8)  
Non-Australia 71.5 (61.9 – 81.2) >0.05 40.6 (30.1 – 51.1) >0.05 
Self-reported health status     
Excellent/very good/good 70.1 (65.0 – 75.3)  43.4 (37.8 – 48.9)  
Fair/poor 82.8 (72.8 – 92.8) <0.05 54.3 (41.1 – 67.5) >0.05 
Post-secondary education     
No 68.7 (60.8 – 76.7)  33.5 (25.5 – 41.6)  
Yes 74.2 (68.4 – 79.9) >0.05 52.1 (45.6 – 58.6) <0.01 
Employment     
Employed 74.3 (68.7 – 79.8)  47.2 (40.8 – 53.5)  
Unemployed or not in 
labour force 68.4 (59.9 – 76.8) >0.05 41.9 (32.9 – 50.8) >0.05 
Private health insurance     
Yes 74.8 (68.6 – 80.9)  51.0 (43.9 – 58.0)  
No 69.3 (62.1 – 76.4) >0.05 39.5 (31.9 – 47.1) <0.05 
Annual household income     
<A$20,000 55.7 (42.2 – 69.3)  33.7 (20.8 – 46.7)  
A$20,000-A$40,000 73.5 (62.0 – 85.1) >0.05 53.1 (40.1 – 66.2) <0.05 
>A$40,000 73.3 (67.1 – 79.5) <0.05 44.6 (37.7 – 51.6) >0.05 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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5.1.3 Profile of CAM Users in Victoria  
 
The state of Victoria (VIC) is considered the pioneer in CAM practitioner regulation in 
Australia and indeed in Western countries. For example, it is currently the only state in 
Australia that has introduced mandatory registration of Chinese medicine practitioners. Thus, 
the use of acupuncture and Chinese herbal medicine (Table 5.1) and, visiting practitioners of 
acupuncture and Chinese herbal medicine have been found to be more prevalent in this state 
(Table 5.2). 
 
Summarised in Table 5.4 is a sub-group analysis of socio-demographic characteristics that 
relate to CAM users and people visits to CAM practitioners in Victoria. The income 
characteristics relating to both CAM users and people visits to CAM practitioners in Victoria 
were most similar to the national figures. That is, the group of people with higher household 
incomes (i.e. more than $40,000/pa) had a much higher prevalence of CAM use (79.5%) and 
visits to CAM practitioners (59.3%) than low-income participants (i.e. less than $20,000/pa) 
(55.2% and 34.4% respectively, p<0.01). Again, similar to the overall national prevalence, the 
high prevalence of visits to CAM practitioners is also significantly higher for those born in 
Australia and among younger adults (both, p<0.05). 
 
  
161 
Table 5.4 Socio-demographic characteristics of CAM users in Victoria 
Users Visited practitioners   
Characteristics* 
% (95% CI) p† % (95% CI) p† 
Gender     
Female 74.2 (66.9 – 81.5)  53.6 (45.3 – 62.0)  
Male 65.1 (57.0 – 73.3) >0.05 42.1 (33.7 – 50.6) >0.05 
Age (year)     
18-34 78.3 (69.5 – 87.1)  57.9 (47.4 – 68.5)  
35-64 68.7 (60.9 – 76.5) >0.05 46.5 (38.1 – 54.9) >0.05 
65+ 58.4 (44.3 – 72.5) <0.05 36.8 (23.0 – 50.6) <0.05 
Country of Birth     
Australia 71.7 (65.5 – 77.9)  52.2 (45.2 – 59.1)  
Non-Australia 63.7 (52.3 – 75.2) >0.05 36.4 (25.0 – 47.8) <0.05 
Self-reported health status     
Excellent/very good/good 70.6 (64.7 – 76.5)  48.2 (41.8 – 54.7)  
Fair/poor 65.1 (50.1 – 80.0) >0.05 46.9 (31.2 – 62.5) >0.05 
Post-secondary education     
No 61.9 (52.9 – 71.0)  41.7 (32.5 – 50.9)  
Yes 75.2 (68.5 – 81.9) <0.05 52.4 (44.6 – 60.1) >0.05 
Employment     
Employed 73.0 (66.2 – 79.7)  49.5 (41.9 – 57.2)  
Unemployed or not in 
labour force 63.4 (54.0 – 72.8) >0.05 43.6 (33.9 – 53.2) >0.05 
Private health insurance     
Yes 71.5 (64.0 – 78.9)  49.6 (41.3 – 57.8)  
No 67.7 (59.5 – 75.8) >0.05 45.9 (37.2 – 54.7) >0.05 
Annual household income     
<A$20,000 55.2 (40.6 – 69.7)  34.4 (20.5 – 48.2)  
A$20,000-A$40,000 64.8 (52.2 – 77.4) >0.05 43.7 (30.7 – 56.8) >0.05 
>A$40,000 79.5 (72.6 – 86.4) <0.01 59.3 (50.9 – 67.6) <0.01 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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5.1.4 Profile of CAM Users in Queensland  
 
Surprisingly, although the prevalence of CAM use in Queensland (QLD) was considerably 
high, the prevalence of visits to CAM practitioners, however, was the lowest (41.4%). This 
raises a safety concern that a relatively large proportion (41.8%) of CAM users in Queensland 
self-administered CAM products and therapies, compared with a relatively lower proportion 
in other states (between 26.7% to 37.5%). After investigating this proportion in the use of 
each of the 17 forms of CAM and visits to CAM practitioners, the larger proportions of 
Queensland adults who self-administered Chinese herbal medicine (76.1%) and Western 
herbal medicine (85.8%) may partially explain the current findings (Table 5.1 and Table 5.2). 
 
The previously mentioned large gender differential in the prevalence of CAM and visits to 
CAM practitioners in Australia nationwide was found to be statistically significant only in 
Queensland (Table 5.5) (female users vs. male users, p<0.01). Female adults in Queensland 
tended to be more likely to use CAM (82.0%) than male adults (59.9%). Interestingly, such a 
gender difference in CAM use was not observed in any of the other states. Furthermore, the 
proportion of CAM users among the group of Queensland young adult (82.1%) was higher 
than in any other state. Also, there was least variation (67.6%, 74.5% and 75.5%, respectively) 
in CAM use among different income earners who resided in Queensland. 
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Table 5.5 Socio-demographic characteristics of CAM users in Queensland 
Users Visited practitioners   
Characteristics* 
 % (95% CI) p†   % (95% CI) p† 
Gender     
Female 82.0 (74.6 – 89.3)  52.1 (42.5 – 61.6)  
Male 59.9 (50.5 – 69.4) <0.01 30.5 (21.5 – 39.4) <0.01 
Age (year)     
18-34 82.1 (72.9 – 91.4)  48.7 (36.6 – 60.8)  
35-64 67.7 (58.8 – 76.5) <0.05 40.2 (30.9 – 49.5) >0.05 
65+ 60.0 (43.4 – 76.7) <0.05 30.5 (14.8 – 46.1) >0.05 
Country of Birth     
Australia 73.5 (66.8 – 80.2)  42.4 (34.9 – 49.9)  
Non-Australia 62.6 (47.5 – 77.8) >0.05 38.0 (22.8 – 53.2) >0.05 
Self-reported health status     
Excellent/very good/good 71.4 (64.6 – 78.1)  40.4 (33.1 – 47.7)  
Fair/poor 68.5 (52.5 – 84.4) >0.05 44.4 (27.4 – 61.4) >0.05 
Post-secondary education     
No 63.6 (54.4 – 72.7)  34.6 (25.6 – 43.7)  
Yes 80.2 (72.3 – 88.2) <0.01 49.6 (39.6 – 59.5) <0.05 
Employment     
Employed 74.2 (66.9 – 81.5)  43.2 (34.9 – 51.4)  
Unemployed or not in 
labour force 67.5 (56.1 – 78.9) >0.05 39.4 (27.5 – 51.2) >0.05 
Private health insurance     
Yes 75.6 (67.4 – 83.8)  46.5 (36.9 – 56.1)  
No 66.4 (57.2 – 75.6) >0.05 36.1 (26.8 – 45.4) >0.05 
Annual household income     
<A$20,000 74.5 (58.6 – 90.5)  28.7 (12.1 – 45.2)  
A$20,000-A$40,000 67.6 (54.0 – 81.1) >0.05 33.1 (19.5 – 46.7) >0.05 
>A$40,000 75.5 (67.5 – 83.4) >0.05 51.8 (42.6 – 61.1) <0.05 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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5.1.5 Profile of CAM Users in South Australia 
 
Overall CAM use in South Australia (SA) was considered to be the lowest in the current study 
(excluding Australian Capital Territory, Northern Territory and Tasmania), although this was 
not the case when considering visits to CAM practitioners rather than CAM use (Table 5.1 
and Table 5.2). Surprisingly, a high prevalence of both homeopathy users and visits to 
homeopaths was observed in South Australia. The proportions of these (8.9% and 4.9%, 
respectively) were double those proportions in Queensland (4.2% of use and 1.5% of 
practitioner visits respectively). Moreover, although the use of energy healing in South 
Australia was the lowest (5.3%), the prevalence of visits to energy healing practitioners in 
South Australia, however, was the highest (4.2%). 
 
In contrast, apart from the previously mentioned low rate of use of acupuncture, Chinese 
herbal medicine, Chinese therapeutic massage and Western herbal medicine in South 
Australia, the lowest rates of naturopathy use (5.5%) and visits to naturopaths were also found 
in South Australia (1.3%), being about three times less than any other state except Queensland 
(p<0.05). 
 
Less significant findings were found in the characteristics of CAM users in South Australia. In 
regard to visits to CAM practitioners, the largest variability in participant characteristics was 
private health insurance and household incomes. The variations were considerably higher than 
for any other state of Australia. For example, South Australian adults with private health 
insurance were two times more likely to visit a CAM practitioner than those South Australians 
without private health insurance (52.0% vs. 20.5%, p<0.01, Table 5.6). Finally, in contrast to 
the considerably higher prevalence of CAM use among females in other states (generally more 
than 70%), the lowest rate of CAM use by females was in South Australia (62.5%). 
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Table 5.6 Socio-demographic characteristics of CAM users in South Australia 
Users Visited practitioners   
Characteristics* 
 % (95% CI) p†   % (95% CI) p† 
Gender     
Female 62.5 (47.9 – 77.1)  43.9 (29.0 – 58.9)  
Male 59.0 (43.9 – 74.2) >0.05 45.2 (29.9 – 60.5) >0.05 
Age (year)     
18-34 66.9 (48.0 – 85.8)  45.2 (25.2 – 65.2)  
35-64 62.5 (48.0 – 77.0) >0.05 49.7 (34.7 – 64.7) >0.05 
65+ 47.4 (23.1 – 71.7) >0.05 30.2 (7.8 – 52.5) >0.05 
Country of Birth     
Australia 60.1 (48.0 – 72.3)  44.0 (31.7 – 56.3)  
Non-Australia 58.7 (36.1 – 81.4) >0.05 40.4 (17.8 – 62.9) >0.05 
Self-reported health status     
Excellent/very good/good 60.3 (48.7 – 71.9)  44.4 (32.6 – 56.2)  
Fair/poor 63.3 (38.4 – 88.1) >0.05 45.3 (19.6 – 71.0) >0.05 
Post-secondary education     
No 54.3 (39.5 – 69.1)  38.0 (23.5 – 52.4)  
Yes 68.0 (53.4 – 82.5) >0.05 51.8 (36.2 – 67.4) >0.05 
Employment     
Employed 66.9 (53.7 – 80.1)  48.4 (34.4 – 62.5)  
Unemployed or not in 
labour force 52.1 (35.4 – 68.8) >0.05 39.0 (22.7 – 55.4) >0.05 
Private health insurance     
Yes 63.0 (51.0 – 74.9)  52.0 (39.7 – 64.4)  
No 53.9 (31.9 – 75.9) >0.05 20.5 (2.7 – 38.4) <0.01 
Annual household income     
<A$20,000 57.5 (25.1 – 89.8)  15.6 #  
A$20,000-A$40,000 59.1 (36.5 – 81.7) >0.05 51.3 (28.4 – 74.3) <0.05 
>A$40,000 61.2 (46.5 – 76.0) >0.05 46.1 (31.0 – 61.2) <0.05 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
#    Too few responses to calculate the CI 
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5.1.6 Profile of CAM Users in Western Australia 
 
In contrast to the less significant findings among CAM users in South Australia, CAM users 
in Western Australia appeared to have a higher correlation with their socio-demographic 
characteristics. Most significantly, Western Australia has the highest CAM prevalence 
(83.2%) among people with post-secondary education than any other state. In addition, when 
comparing those with post-secondary education and those without such education, Western 
Australia is the only state in which significant differences were observed both in CAM users 
and in people visits to CAM practitioners (p<0.01 for CAM users and p<0.05 for people visits 
to CAM practitioners). Also, Western Australia is the only state in which statistically 
significant differences were observed in both the prevalence of CAM use and visits to CAM 
practitioners (p<0.01), with respect to users’ private health insurance coverage status (Table 
5.7). In Western Australia, a large variation was also found in the country of birth of people 
visits to CAM practitioners, that is, people born in Australia were more likely to visit CAM 
practitioners (51.1%) than those born overseas (21.3%, p<0.01). This finding is similar to 
CAM users in Victoria. 
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Table 5.7 Socio-demographic characteristics of CAM users in Western Australia 
Users Visited practitioners 
Characteristics* 
 % (95% CI) p†   % (95% CI) p† 
Gender     
Female 74.2 (62.4 – 86.0)  51.0 (37.5 – 64.5)  
Male 58.9 (45.6 – 72.2) >0.05 33.0 (20.3 – 45.7) >0.05 
Age (year)     
18-34 70.2 (54.7 – 85.7)  38.9 (22.4 – 55.4)  
35-64 69.6 (57.5 – 81.7) >0.05 49.0 (35.8 – 62.1) >0.05 
65+ 48.9 (24.7 – 73.1) >0.05 25.0 (4.1 – 45.9) >0.05 
Country of Birth     
Australia 70.0 (59.5 – 80.5)  51.1 (39.7 – 62.6)  
Non-Australia 58.8 (41.8 – 75.8) >0.05 21.3 (7.1 – 35.5) <0.01 
Self-reported health status     
Excellent/very good/good 66.4 (56.7 – 76.1)  42.8 (32.6 – 53.0)  
Fair/poor 67.8 (43.5 – 92.1) >0.05 37.1 (12.0 – 62.3) >0.05 
Post-secondary education     
No 46.8 (32.7 – 60.9)  29.6 (16.7 – 42.5)  
Yes 83.2 (73.6 – 92.9) <0.01 52.5 (39.6 – 65.5) <0.05 
Employment     
Employed 71.4 (61.1 – 81.7)  45.7 (34.3 – 57.1)  
Unemployed or not in 
labour force 56.0 (38.1 – 73.8) >0.05 32.5 (15.6 – 49.3) >0.05 
Private health insurance     
Yes 75.6 (65.3 – 85.8)  51.1 (39.2 – 63.0)  
No 50.4 (34.5 – 66.4) <0.01 25.7 (11.8 – 39.7) <0.01 
Annual household income     
<A$20,000 74.1 (52.6 – 95.7)  35.9 (12.3 – 59.5)  
A$20,000-A$40,000 51.9 (31.1 – 72.7) >0.05 34.7 (14.9 – 54.5) >0.05 
>A$40,000 66.7 (54.6 – 78.9) >0.05 41.1 (28.4 – 53.8) >0.05 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
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5.1.7 Profile of CAM Users in Other States/Territories 
 
Apart from the five major states discussed above, data on CAM and visits to CAM 
practitioners were also collected from the state of Tasmania (TAS), the Northern Territory 
(NT) and the Australian Capital Territory (ACT). Sixty-one interviews were conducted in 
these regions (26 each in Tasmania and in the Australian Capital Territory, and nine in the 
Northern Territory). Thus, combined results were presented. It is important to note that when 
examining the prevalence of specific use between different characteristics, the sample size is 
too small to calculate a 95% confidence interval in several items (Table 5.8). 
 
In general, approximately half (49.6%, 95%CI: 34.8% to 64.4%) of the adult populations of 
the above three regions combined, were CAM users, while less than one in three (29.4%, 
95%CI: 15.9% to 42.9%) adults had visited CAM practitioners. Specifically, CAM use was 
higher in Northern Territory, being about 71.1% (95%CI: 34.0% to 108.1%), with 38.3% 
(95%CI: -1.4% to 78.1%) visiting CAM practitioners.  
 
The prevalence of CAM use in Tasmania was lower than the national average − about 52.3% 
(95%CI: 32.1% to 72.5%), with 29.7% (95%CI: 11.2 % to 48.2%) visiting CAM practitioners. 
Lastly, in Australian Capital Territory the prevalence of CAM use was about 36.9% (95%CI: 
12.3% to 61.6%), with 25.5% (95%CI: 3.2% to 47.8%) visiting CAM practitioners. Again, as 
noted in the Methodology section, the total number of interviews in these states/territories is 
not adequate to determine conclusive prevalence of CAM use. 
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Table 5.8 Socio-demographic characteristics of CAM users in other states/territories 
Users Visited practitioners   
Characteristics* 
 % (95% CI) p†   % (95% CI) p† 
Gender     
Female 60.4 (38.5 – 82.3)  39.0 (17.2 – 60.9)  
Male 41.3 (21.9 – 60.7) >0.05 22.0 (5.7 – 38.3) >0.05 
Age (year)     
18-34 50.4 (24.1 – 76.6)  38.3 (12.7 – 63.8)  
35-64 62.7 (42.8 – 82.6) >0.05 31.0 (11.9 – 50.0) >0.05 
65+ 8.1 (-11.6 – 27.8) <0.05 8.1# >0.05 
Country of Birth     
Australia 49.0 (32.7 – 65.4)  26.9 (12.4 – 41.4)  
Non-Australia 57.8 (21.7 – 94.0) >0.05 45.2 (8.8 – 81.6) >0.05 
Self-reported health status     
Excellent/very good/good 48.1 (32.1 – 64.0)  31.5 (16.7 – 46.4)  
Fair/poor 59.2 (20.2 – 98.1) >0.05 16.4# >0.05 
Post-secondary education     
No 52 (27.1 – 76.9)  30.2 (7.3 – 53.1)  
Yes 49.7 (31 – 68.3) >0.05 29.8 (12.8 – 46.9) >0.05 
Employment     
Employed 59.0 (40.1 – 78.0)  32.5 (14.4 – 50.5)  
Unemployed or not in 
labour force 37.7 (14.8 – 60.6) >0.05 26.2 (5.4 – 46.9) >0.05 
Private health insurance     
Yes 55.1 (35.1 – 75.1)  34.0 (15.0 – 53.0)  
No 43.1 (21.5 – 64.8) >0.05 24.0 (5.4 – 42.7) >0.05 
Annual household income     
<A$20,000 42.3 (10.1 – 74.4)  0#  
A$20,000-A$40,000 50.4 (12.2 – 88.6) >0.05 31.5# >0.05 
>A$40,000 53.3 (32.8 – 73.7) >0.05 38.1 (18.2 – 58.0) <0.01 
Note: significance levels were adjusted to allow for multiple comparisons 
*    Excludes subjects who did not provide socio-demographic characteristics 
†       Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
#    Too few responses to calculate the CI 
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5.1.8 Geographical Summary of CAM Use in Australia 
The prevalence of CAM use and visits to CAM practitioners in states and territories of Australia can be geographically summarised in the map below 
(Figure 5.1). 
 
Figure 5.1 Prevalence of CAM use in Australia presented in a map 
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5.2 Discussion 
Anecdotally, the practice of some forms of CAM, such as acupuncture and herbal medicine, 
are more common in a number of states in Australia. To a certain degree, the suggestions that 
people who live in New South Wales and Victoria are more likely to use CAM and visit CAM 
practitioners than any other states, has been confirmed in the present study. Thus, this study 
observed that South Australia has a much lower usage of CAM, compared to other states in 
Australia. Logically, the proportion (60.8%) of South Australian residents who used CAM 
seems consistent with previous estimations.11 In addition, the proportion (72.1%) of New 
South Wales adults who used CAM is also consistent with previous New South Wales 
estimations.37,38 
 
As noted in Table 5.1 and Table 5.2, regional differences in the use of certain forms of CAM 
are also in accord with the existing literature. For example, a previous workforce survey 
identified a relatively small number of Western herbal medicine and naturopathy practitioners 
in South Australia, compared to New South Wales, Victoria, Queensland and Western 
Australia.12 Consistently, based on the current survey, the lowest prevalence of both Western 
herbal medicine use and naturopathy use were estimated in South Australia. 
 
Homeopathy is the only CAM modality for which the highest prevalence was observed in 
South Australia. A detailed rationale for the high usage is not clear. However, incidentally, 
there is a view that the high use of homeopathy in South Australia actually relates to the 
history of Germany immigration to that state. The lowest prevalence of homeopathy use was 
reported in Queensland. However, this seems to be in contrast with the general trend observed 
in the current survey that Queensland residents favoured the use of most forms of CAM. So 
there is an aspect of interpreting intra-Australian differences which requires further work 
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around the social, cultural and historical developments in different states (just as these factors 
influence differences across countries). 
 
At the time of conducting the survey, Victoria was still the sole Australian state in which 
acupuncturists and Chinese herbal medicine practitioners were subject to statutory 
registration. Thus, it is not surprising to see that the prevalence of acupuncture and Chinese 
herbal medicine use in Victoria was amongst the highest. In particular, the proportion of 
Victorian residents who had visited acupuncturists was three to four times higher than in 
South Australia and Western Australia. This implied that statutory registration could impact 
greatly on the public’s confidence in using Chinese medicine, thus impacting on the 
proportion of residents from this region seeking Chinese medicine care. The general opinion 
of the impact on public confidence in Chinese medicine practitioner mandatory registration 
was also sought, and is presented in 7.1.5.2. 
 
In Western Australia the prevalence of each individual form of CAM was generally lower than 
those for other states. However, the proportion of Western Australia adults who used energy 
healing such as reiki, and the proportion of Western Australia adults who had visited 
practitioners for energy healing were the highest among all states. In addition, the proportion 
of Western Australia adults who used meditation was higher than the prevalence in New 
South Wales and South Australia, but similar to the prevalence in Victoria and Queensland. 
 
A large regional variation of CAM use was found in the prevalence of aromatherapy. The 
extraordinarily high prevalence in Victoria may indicate a greater aromatherapy market there 
than any other states. In all, there is evidence to conclude that there are regional differences in 
the use of certain forms of CAM in Australia. However, factors that may contribute to such 
differences cannot be answered by the current survey. 
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CHAPTER 6. USE OF FOUR SPECIFIC FORMS OF CAM: 
ACUPUNCTURE, CHINESE HERBAL MEDICINE, 
CHIROPRACTIC AND OSTEOPATHY 
 
As part of the study, specific questions were designed to investigate the usage and related 
issues on four specific forms of CAM. These are acupuncture, Chinese herbal medicine, 
chiropractic and osteopathy. The methodology has been described in Chapter 3.3. This 
Chapter provides results on these therapies and discusses implications of the findings. 
6.1 Results 
6.1.1 Chinese Medicine (Acupuncture and Chinese Herbal Medicine) 
6.1.1.1 Overview 
In this section, data on overall Chinese medicine utilisation and detailed information on 
specific forms of Chinese medicine, for example, acupuncture and Chinese herbal medicine 
are presented. The definition of Chinese medicine user (CM user) refers to a person who uses 
any one of the five major forms of Chinese medicine: acupuncture (ACU), Chinese herbal 
medicine (CHM), Chinese therapeutic massage (CTM), Chinese medicine dietary therapy 
(CMDT), and Qigong, martial art and Tai Chi (QGMATC). This definition also applies to 
those who had visited any one of the five types of Chinese medicine practitioners. 
 
Additional details on acupuncture and Chinese herbal medicine in relation to economic 
consideration, the rationale for use and the perceived and actual benefits and adverse events 
are also presented in this Chapter. Results on regulation and health insurance related to 
Chinese medicine are presented in relevant sections of Chapter 7. 
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6.1.1.2 Total and Specific Prevalence of Chinese Medicine Use 
 
Overall, a total of 210 participants (weighted percentage, 19.3%, 95%CI: 16.9% – 21.7%) 
reported using Chinese medicine (CM) in the 12-month preceding the survey. As expected, 
the most common CM modality was acupuncture (9.2%, 95%CI: 7.5% – 10.9%). The use of 
other CM modalities were: Chinese herbal medicine (7.0%, 95%CI: 5.5% – 8.5%), Chinese 
therapeutic massage (5.1%, 95%CI: 3.8% – 6.4%), Chinese medicine dietary therapy (2.3%, 
95%CI: 1.4% – 3.2%) and Qigong, martial art and Tai Chi (6.0%, 95%CI: 4.6% – 7.4%). 
There were two participants (both female from Australia and from New Zealand) who had 
used all these five forms of CM. A total of 16 participants (7.6% of all CM users) had used all 
three major forms of CM (i.e. Acupuncture, Chinese herbal medicine and Chinese herbal 
medicine). Among those who had used Chinese medicine dietary therapy, five out of 28 
(17.9%) had used Chinese medicine dietary therapy only but had not used other forms of CM 
(see Table 4.4). 
 
A total of 131 participants (11.9%, 95%CI: 10.0% to 13.9%) had visited at least one type of 
CM practitioner. Most acupuncture users (81.1%) had visited an acupuncturist, while the 
majority (75.2%) of Chinese medicine dietary therapy users did not visit a practitioner for the 
therapy. Among all survey participants, a total of 7.5% (95%CI: 5.9% to 9.0%) had visited an 
acupuncturist, while the prevalence of visits to CHM, Chinese therapeutic massage, Chinese 
medicine dietary therapy and Qigong, martial art and Tai Chi practitioners was 2.3% (95%CI: 
1.4% – 3.2%), 3.2% (95%CI: 2.1% – 4.3%), 3.2% (95%CI: 2.1% – 4.2%) and 0.6% (95%CI: 
0.1% – 1.0%), respectively (see Table 4.8). 
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For both prevalence of CM use and visits to CM practitioners, there were some large 
differences between states (Table 6.1 and Figure 6.1). The lowest prevalence was always 
observed in Western Australia (Table 6.1), whereas New South Wales, Queensland and 
Victoria appeared to have a greater prevalence of CM use and visits to CM practitioners. It is 
worth-noting that although 17.2% of South Australia adults had used CM, only 6.5% had 
visited CM practitioners. Specifically, these significant differences in visiting CM 
practitioners were also found in visits to both acupuncturists and Chinese herbal medicine 
practitioners (p<0.05, see Table 5.1 and Table 5.2).  
 
Table 6.1 Regional differences of Chinese medicine use and visits to Chinese medicine 
practitioners 
Used Chinese medicine 
in past 12 months 
Statistical 
difference 
 
States 
Yes (%) No (%) Chi Square p-value 
New South Wales 17.1  82.9 13.276 0.010 
Victoria 22.7 77.3   
Queensland 25.1 74.9   
South Australia 17.2 82.8   
Western Australia 10.3 89.7   
Visited Chinese medicine 
practitioners in past 12 months 
Statistical 
difference 
 
States 
Yes (%) No (%) Chi Square p-value 
New South Wales 11.7 88.3 9.245 0.055 
Victoria 15.4 84.6   
Queensland 13.5 86.5   
South Australia 6.5 93.5   
Western Australia 6.0 94.0   
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Figure 6.1 Prevalence of Chinese medicine use in Australia presented in a map 
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6.1.1.3 Frequency of Practitioner Visits and Expenditure 
 
As noted in Table 4.9, the most frequently visited CAM practitioners were acupuncturists, 
with more than one visit every six weeks (8.75 visits per annum). Together with Chinese 
herbal medicine (CHM, 5.98 visits per annum) and Chinese therapeutic massage (5.43 visits 
per annum), a total of 105 people (9.5% of total survey participants) had visited practitioners 
for any one of three forms of Chinese medicine. This can be transformed into a total of 14.94 
million visits for the adult Australian population (10.16 million, 2.12 million and 2.66 million 
for acupuncturists, CHM practitioners and Chinese therapeutic massage practitioners, 
respectively). 
 
The average out-of-pocket expenditure of visiting a CAM practitioner, as estimated in the 
current survey was A$25 (see Chapter 4.1.7.1). When extrapolating this to the estimated 
national visits to Chinese medicine practitioners, it suggests that a total of A$373.5 million 
was paid out-of-pocket to Chinese medicine practitioners per annum. Of this, A$254 million 
was spent on visiting acupuncturists, A$53 million was spent on visiting CHM practitioners 
and, the remaining A$66.5 million was on Chinese therapeutic massage therapists. 
 
Apart from the costs related to practitioner consultation and treatment, both acupuncture and 
CHM users had also estimated additional costs related to their treatment. And for CHM, users 
had separated the costs of herbal medicine and/or other items related to CHM, such as books 
or equipment. A total of 17 acupuncture users spent additional costs related to acupuncture. 
The estimated cost from one user is considered as outlier ($6,000), applying the same protocol 
in calculating CAM costs (see Chapter 4.1.7.1), thus, among those had spent additional costs 
related to acupuncture, the adjusted median cost was A$88.14. Nationwide, this equals to 
A$21.80 million acupuncture-related costs. 
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Of the total CHM users who had spent additional costs to the actual Chinese herbal medicine 
(71 users, or 6.4% of total participants) and CHM-related products (22 users, or 2.2% of total 
participants), the median cost was A$100 and A$60, respectively, excluding extreme values 
(A$4,500 or above, two were herbs and two were CHM-related items). Thus, the national 
expenditure can be estimated as A$103.11 million for Chinese herbs and A$21.83 million for 
CHM related costs (see Appendix G9 for the original cost and G10 for a summary statistics of 
the adjusted data). 
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6.1.1.4 Acupuncture Treatment Provided by Medical Doctors 
 
Given that there is evidence that a considerable proportion of registered medical doctors (GPs) 
is providing acupuncture treatment to their patients, acupuncture users were asked whether at 
least one of the practitioners they visited for acupuncture treatments was a medical doctor, 
such as a GP or a medical specialist. Of the 82 participants who had visited a practitioner for 
acupuncture treatment, well over one quarter (29.1%) had received acupuncture treatment 
from their GPs. Of these, over half (59.1%) had received acupuncture from their GPs only but 
not from non-GP acupuncturists. 
 
In terms of the frequency of visits to acupuncture practitioners, either to GPs or to traditional 
acupuncturists, participants provided estimations for the 12-month preceding the survey. Of 
the total of 24 adults who had received acupuncture from their GPs, a total of 9.3 visits were 
estimated for the 12-month period, with a median of 4.0 visits per year (two participants 
mentioned they visited their GPs once a week for a spinal injury and arthritis). On the other 
hand, 67 participants had received acupuncture treatment from non-GP acupuncturists, 
including nine persons who had received treatment from both GPs and non-GP providers. 
Among these (67 participants), the average number of visits during the 12-month period was 
7.44, and the median was 4.0. The two highest number of visits were 60 and 45, which were 
estimated by a patient with broken spine and by another patient with chronic fatigue 
syndrome.  
 
When combining all visits to GPs and non-GP acupuncturists (considered as visiting a 
practitioner for acupuncture), the mean number of visits per year was 8.75, with a median of 
4.0. The mean number of visits was used to estimate the national total number of visits for 
acupuncture treatment in Australia (see Table 4.9). 
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6.1.1.5 Characteristics of Chinese Medicine Users 
 
The common characteristics for Chinese medicine (CM) users are consistent with most 
previous findings on CAM users. In general, relatively young, with a secondary education and 
employed contributed significantly to a relatively high prevalence of CM use (p<0.05). 
Furthermore, the most significant factor related to the use of CM and visits to CM 
practitioners was educational background. Compared to those without post-secondary 
education, people having a post-secondary education appeared to be more likely to use CM 
(22.4% vs. 15.3%) and to visit CM practitioners (14.8% vs. 8.1%) (p<0.01) (Table 6.2). 
 
For each CM modality (see Table 4.6), the demographic statistics related to individual 
prevalence were different. The above noted marked educational difference in CM use was also 
found in the use of acupuncture and Chinese herbal medicine (any of the modalities, p<0.01), 
but not in other forms of CM. Surprisingly, Australian-born adults were more likely to use 
acupuncture (10.2%) than those born overseas (6.5%, p<0.05), but less likely to use CHM 
(5.5% vs. 11.1%, p<0.05) and Chinese medicine dietary therapy (1.7% vs. 4.7%, p<0.05). 
 
A low prevalence of CHM use was also observed in those aged 65 or above (2.6% compared 
to 8.1% among those aged 18-34, p<0.05) and those unemployed (4.6% compared to 8.1% 
among employed participants, p<0.05) (Table 4.6). Moreover, for Chinese therapeutic 
massage, the only significant difference in use was found between younger adults (aged 18-34 
5.7%) and older adults (65 and older, 2.4%, p<0.05). Interestingly, 28 participants (2.8% of 
total participants) had used Chinese medicine dietary therapy, all of whom were from the 
group of people who rated their personal health as good or better; whereas, no participants 
who rated themselves in poor health had used Chinese medicine dietary therapy (p<0.01). Not 
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unexpectedly, younger people were more likely to practice Qigong, martial art and Tai Chi 
(9.5%) than the middle-age group (4.7%, p<0.01) and older people (2.9%, p<0.01). 
 
Table 6.2 Socio-demographic characteristics of users of Chinese medicine 
 
CM Users 
Visited CM 
practitioner 
  
Characteristic# 
 % (SE %) p†  % (SE %) p† 
Gender       
Female 21.1 (1.8)  11.8 (1.4)  
Male 17.5 (1.7) 0.1270 12.0 (1.4) 0.9447 
Age (year)     
18-34 21.8 (2.3)  13.4 (1.9)  
35-64 19.3 (1.7) 0.3718 11.7 (1.4) 0.4485 
65+ 14.8 (2.6) 0.0451* 10.2 (2.2) 0.2623 
Country of Birth     
Australia 19.2 (1.4)  12.9 (1.2)  
Non-Australia 19.3 (2.5) 0.9566 9.2 (1.8) 0.0960 
Post-secondary education     
No 15.3 (1.7)  8.1 (1.3)  
Yes 22.4 (1.7) 0.0032* 14.8 (1.4) 0.0005* 
Self-reported health status     
Excellent/very good/good 18.9 (1.3)  11.6 (1.1)  
Fair/poor 21.1 (3.2) 0.5306 12.9 (2.6) 0.6538 
Employment     
Employed 20.9 (1.6)  12.8 (1.3)  
Unemployed or not in labour force 15.9 (1.9) 0.0417* 9.8 (1.6) 0.1298 
Private Health Insurance     
Yes 19.5 (1.6)  13.3 (1.4)  
No 19.4 (1.8) 0.9574 10.3 (1.4) 0.1389 
Annual household income     
<A$20,000 18.3 (3.1)  9.5 (2.3)  
A$20,000-A$40,000 18.2 (2.7) 0.9902 10.0 (2.1) 0.8725 
>A$40,000 19.9 (1.7) 0.6455 12.9 (1.4) 0.2026 
#  Excludes subjects who did not provide socio-demographic characteristics 
†  Probability of proportion being significantly different from the first value in each 
demographic category (Z-test) 
*  Significance level (p<0.05) 
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6.1.1.6 Chinese Medicine Utilisation–Regression Analyses 
 
The methodology of conducting multivariate logistic regression analyses was detailed in 
Chapter 3.6.4.3. With an interest to produce a model that best describe the characteristics of 
Chinese medicine (CM) users. Separate regression models were developed. These are on 
overall CM use (of any one of the five modalities), on acupuncture use and on Chinese herbal 
medicine use. Again, unless otherwise indicated, the regression results presented are 
unweighted. 
 
Variables that significantly (p<0.05) related to CM or acupuncture or CHM use were 
summarised in Table 6.3. These were the variables that had been entered into each individual 
regression model. The best-fit significant results of the multivariate analysis are presented in 
Table 6.4. They show post-secondary education, had consulted a GP in the preceding 12-
month and coverage of CAM influenced the private insurance purchase contributed 
significantly to a participant’s decision to use acupuncture. In addition, for the use of CHM, 
the factors pertaining to a participant’s age ranges and country of birth were also significant 
predictors.  
 
Considering the overall use of CM, similar to the findings on acupuncture users, the factors of 
educational background and the belief that coverage of CAM influenced the private insurance 
purchase were statistically significant. It is also worth noting that being resident in different 
regions in Australia may also impact significantly on the possibility of CM use. As shown in 
Table 6.4, when using Western Australia as the reference group, the Victoria adults and the 
Queensland adults were respectively 2.5 and 3.0 times more likely to use CM than adults in 
Western Australia. 
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Table 6.3 Predictor variables employed in the regression models on Chinese medicine 
use 
Predictors ACU CHM CM 
Demographic factors (block 1) … … … 
Age group  … Yes … 
Residential area  … … Yes 
Education  Yes Yes Yes 
Employment  … Yes Yes 
Country of birth  … Yes … 
Health factors (block 2) … … … 
Visited a GP in past 12 months Yes … … 
Visited a GP 4 or more times in past 12 months  … … … 
External factors (block 3) … … … 
Coverage of CAM influences health insurance purchase Yes Yes Yes 
CAM should be regulated as rigorously as Western 
medicine 
… … Yes 
Health conditions (block 4) 
Visited a GP for 18 specific health problems 
… … … 
Condition No.1: health check-up Yes … … 
Condition No.8: diabetes … … Yes 
Condition No.9: gastrointestinal Yes … … 
Condition No.11: high blood pressure … Yes … 
Condition No.18: trauma/injury Yes … Yes 
ACU: acupuncture, CHM: Chinese herbal medicine, CM: Chinese medicine 
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Table 6.4 Multivariate analyses of predictor variables for Chinese medicine use 
Predictors Use of acupuncture 
Odds ratio & (95% CI) 
Use of CHM 
Odds ratio & (95% CI) 
Use of CM 
Odds ratio & (95%CI) 
No 1.0  1.0 
 
Post-secondary education Yes 1.678 (1.044–2.697)*  1.485 (1.02–2.146)* 
 
18-34  3.426 (1.282–9.152)*  
 
35-64  2.685 (1.037–6.956)*  
Age 65+  1.0  
Overseas  1.0  
 
Country of birth Australia   0.434 (0.260–0.723)**  
New South Wales   1.691 (0.787–3.633) 
Victoria   2.506 (1.161–5.410)* 
Queensland   3.012 (1.367–6.637)** 
South Australia   1.768 (0.689–4.538) 
 
 
 
 
Region Western Australia   1.0 
No 1.0   
Consulted a GP in the past 12 
months Yes 2.064 (1.010–4.217)*   
No 1.0  1.0 Coverage of CAM influences 
health insurance purchase Yes 2.201 (1.366–3.546)**  2.115 (1.463–3.057)** 
Omnibus Tests of Model Coefficients    
Chi square (degree of freedom, p value) 23.044 (3, <0.0001) 16.539 (3, =0.001) 35.059 (6, <0.0001) 
Percentage accurate in classification 90.7 92.5 79.4 
* p<0.05; ** p<0.01; CI: confidence interval; CM: Chinese medicine; CHM: Chinese herbal medicine 
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6.1.1.7 Rationale for Use of Acupuncture and Chinese Herbal Medicine  
Acupuncture 
A total of 97 acupuncture users responded to the question on rationale for use. The vast 
majority (92.0%) said it was for the purpose of treating medical conditions, including 14.1% 
who used it for both general health improvement and medical conditions. The remaining 8.0% 
used acupuncture for improving general health and well-being only. Among those who used 
acupuncture for a medical condition, the most common conditions were back pain and related 
problems (20.7%), shoulder pain and problems (15.5%), arthritis (8.5%), injury (7.0%) and 
knee-related problems (5.1%). The detailed medical conditions related to the use of 
acupuncture are presented in Table 6.5. Specifically and significantly, the majority of those 
who used acupuncture for treating medical conditions were aged 35-64 (97.2%) and 65 and 
older (92.0%), while only 80.6% users aged 18-34 used acupuncture for this purpose 
(χ2=6.258, p=0.044). 
Table 6.5 Medical conditions related to the use of acupuncture treatment 
Medical condition 
Number 
of cases Medical condition 
Number 
of cases 
Musculoskeletal related: … Chronic fatigue syndrome 2 
Back pain and related 18 Gastrointestinal 2 
Non-specific muscular problems 17 Stop smoking 2 
Shoulder related 12 Anxiety and depression 1 
Arthritis 8 Blood cholesterol 1 
Injury-related 6 Energy-related problems 1 
Knee-related 5 Gynaecologic problems 1 
Neck-related 3 Hay fever 1 
Spinal-related 3 Infertility 1 
Ankle-related 1 Insomnia 1 
Multiple sclerosis 1 Irregular heart beat 1 
Other conditions: … Loss weight 1 
Headache 3 Lung related 1 
Sinus problem 3 Pregnancy 1 
Asthma 2 Prostate problem 1 
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Chinese Herbal Medicine (CHM) 
A total of 73 CHM users responded to the question on rationale for use. About two thirds 
(60.4%) used it to treat medical conditions, including 29.7% who used it both for general 
health improvement and medical conditions. Thus, over 39.6% used CHM to improve general 
health and well-being only. Among those who used CHM for a medical condition, the most 
common conditions were colds and flu (11.6%), and problems related to energy level (8.5%). 
There were at least 30 different conditions for which people had used CHM (Table 6.6). 
Specifically, the highest prevalence of CHM use for medical conditions was among those 
aged 35-64 (72.0%), followed by those aged 18-34 (51.0%), while only 14.8% of those aged 
65 and older used CHM for treating medical conditions (χ2=7.292, p<0.026). In addition, 
those having private health insurance were also more likely to use CHM for medical 
conditions (73.0%) than those without it (41.6%, χ2=6.935, p=0.008). 
 
Table 6.6 Medical conditions related to the use of Chinese herbal medicine treatment 
Medical condition 
Number 
of cases Medical condition 
Number 
of cases 
Colds/flu 6 After hysterectomy  1 
Energy related problems 4 Blood cholesterol 1 
Asthma 3 Chronic fatigue syndrome 1 
Anxiety and depression 3 Diabetes 1 
Back pain and related 3 Heart-related 1 
Hay fever 3 High blood pressure 1 
Gastrointestinal 3 Infertility 1 
Arthritis 2 Injury related 1 
Cancer 2 Leukaemia 1 
Eye problems 2 Low immune system 1 
Gynaecologic problems 2 Nervous condition 1 
Neck-related 2 Lung-related 1 
Non-specific muscular problems 2 Toothache 1 
Headache 2 Sinus problem 1 
Shoulder related problems 2 Skin problem 1 
Ankle related problems 1 Stress relief 1 
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6.1.1.8 Outcomes of Use of Acupuncture and Chinese Herbal Medicine  
 
In an effort to compare expectation of acupuncture or CHM users with the actual outcomes of 
treatment, users were asked to respond to a question of whether the treatment they used had 
cured the disease/solved the problem, relieved the symptoms and/or improved general health 
and well-being. 
 
Expectations of and Actual Outcome of Using Acupuncture 
 
Table 6.7 summarised the responses (number and percentage) from acupuncture users on their 
expectations and outcomes. Nearly half (48.5%) of users expected acupuncture could cure 
their disease. After receiving treatment, over half (59.2%) of these users considered 
acupuncture had cured their disease or had solved the health problem they had before the 
treatment. In addition, seven out of 30 (23.3%) users who did not consider acupuncture would 
cure their disease found acupuncture did provide such an outcome. A further six users who 
had been unsure whether acupuncture would cure their disease/solve their problem had also 
experienced a positive outcome, thus, the total positive outcome of curing diseases or solving 
health problems was 41.6%.  
 
More users considered the outcome of acupuncture would be a relief of symptoms (72.3%) or 
that it would improve general health and well-being (71.3%) than cure the diseases (48.5%). 
Among those who considered acupuncture would relieve their symptoms of illnesses, the 
majority (89.0%) had experienced a positive outcome. A high proportion of users who did not 
believe the outcome would be a relief of symptoms, or who were uncertain about this 
outcome, also reported a positive outcome (90.0% and 77.8%, respectively). This represented 
a total positive outcome of 87.1% in the use of acupuncture to relieve symptoms. 
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In all, nearly four out of five (78.2%) users considered acupuncture likely to improve their 
general health and well-being. The percentage was higher among those who had a positive 
expectation of using acupuncture to improve their general health (i.e. 86.1%). When taking no 
consideration of users’ expectations towards acupuncture before treatment, about one-third 
(33.7%) users considered that acupuncture had helped them achieve all three outcomes. 
However, six acupuncture users responded that there was no effect after treatment. 
Demographic information of none of these six users had been found to be particular 
noticeable, although these users resided in four different states other than Victoria. 
 
Table 6.7 Expectations of and actual outcomes of using acupuncture 
After treatment (outcome)  
Before Treatment (expectation) 
Yes 
 n (%)* 
No 
 n (%)* 
Not sure 
 n (%)* 
Cure the disease/solve the problem, n (% of users)** 
Yes 49 (48.5%) 29 (59.2%) 18 (36.7%) 2 (4.1%) 
No 30 (29.7%) 7 (23.3%) 23 (76.7%) 0 (0%) 
Not sure 22 (21.8%) 6 (27.3%) 10 (45.5%) 6 (27.3%) 
Total 101 42 (41.6%) 51 (50.5%) 8 (7.9%) 
Relief of symptoms, n (% of users)** 
Yes 73 (72.3%) 65 (89.0%) 7 (9.6%) 1 (1.4%) 
No 10 (9.9%) 9 (90.0%) 1 (10.0%) 0 (0%) 
Not sure 18 9 (17.8%) 14 (77.8%) 1 (5.6%) 3 (16.7%) 
Total 101 88 (87.1%) 9 (8.9%) 4 (4.0%) 
Improve general health and well-being, n (% of users)** 
Yes 72 (71.3%) 62 (86.1%) 7 (9.7%) 3 (4.2%) 
No 16 (15.8%) 8 (50.0%) 8 (5.0%) 0 (0%) 
Not sure 13 (12.9%) 9 (69.2%) 3 (23.1%) 1 (7.7%) 
Total 101 79 (78.2%) 18 (17.8%) 4 (7.7%) 
*  Percentages are of users within each row category 
** Percentages are of total acupuncture users 
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Expectation of and Actual Outcome of Using Chinese Herbal Medicine 
Table 6.8 summarises the responses of CHM users on their expectations and outcome of using 
CHM. Similar to the expectation of acupuncture curing disease, just over half (53.2%) of 
users expected CHM would cure their disease. After receiving treatment, over two thirds 
(70.7%) of these users considered CHM had cured their disease or had solved the health 
problem they had before treatment. In addition, nearly one in five (16.7%) users who did not 
consider CHM would cure their disease had found CHM did provide such an outcome. A 
further eight users who were unsure whether CHM would cure their disease/solve their health 
problem had experienced a positive outcome, thus, the total positive outcome of curing 
diseases or solving problems was 51.9%. 
 
More users considered the outcome of CHM would be a relief of symptoms (79.2%) or would 
improve general health and well-being (84.4%) than cure the diseases (53.2%). Among those 
who considered CHM would relieve their symptoms of illnesses, the majority (90.2%) 
experienced a positive outcome. A high proportion of users who had not believed a relief of 
symptoms was possible or who had been uncertain about such an outcome also reported a 
positive outcome (75.0% and 66.7%, respectively). This represented a total positive outcome 
of 85.7% towards relieving symptoms by CHM. 
 
In all, nearly nine out of ten (89.6%) users considered CHM was favourable in improving their 
general health and well-being. The percentage was higher among those who had a positive 
expectation of using CHM to improve their general health (i.e. all but two users, or 96.9%). 
When taking no notice of users’ expectations towards CHM before treatment, a total of 33 
(42.9%) users considered that CHM had helped them achieve all three outcomes. In contrast, 
there were two CHM users who reported there was no effect after treatment. Neither of these 
had expected CHM would cure their disease or relieve their symptoms. 
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Table 6.8 Expectations of and actual outcomes of using Chinese herbal medicine 
After treatment (outcome)  
Before Treatment (expectation) Yes, 
n (%)* 
No, 
n (%)* 
Not sure, 
n (%)* 
Cure the disease/solve the problem, n (% of users)** 
Yes 41 (53.2%) 29 (70.7%) 7 (17.1%) 5 (12.2%) 
No 18 (23.4%) 3 (16.7%) 15 (83.3%) 0 (0%) 
Not sure 18 (23.4%) 8 (44.4%) 2 (11.1%) 8 (44.4%) 
Total 77 40 (51.9%) 24 ( 1.2%) 13 (16.9%) 
Relief of symptoms, n (% of users)** 
Yes 61(79.2%) 55 (90.2%) 3 (4.9%) 3 (4.9%) 
No 4 (5.2%) 3 (75.0%) 1 (25.0%) 0 (0%) 
Not sure 12 (15.6%) 8 (66.7%) 4 (33.3%) 0 (0%) 
Total 77 66 (85.7%) 8 (10.4%) 3 (3.9%) 
Improve general health and well-being, n (% of users)** 
Yes 65 (84.4%) 63 (96.9%) 2 (3.1%) 0 (0%) 
No 4 (5.2%) 0 (0%) 3 (75.0%) 1 (25.0%) 
Not sure 8 (10.4%) 6 (75.0%) 0 (0%) 2 (25.0%) 
Total 77 69 (89.6%) 5 (6.5%) 3 (3.9%) 
*  Numbers and percentages are of users within each row category 
** Numbers and percentages are of total acupuncture users 
 
 
General Helpfulness of Acupuncture and Chinese Herbal Medicine 
All users also rated their experience on the overall general helpfulness of acupuncture and 
CHM. A great proportion of users considered acupuncture treatment they had used was very 
helpful (60.0%) or somewhat helpful (30.1%), while a small proportion of users considered 
the outcome was not very helpful (six users, 5.1%) or not at all helpful (three users, 2.7%). 
These proportions were similar among the rating towards CHM. The vast majority of CHM 
users believed CHM treatment they had used was very helpful (55.6%) or somewhat helpful 
(39.3%), while two persons considered CHM was not very helpful or not at all helpful.
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6.1.1.9 Safety Concerns of Acupuncture and Chinese Herbal Medicine Use 
 
Adverse Events after Acupuncture and Chinese Medicine Treatment 
 
Among all acupuncture users, four persons reported adverse events (patient self-perceived) 
after having acupuncture treatment, but one of the answers was not recorded by the 
interviewer. Three users referred to the pain of the needle (whether or not it should be 
considered as an adverse event is debatable), and one of them also mentioned having a bruise 
on the skin. This corresponds to an incidence rate of adverse event of 3 in 100 acupuncture 
users. Alternatively, among all participants who had visited acupuncturists, a total of 699 
consultations had been made. This reflects an adverse event incidence rate of 4.3 per 1,000 
consultations. 
 
For Chinese herbal medicine (CHM), seven persons mentioned adverse event but one of the 
answers was not recorded by the interviewer. Two users experienced nausea after taking 
CHM; another two users considered the taste of the herbs as unpleasant or too strong. One 
person felt dizzy, and another user stated that “the liver cleansing power played havoc with 
me”. Thus, this corresponds to an incidence rate of 7.8% among CHM users. More strictly, 
when the definition of adverse event excludes mild gastrointestinal symptoms (e.g. nausea, 
unpleasant taste and discomfort), the incidence rate can be estimated as approximately 2.6%. 
However, whether the participants who encountered CHM adverse events used herbs that had 
been prescribed by their CHM practitioners or were self-prescribed was not established (a 
total of 160 consultations had been made among all CHM users, but the rate of self-
prescription was considerable high). Thus, an adverse event incidence rate per 1,000 
consultations seems inappropriate for CHM users.
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6.1.1.10 Referral Pattern and Future Use of Acupuncture 
 
Referral Pattern 
 
Most commonly, acupuncture users had received advice from their friends or relatives 
(40.8%). Advice from a medical doctor accounted for just over one fifth (20.7%) of the total 
responses. Some users had also received advice from a complementary medicine practitioner 
(18.7%), or from a newspaper, television and the Internet (4.2%). Only one user was referred 
by another health professional, such as a nurse. 
 
It is of safety concern that one in six users (17.8%) did not receive advice from any source. In 
particular, the use of acupuncture without receiving advice was more common in those aged 
35-64 (27.1%) than the younger group (18-34, 9.3%) and those aged 65 and older (none did 
not receive advice, χ2=8.230, p=0.016). In addition, middle-age users were also less likely 
(11.0%) to receive advice from a friend or a relative than the younger (46.3%) and older 
(49.2%) users, (χ2=6.953, p=0.031). those with private health insurance were more likely to 
receive advice from CAM practitioners to use acupuncture (25.7% with insurance vs. 5.7% 
without insurance, χ2=5.915, p=0.015). 
 
Future Use of Acupuncture 
 
Among all survey participants, nearly two thirds (62.4%) reported they would consider 
acupuncture as an option for their health care in the future, while nearly one third (30.4%) 
would not consider; 7.2% of users were not sure whether or not they would consider this 
option. More specifically, among the total of 991 participants who indicated they would 
consider acupuncture in the future, younger adults, those with postsecondary education, 
private health insurance and a higher income range were more likely to use acupuncture again 
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(Table 6.9). In addition, compared to other states, a relatively lower proportion of South 
Australia residents said they would consider using acupuncture in the future, although this is 
not statistically significant (χ2=8.552, p=0.073). On the other hand, among acupuncture users, 
the vast majority (94.7%) indicated they would use acupuncture again. Of the three users who 
indicated they would not consider using acupuncture in the future, none had previously 
experienced side-effects after using acupuncture, but two acupuncture users found it had not 
been very helpful for their health conditions (i.e. arthritis and osteoarthritis). 
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Table 6.9 Consideration for the use of acupuncture treatment in the future 
Consider using 
acupuncture in the future 
Statistical 
difference 
 
Characteristic 
Yes (%) No (%) Chi Square p 
Gender   0.216 0.642 
Female 66.5 33.5   
Male 67.9 32.1   
Age (year)   6.315 0.043 
18-34 69.2 30.8   
35-64 68.0 31.2   
65+ 59.0 41.0   
Country of Birth   2.554 0.11 
Australia 68.8 31.2   
Non-Australia 63.1 36.9   
State   8.552 0.073 
New South Wales 70.6 29.4   
Victoria 67.3 32.7   
Queensland 69.0 31.0   
South Australia 54.5 45.5   
Western Australia 62.7 37.3   
Self-reported health status   0.505 0.477 
Excellent/very good/good 67.6 32.4   
Fair/poor 64.6 35.4   
Post-secondary education   6.537 0.011 
No 63.0 37.0   
Yes 70.7 29.3   
Employment   2.569 0.109 
Employed 69.1 30.9   
Unemployed or not in labour force 64.0 36.0   
Private Health Insurance   10.176 0.001 
Yes 71.6 28.4   
No 62.0 38.0   
Annual household income     
<A$20,000 57.8 42.2 10.559 0.005 
A$20,000-A$40,000 69.8 30.2   
>A$40,000 71.7 28.3   
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6.1.1.11 Referral Pattern and Future Use of Chinese Herbal Medicine  
 
Referral Pattern 
 
Similar to the referral pattern for the use of acupuncture, most commonly, CHM users had 
received advice from their friends or relatives (45.4%). Advice from CAM practitioners 
accounted for just over one quarter (25.4%) of the total responses. However, only 6.5% users 
had received advice from a medical doctor. Receiving advice from a newspaper, television 
and the Internet (8.5%) and other health professionals (7.3%) constituted a relatively high 
proportion of responses. It is a safety concern that nearly one in 10 users (9.9%) did not 
receive advice from any source. In all, none of the demographic information was remarkable 
in relation to the referral pattern for CHM use. 
 
Future Use of Chinese Herbal Medicine 
 
Among all survey participants, over half (52.9%) said they would consider CHM as an option 
for their health care in the future, while over one third (35.0%) would not consider it as an 
option; 12.1% users were not sure whether or not they would consider this treatment. More 
specifically, among the total of 941 participants who had answered definitively about whether 
or not they would consider CHM in the future, those female, younger adults, who resided in 
New South Wales, Victoria and Queensland, and who were employed were more likely to use 
CHM again (Table 6.10). Similar to acupuncture use, the lowest rate of future projected CHM 
use among states was also reported in South Australia. On the other hand, among CHM users, 
the vast majority (97.5%) reported they would use CHM again. Of the two users who said they 
would not consider CHM in the future, one had previously experienced a side-effect after 
using CHM (dizziness). Another person had used CHM for his back pain and high blood 
pressure problem, but mentioned it had not been very helpful. 
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Table 6.10 Consideration for the use of Chinese herbal medicine treatment in the future 
Consider using CHM in 
the future Statistical difference 
 
Characteristic 
Yes (%) No (%) Chi Square p 
Gender   8.004 0.005 
Female 64.7 35.3   
Male 55.7 44.3   
Age (year)   28.518 0.0001 
18-34 66.8 33.2   
35-64 62.0 38.0   
65+ 41.4 58.6   
Country of Birth   1.226 0.268 
Australia 61.3 38.7   
Non-Australia 57.1 42.9   
State   17.086 0.002 
New South Wales 62.4 37.6   
Victoria 66.5 33.5   
Queensland 61.6 38.4   
South Australia 42.8 57.2   
Western Australia 50.3 49.7   
Self-reported health status   2.969 0.085 
Excellent/very good/good 61.3 38.7   
Fair/poor 53.7 46.3   
Post-secondary education   3.738 0.053 
No 56.7 43.3   
Yes 63.0 37.0   
Employment   6.687 0.01 
Employed 63.4 36.6   
Unemployed or not in labour force 54.6 45.4   
Private Health Insurance   2.905 0.088 
Yes 63.2 36.8   
No 57.7 42.3   
Annual household income   4.487 0.106 
<A$20,000 52.9 47.1   
A$20,000-A$40,000 63.3 36.7   
>A$40,000 61.9 38.1   
CHM: Chinese herbal medicine
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6.1.2 Chiropractic 
 
6.1.2.1 Overview 
As noted above, the overall prevalence of chiropractic use in Australia was 16.1% (95%CI: 
13.9% – 18.3%), being one of the most popular forms of CAM in Australia. The vast majority 
(90.6%) of chiropractic users had visited practitioners for therapy of all forms of CAM users. 
Chiropractic users had the lowest proportion (9.4%) who self-administrated the therapy. This 
also implies that approximately one in seven adult Australians (14.6%, 95%CI: 12.4% – 
16.7%) had visited a chiropractor in the 12-month preceding the survey in 2005. 
 
In general, those born in Australia who had private health insurance and higher household 
incomes were more likely to use chiropractic (p<0.01, Table 4.6). Gender, age and educational 
background did not appear to be major factors related to chiropractic use. On the other hand, 
there were smaller variations in users in different states, although the prevalence in 
Queensland (14.4%) and Western Australia (14.9) was slightly lower than the national 
average (not significant) while slightly higher than national average prevalence was reported 
in New South Wales (17.0%), Victoria (17.4%) and South Australia (17.0%) (see Table 5.1 
and Table 5.2). 
 
In terms of the frequency of visiting chiropractors, an annual rate of approximately 8.4 times 
per user was estimated for all users, which approximates to 19.05 million visits per year in 
Australia (see Table 4.9). The average out-of-pocket expenditure of visiting a CAM 
practitioner, as estimated in the current survey was A$25 (see Chapter 4.1.7.1). This suggests 
that a total out-of-pocket expenditure of A$476 million on chiropractor visits. In addition, of 
those users, 23 had incurred additional costs such as books and equipment related to their 
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chiropractic treatments. The median total chiropractic-related expenditure was A$200. Thus, 
nationwide, A$68.37 million would had spent on chiropractic-related items other than costs 
related to practitioner visits. This suggests, Australia nationwide, the total out-of-pocket 
expenditure spent on chiropractic services in the 12-month period was approximately A$544 
million. (see Appendix G9 for the unadjusted expenditure and G10 for a summary statistics of 
the adjusted data). 
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6.1.2.2 Rationale for the Use of Chiropractic 
 
After being identified as chiropractic users, participants were also asked about their main 
reasons (multiple responses) for using chiropractic. In all, well over two thirds (68.6%) used 
chiropractic for the relief of symptoms, with nearly half (42.5%) using chiropractic for the 
purpose of relieving symptoms only and not for any other purpose. Approximately one third 
(32.3%) used chiropractic for improving general health and well-being, with over 11.9% using 
it, exclusively to improve general health and well-being. Also, about one third (36.2%) of 
chiropractic users used it to improve the ability to undertake normal daily activities, while 
nearly one in 10 (9.4%) users also used chiropractic to improve their sporting performance. 
About 5.3% used chiropractic for all four purposes. 
 
More specifically, cross-tabulation analyses revealed that the only gender difference in the 
reasons for using chiropractic was to improve sporting performance. Not surprisingly, the use 
of chiropractic to improve sporting performance by male users (15.7%) was much higher than 
female users (4.0%) (χ2=6.828, p=0.009). Among different age groups, the only difference in 
the reasons for using chiropractic was to improve the ability to undertake normal daily 
activities. More than half (51.9%) of those 65 years of age or older used chiropractic for this 
purpose, compared with 38.2% of those aged 35-64 and 24.3% of those aged 18-34 (χ2=6.292, 
p=0.043). Other factors, such as education level, employment status and personal health status 
did not appear to influence choosing chiropractic.  
 
In terms of the specific symptoms for which users had sought chiropractic, nearly two thirds 
(65.7%) had used it for back pain or back-related problems. Other common conditions for 
which users had resorted to chiropractic were neck pain and related problems (20.7%), non-
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specific musculoskeletal problems (14.9%), headache and migraine (9.3%), and shoulder pain 
and related problems (5.3%). In addition, among those had used chiropractic to relieve 
symptoms, near half (43.9%) did so solely to relieve back pain or back-related problems and 
not for any other health conditions. On the other hand, only one person reported using 
chiropractic for a condition/symptom unrelated to a musculoskeletal problem (a 
gynaecological condition). 
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6.1.2.3 Use of Chiropractic–Regression Analyses 
 
Bivariate analyses revealed that nine predictor variables were significantly associated with 
chiropractic use: income range, country of birth, had consulted a GP in the preceding 12 
months, consulted a GP four times or more in the preceding 12 months, covered by private 
health insurance coverage of CAM influences the purchase of health insurance, visited a GP 
for back problems, visited a GP for cancer, and visited a GP for diabetes. These were entered 
into the logistic regression model by the stepwise method.  
 
Table 6.11 presents the results of the significant regression model for chiropractic users. It 
was not unexpected that those had visited a GP for back problems were 3.5 times more likely 
to have also used chiropractic than those who had not visited a GP for back problems. Also 
participants’ household income status substantially influenced their use of chiropractic. 
Compared to the low-income participants, people with a household income A$20,000 - 
A$40,000 were 3.3 times more likely to use chiropractic. The odds ratio increased to 3.8 times 
more likely to use chiropractic among those with a household income higher than A$40,000. 
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Table 6.11 Multivariate analyses of predictor variables for chiropractic use 
Predictors Odds ratio (95% CI) 
 <A$20,000 1.0 
 A$20,000-A$40,000 3.318 (1.510–7.287)** 
Income range >A$40,000 3.787 (1.844–7.777)** 
Overseas 1.0  
Country of birth Australia  2.070 (1.241–3.454)** 
No 1.0 Consulted a GP in the past 12 
months Yes 1.995 (1.133–3.513)* 
No 1.0 Coverage of CAM influences 
health insurance purchase Yes 2.325 (1.560–3.463)** 
No 1.0 
Visited a GP for back problems Yes 3.494 (1.447–8.437)** 
Omnibus Tests of Model Coefficients  
Chi square (degree of freedom, p value) 60.236 (6, <0.0001) 
Percentage accurate in classification 83.4 
* p<0.05; ** p<0.01; CI: confidence interval.
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6.1.2.4 Outcomes and Safety Concerns of Use of Chiropractic 
 
Users were asked the specific outcomes after their use of chiropractic. Almost three quarters 
(71.9%) mentioned that it relieved pain; half (50.2%) found it improved their ability to 
undertake normal daily activities; nearly half (45.5%) also found it improved their well-being; 
an additional 23.1% of users also considered chiropractic had decreased a disability. In total, 
nearly one in five (19.5%) users found that, after seeking chiropractic treatment, they had 
achieved all four outcomes. 
 
Older people (58.2%) and those from the middle-age group (aged 34-64, 58.9%) were more 
likely to use chiropractic to improve their ability to undertake normal daily activities than the 
younger adults (aged 18-34, 30.7%) (χ2=11.08, p=0.004). Also, a higher proportion of users 
with poor or fair health reported a helpful outcome of decreased disability (38.6%) and 
improved normal daily activity (67.5%) than those who considered themselves to be in better 
health (19.5%, χ2=5.481, p=0.019; and 46.4%, χ2=4.751, p=0.029, respectively). 
 
It may be of particular interest that there were fewer users in Victoria (58.4%) and Queensland 
(65.6%) who provided a positive answer to the outcome of pain relief than users in New South 
Wales (82.3%), South Australia (81.3%) and Western Australia (83.9%) (χ2=9.852, p=0.043). 
No additional regional difference was observed in other outcomes. On the other hand, more 
users with private health insurance believed chiropractic had improved their general health 
(51.6%) than people without private health insurance (33.0%) (χ2=5.303, p=0.021). 
 
All users also rated their experience on the overall general helpfulness of chiropractic. The 
majority of users believed the chiropractic treatment they had used was very helpful (71.4%) 
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or somewhat helpful (21.6%), while a small proportion of users received a less helpful 
outcome (not very helpful, 2.6%, and not at all helpful, 2.4%). 
 
Among all users, a total of nine persons reported adverse events (patient self-perceived) after 
having chiropractic treatment. These included pain after treatment (three persons), 
headache/migraine immediately after treatment (two persons), and tiredness (one person). The 
worst scenario was aggravation of a major back injury (treatment was provided without an x-
ray). Two reported adverse events which could be considered as “dissatisfaction of treatment”, 
were “it does not do any thing”, and “you tend to go back and they fix it”. Thus, this (7 
reported adverse events) corresponds to an incidence rate of 4.0% among users. Alternatively, 
among all participants who had visited chiropractors, a total of 1,352 consultations were 
made. This reflects an adverse event incidence rate of 5.2 per 1,000 consultations. 
 
With respect to the general opinion on the safety aspect of chiropractic, over 81.0% of all 
survey participants either strongly agreed (16.5%), agreed (43.6%) or partially agreed (20.9%) 
that chiropractic is safe. Perception of safety was even more convincing when the opinion of 
chiropractic users is considered. Those who strongly agreed that chiropractic is a safe form of 
treatment increased from 16.5% of all survey participants to 43.2% of chiropractic users. On 
the other hand, those who did not agree that “chiropractic is a safe form of treatment” 
decreased from 9.6% of all participants to approximately 1.9% (three users) of chiropractic 
users. In the latter category, one had encountered an adverse effect (i.e. severe pain). 
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6.1.2.5 Referral Pattern and Future Use of Chiropractic 
 
In terms of using chiropractic on the advice of other people, the most common response was 
from users’ friends or relatives (43.6%). Advice from a medical doctor accounted for exactly 
one fifth (20.0%) of the total responses. Some users also received advice from a 
complementary medicine practitioner (7.2%), from a newspaper, television and the Internet 
(1.3%) or from another health professional such as a nurse (2.6%). 
 
It is of safety concern that over one quarter (27.2%) of chiropractic users did not receive 
advice from any source. In particular, the use of chiropractic without receiving advice was 
much more common in those aged 65 and older (45.6%) and those aged 35-64 (31.2%) than in 
the younger group (18-34, 9.6%, χ2=13.505, p=0.001). As may have been expected, those 
having a better health (self-rated) were more likely to receive advice from a friend or relative 
(47.0% vs. 27.8%, χ2=4.051, p=0.044), while those having poor or fair health were more 
likely to receive advice from their medical doctor (36.9% vs. 16.1%, χ2=7.208, p=0.007). In 
contrast, those who had private health insurance were less likely to receive advice from their 
medical doctor to use chiropractic (15.6% vs. 29.0%, χ2=4.286, p=0.039), but more likely to 
use chiropractic without any advice (32.7% vs. 16.7%, χ2=4.957, p=0.026). 
 
Among all survey participants, well over two thirds (68.1%) said they would consider 
chiropractic as an option for their health care in the future, while 26.9% would not consider it. 
More specifically, among the total of 1,015 participants who had made a definitive answer of 
whether or not they would consider chiropractic in the future, the younger, male adults, who 
resided in the states of New South Wales and Western Australia, were in a better health, 
employed and in the higher income range, were more likely to use chiropractic (Table 6.12). 
On the other hand, among chiropractic users, the vast majority (93.3%) said they would use 
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chiropractic again. Of the ten users (5.1%) who said they would not consider using 
chiropractic in the future, two had previously experienced side-effects after using chiropractic, 
including severe pain and aggravation of a major back injury. 
 
Table 6.12 Consideration for the use of chiropractic treatment in the future 
Consider using 
chiropractic in the future Statistical difference 
 
Characteristic 
Yes (%) No (%) Chi Square p 
Gender   5.667 0.017 
Female 68.3 31.7   
Male 75.1 24.9   
Age (year)   17.184 0.0002 
18-34 79.1 20.9   
35-64 70.2 29.8   
65+ 62.0 38.0   
Country of Birth   0.001 0.993 
Australia 71.8 28.2   
Non-Australia 71.9 28.1   
State   19.637 0.001 
New South Wales 76.5 23.5   
Victoria 68.5 31.5   
Queensland 68.3 31.7   
South Australia 58.0 42.0   
Western Australia 82.7 17.3   
Self-reported health status   4.014 0.045 
Excellent/very good/good 72.8 27.2   
Fair/poor 64.9 35.1   
Post-secondary education   0.017 0.896 
No 71.9 28.1   
Yes 71.5 28.5   
Employment   9.695 0.002 
Employed 74.9 25.1   
Unemployed or not in labour force 65.6 34.4   
Private Health Insurance   0.293 0.588 
Yes 70.9 29.1   
No 72.5 27.5   
Annual household income   9.970 0.008 
<A$20,000 64.3 35.7   
A$20,000-A$40,000 68.1 31.9   
>A$40,000 75.7 24.3   
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6.1.3 Osteopathy 
6.1.3.1 Overview 
As above noted, the overall prevalence of osteopathy use in Australia was 4.6% (95%CI: 3.3% 
– 5.9%, a total of 51 unweighted numbers of users). As a provider-based therapy, most 
osteopathy users (76.4%) had visited practitioners for treatment. Surprisingly, the proportion 
of self-administrating users (23.6%) was quite high. In total, approximately one in every 28 
adult Australians (3.5%, 95%CI: 2.4% – 4.6%) had visited an osteopath in the 12 months 
preceding the survey in 2005. 
 
There are different forms of osteopathy in clinical practice, of which the most commonly 
known and reported by the survey participants was as a form of massage therapy (66.1%). At 
least half the participants also considered that the type of osteopathy treatment they had used 
was the mobilisation or “popping of joints” (58.6%), stretching (58.5%), or a gentle technique 
(may be called functional or cranial, 51.3%). Over 57.3% also mentioned that they had 
received exercise advice from their osteopathy practitioners.  
 
Consistent with the characteristics that related to overall CAM use, female (5.8%) participants 
were more likely to use osteopathy than male participants (3.3%, p<0.05). Interestingly, those 
in the middle household income range used the least osteopathy (1.3%), while those in the 
lower and higher income ranges used osteopathy much more (6.7% and 5.5% respectively, 
p<0.05) (Table 4.6). In addition, osteopathy use appeared to vary between states. Participants 
from New South Wales and Victoria were more likely to use osteopathy than those from any 
other states (p<0.05, Table 5.1). In relation to the characteristics of those who visiting an 
osteopath, in addition to the differences in the use of osteopathy, educational background and 
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private health insurance coverage also appeared to be determinants of osteopathy use (Table 
5.2). 
 
Users of osteopathy visited practitioners approximately 5.9 times per annum. Thus, a total of 
3.08 million visits were estimated per annum in Australia (see Table 4.9). Using the average 
out-of-pocket expenditure of visiting a CAM practitioner, as estimated in the current survey 
(A$25, Chapter 4.1.7.1), this equals A$77 million spent on osteopath visits in the 12 months 
preceding the survey. In addition, ten osteopathy users indicated that they had spent additional 
money on items such as books and equipments related to their osteopathy treatments. The 
median cost was A$50.0. Thus, nationwide, the total out-of-pocket expenditure on osteopathy 
in the 12-month period can be estimated as A$83.47 million, with A$6.47 million spent on 
items other than practitioner visits (see Appendix G9 for the unadjusted expenditure and G10 
for a summary statistics of the adjusted data). 
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6.1.3.2 Rationale for the Use of Osteopathy 
 
Osteopathy users were asked the same questions as were put to chiropractic users about their 
main reasons for seeking treatment (see Chapter 6.1.2.2), and they also provided multiple 
responses to their rationale for use. In all, over three quarters (75.9%) used osteopathy for the 
relief of symptoms, including nearly two fifths (38.0%) who used it solely for the purpose of 
relieving symptoms. Over two fifths (40.6%) used osteopathy to improve general health and 
well-being, including 14.5% who used it for the purpose of improving general health and 
well-being only, rather than for other purposes. More than two fifths (41.9%) of participants 
used osteopathy to improve their ability to undertake normal daily activities, while nearly one 
in six (17.1%) used osteopathy to improve their sporting performance. 
 
Cross-tabulation analyses revealed an interesting finding. Those born overseas used 
osteopathy to improve general health and well-being much more than those born in Australia 
(70.6% vs. 33.5%, χ2=4.297, p=0.038). On the other hand, the only gender difference in the 
reasons for using osteopathy was to improve the ability to undertake normal daily activities. In 
this respect, female users were three times (54.2%) more likely to use osteopathy than male 
users (19.7%, χ2=5.443, p=0.020).  
 
Among users who had resorted to osteopathy for the relief of symptoms, 48.4% had used it for 
back pain or back related problems, 35.2% had used it for non-specific musculoskeletal 
problems (eg. restricted movement), 22.9% had used it for shoulder problems, and 10.7% for 
neck problems. Osteopathy users had also used it for other conditions, such as headache, 
spinal or knee problems. In addition, among those had used osteopathy to relieve symptoms, 
nearly one quarter (24.7%) had used it solely to relieve back pain or back-related problems 
only.
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6.1.3.3 Use of Osteopathy–Regression Analyses 
Bivariate analyses revealed that five predictor variables were significantly associated with 
osteopathy use: gender, income range, coverage of CAM influences the purchase of private 
health insurance, visiting a GP for back problems, and visiting a GP for heart-related 
problems. These were entered into the logistic regression model by the stepwise method. 
 
As presented in Table 6.13, those who had visited a GP for back problems were 4.3 times 
more likely to have also used osteopathy than those who without back problems. It is worth 
further investigating why the highest odds ratio of osteopathy use was those with the lowest 
household incomes. Compared to those with a household income of A$20,000 A$40,000, 
people who earned less than A$20,000 were up to 18 time more likely to use osteopathy. The 
odds ratio of people with the lowest incomes using osteopathy was high, (1.6 times higher, but 
not statistically significant) compared to those with household incomes higher than A$40,000 
(see Table 4.6). This finding may be somewhat unreliable due to the relatively small sample 
size (45 osteopathy users) entered into the regression analysis. 
 
Table 6.13 Multivariate analyses of predictor variables for osteopathy use 
Predictors Odds ratio (95% CI) 
 <A$20,000 1.0 
 A$20,000-A$40,000 0.054 (0.007–0.429)** 
Income range >A$40,000 0.624 (0.298–1.306) 
No 1.0 
Coverage of CAM influences health 
insurance purchase Yes 4.760 (2.139–10.592)** 
No 1.0 
Visited a GP for back problems Yes 4.318 (1.137–16.402)* 
Omnibus Tests of Model Coefficients  
Chi square (degree of freedom, p value) 34.817 (4, <0.0001) 
Percentage accurate in classification 95.0 
* p<0.05; ** p<0.01; CI: confidence interval
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6.1.3.4 Outcomes and Safety Concerns of Use of Osteopathy 
 
In regard to the outcomes of osteopathy use, over three quarters (79.5%) of users mentioned 
that it relieved pain; three out of five users (60.5%) found it improved their ability to 
undertake normal daily activities; nearly half (45.6%) also found it improved their well-being; 
an additional 40.6% of users considered osteopathy had decreased a disability. In total, nearly 
one in three (29.7%) users found that, after seeking osteopathy treatment, they had achieved 
all four outcomes. None of the particular user characteristics was found significantly related to 
different outcomes. 
 
All except two users rated their experience on the overall general helpfulness of using 
osteopathy. The majority of users believed their osteopathy treatments were very helpful 
(64.2%) or somewhat helpful (28.4%), while only two users reported a less helpful outcome 
(one did not believe it was very helpful, while another believed it was not at all helpful).  
 
Importantly, a total of four users (an incidence rate of 7.8%) reported adverse events (patient 
self-perceived) after having osteopathy treatment. These included more pain, soreness, “very 
tired’’ and “neck cracks a lot more after treatment’’. However, it is important to note that all 
of these were controversial in terms of whether or not they should be considered as adverse 
events. The adverse event incidence rate per 1,000 consultations was not calculated against 
the osteopathy treatment. 
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6.1.3.5 Referral Pattern and Future Use of Osteopathy 
 
The most common referral channel for using osteopathy was from users’ friends or relatives 
(38.1%). Advice from complementary medicine practitioners accounted for over one fifth 
(21.5%) of the total responses, closely followed by advice from a medical doctor (16.1%). 
Two additional users were referred by other health professionals, such as a nurse (one person) 
and through newspapers, television and Internet (one person). However, there were six users 
(13.2%) did not receive advice from any source. Four of them were from New South Wales 
and five of them were female. 
 
Among 32 osteopathy users who were employed at the time of the survey, only two (weighted 
percentage, 6.4%) had received advice from their medical doctors while six out of 18 (29.5%) 
unemployed osteopathy users had received advice from a medical doctor (χ2=4.686, p=0.030). 
One third (ten out of 28, 33.7%) of the users aged 35-64 had received advice from a 
complementary medicine practitioner, while only one user aged 65 and older and none from 
the group aged 18-34 had received advice from a CAM practitioner (not statistically 
significant, χ2=5.899, p=0.052).  
 
Among all survey participants, just over half (52.0%) said they would consider osteopathy as 
an option for their health care in the future; 24.9% would not consider, and the remaining 
23.1% were not sure about osteopathy (e.g. lack of knowledge of osteopathy and did not 
respond to the current question). On the other hand, among osteopathy users, five users 
(12.4%) said they would not consider using osteopathy again. This included one person who 
had experienced a side-effect (pain) after using osteopathy. 
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Finally, among the total of 814 participants with a definite response to whether or not they 
would consider osteopathy in the future, there was no difference between participants’ socio-
demographic characteristics and their decision to use osteopathy in the future (Table 6.14). 
 
Table 6.14 Consideration for the use of osteopathy treatment in the future 
Consider using 
osteopathy in the future Statistical difference 
 
Characteristic 
Yes (%) No (%) Chi Square p 
Gender   0.039 0.843 
Female 67.3 32.7   
Male 68.0 32.0   
Age (year)   4.316 0.116 
18-34 69.4 30.6   
35-64 68.9 31.1   
65+ 59.9 40.1   
Country of Birth   0.727 0.394 
Australia 67.0 33.0   
Non-Australia 70.3 29.4   
State   8.183 0.085 
New South Wales 68.2 31.8   
Victoria 73.9 26.1   
Queensland 67.5 32.5   
South Australia 56.6 43.4   
Western Australia 63.4 36.6   
Self-reported health status   1.009 0.315 
Excellent/very good/good 68.3 31.7   
Fair/poor 63.6 36.4   
Post-secondary education   0.412 0.521 
No 68.8 31.2   
Yes 66.7 33.3   
Employment   2.426 0.119 
Employed 69.7 30.3   
Unemployed or not in labour force 64.3 35.7   
Private Health Insurance   0.404 0.525 
Yes 68.7 31.3   
No 66.6 33.4   
Annual household income   0.218 0.897 
<A$20,000 66.6 33.4   
A$20,000-A$40,000 69.2 30.8   
>A$40,000 67.6 32.4   
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6.2 Discussion 
 
6.2.1 Chinese Medicine (Acupuncture and Chinese Herbal Medicine) 
Until the introduction of Western medicine in China in the 18th century,156 traditional Chinese 
medicine (CM) had been the primary form of health care for several thousand years.157 Even 
now, Chinese medicine provides 40% of health-care services to the Chinese population. 158 
Moreover, during the past several decades, Chinese medicine has become part of the health-
care systems of many other Asian regions 159,160 and, more recently, it has been gaining 
acceptance in most Western countries as a therapeutic alternative to conventional Western 
medicine.3,11 In recent years, the integration of Chinese medicine in the conventional medical 
settings in the Western countries is not uncommon. For example, through an integrative 
health-care approach, the Center for East-West Medicine within the Department of Medicine 
at the University of California, Los Angeles believed that Chinese medicine has much to offer 
to patients with cancer.161 The increasing popularity of Chinese medicine in Western countries 
has been accompanied by concerns about its efficacy 162,163 and safety,164,165 both when used 
alone and in combination with Western medical treatments. 
 
The information available on the use of Chinese medicine in Australia comes from a landmark 
study completed in 1996 (and the publication of “Toward a Safer Choice – the Practice of 
Traditional Chinese Medicine in Australia”).166 It is important to note that the 1996 study was 
a Chinese medicine national workforce survey for which the CM participants were 
practitioners and educators, and the focus was on education, the risks and benefits associated 
with the practice of CM, and regulatory frameworks. The study provided a profile of patients 
who choose to use CM by asking practitioners to complete a questionnaire for every patient 
treated on a specific day. Since the study subjects had chosen to use CM, it was not able to 
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provide information on the prevalence and patterns of CM use in the general population. It 
also did not provide insightful information on public perceptions of CM. The study was 
conducted a decade ago and there would seem to have been dramatic changes since then in the 
public use of CM in Australia. 
 
The use of Chinese medicine, as a defined health-care approach, was not specifically 
researched in most surveys in Australia and overseas, and consequently there is a lack of 
nationwide, population-based representative data on Chinese medicine use in Australia. 
Addressing this deficiency, the current study included the major modalities of Chinese 
medicine (acupuncture, Chinese herbal medicine, Chinese therapeutic massage, Chinese 
medicine dietary therapy, Qigong, martial art and Tai Chi) as the totality of CM. 
 
With the above broader definition of CM, the current study presents an estimation of the 
national and regional prevalence of CM use among the general population in Australia. Nearly 
one in five adult Australians had used any one form of CM in the 12-month period preceding 
the survey, and one in nine had visited CM practitioners in the 12-month period. These 
findings again echo the increasing popularity of all forms of CAM in Australia. There is a lack 
of accurate information of CM use among the general population in other Western countries. 
Systematic literature searches (see Chapter 2) have identified only one similar study which 
investigated such CM information in Western countries. The estimated CM prevalence 
(17.2% visited CM practitioners in the two-year period) in New York City’s Chinatown is 
higher than the current Australian estimation.100 However, this New York study was based on 
randomly selected Chinatown residents. 
 
According to the current national survey, the lowest prevalence of CM use was found in the 
state of Western Australia, and the lowest prevalence of visits to CM practitioners was found 
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in Western Australia and South Australia. Specifically, the marked differences between 
different states, in fact, were for the two major Chinese medicine modalities: acupuncture and 
Chinese herbal medicine, both in overall use and prevalence of visits to practitioners (see 
Table 5.1 and Table 5.2). Thus, the current survey confirmed two research hypotheses: 1) 
certain forms of CAM are more prevalent in some states within Australia and, 2) among all 
states and territories, Chinese medicine, including acupuncture and CHM, is more prevalent in 
New South Wales, Victoria and Queensland. 
 
The current study also found acupuncturists were visited more frequently than practitioners of 
the other 16 forms of CAM. The result is not surprise, as numerous reports have suggested the 
popularity of acupuncture use both in Australia and overseas. 5,6,17,102,167,168 With the 
continuing increase in scientific evidence relating to the mechanism and efficacy of 
acupuncture in treating certain chronic diseases,169-172 there is little doubt that acupuncture is 
one of the most popular forms of CAM in Western countries. It is being used by millions of 
patients, and is practiced by traditional acupuncturists, medical doctors,95 and by many other 
health professionals, such as licensed chiropractors and nurses. 
 
The total estimated number of visits to acupuncturists in Australia is substantial in terms of 
the frequency of visits and the cost to the Australian health system. As mentioned earlier, the 
Australian national health insurance, Medicare, only covers the cost of acupuncture services 
provided by registered medical practitioners. Thus, the current estimated millions of 
acupuncture treatments were mainly borne by the users. The cost implications and non-
claimable acupuncture services provided by non-GP acupuncturists meant that in the current 
study, one in five people who had received acupuncture treatment, received it from GPs only. 
Secondary analysis of the 1996 Health Insurance Commission data reveals that there were 
960, 000 Medicare claims for acupuncture in the 1996-97 financial year, totalling $17.7 
  
217 
million in reimbursements.167 It is worth noting that these approximately one million claims 
did not include acupuncture treatments funded by Workers Compensation and the Department 
of Veterans Affairs, or treatments provided in public hospitals. After 10 years of growing 
popularity of acupuncture use and practice in Australia, the current estimated 10.16 million 
visits to acupuncturists, including services provided by GPs and non-GPs, seems to be 
consistent with the data and reflects the increasing trend of using acupuncture. 
 
The current survey also estimated that the combined total number of practitioner visits by 
adult Australians for acupuncture, CHM and Chinese therapeutic massage was about 15 
million. However, the figure must be interpreted with extreme caution. Based on the nature of 
Chinese medicine, most CM practitioners practice both acupuncture and Chinese herbal 
medicine. This is also evidenced by a report of the Chinese Medicine Registration Board of 
Victoria in June 2006 that, nearly 60% of registered CM practitioners in Victoria are 
registered for both acupuncture and CHM.173 In addition, the application of Chinese 
therapeutic massage in CM practitioners’ practice is not unusual. 
 
The current survey found that the characteristics of CM users are similar to the general 
characteristics of CAM users. However, for both CM users and people who had visited CM 
practitioners, there was no gender difference or difference in whether or not they had private 
health insurance. However, the use of acupuncture and Chinese herbal medicine between 
adults who were born in Australia or overseas was significant. Acupuncture appears have been 
more accepted than CHM by Australian-born adults. That is, a significantly higher proportion 
of Australian-born adults used acupuncture, but a significantly lower proportion of Australian-
born adults used CHM, when compared to those born overseas. Furthermore, multivariate 
analyses found those born overseas were 2.3 times more likely to use CHM than the 
Australian-born residents. 
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In clinical practice, Chinese medicine treatment is typically highly individualised and based 
on a holistic philosophy value. It was also expected that people have used acupuncture and 
CHM for varied health conditions. Thus, the current survey participants mentioned that they 
used CM for over 30 different health conditions. What the common forms of herbs that are 
being used for specified health conditions were not researched. However, about three-quarters 
of acupuncture users used acupuncture for musculoskeletal- related conditions, notably for 
back pain and shoulder problems.  
 
It is interesting to note that over one third of CHM users actually used CHM for general health 
and well-being. The individual names of each of the CHM modalities that were used by 
survey participants are beyond the scope of the current survey. However, there were a large 
proportion of people who self-used CHM, particularly for general health, rather than specified 
health conditions. This implies that a number of people may use herbal supplements to 
improve their health, such as Ginseng to enhance the immune system, which is based on 
Chinese medicine theory, (to “tonify” the Qi of the body). 
 
Consumers are asserting their rights to choose different modes of health care. As one of the 
most commonly used forms of CAM, Chinese medicine is used by consumers from diverse 
cultural backgrounds. Since the publication of a review of Chinese medicine practice in 
Australia by Bensoussan, Myers et al., 166 CM has experienced significant development. 
Firstly, the introduction of the statutory regulation of Chinese medicine practitioners in 
Victoria, enforced by the Victorian Chinese Medicine Registration Act 2000, made Victoria 
the first state in Australia to register Chinese medicine practitioners. Implementation of 
Chinese medicine practitioner registration in Victoria is an important initiative for the 
profession and should lead to enhanced public safety and confidence in Chinese medicine use 
in Australia. Secondly, it is highly likely that other states will follow Victoria’s lead in the 
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future. For example, the discussion documents on regulatory considerations in the states of 
New South Wales and Western Australia.174,175 Thus, the current survey has investigated the 
impact of the CM Registration Act on public attitudes to Chinese medicine (see regulation 
section, Chapter 7.1.5). In all, participants suggested that a much more stringent surveillance 
system in all states and territories is necessary to protect the public from unregistered and 
unqualified Chinese medicine practitioners. 
 
It is of safety concern that one in six acupuncture users and one in ten CHM users did not 
receive advice from any source in using these therapeutic treatments. As mentioned above, 
there are increasing concerns about the adverse events that may relate to the use of CAM 
therapies and products. This safety concern extends if the CAM use was not supervised or had 
been used concurrently with other CAM products and/or conventional medicines. The results 
also suggest an educational approach should be developed by government authorities, such as 
the TGA and, professional registration bodies, such as the Chinese Medicine Registration 
Board, to improve the awareness of the potential risks among therapies and products, which 
are not exclusively related to any individual forms of CAM or conventional medicine.  
 
In summary, the utilisation of different forms of CM in Australia is more prevalent among the 
general population than had been generally assumed. There are marked differences in the 
overall CM prevalence among different states. The variations between states are found mainly 
in the utilisation of acupuncture and Chinese herbal medicine. While more research must to be 
undertaken to improve the understanding of the mechanism and efficacy of CM, strategic 
health planning is also necessary to keep consumers and health professionals informed about 
the safety aspects of different forms of CM. 
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6.2.2 Chiropractic 
 
Both chiropractic and osteopathy are manipulative therapies, for which practitioners use their 
hands (as well as modern technology) to diagnose and treat abnormalities of the structure and 
function of the musculoskeletal system of the body. 176 One does not need to look very far to 
search for the popular use of such manipulative therapies in different countries. According to 
previous CAM surveys, at least 11% of Americans,3 13% of Canadians,6 and 16.7% of 
Australians11 used chiropractic in a 12-month period. The current survey revealed a similar 
prevalence: 16.1% of adult Australians used chiropractic. 
 
The current survey found a higher overall CAM prevalence compared to previous regional 
surveys.11 Individual prevalence of most forms of CAM estimated in the current survey was 
also relatively higher than those found previously in Australian regional studies. Perhaps, with 
the exception of multivitamins, that is, different definitions were used in different surveys and 
a comparison was not available, the only higher prevalence observed in previous surveys 
compared to the current survey was the use of chiropractic. In fact, the prevalence of 16.7% 
estimated in the South Australian study was based on the proportion of people who had visited 
chiropractors. This was higher than the current national estimation of people who had visited a 
chiropractor (14.6%). A small proportion of chiropractic users self-administrated, and details 
were not collected in the current survey. Again, the finding may be reasonably explained by 
the regional differences among different states. The current survey found that the states of 
South Australia, Victoria and New South Wales had a higher than national average prevalence 
of chiropractic use, whereas the prevalence of chiropractic in other states was slightly lower 
than the national average. The chiropractic prevalence in South Australia (17.0%) in the 
current survey seems to be consistent with a 2004 South Australia regional estimation 
(16.7%).11 
  
221 
In all states and territories of Australia, chiropractic is subject to practitioner registration. 
Despite the evidence of high prevalence of use in Australia,11 little is known about who the 
chiropractic users are in Australia, why they use it, and the perceptions and consequences of 
chiropractic treatment. On the other hand, these matters were investigated in the US,177 
Canada,178 Denmark,179,180 the Netherlands,181 and in Sweden.182 Nevertheless, the profile of 
middle-aged Australian women who consult a chiropractor or osteopath has been published 
recently, based on a large-scale longitudinal study on women’s health.183 It revealed that 
women living in non-urban areas and women with a lower level of education were more likely 
to use chiropractic or osteopathy. Such findings were not supported by the current survey. 
However, the current survey suggests Australian-born adults are significantly more likely to 
use chiropractic than those born overseas (odds ratio=2.07).  
 
Similar to the mean number (9.8) of chiropractor visits per annum in the US in 1996,3 the 
current survey also reveals that chiropractors are the second most-frequently visit of all forms 
of CAM practitioners. The average of 8.4 visits per year per chiropractic user represents over 
19 million visits by all adult Australians. As noted, the costs related to chiropractor visits are 
still mainly borne by consumers. In addition to consultation and treatment costs, 
approximately one in eight chiropractic users indicated that they also spent money on books or 
equipment related to chiropractic treatment. Thus, the economic burden borne by chiropractic 
users in Australia seems substantial. It is interesting to note, based on one year health service 
records from over 2,000 low-back pain patients, a US study suggested that the mean costs 
associated with chiropractic patients were significantly higher than those patients treated by 
medical doctors.184 
 
The use of chiropractic for back pain and back-related problems is well documented in the 
literature.177-179,181 The current survey further confirms such a finding among the Australian 
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general public. Nearly two thirds of chiropractic use was for back pain or back-related 
problems. Thus, multivariate analysis estimated that the chance of Australian people using 
chiropractic was about 3.5 times higher among those with back problems, compared to those 
without back problems. Furthermore, the use of chiropractic treatment for a specific health 
condition, rather than for the musculoskeletal system, is not common in the current survey. Of 
176 chiropractic users, only one person used it for a gynaecological condition. In contrast, a 
much higher prevalence of non-musculoskeletal complaints in chiropractic practice was found 
in a multinational study, which accounted for about one in ten (10.3%) of all chief 
complaints.185 
 
A previous survey found similar proportions of Australian adults with lower back pain had 
consulted GPs (22.4%) or chiropractor (19.3%), which was considerably higher than the 
proportion of consultations with physiotherapists (13.4%).186 Thus, the researchers further 
suggested that visits to chiropractors may have a greater “market share” in Australia, while 
due to historical and other reasons, physiotherapists have been much more commonly 
accepted as a form of allied health in the national health system in Australia. Nevertheless, the 
Australian Government is increasing the exclusive ancillary position of chiropractic, including 
osteopathy treatment, the Australian national health system (Medicare) now provides limited 
rebates for people with chronic conditions and complex care needs.187 
 
In the current survey, after receiving chiropractic treatment, almost three quarters of the users 
considered it was very helpful, and a similar proportion of users also agreed chiropractic had 
relieved various forms of pain. Although nearly half of all users considered chiropractic had 
also improved their general health and well-being, detailed non-musculoskeletal responses to 
chiropractic treatment have not been investigated in the current study. A multinational survey 
of chiropractic patients in seven countries estimated that positive non-musculoskeletal 
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reactions to chiropractic were not rare, with an improvement in breathing (27%), digestion 
(26%) and circulation (21%) being most common.188 The specific benefits of chiropractic are 
necessary in future chiropractic research in Australia. 
 
It is worth mentioning that one in five chiropractic users received advice from their medical 
doctors to use chiropractic. In past decades, many efforts have been made to integrate 
conventional medicine and CAM therapies.95,189,190 Many health professionals are now 
working in a multi-disciplinary environment. For example, one in 10 chiropractors in the US 
is practicing as a member of a multi-disciplinary team that includes medical doctors191 and, 
most chiropractors had received a referral from medical doctors in the US.192 Such 
information is limited in Australia, so future studies may concentrate on a strategy to improve 
the communication between these two professions (i.e. chiropractor and GP). Follow-up 
studies should reveal the barriers and motivations of patient referral. 
 
A moderate proportion of users (27.2%) did not receive any advice in seeking chiropractic 
care. This seems to be consistent with the fact that most survey participants considered 
chiropractic treatment to be safe and the adverse event rate reported by all users was less than 
three per 1,000 consultations. Limited Australian literature provides information on concerns 
about adverse events and safety issues relating to chiropractic. It has been suggested that 
adverse events were more commonly reported if a practitioner applied cervical spine 
manipulation rather than mobilisation.193 On the other hand, a previous study revealed that 
some people experienced dizziness, nausea or other “abnormal reaction” after treatment.194 In 
addition, although rare, serious adverse events such as stroke and vertebral artery dissection 
after cervical spine manipulation continue to be reported.195 In the current survey, a major 
back injury, due to chiropractic treatment provided without performing an x-ray, was reported 
by one of the participants. Chiropractic practitioners should be alerted in terms of precautions. 
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6.2.3 Osteopathy 
 
As noted, osteopathy is one of the major forms of manipulative CAM therapies. More 
popularly, a study in Scotland found 12% osteopath use in 1999.196 A 1998 UK study found a 
4.3% use of osteopathy in a 12-month period, and a 13% lifetime use.5 The use of osteopathy 
was found to be not very common in Canada (less than 4%).6 According to two UK 
studies,5,17 the prevalence of osteopathy in the UK was higher than the prevalence of 
chiropractic. The proportion of Australians who used osteopathy treatment, however, is far 
less than chiropractic, as evidenced in previous Australian regional CAM surveys (0.4% 
visited osteopaths and 16.7% visited chiropractors),10,11 and the current survey shows 4.6% 
visited osteopaths compared to 16.1% who visited chiropractors). 
 
According to the second Osteopathic Survey of Health Care in the US in 2000, the prevalence 
of the use of osteopathy then was 7%, with a lifetime use of 16%.197 It is important to note 
that osteopathic medicine was not included as a form of CAM in the US surveys.1,3,4 
Practitioners of osteopathic medicine in the US are fully trained as doctors of osteopathic 
medicine (D.O.). They are licensed medical physicians with the same professional level as 
other physicians in the US health system.116 According to the United States Code of Federal 
Regulations, the practice of osteopathic medicine is included in the definition of allopathic 
family medicine (commonly known as Western medicine).198 Thus, osteopathy practitioners in 
the US can do anything that a conventional medical doctor can do, in all 50 states in the 
US.199 For historical and other reasons, osteopathy treatment may not be considered as a form 
of CAM in the US.200 However, it is still classified under one of the five NCCAM domains of 
CAM (i.e. the umbrella of manipulative and body-based practices).36 In most countries, 
including Australia, osteopathy is commonly included as part of the CAM definition. This 
definition is used in the current study. 
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Unlike the small variations in the use of chiropractic between different states in Australia, the 
prevalence of osteopathy in different states seemed to vary significantly. The proportion of 
adults in the states of South Australia and Western Australia who used osteopathy was lowest 
among the other states. This finding, however, must be interpreted with caution, due to the 
small number of survey participants who had used osteopathy across all states.  
 
Osteopathy, chiropractic and other manipulative therapies, including certain allied health 
professions (e.g. physiotherapy), share some common functional techniques, such as 
mobilisation. The current survey revealed that most commonly, about two thirds of osteopathy 
users considered the forms of osteopathy treatment they received were massage-like. In 
addition, at least half of osteopathy users also described the treatment as mobilisation, 
“popping of joints”, strength, or cranial therapy. Thus, a variety of the techniques used by 
osteopaths are highly associated with techniques that deal with musculoskeletal systems. A 
US national survey with osteopathy practitioners revealed that the of majority practitioners 
used the high-velocity thrust technique, and, together with the soft tissue technique, these 
were the most frequently used.201 However, high-velocity thrust, was not mentioned by 
osteopathy users in the current study. This may be due partially to the technical term, known 
by the practitioners rather than patients. 
 
Confirming a common finding,183,202 the current survey also found that about half of the 
osteopathy users saw osteopaths for the purpose of back pain or back-related problems. The 
current survey estimated that those who had visited a GP for back problems were more than 
four times more likely to use osteopathy. On the other hand, among all demographic factors 
that related to osteopathy use, it is of interest to note the lowest prevalence was among those 
with a middle range of household income (A$20,000-A$40,000). However, such information 
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was not commonly reported in previous CAM studies, including the noted CAM study in the 
US,197 and an Australian osteopathic study.183 
 
Similar to the other CAM therapies, the costs related to osteopathy use in Australia are still 
borne mainly by the consumers. Very little research has been published on the economic 
aspects of osteopathy therapy, compared to such literature on acupuncture and chiropractic. 
Despite the legal status of osteopathic practitioners who form part of the managed health-care 
system in the US, it was suggested that studies on the cost-effectiveness of osteopathy are not 
consistent with conventional medical literature.203 
 
Osteopathy users in a national survey in the US considered osteopathy was more beneficial for 
musculoskeletal conditions than other internal conditions.204 The overall satisfaction of 
patients who attended ambulatory osteopathy clinics was found to be significantly associated 
with the relief of pain or discomfort.205 Consistently, over three-quarters of osteopathy users 
in the current survey considered osteopathy to be very helpful in terms of relieving pain. The 
surveyed osteopathy users also mentioned the usefulness of improving normal daily activities 
and general well-being. However, the specific benefits after osteopathy treatment are poorly 
understood in Australia. 
 
In the current survey, a few osteopathy users reported they had experienced discomfort after 
treatment, such as pain, soreness and tiredness. As noted above, such reports deviate from the 
commonly discussed adverse events related to manipulative therapies. Issues relating to the 
safety of users are important in promoting the use of osteopathy treatment among the general 
population, and should be properly addressed in future integrative medical care in Australia. 
Again, very little literature is available. 
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Similar to the overall use of CAM and the use of chiropractic and acupuncture in the current 
survey, the most common referral channel for using osteopathy was from a user’s friends or 
relatives. Only one in five osteopathy users had received advice from other CAM practitioners 
and about one in six had received advice from a GP. These data were self-reported by the 
survey participants. The referral pattern between osteopathy practitioners and GPs, as well as 
between osteopaths and other CAM practitioners, is unknown in the Australian health context. 
Such referral information to osteopaths, as well as to other CAM practitioners is significant, in 
terms of the implications for health resources planning and of safety interest to consumers, 
practitioners and the government. 
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CHAPTER 7. FACTORS RELATED TO CAM USE  
 
In this Chapter, matters related to CAM use, such as rationale for using CAM, benefits and 
risks related to CAM use, concurrent use of CAM and Western medicine, health insurance 
coverage of CAM and, regulatory issues on CAM use are presented. 
7.1 Results 
7.1.1 Rationale for CAM Use 
 
All CAM users were asked to respond to seven pre-defined statements about complementary 
medicine and its comparison with Western medicine. These statements were based on 
previous studies on the rationale for CAM use. Survey respondents agreed/disagreed with 
such statements, or provided a neutral answer (“no comment”). 
 
Nearly half (44.1%) of the CAM users agreed that Western medicine would improve their 
medical conditions but would not cure them. This proportion was not significantly different 
among different socio-demographic groups of people. However, it is not surprising that those 
users with a relatively poor health condition tended to agree more with this statement than 
those in better health (55.3% vs. 42.0%, χ2=9.76, p=0.008). 
 
Nearly one in nine users (11.5%) considered Western medicine would not improve their 
medical conditions, although over three quarters (75.4%) disagreed with this. Among those 
who considered Western medicine would not improve their medical conditions, there was no 
difference between those who had visited a medical doctor in the 12-month preceding the 
survey and those who had not visited one (11.1% vs. 13.3%, χ2=0.983, p=0.612). 
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Of particular concern is the proportion (24.8%) of participants who considered the services 
provided by their GPs as generally unsatisfactory. Typically, a relatively higher proportion 
was reported by those without post-secondary education (28.9% vs. 22.0%, χ2=7.662, 
p=0.022), those unemployed (30.8% vs. 22.0%, χ2=8.808, p=0.012), those having a lower 
income range (34.3%, 32.4% and 19.4%, respectively, among people with incomes of less 
than A$20,000, between A$20,000 and A$40,000; and higher than A$40,000, χ2=17.307, 
p=0.002), those without private health insurance (32.2% vs. 19.9%, χ2=15.193, p=0.001), and 
those with a poor health condition (35.9% vs. 22.8%, χ2=9.366, p=0.009). 
 
Over half of all CAM users (56.4%) considered that Western medicine had a relatively high 
risk of side effects, while over three quarters (76.0%) considered CAM to be relatively safe. 
On the other hand, among all users, approximately 5.4% considered neither Western medicine 
nor CAM as safe. There was no significant difference among gender and age groups with 
respect to these safety statements. However, fewer old people agreed that CAM is relatively 
safe, while a relatively high proportion of them did not respond to this statement (p<0.05). 
 
Over three quarters (75.9%) and over four fifths (80.5%) of CAM users considered that CAM 
provides a more holistic approach to health or is a more natural approach to treatment. Most 
significantly, the proportions of females or of younger adults who agreed with both these 
statements were much higher than males or older people. For example, 83% of females agreed 
that CAM is a holistic approach, while only 67.4% of males agreed with this statement 
(p<0.05). In total, 3.6% disagreed that CAM provides more holistic care or a natural approach 
to treatment, with the majority of them (83.2%) being male participants. 
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7.1.2 Regression Analyses on CAM Use 
 
In Chapters 4.1.4.2 and 4.1.5.3, cross-tabulation analyses and tests of significance were 
carried out with each of the variables considered one at a time, in order to identify the general 
pattern of the overall association of participants’ characteristics and their CAM utilisation 
status. Using the same approach (see Chapter 3.6.4.3), multivariate regression analyses on 
CAM use and on visits to CAM practitioners were conducted. 
 
7.1.2.1 Variables that Related to the Use of CAM 
In the initial step, the inter-correlations of potential predictor variables were examined 
(Appendix G11). In general, the inter-correlations of these variables are not highly correlated 
with each other, and thus fulfil the general requirement of avoiding collinearity prior to 
regression analysis. Similarly, the inter-correlations among other blocks of predictor variables 
and CAM use were also examined, with similar findings. Secondly, guided by the findings of 
the characteristics associated with CAM use (see Table 4.5), a bivariate analysis of all 
predictor variables and CAM use was conducted by cross-tabulation chi square tests (Table 
7.1). It shows that 11 variables (where p<0.05) are significantly related to CAM use. This will 
assist the development of the regression model. Detailed statistics are presented in Appendix 
G12. 
 
The development of the regression model proceeded by entering stepwise (based on Wald 
statistics), four blocks of predictor variables (where significant at the bivariate level): block 
one was demographic factors; block two, health factors; block three, external factors and 
block four, the 18 specific health conditions for which participants had visited GPs (Table 
7.1). The best-fit significant results of the multivariate analysis are presented in Table 7.2. 
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After all demographic variables were statistically controlled, it is apparent that gender, age 
and educational background are significant predictors for CAM use. Female participants were 
1.9 (95% CI: 1.4 to 2.6) times more likely to use CAM than male participants. Similarly, the 
odds of those aged 18-34 being CAM users was 1.8 (95% CI: 1.1 to 3.0) times higher than 
those aged 65 and older. In addition, people with post-secondary education were 2.0 (95% CI: 
1.5 to 2.7) times more likely to use CAM than those without post-secondary education (Table 
7.2). 
 
After entering the second block of predictor variables, the above noted demographic results 
remained significant (Table 7.2). Additional predictor variables were estimated. Those 
participants who had consulted a GP in the preceding 12 months were 1.7 (95% CI: 1.5 to 2.8) 
times more likely to use CAM than those who had not visited a GP in the preceding 12 
months. Consistent with this, those participants who had consulted a GP four or more times in 
the preceding 12 months were also 1.4 (95% CI: 1.0 to 2.1) times higher than those had 
visited a GP less than four times. The percentage of accurate classification (PAC) increased 
slightly from 70.1 to 70.7.  
 
The results in block three further suggest that those agreed with the statement of “insurance 
coverage of CAM influences the decision to purchase health insurance” were 3.0 (95% CI: 2.2 
to 4.2) times more likely to use CAM than those who did not agree with the statement, after 
all other predictor variables were statistically controlled. The Omnibus Tests, which provided 
an indication of how well the model executes, increased to a chi square value of 102.823 
(df=7, p<0.0001). The percentage of accurate classification further increased to 72.0 (Table 
7.2). 
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Table 7.1 Bivariate analyses of predictor variables for CAM use 
Predictors 
χ 2 (degree of 
freedom) p value 
Demographic factors (block one)   
Gender (female=0, male=1) 15.119 (1) 0.0001 
Age group (18-34 year old, 35-64, 65+) 17.494 (2) 0.0002 
Residential area (New South Wales, Victoria, Queensland, 
South Australia, Western Australia) 
4.604 (4) 0.33 
Education (post-secondary education: yes/no) 20.811 (1) <0.0001 
Employment (yes/no) 10.330 (1) 0.001 
Income (<A$20,000, A$20,000-A$40,000, >A$40,000) 10.758 (2) 0.005 
Country of birth (Australia=1, overseas=0) 2.315 (1) 0.128 
Health factors (block two)   
Self-rating health status (excellent/very good/good, fair/poor) 0.659 (1) 0.417 
Visited a GP in past 12 months (yes/no) 10.468 (1) 0.001 
Visited GP 4 or more times in past 12 months (yes/no) 6.434 (1) 0.011 
External factors (block three)   
Covered by private health insurance (yes/no) 6.458 (1) 0.011 
Coverage of CAM influences insurance purchase (yes/no) 84.285 (1) <0.0001 
Believe CAM should be regulated as rigorously as Western 
medicine (yes/no) 
1.987 (1) 0.159 
Health conditions (block four) 
Visited GP for 18 specific health problems (dichotomous measures: yes/no): 
1. Health check-up 2.657 (1) 0.103 
2. Arthritis 0.451 (1) 0.502 
3. Asthma 0.001 (1) 0.980 
4. Back problems 2.358 (1) 0.125 
5. Cancer 2.804 (1) 0.094 
6. Cold/flu/fever 0.491 (1) 0.484 
7. Depression 1.070 (1) 0.301 
8. Diabetes 1.867 (1) 0.172 
9. Gastrointestinal 3.551 (1) 0.060 
10. Gynaecologic 0.349 (1) 0.555 
11. High blood pressure 1.906 (1) 0.167 
12. High cholesterol 0.003 (1) 0.986 
13. Heart problems 0.106 (1) 0.744 
14. Lung problems 4.243 (1) 0.039 
15. Other pains 1.157 (1) 0.282 
16. Pregnancy 1.746 (1) 0.186 
17. Skin problems 0.004 (1) 0.951 
18. Trauma/injury 5.477 (1) 0.019 
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Table 7.2 Multivariate analysis of predictor variables for CAM use 
Predictors Block 1, odds ratio & (95% CI) 
Block 2, odds ratio & 
(95% CI) 
Block 3, odds ratio & 
(95% CI) 
Block 4 
Gender    N/S 
Male 1.0 1.0 1.0  
Female 1.885 (1.382–2.570)** 1.678 (1.221–2.305)** 1.612 (1.162–2.235)**  
Age (year)     
18-34 1.0 1.0 1.0  
35-64 0.726 (0.507–1.039) 0.658 (0.456–0.950)* 0.718 (0.492–1.049)  
65+ 0.545 (0.336–0.884)* 0.433 (0.261–0.716)** 0.525 (0.312–0.883)*  
Post-secondary education     
No 1.0 1.0 1.0  
Yes 1.995 (1.465–2.717)** 2.058 (1.504–2.816)** 1.898 (1.372–2.618)*  
Consulted GP in the past 12 months     
No  1.0 1.0  
Yes  1.686 (1.118–2.541)* 1.586 (1.037–2.427)*  
Consulted GP ≥4 times in the past 12 months     
No  1.0 1.0  
Yes  1.447 (1.009–2.075)* 1.590 (1.096–2.306)*  
Coverage of CAM influences insurance purchase     
No   1.0  
Yes   2.991 (2.155–4.150)**  
Omnibus Tests of Model Coefficients     
Chi square (degree of freedom, p value) 42.142 (4, <0.0001) 57.912 (6, <0.0001) 102.823 (7, <0.0001)  
Percentage accurate in classification 70.1 70.7 72.0  
* p<0.05; ** p<0.01; N/S: no significant variable identified; CI: confidence interval. 
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7.1.2.2 Variables that Related to Visiting CAM Practitioners 
 
As shown in Table 7.3, 12 predictor variables are significantly related to visiting CAM 
practitioners at a bivariate level. Table 7.4 presents the multivariate analysis results. Similar to 
the findings on CAM use, for visiting CAM practitioners, it was shown that, in addition to 
gender and educational background, household income ranges and participants’ country of 
birth are significant predictors for CAM practitioner visits. Among these predictor variables, 
household income appeared to be the most significant factor. Participants with an income 
range between A$20,000 and A$40,000 were 2.0 (95% CI: 1.2 to 3.2) times more likely to use 
CAM than participants with an income of less than A$20,000. In addition, the odds of those 
having an income higher than A$40,000 being CAM users was 2.3 (95% CI: 1.5 to 3.5) times 
higher than those with an income of less than A$20,000. 
 
Again, similar to the findings on CAM users, after entering block 2 and block 3 variables, two 
variables were found to contribute significantly to the model for visits to CAM practitioners: 
consulted a GP in the past 12 months and how insurance coverage of CAM influences 
insurance purchase. Among demographic, health and external factors, the influence of 
insurance coverage of CAM on the purchase of health insurance was the most significant 
factor associated with visiting a CAM practitioner. Those who believed that insurance 
coverage of CAM would influence their purchase of health insurance were 3.5 (95% CI: 2.6 to 
4.7) times more likely to visit CAM practitioners than those without such a belief. 
 
The above regression model (Table 7.4, block four) also suggested that two additional factors 
were associated with CAM practitioner visits. People who had consulted a GP for back 
problems or for trauma/injury problems were 2.0 to 2.6 times more likely to have visited 
CAM practitioners than people with other specific health conditions. 
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Table 7.3 Bivariate analyses of predictor variables for CAM practitioner visits 
Predictors 
χ2 (degree of 
freedom) p-value 
Demographic factors (block one)   
Gender (female=0, male=1) 11.510 (1) 0.001 
Age group (18-34 year old, 35-64, 65+) 8.749 (2) 0.013 
Residential area (New South Wales, Victoria, Queensland, 
South Australia Western Australia) 
2.497 (4) 0.645 
Education (post-secondary education: yes/no) 24.114 (1) <0.0001 
Employment (yes/no) 3.700 (1) 0.054 
Income (<A$20,000, A$20,000-A$40,000, >A$40,000) 17.836 (2) 0.0001 
Country of birth (Australia=1, overseas=0) 7.467 (1) 0.006 
Health factors (block two)   
Self-rating health status (excellent/very good/good, fair/poor) 0.515 (1) 0.473 
Visited a GP in past 12 months (yes/no) 17.077 (1) <0.0001 
Visited GP 4 or more times in past 12 months (yes/no) 7.712 (1) 0.005 
External factors (block three)   
Covered by private health insurance (yes/no) 13.616 (1) 0.0002 
Coverage of CAM influences insurance purchase (yes/no) 101.357 (1) <0.0001 
Believe CAM should be regulated as rigorously as Western 
medicine (yes/no) 
2.313 (1) 0.128 
Health conditions (block four) 
Visited GP for 18 specific health problems (dichotomous measures: yes/no): 
1. Health check-up 0.394 (1) 0.530 
2. Arthritis 0.131 (1) 0.718 
3. Asthma 0.039 (1) 0.844 
4. Back problems 8.683 (1) 0.003 
5. Cancer 6.468 (1) 0.011 
6. Cold/flu/fever 0.161 (1) 0.688 
7. Depression 0.959 (1) 0.327 
8. Diabetes 0.007 (1) 0.935 
9. Gastrointestinal 0.289 (1) 0.591 
10. Gynaecologic 0.007 (1) 0.931 
11. High blood pressure 2.935 (1) 0.087 
12. High cholesterol 1.086 (1) 0.297 
13. Heart problems 0.000 (1) 0.995 
14. Lung problems 0.521 (1) 0.470 
15. Other pains 0.007 (1) 0.935 
16. Pregnancy 1.481 (1) 0.224 
17. Skin problems 0.088 (1) 0.770 
18. Trauma/injury 11.761 (1) 0.001 
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Table 7.4 Multivariate analyses of predictor variables for CAM practitioner visits 
Predictors Block 1, odds ratio & (95% CI) 
Block 2, odds ratio 
& (95% CI) 
Block 3, odds ratio 
& (95% CI) 
Block 4, odds ratio 
& (95% CI) 
Male 1.0 1.0 1.0 1.0  
Gender Female 1.82 (1.36–2.44)** 1.67 (1.25–2.25)** 1.62 (1.20–2.21)** 1.67 (1.23–2.29)** 
No 1.0 1.0 1.0 1.0  
Post-secondary education Yes 1.84 (1.36–2.49)** 1.85 (1.37–2.51)** 1.70 (1.24–2.40)** 1.72 (1.25–2.36)** 
 <A$20,000 1.0 1.0 1.0 1.0 
 A$20,000-A$40,000 1.98 (1.23–3.18)** 2.03 (1.26–3.27)** 1.80 (1.09–2.96)** 1.77 (1.08–2.93)* 
Income >A$40,000 2.31 (1.53–3.50)** 2.41 (1.59–3.67)** 2.21 (1.43–3.41)** 2.21 (1.42–3.42)** 
Overseas 1.0 1.0 1.0 1.0  
Country of birth Australia  1.53 (1.08–2.16)* 1.51 (1.06–2.14)* 1.67 (1.16–2.42)** 1.68 (1.16–2.44)** 
No  1.0 1.0 1.0 Consulted GP in the past 
12 months Yes  1.97 (1.34–2.90)** 1.99 (1.33–2.97)** 1.82 (1.21–2.74)** 
No   1.0 1.0 Coverage of CAM 
influences insurance 
purchase Yes   3.50 (2.58–4.74)** 3.52 (2.59–4.79)** 
No    1.0  
Back problems Yes    2.61 (1.05–6.50)* 
No    1.0  
Trauma/injury Yes    2.05 (1.02–4.12)* 
Omnibus Tests of Model Coefficients     
Chi square (degree of freedom, p value) 59.12 (5, <0.0001) 71.43 (6, <0.0001) 140.00 (7, <0.0001) 149.11 (9, <0.0001) 
Percentage accurate in classification 60.1 62.4 67.5 68.1 
* p<0.05; ** p<0.01; CI: confidence interval 
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7.1.3 Use of CAM and Western Medicine 
 
7.1.3.1 Use of Western Medicine 
 
Slightly over 80.8% of respondents reported that they had visited a general practitioner (GP) 
or medical specialist in the 12 months prior to the survey (hereafter, visits to a GP). The mean 
number of visits to a GP per respondents in this survey was 5.53 times in the 12-month 
period. When this figure was projected to the whole Australian adult population, the total 
estimated visits to GPs were 69.29 million times. 
 
Among these respondents who had visited a GP, almost one fifth (19.1%) consulted a GP only 
for a general health check-up, to receive a prescription or immunization and/or, for travel or 
work-related medical examination purposes. Over six in ten respondents (60.1%) visited for a 
single medical problem and 20.8% for at least two medical problems. The most common 
medical problems for which respondents visited a GP were cold/flu or virus infection (12.2% 
of total visits), (high) blood pressure (10.3%), injury and trauma (6.6%), arthritis and gout 
(5.4%), and heart problems (5.1%). 
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7.1.3.2 Concurrent Use of CAM and Western Medicine 
 
Almost two out of five participants (38.1%) had visited both a medical doctor and a CAM 
practitioner in the preceding 12-month period, whereas 42.7% had visited a medical doctor 
only and 6% had visited a CAM practitioner only. The remaining 13.2% of participants had 
not visited a medical doctor or a CAM practitioner (Figure 7.1). A relatively high proportion 
of people who had visited a medical doctor for back problems or trauma/injury had also 
visited a CAM practitioner (71% and 66% respectively). 
 
Among all participants, those who had visited a medical doctor in the preceding 12 months 
were more likely to have also used any one of the 17 forms of CAM (71.1%) than those who 
had not visited a medical doctor (59.5%, χ2=10.468, p=0.001). Consistently, those participants 
who had visited a medical doctor in the preceding 12 months were more likely to have also 
visited a CAM practitioner (47.2%) than those who had not visited a medical doctor (31.2%, 
χ2=17.077, p<0.001). 
 
Figure 7.1 Visits to CAM and Western medical practitioners 
Visited CAM 
practitioner only, 
6.0%
Did not visit 
CAM and WM 
practitioners, 
13.2%
Visited both 
CAM and WM 
practitioners, 
38.1%
Visited WM 
practitioner only, 
42.7%
 
WM: Western medicine; CAM: complementary and alternative medicine
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With respect to concurrent use, all identified CAM users were asked to respond to whether 
they had always used CAM alone, always used it together with Western medicine or 
sometimes used the two together. Approximately one in five (21.8%) CAM users had always 
used CAM and Western medicine together, only one in eight (13.2%) CAM users always used 
CAM alone, and over half (54.1%) had used CAM sometimes together with Western medicine 
(the remaining 10.9% did not respond to this question). The total proportion of CAM users 
who mentioned that they sometimes or always used CAM and Western medicine together 
(75.9%) was similar to the above noted proportion within CAM users who had also visited a 
medical practitioner in the preceding 12 months (71.1%). 
 
Cross-tabulation analyses further revealed that the most significant difference of always using 
CAM together with Western medicine had been found between different age groups (Figure 
7.2). That is, a relatively higher proportion (37.9%) of those aged 65 or older had always 
concurrently used both CAM and Western medicine than those younger groups (χ2=22.079, 
p<0.001). 
 
Figure 7.2 Concurrent use of CAM and Western medicine among different age groups 
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Always use CAM together with WM
Always use CAM alone 
 
Note: proportions were calculated excluding people who did not respond to this question.
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7.1.3.3 Communication between Consumers and Practitioners 
 
Among the 865 participants who had visited a medical doctor in the preceding 12 months, 
almost three quarters (71.2%) were CAM users. Of these, less than half (44.9%) indicated that 
they always informed their medical doctors about their use of CAM, but almost one in five 
(17.9%) participants never informed their medical doctors about their CAM usage. An 
additional one third (30.3%) had sometimes informed their GPs.  
 
Significantly, female CAM users were more likely to discuss their CAM use with their GPs 
than male users were (52.2% vs. 40.4%), whereas a relatively higher proportion (27.4%) of 
male users than female users (14.5%) had never done this (χ2=18.279, p<0.001, Figure 7.3). 
Perhaps surprisingly, users who were unemployed at the time of the survey were more likely 
to always inform their GPs than those who were employed (55.0% vs. 42.9%, χ2=8.793, 
p=0.012). Surprising also, a higher proportion (59.2%) of older users (aged 65 and older) 
always informed their GPs than those in the younger age groups (35-64 years, 49.4% informed 
a GP; 18-34 years, 37.8% informed their GPs, χ2=18.870, p=0.001). 
 
Figure 7.3 Gender difference in informing general practitioners about CAM use 
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 Note: proportions were calculated excluding people who did not respond to this question. 
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The most common reasons given by the surveyed CAM users for discussing their use of CAM 
with their medical doctors were that they considered it necessary to do so (66.9%). Nearly one 
quarter (23.3%) of the CAM users had received advice from their GPs to use CAM, whereas 
an additional 13.9% informed their GPs because their GPs had asked about their CAM use. 
Interestingly, the only significant difference in the proportions of informing GPs among 
different socio-demographic groups was in users’ employment status. A relatively higher 
proportion of those employed (16.0%) than those unemployed (9.4%) had informed their GPs 
because their GPs had asked them about their CAM use (χ2=4.093, p=0.043). 
 
The most common reasons given by the CAM users in the survey for not discussing their use 
of CAM with their medical doctors were that they did not consider it necessary to do so 
(58.1%), and that they had not been asked by their doctors (22.4%). In addition, 10.1% of the 
CAM users considered that their GPs may not have been happy to know that their patients had 
used CAM. Nearly one in ten CAM users (9.6%) further responded that they had just 
forgotten to mention their CAM use to their GPs. Furthermore, there were two users whose 
GPs had advised them not to use CAM; the specific reason for this was not collected. 
 
Not surprisingly, male users (70.8%) did not consider it necessary to inform their GPs 
compared with (47.8%, χ2=6.926, p=0.008) female users. Not unexpectedly, more female 
CAM users (21.3% compared to 3.2%, χ2=10.69, p=0.001, of male users) were concerned 
about their GPs being unhappy if they knew about their patients’ use of CAM. The view that 
GPs may not be happy was more common among those without post-secondary education 
(17.1%) than those with post-secondary education (5.8%, χ2=4.228, p=0.040). 
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7.1.4 Health Insurance and the Use of CAM 
 
7.1.4.1 National Health Insurance Coverage of CAM 
Currently, the national health care system (Medicare) in Australia does not cover the costs 
related to nearly all CAM products and practitioners, with the exception of acupuncture 
treatment provided by a registered medical doctor and very limited allied health services 
(including chiropractic and osteopathy treatments) for patients with chronic diseases. All 
survey participants were asked about their perceptions towards the possible extension of 
Medicare coverage to the four common provider-based and regulated CAM therapies: 
acupuncture, Chinese herbal medicine, chiropractic and osteopathy. Participants were 
informed prior to the questions that “realising there is limited amount available to fund 
Medicare, do you think …?”. This was an effort to minimise the possible bias of “more free 
coverage is always welcomed”, as commented on by some researchers prior to the survey. 
 
Visits to Acupuncturists 
 
Over three quarters (82.4%) acupuncture users responded that Medicare should cover 
acupuncture treatment provided by acupuncturists, in addition to that provided by GPs. The 
view was also supported by a large proportion of survey participants (71.4%). Of this number, 
11.9% said this was conditional on the acupuncturist being registered with the relevant 
government body. Cross-tabulation further revealed that the biggest variation in proportions of 
participants responding affirmatively to this question was regional difference. In general, 
South Australia residents did not consider that Medicare coverage be extended to acupuncture 
(60.3% compared to 76.1% in New South Wales, 79.7% in Victoria, 84.5% in Queensland, 
78.5% in Western Australia, χ2=18.898, p=0.001). However, among acupuncture users, this 
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regional difference was not found (χ2=3.479, p=0.481). No other additional marked difference 
was found in other demographic information. 
 
Visits to Chinese Herbal Medicine Practitioners 
 
With respect to Medicare coverage of Chinese herbal medicine (CHM) practitioners, over half 
of participants (57.4%) considered Medicare should also cover visits to CHM practitioners; 
8.4% of this number believed this should be conditional on the CHM practitioner being 
registered with the relevant government body. It is worth noting that the Medicare coverage to 
CHM practitioners was demanded by vast majority of the current CHM users (90.2%). Cross-
tabulation analysis further revealed that several demographic characteristics were significantly 
related to the participants’ response to this question. Notably, those (69.1%) without post-
secondary education were more likely to suggest coverage than those with post-secondary 
education (58.7%, χ2=11.103, p=0.001). In contrast, the proportion (57.6%) of participants 
with household income more than A$40,000 who expressed a positive coverage was less than 
the proportion of those with a lower household income (A$20,000-A$40,000, 71.5%, and 
<A$20,000, 67.0%, χ2=12.83, p=0.002).  
 
Among different age and gender groups, the proportions of participants responding to the 
question on national health insurance coverage of CHM were significantly different. Female 
adults (66.1%) were more in favour of extending the coverage to CHM than male adults 
(60.0%, χ2=3.856, p=0.05). In contrast, the younger adults (aged 18-34, 56.0%) were less in 
favour of extending the coverage to CHM than the older people (35-64, 66.0% and 65+, 
67.6%, χ2=9.830, p=0.007). Among CHM users, a marked difference was not found, or the 
sample size was too small, to draw a significance finding on cross-tabulation analysis.  
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Visits to Chiropractors 
As with acupuncture, a relatively high proportion of participants considered it necessary for 
chiropractic treatment to be covered by Medicare (73.6% among all participants, or 87.1% 
among current chiropractic users). As could be expected, a higher proportion of positive 
suggestions came from those without private health insurance coverage (83.2% compared to 
those with private health insurance, 73.9%, χ2=12.287, p=0.0005), and among those with a 
poor or fair health condition (84.8% compared to those with better health, 76.9%, χ2=4.658, 
p=0.031). Furthermore, those without post-secondary education were more likely to be in 
favour of Medicare coverage of chiropractic than those with post-secondary education (83.7% 
vs. 74.0%, χ2=13.705, p=0.0002). In general, there was no regional difference between the 
proportion of people who agreed and disagreed with Medicare coverage for chiropractic. 
However, among those who had used chiropractic, no such marked socio-demographic 
differences were identified. 
 
Visits to Osteopaths 
Regarding Medicare coverage of osteopathy treatment, compared to the above three CAM 
therapies, a relatively lower proportion (56.7%) of survey participants considered it should be 
covered. Among users, the proportion was increased to 85.8%. Marked differences were 
found in participants’ responses towards osteopathy treatment. Similar to covering 
chiropractic treatment, a higher proportion of positive suggestions came from those without 
private health insurance (74.7% compared to those with private health insurance, 64.6%, 
χ2=10.42, p=0.001), and among those without post-secondary education (74.5%) than those 
with such education (65.1%, χ2=8.884, p=0.003). When it came to the monetary aspect, it was 
not unexpected that the proportion (81.3%) of lower-income participants (<A$20,000) who 
were positive about Medicare coverage was much higher than those among the higher-income 
participants (A$20,000-A$40,000, 73.0%, and >A$40,000, 64.1%, χ2=15.979, p=0.0003). 
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Similar to acupuncture, there is a significant regional difference of the proportions of people 
who considered Medicare should cover osteopathy. In general, South Australia and Western 
Australia residents were more reluctant to suggest that Medicare coverage should extend to 
osteopathy (57.3% and 61.4%, respectively, compared to 70.2% in New South Wales, 73.2% 
in Victoria and 72.2% in Queensland, χ2=9.770, p=0.044). For cross-tabulation analysis 
among osteopathy users, the sample size is relatively small to draw a significant conclusion. 
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7.1.4.2 Private Health Insurance Coverage of CAM 
 
Information on participants’ private health insurance coverage (PHI) status, has been analysed 
earlier as one of the key demographic characteristics in making comparisons of a series of 
questions on the possible correlation of private health insurance and the utilisation on CAM. 
Subgroup analyses on private health insurance among users of 17 specific forms of CAM, as 
well as on those who had visited relevant CAM practitioners were presented in Table 4.5, 
Table 4.6, Table 4.10 and Table 4.11. In addition, participants’ insurance claim history on 
CAM, as well as detailed opinions on private health insurance coverage of four regulated 
forms of CAM: acupuncture, Chinese herbal medicine, chiropractic and osteopathy are 
presented. 
 
Overall, more than half (55.7%) of the survey respondents had private health insurance cover 
in the 12 months preceding the survey. A much smaller proportion (28.1% among all 
participants, or 50.4% among respondents with private health insurance cover) indicated that 
their health insurance provided rebates on their expenditure on CAM, and approximately one 
quarter (25.4%) of the participants did not remember or were not sure about CAM coverage. 
Among all participants, less than one in seven (13.9%, or 24.9% among participants with 
private health insurance cover) actually received some form of CAM rebate from their 
insurance companies in the preceding 12 months. 
 
Among the 150 participants who had received health insurance CAM rebates, nearly half 
(49.5%) were for visits to chiropractors, one in three (35.2%) were for Western massage 
therapy. Visits to acupuncturists were the third (18.8%) most popular form of complementary 
therapies for which CAM users claimed a health insurance rebate, closely followed by claims 
for visits to naturopaths (12.2%) and osteopaths (11.2%). A number of CAM users had also 
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claimed for other forms of CAM or visits to CAM practitioners. These included Chinese 
herbal medicine (5 people), homeopathy (5), aromatherapy (5), Western herbal medicine (4), 
Chinese therapeutic massage (3), clinical nutrition (3), yoga (2), meditation (1) and energy 
healing (1). In addition, three persons had claimed for other forms of CAM, rather than the 17 
investigated.  
 
Among those who had received a CAM rebate, nearly one third (31.0%) had claimed for two 
or more forms of CAM in the preceding year. However, among those who had received at 
least one rebate from their private health funds, little variation between different demographic 
characteristics was found. An exception is those with post-secondary education, who were 
more likely to have claimed for CAM (30.9%) than those without post-secondary education 
(16.3%, χ 2=14.203, p=0.0002). 
 
Consistent with the high frequencies of people receiving rebates for chiropractic and massage 
therapy, people having private health insurance were more likely to choose chiropractic 
treatment (19.0%) than those without (12.4%, χ2=8.234, p=0.004), and were more likely to 
use massage therapy (32.5%) than those without (20.9%, χ2=17.625, p<0.0001). 
 
Participants’ attitudes toward the possible influencing factors that may have attracted them to 
purchase insurance are important considerations for the health insurance industry. Participants 
were asked: “If a particular private health insurance company offered coverage of CAM for no 
or little additional cost, would that influence you to buy insurance from that company?” 
Among all participants, nearly half (45.0%) agreed that coverage of CAM would influence 
their decision on purchasing health insurance; a further 10.4% said it would probably 
influence their decision, whereas the remaining 44.5% would not consider this to be an 
influencing factor. When examining specific characteristics of all participants, it is clear that 
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the younger adults with post-secondary education, employed, with private health insurance 
and with a higher household income would be more likely to consider that this would 
influence their purchase of health insurance (Table 7.5). In addition, those identified as CAM 
users in the current study appeared to be more influenced than non-CAM users (Table 7.5). 
 
Table 7.5 Will CAM coverage influence the purchase of private health insurance? 
CAM coverage influence 
the purchase of insurance 
in the future 
Statistical difference 
 
Characteristic 
Yes (%) No (%) Chi Square p 
Age (year)   35.708 <0.0001 
18-34 60.2 39.8   
35-64 50.6 49.4   
65+ 31.4 68.6   
Post-secondary education   14.783 0.0001 
Yes  55.9 44.1   
No 43.4 56.6   
Employment   28.817 <0.0001 
Employed 56.9 43.1   
Unemployed or not in 
labour force 
39.2 60.8   
Private health insurance   20.681 <0.0001 
Yes 56.8 43.2   
No 42.0 58.0   
Annual household income   12.279 0.002 
<A$20,000 38.6 61.4   
A$20,000-A$40,000 55.2 44.8   
>A$40,000 54.2 45.8   
Current CAM user   84.016 <0.0001 
Yes 60.2 29.8   
No 28.1 71.9   
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Concerning insurance coverage on the four regulated forms of CAM in Australia (i.e. 
acupuncture, Chinese herbal medicine, chiropractic and osteopathy), all participants were 
asked: “Even if you have to pay a slightly higher premium, do you think visits to [name of one 
of the four CAM] should be covered by private health insurance, with no gap to pay?” 
 
Acupuncture 
 
A total of 70.5% of the participants considered visits to an acupuncturist should be covered by 
private health insurance even they had to pay a slightly higher premium; this figure includes 
6.7% who advocated such coverage only if the acupuncturists were registered. However, 
nearly one in five (18.9%) participants believed it did not need to be covered by private health 
insurance. The proportion who agreed acupuncture should be covered by private health 
insurance increased to 81.7% among current acupuncture users, while the proportion (13.0%) 
who believed acupuncture should not be covered remained relatively high. Among all 
participants and among all acupuncture users, no marked difference was observed between 
different characteristics in responding to whether or not acupuncture should be covered by 
private health insurance. 
 
Chinese Herbal Medicine (CHM) 
 
Nearly two thirds (64.9%) of all participants considered visits to CHM practitioners should be 
covered by private health insurance, even they had to pay a slightly higher premium. This 
number included 4.1% who were in favour of such coverage only if the practitioners were 
registered. However, more than one quarter (25.6%) of participants believed CHM did not 
need to be covered by private health insurance. The proportion of participants who agreed that 
visits to CHM practitioners should be covered by private health insurance increased to 81.0% 
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among current CHM users, while the proportion (15.0%) who considered visits to CHM 
practitioners should not be covered was also relatively high.  
 
Among all participants, a few marked differences were observed in the characteristics in 
responding to whether visits to CHM practitioners should be covered by private health 
insurance. Surprisingly, the proportion (75.9%) of participants without private health 
insurance who believed that visiting CHM practitioners should be covered was higher than the 
proportion among those currently having private health insurance (68.8%, χ 2=5.887, 
p=0.015). On the other hand, CHM users were more likely to suggest private health insurance 
coverage for CHM (84.3%) than non-CHM users (70.7%, χ2=6.018, p=0.014). 
 
Chiropractic 
 
A high proportion (79.9%) of all participants considered visits to chiropractors should be 
covered by private health insurance, even they had to pay a slightly higher premium. 
However, the proportion of participants (14.1%) who believed chiropractic did not need to be 
covered was also relatively high. The proportion who agreed chiropractic should be covered 
increased to 90.4% among chiropractic users, whereas the proportion of people who believed 
chiropractic should not be covered decreased to 6.4%. Consistent with this, chiropractic users 
in the current study appeared to request chiropractic to be covered by private health insurance 
more than non-chiropractic users (93.4% vs. 83.4%, χ2=10.987, p=0.001). 
 
Specifically, the younger adults without post-secondary education and without private health 
insurance were more likely to agree that chiropractic should be covered by private health 
insurance (Table 7.6). When examining the attitude towards chiropractic coverage among 
chiropractic users only, these marked differences however, did not exist. 
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Table 7.6 Should visits to chiropractors be covered by private health insurance? 
Should be covered by private 
health insurance? Statistical difference 
 
Characteristics 
Yes (%) No (%) Chi Square p 
Age (year)   6.017 0.049 
18-34 88.2 11.8   
35-64 84.9 15.1   
65+ 79.9 20.1   
Post-secondary education   6.797 0.009 
Yes  82.5 17.5   
No 88.4 11.6   
Private Health Insurance   6.085 0.014 
Yes 82.9 17.1   
No 88.4 11.6   
 
Osteopathy 
Nearly two thirds (65.7%) of all participants believed visits to osteopaths should be covered 
by private health insurance, even they had to pay a slightly higher premium; 17.0% believed it 
did not need to be covered. The proportion of participants who agreed osteopathy should be 
covered by private health insurance increased to 84.2% among current osteopathy users, while 
one in ten (9.3%) believed osteopathy should not be covered. 
 
The percentage of those osteopathy users in the current study who considered that osteopathy 
be covered by private health insurance was greater than for non-osteopathy users (90.0% vs. 
78.9%, χ2=3.301, p=0.069, not statistically different). On the other hand, a higher proportion 
of participants without private health insurance (83.0%) considered that visits to osteopaths 
should be covered by private health insurance than those currently having private health 
insurance (77.2%, χ2=4.568, p=0.033). Among all participants and among all osteopathy 
users, no additional marked difference was observed between different characteristics in 
responding to whether or not osteopathy should be covered by private health insurance. 
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7.1.5 Regulation and the Use of CAM 
7.1.5.1 CAM Products and Government Regulation 
 
Currently in Australia, the regulation of therapeutic products, including CAM products, is 
separated from CAM practitioner regulation (mandatory registration). 
 
All survey participants were asked whether CAM products should be subjected to rigorous 
regulation, similar to the standards set for Western medicine. A total of 944 participants 
(unweighted figure) responded to this question, while 123 participants did not respond. 
Among all participants, nearly three quarters (73.6%) considered that CAM products should 
be regulated as rigorously as Western medicine products, whereas 15.3% did not consider this 
necessary. Of the 944 participants, a higher proportion of female adults (86.2%) than male 
participants (79.3%, χ2=7.977, p=0.005) were in favour of such regulation. Age and other 
demographic factors seemed to have little influence on the proportion of those in favour of 
regulation of CAM products. 
 
Among CAM users, a very similar proportion (74.0%) agreed that CAM products should be 
regulated in the same way as Western medicine products. A proportion of CAM users (16.6%) 
did not agree with this statement, which was slightly higher than the proportion of all 
participants (15.3%). The above noted gender differential between people who agreed and 
disagreed with the regulation statement remains significant among CAM users, although such 
variation is smaller (84.8% among female CAM users compared to 78.0% among male users, 
χ2=5.189, p=0.023). 
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7.1.5.2 CAM Practitioner Registration 
Acupuncturists 
 
Participants were asked to respond to a question of relatively recent mandatory registration of 
two types of CAM practitioners: acupuncturists and Chinese herbal medicine practitioners in 
Victoria. These two types of practitioners are only subjected to government registration in 
Victoria, however, such registration will be implemented in the states of Western Australia 
and New South Wales in the near future. Public attitudes towards the implementation of 
registration in Victoria and the necessity for implementing it in all states and territories around 
Australia were sought from all participants. 
 
Well over four fifths (86.0%) believed that the mandatory registration of acupuncturists in 
Victoria provided for greater public safety and confidence in acupuncture. When excluding 
those who did not respond to this question, the biggest disagreements were between female 
and male participants and between people with and without private health insurance. A higher 
proportion (95.8%) of female participants agreed with the public safeguards provided by 
government regulation than male participants (91.4%, χ2=7.924, p=0.005), and people with 
private health insurance appear to be more likely to agree with government regulation (95.8%) 
than those without private health insurance (90.8%, χ2=9.898, p=0.002). 
 
When examining the responses of acupuncture users only, there is no gender difference, 
whereas there is a marked difference between people having and not having private health 
insurance. That is, all but one acupuncture user with private health insurance (98.6%) agreed 
with the safety viewpoint, while only 84.6% of acupuncture users without private health 
insurance agreed (χ2=6.920, p=0.009). 
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Given the existence of regulation in Victoria, it is of particular interest to examine the possible 
regional difference in response to the question on acupuncture regulation provides public 
safety. However, for all participants, there is no marked difference among states; the 
proportion (93.8%) of Victoria participants who agreed with the statement ranges in the 
middle among all states (from 91.9% to 97.4%, χ2=3.38, p=0.496). In addition, a similar trend 
is also observed among acupuncture users only. 
 
Similar to the proportion of people who believe that mandatory registration of acupuncturists 
in Victoria would provide greater public safety, a high proportion (86.4%) of participants 
believed that all states and territories should require government regulation of acupuncturists. 
While there was less variance of gender difference, a statistically significant difference was 
observed between different age groups. A relatively higher proportion (95.3%) of middle-aged 
(35-64) participants agreed acupuncturists in all states and territories should be regulated than 
younger adults (18-34, 91.1%) and older adults (65+, 91.5%, χ2=6.602, p=0.037). The age 
differential, however, did not exist among acupuncture users only.  
 
The above noted difference between people with and without private health insurance towards 
the statement on public safety and confidence is also observed in the statement on the 
implications of government regulation on acupuncture in all states and territories. Among 
those participants with private health insurance, 95% responded positively, while only 90.6% 
of those without private health insurance (χ2=9.134, p=0.003) responded positively. Among 
acupuncture users, the positive response was 98.6% among those with private health 
insurance but only 84.3% among those without private health insurance (χ2=6.970, p=0.008). 
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Chinese Herbal Medicine Practitioners 
 
The regulation of Chinese herbal medicine (CHM) practitioners in Australia is in the same 
situation as that relating to acupuncturists, that is, the registration of CHM practitioners is 
mandatory only in Victoria. In general, visits to acupuncturists are more common than visits 
to Chinese herbal medicine practitioners (Table 4.8). In an attempt to validate possible 
similarities and/or differences in attitudes towards the regulation of acupuncturists and CHM 
practitioners, all participants were also asked to respond to regulatory questions on CHM 
practitioners, similar to that regulatory question on acupuncturists, discussed above. 
 
Similar to the findings on the regulation of acupuncturists, well over four fifths (82.7%) 
believed the mandatory registration of CHM practitioners in Victoria provided for greater 
public safety in CHM. When excluding those who did not respond to the regulatory question, 
the biggest variation in responses was between female and male participants and between 
people with different income ranges. A higher proportion (94.3%) of female participants 
agreed with the public safeguard on CHM than male participants (88.9%, χ2=8.832, p=0.003), 
and those participants with middle-range household income (A$20,000-A$40,000) were also 
more likely to appreciate government regulation (96.0%) than those with an income of less 
than A$20,000 (88.5%) and those with an income higher than A$40,000 (91.9%, χ2=6.395, 
p=0.041). When examining the responses of CHM users only, none of these differences was 
observed. 
 
In terms of the possible regional difference in responding to current regulation on CHM 
practitioners in Victoria, both among all participants and among CHM users, there was no 
significant regional difference. However, surprisingly, the proportion (81.8%) of CHM users 
in New South Wales who believed that regulation of CHM practitioners would enhance public 
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safety was considerable lower than the proportions in other states (95.0% to 100.0%), 
although it is not statistically significant (χ2=4.505, p=0.342).  
 
With respect to the implementation of CHM regulation in all states and territories, a high 
proportion (85.0%) of participants believed all states/territories should require government 
regulation of CHM practitioners. However, both among all participants and among CHM 
users, there was no marked difference between different demographic information. 
Nevertheless, the proportions of CHM users in New South Wales and South Australia (77.7% 
and 85.4%, respectively) who considered all states/ territories should regulate CHM 
practitioners were considerable lower than the proportions in other states (94.5% to 100.0%), 
although it is not statistically significant (χ2=5.584, p=0.232). 
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7.1.6 Lifetime Use of CAM 
 
In addition to the 737 (weighted percentage 68.9%) participants who have been identified as 
CAM users in the current study, 42 (4.1%) used prayer (when considered as a form of CAM) 
and three (0.34%) used other forms of CAM only. Thus, when these are included, a higher 
proportion (73.4%) of CAM prevalence is estimated by the current survey. 
 
The remaining 285 participants who did not use any form of CAM (this also excluded prayer 
and other forms of CAM) in the 12 months preceding the survey were asked about their 
lifetime use of CAM. Of these, a further 39.3% had used CAM at some time. Thus, among all 
participants in the current survey, 83.7% had used CAM products or had visited CAM 
practitioners at some time in their lives. On the other hand, among the lifetime-only CAM 
users (i.e. not a current CAM user, 110 in total), the demographic characteristics are similar to 
the above-noted characteristics among those CAM users (Table 7.7). 
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Table 7.7 Socio-demographic characteristics of lifetime-only CAM users 
Lifetime CAM user Statistical difference  
Characteristic Yes (%) No (%) Chi Square p 
Gender   10.644 0.001 
Female 52.2 47.8   
Male 32.4 67.6   
Age (year)   15.041 0.001 
18-34 43.4 56.6   
35-64 47.1 52.9   
65+ 18.0 82.0   
Country of Birth   2.026 0.155 
Australia 42.9 57.1   
Non-Australia 33.4 66.6   
State   9.864 0.043 
New South Wales 41.8 58.2   
Victoria 34.2 65.8   
Queensland 43.7 56.3   
South Australia 21.0 79.0   
Western Australia 57.4 42.6   
Self-reported health status   7.536 0.006 
Excellent/very good/good 43.0 57.0   
Fair/poor 18.6 81.4   
Post-secondary education   0.376 0.540 
No 38.5 61.5   
Yes 42.1 57.9   
Employment   8.589 0.003 
Employed 47.2 52.8   
Unemployed or not in labour force 29.2 70.8   
Private Health Insurance   0.852 0.356 
Yes 42.8 57.2   
No 37.3 62.7   
Annual household income   4.965 0.084 
<A$20,000 27.2 72.8   
A$20,000-A$40,000 43.6 56.4   
>A$40,000 45.8 54.2   
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7.1.7 Future Use of CAM 
 
Among all survey participants, over four fifths (81.0%) reported that they would consider 
using CAM for their health care in the future, while a relatively small proportion (11.2%) 
would not consider using it; the remaining 7.7% preferred not to respond to this question or 
were unsure about their future use of CAM. More specifically, of the 988 participants who 
made a definitive answer as to whether or not they would consider using CAM in the future, 
those who were female, younger adults, in a better health condition, employed and with higher 
income range were more likely to use CAM in the future (Table 7.8). 
 
On the other hand, among CAM users, the vast majority (93.4%) indicated they would use 
CAM again, whereas 3.4% users would not consider using CAM in the future. Of these 25 
CAM users who would not consider using CAM in the future, none, surprisingly, had 
previously experienced side-effects after using acupuncture, Chinese herbal medicine, 
chiropractic or osteopathy. Furthermore, the proportion of people who would consider using 
CAM in the future increased to 95.4% of those who had visited a CAM practitioner in the 
previous 12 months. 
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Table 7.8 Consideration for CAM use in the future 
Consider using CAM in 
the future 
Statistical difference  
Characteristic 
Yes (%) No (%) Chi Square p 
Gender   10.717 0.001 
Female 91.3 8.9   
Male 84.3 15.7   
Age (year)   35.067 0.0001 
18-34 94.1 5.9   
35-64 87.8 12.2   
65+ 75.3 24.7   
Country of Birth   2.670 0.102 
Australia 88.8 11.2   
Non-Australia 84.8 15.2   
State   8.062 0.089 
New South Wales 88.3 11.7   
Victoria 89.6 10.4   
Queensland 89.8 10.2   
South Australia 78.2 21.8   
Western Australia 87.9 12.1   
Self-reported health status   18.924 0.0001 
Excellent/very good/good 89.7 10.3   
Fair/poor 77.0 23.0   
Post-secondary education   3.183 0.074 
No 85.6 14.4   
Yes 89.4 10.6   
Employment   19.666 0.0001 
Employed 91.3 8.7   
Unemployed or not in labour force 81.6 18.4   
Private Health Insurance   2.794 0.095 
Yes 89.3 10.7   
No 85.7 14.3   
Annual household income   14.317 0.001 
<A$20,000 79.2 20.8   
A$20,000-A$40,000 91.4 8.6   
>A$40,000 90.0 10.0   
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7.2 Discussion 
7.2.1 Rationale for CAM Use 
Apart from the characteristics discussed above relating to CAM use, there are factors that are 
often reported to be associated with a high prevalence of CAM, such as “perceived holistic 
approach of dealing with general health and diseases by CAM products and therapies”, 
“perceived unmet health-care needs”, “perceived higher risk of conventional medicine, or 
perceived lower risk of non-conventional medicine”, and “belief in the efficacy of 
conventional medicine and/or the actual experience of the efficacy of the therapies”.46 
 
This survey asked all CAM users about their attitudes towards some common beliefs and 
attitudes to CAM use. However, in the survey, data on such beliefs and attitudes were not 
collected from those who were not CAM users. This consequently limits the extent to which 
the current survey can interpret the attitudes towards the use of CAM and conventional 
medicine. A comprehensive rationale for CAM use, in particular the rationale for not using 
CAM in Australia, remains unclear at this stage. Nevertheless, over half of CAM users 
believed Western medicine had a relatively high risk of adverse events, while less than a 
quarter of CAM users did not agree CAM is relatively safe. On the other hand, a relatively 
high proportion of CAM users (well over three quarters) agreed that CAM is a holistic or a 
natural approach to treatment. 
 
When it comes to medical/health services, there is evidence of people using CAM because 
they have a poor perception of other health services.206-208 A small proportion of the current 
study’s participants also expressed this view. Nearly one in four CAM users in this survey 
believed that the service provided by their GPs was generally unsatisfactory. However, again, 
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whether such a viewpoint differed between CAM users and non-CAM users is unknown, as 
non-CAM users were not asked whether or not they were satisfied with medical services. The 
association between the attitudes towards, and experience of, Western medicine and their use 
of CAM is non-conclusive in the literature. Astin’s US study found that negative attitudes 
towards, and experience of, conventional medicine were not predictive of CAM use.46 In 
contrast, some earlier studies, based mainly on clinical patients, found a positive association 
towards CAM use.209-212 Thus, in a recent study, it was suggested that although being “very 
satisfied” with overall care was significantly associated with much less CAM use, satisfaction 
with doctor-patient interaction was not associated with CAM use.213 
 
There is ample evidence to suggest that those who are female and in a relatively higher social 
class are more likely to use CAM. This was also confirmed in the current survey. However, 
these characteristics of CAM users should not be confused with the rationale for CAM use. In 
addition, it would be more appropriate to describe attitudes and perceptions towards CAM use 
as factors that may relate to CAM use, rather than the “rationale” or “why” people use CAM. 
 
Grzywacz et al. suggested that adults of different ages and races are using different forms of 
CAM to treat illnesses or prevent them. 153 The demographic characteristics related to CAM 
use, such as age range and income range, refer, in fact, to individuals’ spending power 
(income), and the fact that the current middle-age adults were highly exposed to CAM during 
its rapid proliferation during the past two decades.153 Thus, rather than concluding that a 
group of factors may have contributed to overall CAM use, there may have been numerous 
factors that could have contributed to different CAM modalities. CAM therapies aimed 
primarily at treatment, such as alternative-medicine systems (e.g. Chinese medicine), may be 
better explained by a health-behaviour model, guided by scientific evidence of efficacy and 
safety, and the health conditions of the users. Whereas, CAM therapies that are generally used 
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for the promotion of health (e.g. meditation and other mind-body therapies) may be better 
explained by a health-belief model, guided by a holistic approach and perceptions of use. 153 
 
As noted above, CAM utilisation studies are commonly conducted with cancer patients. 
Studies on rationale or on why patients choose CAM are also more commonly conducted with 
cancer patients. This has been emphasised in a recent published systematic review of 52 
cancer studies.214 The review revealed that such results are more promising in terms of clinical 
implications of CAM use. It found that frequently reported factors influencing CAM use were 
the belief that conventional medical treatment (e.g. chemotherapy) had harmful side-effects,215 
that CAM could control the side-effects believed to be caused by Western medicine216-219 and 
that CAM was a non-toxic or less harmful therapy than Western medicine.63,220-224 However, 
it is still important to note that the definition of overall CAM is still a major barrier to a 
generalisation of the above findings. Thus, perhaps the rationale for CAM use may be 
particularly important for health-care professionals in clinical practice, if such a model of the 
rationale for using CAM was established on the basis of a single cohort of clinical patients. 
 
Finally, given the increasing emphasis on scientific evidence for both CAM and Western 
medicine, it is important to evaluate the resources where people receive information 
(particularly evidence of efficacy), and what types of resources or health interventions would 
influence the choices of CAM therapies. Ideally, these should be based on the use of CAM for 
specific health conditions, to better comprehend the complex trend of health-seeking 
behaviours.
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7.2.2 Regression Analyses on CAM Use 
 
Participants’ characteristics of CAM use discussed above were based on statistical analyses at 
a bivariate level. Therefore, such findings have not been adjusted for potential confounders 
that may influence the associations of CAM with some particular characteristics. Such an 
approach is commonly used in the early stages of exploring the factors that may relate to 
CAM use, or as confirmatory analyses of previous findings, which is consistent with the 
objectives of the current survey. On the other hand, multivariate regression analyses were 
conducted to further confirm previous findings in Australia and overseas, and to discover the 
likelihood of individual factors that were related to CAM use among adult Australians. 
 
In terms of demographic information, gender, age and educational background were found to 
be statistically associated with CAM use among current survey participants. In this respect, 
the odds ratio of females versus males using CAM was estimated as 1.6 in the current survey 
(the final predictive model, see Table 7.2), which is the same as the 2000 South Australian 
survey,10 is very similar to an earlier 1993 South Australia study (odds ratio=1.7),9 and is 
slightly higher than a 1999 Canadian study (odds ratio=1.3).48 
 
The current survey also estimated that educational background is highly associated with CAM 
use. That is, those people with a post-secondary education are 1.9 times more likely to use 
CAM than those without a post-secondary education. This significant finding was also 
reported in the 2000 South Australia study, although the odds ratio was less significant.10 It is 
of interest to note that in an in-depth US study on why patients use CAM, education also 
emerged as the only significant socio-demographic variable that will predict CAM use.46 
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In the current survey, age also emerged as another significant factor that predicts CAM use. 
While this was not reported in the 2000 South Australia study, 10 it had been previously 
estimated in a 1993 South Australia study9 conducted by the same group of researchers. The 
estimated odds ratios were similar. The oldest age range (55+ in the South Australia study or 
65+ in the current survey) appeared to have the smallest odds ratio (i.e. less likely to use 
CAM). Again, this was consistent with the 1999 Canadian study.48 
 
The health behavioural model (HBM)225is one of the conventional models used to study health 
behaviour as a predictor of health care use. Thus, this may be particularly relevant in 
predicting the use of CAM services. Some researchers have taken this model into 
consideration.226 It has been hypothesised and confirmed that individual believes the 
philosophic of CAM use related to holistic and natural characterises are more likely to use 
CAM.46 In addition, individual with “perceived unmet health care needs” was also found to be 
1.5 times more likely to be CAM users than those without such a perception. 48 Unfortunately, 
in the current study, data related to health behaviour was collected from CAM users only, and 
not from all surveyed participants. Therefore, it is not possible to include such data into a 
predictive model for this study. Nevertheless, other perceptions that are possibly associated 
with the use of CAM by adult Australians were collected, and emerged from the regression 
analysis. Notably, the view of health insurance coverage of CAM influences the decision to 
purchase of such insurance was frequently reported only among those CAM users. 
 
Finally, although specific health conditions were not found significantly as predictor variables 
in the model of CAM use, back problems and trauma/injury were found to be significantly 
associated with those who had visited CAM practitioners over a 12-month period. The odds 
ratio (2.6) of people with back problems seeking CAM practitioners in the current survey was 
similar to a previous US study (2.3).46
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7.2.3 Impact of Health Insurance on CAM Use 
 
National Health Insurance 
 
CAM has become a vast resource for health care internationally. The increasing popularity of 
CAM is also echoed by the increasing involvement of health insurance companies. In the US, 
based on a national survey,227 Wolsko reported that full or partial coverage of CAM by health 
insurance providers is strongly associated with high-frequency use of CAM services. In the 
United Kingdom, there is a growing trend for the National Health Service to cover 
complementary medicine services.228 
 
As CAM becomes widely available and acceptable in Australia, there is greater public interest 
in CAM being included under the cover provided by the national health insurance system 
(Medicare). For example, a study conducted over 10 years ago found that acupuncture services 
in Australia have risen steadily over the past two decades, and 15.1% of GPs in Australia have 
claimed Medicare rebates for acupuncture treatment.167 Certainly, with the increasing 
evidence of a large proportion of GPs in Australia now practicing acupuncture and other CAM 
therapies,95 the number of Medicare claims for acupuncture services performed by GPs is 
considerable. In 2002-2003, as estimated by the Australian Institute of Health and Welfare, 
the Australian Health Insurance Commission (HIC) provided A$13.5 million for 595,000 
acupuncture Medicare procedures performed by medical practitioners.147 
 
However, research on national health insurance and private health insurance and CAM use in 
Australia is extremely limited. Previous health surveys and surveys on CAM in Australia 
failed to investigate the possible correlation between insurance and CAM use, and did not 
explore the perceptions of, and attitudes towards, insurance and CAM use among Australians. 
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Thus, it is important to note from the current survey that approximately three quarters of 
participants who considered visits to practitioners of acupuncture and chiropractic should be 
covered by the Australian national health care; even though the surveyed participants were 
asked to take into account that there is limited money to fund Medicare for all Australians. 
Well over half of all participating adults considered Medicare should also cover visits to 
practitioners of Chinese herbal medicine and osteopathy, regardless of their status as current 
CAM users. 
 
A recent endorsement from the Australian Government is promising for the future integration 
of CAM in the national health system. Thus, from 1 July 2005, new items on the Medicare 
Benefits Schedule (MBS) will make it easier for GPs to manage the health care of patients 
with chronic medical conditions, including patients needing multidisciplinary care. Eligible 
Australian patients are now allowed to receive up to five Medicare rebates from certain allied 
health practitioners, including chiropractors and osteopaths.187  
 
As Pelletier and Astin pointed out, an increasing number of health providers, including 
hospitals, in the US are incorporating CAM to meet the high demand from consumers; 
however, the uncertainty about the profitability of CAM is a primary obstacle to such 
integration.229 Thus, a representative national survey in Australia should be carried out to 
assess the true consumer demand of CAM coverage and reimbursement from Medicare. 
Optimistically, it will derive a set of commonly demanded CAM to be included in the 
Medicare system, which is rapidly growing in use and which is supported by growing rigorous 
scientific evidence.  
  
268 
Private Health Insurance 
 
The “legitimisation” of a number of forms of CAM practice through statutory regulation in 
states or nationwide in Australia, for example, chiropractic, osteopathy, Chinese herbal 
medicine and acupuncture, and approval by the Therapeutic Goods Administration to market 
certain complementary medicines, raises considerations of relative access and equity for CAM 
and mainstream health care. As noted, in Australia, CAM treatments do not qualify for 
Medicare rebates, with the exception of limited referral services for chiropractic and 
osteopathic treatments, and acupuncture delivered by medical practitioners accepted by the 
Health Insurance Commission. Nevertheless, at present, some forms of CAM have attracted 
limited coverage from most major private health insurance funds in Australia.  
 
In Australia, in March 2006, nearly half (43.1%) the Australian population were covered by 
private health insurance.230 Most health insurance providers in Australia, including the 
Hospitals Contribution Fund of Australia (HCF), Newcastle Industrial Benefits (NIB) private 
health funds, Medibank Private Limited and the Medical Benefits Fund of Australia Limited 
(MBF) had benefit packages, which included rebates for some forms of CAM (generally 
chiropractic, remedial massage, osteopathy and acupuncture). However, detailed availability 
and public demand for private health insurance rebates for CAM in Australia is unknown. 
 
In the current study, although over half (55.7%) of survey participants had private health 
insurance, less than one in seven (13.9%) had received a rebate from their insurance 
companies for CAM services in the previous 12 months. It appears that the cost of using CAM 
is mainly borne by individuals. With some 1.87 million Australians being recipients of the age 
pension (low household incomes),149 the socio-economic implications of high levels of CAM 
use in the elderly needs to be considered. 
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The use of chiropractic remains one of the most substantial CAM services in Australia and 
overseas.11,231 A considerably high prevalence of chiropractic has also been found in this 
study, and it was for the most popular forms of CAM, together with remedial massage and 
acupuncture, that CAM users had lodged health insurance claims. In particular, nearly half of 
those people who had received private health insurance rebates on CAM were for chiropractic 
services. This may be partially explained by the fact that, the practice of chiropractic in 
Australia, which has a history of over 100 years ago,232 and which has been subjected to 
mandatory registration with regulatory bodies in all states and territories of Australia, is one of 
the earliest and most common forms of CAM services covered by private health insurance in 
Australia. Perhaps, it is not surprising that, in the US, a large telephone interview study 
revealed that virtually all the insurance providers in three states in the northeast of the US 
cover chiropractic services in some form, whereas only less than half of the insurance 
companies cover acupuncture or massage therapy.233 
 
Perhaps one can also expect that people with private health insurance are more likely to 
choose chiropractic and remedial massage, as at least part of these services are currently 
covered by private health insurance in Australia. The present study has confirmed this 
supposition. Similarly, it is clear that a much higher proportion of people with private health 
insurance are likely to choose acupuncture services than those without such coverage. Given 
that the mandatory registration of acupuncture practitioners has been in place in Victoria, and 
is soon to be introduced in some other states in Australia, the association of private health 
insurance and acupuncture use also needs further investigation. Among all participants in this 
survey, nearly half agreed that insurance coverage of CAM would influence their decision on 
purchasing health insurance. It is of interest to note that a four-year retrospective data analysis 
on insurance claims suggested that people with chiropractic insurance coverage had lower 
annual health-care expenditure, compared to those without such coverage.234 
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Based on existing literature, there is strong evidence that many cancer patients will seek CAM 
therapies if insurance covers the cost.235 More specifically, the use of naturopathy and 
acupuncture were more common, while the use of chiropractic was less common for cancer 
patients than people without cancer. 235 Detailed information on which forms of CAM have 
been claimed for which specific health conditions were not researched in this survey. 
Australian literature in this area has not been reported. Nevertheless, the majority of the 
current survey participants suggested private health insurance should cover the common forms 
of CAM, such as acupuncture and chiropractic. Thus, private health insurances in Australia 
cover certain common forms of CAM to a certain extent (approximately A$400-A$600 per 
year for a single person). However, it is not comprehensively understood whether consumers 
are fully utilising such coverage and what their attitudes towards the extent of the coverage 
are. 
 
Finally, the consequences (particularly the economic aspects for the consumers and insurance 
companies) of including CAM in private health insurance policy have been poorly researched 
in Australia and overseas. This suggests the need for a representative national survey in the 
near future to meet the demands of rapidly growing CAM use and the potential requirements 
of insurance coverage in Australia.  
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7.2.4 Impact of Regulation on CAM Use 
 
A regional Australian study in 2000 suggested that there has been a steady increase in the use 
of CAM by the South Australian population in the previous 10 years.10 However, researchers 
also suggested a decline in the CAM market in 2004,11 which could be attributed to consumer 
response to the adverse publicity generated by the TGA recalling Pan Pharmaceutical products 
from the market in 2003.236 In contrast to this finding, the current survey found an increase in 
CAM use, when compared to these South Australia studies in 1993, 2000 and 2004.9-11 
However, the CAM classification used in these surveys was inconsistent, the targeted 
population were divergent (regional and national), and importantly, the current survey 
suggests the lowest CAM prevalence was, in fact, found in the state where the regional studies 
were conducted (South Australia). 9-11 Thus, whether the Pan Pharmaceutical product recall 
would have impacted on the popularity of CAM use in Australia is unclear. As a cross-
sectional survey, the current survey is not able to confirm the trend of CAM use over time. 
 
To strengthen the framework of CAM regulation in Australia in 2005 the Australian 
Government accepted most of the recommendations made by the Expert Committee on 
Complementary Medicines in the Australian Health System.26 It is essential that a safety guide 
be established for the Australian general public to address continuing concerns of CAM use. 
Therefore, importantly, the Therapeutic Goods Administration has recently published a series 
of Australian regulatory guidelines for complementary medicines (ARGCM) to ensure that all 
therapeutic goods, including complementary medicines use and practice in Australia, are 
subject to rigorous standard.237-241 
 
Whether such regulatory guidelines will contribute to the future increased use of CAM is 
unclear and will be hard to determine. As Weir suggest, there are many factors that may 
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contribute to the increasing use of CAM, including the higher cost of conventional medicine 
and the inability of science to provide a cure for all illnesses with a single form of 
medicine.242 From a sociological perspective, Coulter and Willis also suggested that the “baby 
boomers” in Australia will age with a variety of chronic diseases, which are often considered 
to amenable to treatment by some forms of CAM.243 The increasing availability of health 
insurance coverage for CAM will also increase the likelihood of people choosing a CAM 
service.243 
 
Some three quarters of participants in the current survey considered CAM products should be 
regulated as rigorously as Western medicine. This figure includes those who did not identify 
themselves as CAM users. This, perhaps, further reflects a demand from the general public to 
have safer CAM products in Australia. In addition, this also echoes the findings of a recent 
South Australia survey that about half the survey participants assumed that a government 
agency tested CAM products. 11 
 
Currently, the practice of Chinese medicine in Australia, outside the jurisdiction of Victoria, is 
not subject to statutory registration. Nationwide, with the exception of chiropractic and 
osteopathy, there is no statutory registration requirement for other CAM professions. Over the 
past decades, some CAM professions in Australia have developed a self-regulatory system. 
Such regulatory mechanisms have been established in the absence of, or to complement 
legislation requiring mandatory registration, and rely on voluntary compliance by members of 
the relevant professions and industry organisations.244 In Australia, the Australian Self-
Medication Industry (ASMI) is the highest profile organisation representing industries 
involved in the manufacture and distribution of non-prescription consumer health-care 
products, such as over-the-counter medicines and complementary medicines.  
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In the interests of comprehending better the potential impact of the introduction of the 
statutory registration of Chinese medicine in a state of Australia (Victoria), this study 
specifically asked participants’ about their perceptions toward this regulation. This study 
found that well over four fifths of survey participants considered that the statutory registration 
of Chinese medicine practitioners, including acupuncturists and Chinese herbal medicine 
practitioners, provided for greater public safety and confidence in these forms of CAM. 
Significantly, there were similar proportions of survey participants from other states and 
territories. Furthermore, when asked whether acupuncturists and Chinese herbal medicine 
practitioners should be subject to registration with government authorities in all states and 
territories of Australia, again, well over four fifths of all survey participants considered it 
necessary. Such a proportion was observed both among the Victorian participants and 
participants from any other states/territories. Thus, as Carlton and Bensoussan commented, the 
Victorian Chinese Medicine Registration Act provides a model for regulating those CAM 
professions where the practices are potentially intrusive and dangerous. 244 
 
A previous study in Melbourne in 2002 found a large proportion of survey participants would 
consult a Chinese medicine practitioner who was not registered, and only 20% considered that 
such a registration system would make them more confident about consulting Chinese 
medicine practitioners.62 As noted above, a large proportion of participants from this survey 
considered that statutory registration of Chinese medicine professions was important. Thus, it 
appears that Chinese medicine has been valued in Victoria since its introduction. 
Unfortunately, whether people are still prepared to consult an unregistered Chinese medicine 
practitioner was not asked in current study.
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7.2.5 Risks Associated with CAM Use 
 
The risks associated with the use of CAM are growing concerns for consumers, health 
professionals and governments. There is a widespread and misguided belief amongst 
consumers of many types of CAM products that since they are derived from natural sources 
they must be safe. However, herbal therapies are frequently complex mixtures of potentially 
biologically active ingredients. Such remedies may have multiple actions and may carry a high 
risk of both direct adverse effects and of adverse effects arising from interactions between 
their constituents and concurrent conventional therapeutic agents. It is of particular 
importance to note that nearly half of a survey population in Australia wrongly believed that 
CAM had been independently tested by a government agency before being sold.11 
Surprisingly, those younger than 35 years old, who were better educated and had a relatively 
high income comprised a higher proportion of people who held this belief.11 
 
Additional concerns relate to the quality/purity of CAM products, the training of CAM 
practitioners, and the possibility that patients may discontinue beneficial conventional 
treatments. These concerns are particularly relevant to the elderly and to victims of chronic 
illness, due to factors such as the high prevalence of chronic diseases of the elderly, greater 
use of conventional medication, and their likely greater susceptibility to adverse effects and to 
therapeutic interactions. These issues may be compounded by poor communication between 
patients, CAM practitioners and conventional health-care practitioners, and indeed, by a lack 
of understanding by patients and practitioners of the potential adverse effects of CAM use. 
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Adverse Events of CAM Use 
 
The potential risks associated with the use of medicinal products are not completely 
avoidable. These apply to all forms of medicines and therapies, including both Western 
medicine and CAM. Adverse events may occur with the use of products that have problems of 
contamination, toxicity, lack of quality control and inappropriate labelling, 11 as well as 
problems related to the advice provided by health professionals (it could be negligence). In 
addition, reports on interactions between CAM and Western medicine are not unusual.245-248  
 
It is important that consumers should be aware of the potential negative effects of all 
medicines or treatments they are taking. Current survey participants were asked about their 
experiences of encountering adverse events after using acupuncture, Chinese herbal medicine, 
chiropractic and osteopathy (only if such a participant used one of these four forms of CAM). 
As noted-above, four participants claimed they experienced adverse events after acupuncture 
treatment. However, when the definition of adverse event relating to acupuncture was 
specified according to standards developed in collaboration with the British Medical 
Acupuncture Society,249 there was only one case which qualified as an adverse event (bruise). 
 
An adverse event rate per 1,000 or per 10,000 practitioner consultations have been 
reported.250-252 Survey participants in the current study provided an estimated incidence of 14 
adverse events per 10,000 acupuncture consultations, which is much lower than the adverse 
event rate estimated by a prospective survey of 32,000 acupuncture consultations in the UK 
(i.e. an incidence of 684 per 10,000 consultations).249 However, the current estimation was 
based on self-reported cases from those surveyed adults, whereas the UK study was based on 
reports from acupuncture practitioners over a 21-month period. The data are not directly 
comparable. 
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In the current survey, users of CHM, chiropractic and osteopathy also provided information on 
adverse events that may have been related to such CAM use. For the reasons mentioned in 
Chapters 6.1.1.9 and 6.1.3.4, the commonly estimated incidence rate per 1,000 consultations 
was not available for CHM and osteopathy. The current survey participants reported a 
relatively high incidence (2.96 per 1,000 consultations) of adverse events related to 
chiropractic treatment. Comparable data reported among Australian chiropractors were not 
identified at the time of writing this thesis. Nevertheless, it is important to point out that safety 
issues have attracted continuing safety concerns in previous studies in Australia. Thus, it has 
been commented that the practices of forms of CAM are not risk-free, and fatalities have 
occurred.12,164,253 The incidence reported by Chinese medicine practitioners (including 
acupuncture and CHM) was estimated at 1.6 per 1,000 consultations.164 Adverse events 
associated with herbal medicines, nutritional substances and homeopathic medicines was 
estimated at 2.3 per 1,000 consultations.12 
 
In Australia, reports of suspected adverse reactions to drugs/medicines are sought from health 
professionals and are also received from consumers. Section 29A of the Therapeutic Goods 
Act 1989 requires sponsors of medicines registered or listed in Australia to report adverse 
reactions.237 However, as stated in the report submitted by the Expert Committee on 
Complementary Medicines in the Health System to the Minister for Health and Ageing, 
Australian Commonwealth Government, “the current adverse reaction reporting system may 
be biased away from complementary medicines, because complementary medicines are 
usually self-prescribed and problems may not be reported, should they arise”.14 Recently, a 
special “1800” telephone number has been established within the Therapeutic Goods 
Administration to facilitate reporting of adverse reactions26 in an effort to strengthen the 
collection of adverse event.12 
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Concurrent Use of CAM and Western Medicine 
 
Some consumers are so committed to CAM products and therapies that they actively self-
prescribe or self-administer CAM. In the current study a high proportion of participants used 
CAM and conventional medical services concurrently, and that many CAM users did not 
inform their medical doctors (and the medical doctors did not ask) about their use of CAM. 
Clearly, these findings are of concern, given the increasing reports of side-effects of CAM 
products254 and other problems, such as contamination of CAM products.255  
 
A Canadian study conducted over a decade ago found users of chiropractic tended to also be 
concurrent users of conventional health care.256 However, most studies in the current literature 
failed to investigate the concurrent use of specific forms of CAM and Western 
medicine.11,47,257-259 Perhaps, one of the biggest limitations of the current literature on the 
concurrent use of CAM and Western medicine is that it has failed to collect detailed 
information on which specific forms of CAM have been commonly used concurrently with 
Western medicine, and to what extent (e.g. used on the same day, for the whole duration of 
the illness, or only used intermittently). Addressing these limitations, in a recently published 
South Australia study,11 CAM and Western medicine use on the same day was investigated, 
and the study found that about half of CAM users had concurrently used Western medicine. 
Due to the time and resource limitations, the current survey was not designed to collect such 
data.  
 
It is worth noting that the pattern of concurrent use has been found to be related to some 
specific characteristics, such as gender and age.260 In addition, some studies have also 
suggested that the greater the value the participants attached to spirituality, the greater the 
likelihood of users to use both treatments.46,210,260 A national survey in the US further revealed 
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that adults who used both CAM and Western medicine appeared to value both, and were less 
concerned about their medical doctor’s disapproval than about the their doctor’s inability to 
understand or incorporate CAM therapy use within the context of their medical 
management.259 Supporting this finding, a relative lower proportion of CAM users in the 
current survey was concerned that their medical doctors may not approve of their use of CAM. 
 
The concurrent use of CAM and Western medicine among those over 65 years old is 
becoming a matter of concern, as the proportion of concurrent was about 80%, being the 
highest among all ages.11 Similarly, in the current survey, a significantly higher proportion of 
participants aged 65 and above had concurrently used both CAM and Western medicine than 
those of younger ages. The rationale of users for such concurrent use certainly warrants 
investigation in further studies. The high prevalence of concurrent use also suggests the need 
to educate older people to understand better the potential risks of concurrent use, and increase 
the awareness of voluntary communication of such use between older people and the health 
professionals. 
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Communication between Consumers and Practitioners 
 
The concurrent use of both CAM and Western medicine may increase risk, as the 
pharmacological action and therapeutic mechanism of most forms of CAM products and 
therapies are inadequately understood to allow health professionals to identify possible 
interactions. The use of CAM does not, in general, suggest dissatisfaction with conventional 
medicine.259,261 Thus, more recently, researchers have addressed the communication gap 
between conventional and alternative medicine.262-266 In an interest to keep patients, CAM 
practitioners and medical doctors informed, and to provide better guidance to patients 
regarding the safety and efficacy of the concurrent use of CAM and Western medicine, the 
disclosure of CAM use to health professionals seems to be a critical step in future integrative 
health-care. Thus, comprehensive information to advise patients to use CAM is particular 
welcome.267 
 
The reported non-disclosure rates are significantly high. About half of the current survey 
participants had only sometimes, or never informed their medical doctors about their CAM 
use. A national US survey estimated that nearly two thirds (63%) of CAM users did not 
disclose at least one of their CAM therapies.259 Furthermore, qualitative studies on clinical 
patients also discovered a high proportion of non-disclosure. For example, a study on women 
with breast cancer found that nearly half (46%) did non disclose their use of CAM,266 while 
another study on cancer patients revealed 34% non-disclosure.264 The lowest disclosure rate, 
in the literature, was 23% among older, rural women.268 
 
Although, as noted above, a significantly high proportion of participants aged 65 and older 
concurrently used both CAM and Western medicine than those in the younger age groups, 
these older CAM users, in fact, had a significantly higher proportion of always informed their 
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medical doctors of their CAM use than younger CAM users. This may be partially explained 
by the increasing popularity of CAM which has occurred in the past two decades, and most 
forms of CAM are relatively new to older people. While they are sensitive to CAM treatment 
to improve their health conditions, older people may be more proactive in informing their 
GPs, to optimise their health-care outcomes. 
 
In the current study, the main reasons for non-disclosure volunteered by survey participants 
were, “medical doctors did not need to know”, and the “doctor did not ask”. Similar findings 
were commonly reported,269-271 and have also been summarised in a recent review.98 
However, such “don’t know” or “don’t ask” results are no longer acceptable in modern health 
care, and a proactive management system is needed to approach individualised personal 
health.261 
 
It is of interest to examine the perspectives of conventional health professionals about the 
communication of CAM use with their patients. A study conducted in the state of Ohio, in the 
US, found that none of the physicians would terminate the physician-patient relationship if a 
patient used CAM, in addition to the prescribed conventional medicines.263 This should not be 
unexpected, as the use of CAM by conventional medical doctors themselves was quite high,265 
and there are increasing debates about the benefits of conventional doctors proactively asking 
patients about their use of CAM.261,267,272 
 
As a greater understanding develops about the question of the interaction of CAM with 
conventional medicines and the matter of full disclosure of such use, various ethical and legal 
issues are raised.273,274 Even more contentious than ignoring patients’ use of CAM, is the 
possibility that conventional medical doctors may be at risk of potential malpractice 
liability.275 For example, as scientific evidence of CAM is increasingly acceptable to the 
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conventional medical system, there is a strong argument that medical doctors should advise 
patients about the CAM treatment options, in addition to other medical treatment options, to 
satisfy the duty of care of a medical doctor.276 On the other hand, on the basis of existing US 
laws, “a physician referral to a CAM provider could be considered a “negligent” decision if it 
delays or eliminates the patient’s opportunity to obtain necessary medical treatment”.277 
However, the risk of litigation for medical doctors’ failure to provide adequate information on 
CAM to patients is probably low at this stage.278 
 
In Australia, according to the General Guidelines for Medical Practitioners on Providing 
Information to Patients, published by the National Health and Medical Research Council, a 
“medical doctor should encourage patients to reflect on opinions, ask more questions, and 
should be assist patients in seeking other medical opinion where this is requested”.279 Thus, in 
2002, the Australian Medical Council posted a position statement (Section 4.4): “the medical 
practitioners should specifically ask patients about their use of complementary medicine and 
take account of this in their management of conditions. Medical practitioners should be 
sufficiently well informed about complementary medicine to be able to provide advice to 
patients when appropriate.”280 
 
In summary, the fact of concurrent use of CAM and Western medicine, and possibly other un-
named forms of medicines or therapies, is no longer uncommon in today’s health-care system. 
The trend of such use may increase over time. A better understanding of the benefits of 
complementary and alternative medicine, and the potential risks of using these medicines is 
critical to improve the communication of such use between patients and health professionals. 
 
  
282 
7.2.6 Lifetime Use and Future Use of CAM  
 
In addition to investigating the prevalence of CAM use over a 12-month period, the current 
survey has also investigated the lifetime usage of CAM, that is, its use at least once at any 
time previously. Approximately five out of six adult Australians have used CAM at some time 
in the past. The prevalence is comparable to a previous regional study in New South Wales, 
where three-quarters of the adults reported on a lifetime use of CAM.38 In addition, consistent 
with noted regional differences of CAM use found in the current survey, the prevalence of 
lifetime use only (precluding current users) varied among different states. For example, the 
prevalence of lifetime use only in South Australia was found to be significantly lower − about 
half the prevalence found in New South Wales, Queensland and Western Australia. However, 
there may be a recall bias for lifetime CAM prevalence, as participants may have used non-
Western medicine years ago, and not able to recall the details. 
 
Lifetime use of CAM is occasionally reported among CAM surveys. In general, a significantly 
higher prevalence of lifetime use was reported, compared to the prevalence over a 12-month 
period. This is evident in several frequently cited CAM surveys. For example, the prevalence 
rose from 42.1% for a 12-month period to 67.6% for a lifetime period in the 1997 US national 
survey.281 The prevalence of lifetime use also increased from 50% to 73% in the 1997 
Canadian national survey,6 and from 28.3% to 46.6% in the UK survey.5 Furthermore, the UK 
and Canadian studies also provided detailed information on the lifetime use of each of the 
individual forms of CAM. The lifetime use of these therapies was generally consistent with 
the popularity of use for each modality in a 12-month period.5,6 Limited information of such 
lifetime CAM use is available in the Australian literature, and has not been investigated in the 
current survey. 
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It is apparent that the use of complementary medicine is more popular in Australia and in 
many Western countries than it was a decade ago. It is not hard to find reasons why this type 
of medicine is becoming more popular. The increasing scientific evidence of the efficacy and 
safety of certain CAM therapies, and perhaps the recognition of the cost-effectiveness of some 
specific forms of CAM would partially explain its popularity. Thus, for various reasons (not 
investigated in the current survey), a large proportion of the surveyed participants indicated 
that they would use CAM in the future, and a vast majority of the current users will use CAM 
again. 
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CHAPTER 8. GENERAL DISCUSSION, CONCLUSIONS 
AND POLICY IMPLICATIONS 
 
8.1 Overview of the CAM Survey 
 
The detailed outcomes of conducting the survey are presented in Chapter 4.1. In brief, a total 
of 1,067 interviews were conducted with a representative cohort of adult Australians. By 
employing a random-digit telephone dialling method to contact potential participants, and by 
applying a national quota to ensure representativeness, the study population can be regarded as 
representative of the national Australian adult population. In addition, the representativeness 
of the study population is further confirmed though a series of statistical analyses (see Chapter 
4.1.3). 
 
Using a predefined quality assurance protocol, the survey information was captured during 
interviews and recorded in a computer-assisted telephone interview system. Thus, missing 
data were minimised. The validity of the data was extended after scale reliability analyses 
were carried out for different sections of the instrument, which confirmed its internal 
consistency of items measured by the scale. Finally, after all data were collected, a data-
weighting process was applied before generating the survey results and performing 
consequent analyses. Thus, all data were adjusted to represent the national population. 
 
Although the current study was conducted with an appropriate sample size and a national 
representative population, it is also important to note the study limitations when interpreting 
the results, in particular those concerning state differences. These are discussed below. 
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8.2 Limitations of the CAM Survey 
 
The response rate is always a major concern for survey researchers, and is dependent on what 
is considered to be a completed interview. The rate can vary significantly according to some 
experienced survey companies. The response rate of the current survey is lower than for some 
other population surveys of its kind and could be considered as a significant study 
shortcoming. It seems likely that the employment of national quotas for gender and age-range 
during the recruitment stage limited voluntary participation and impacted significantly on the 
final response rate. This is further evidenced by the fact that when a particular quota category 
was filled (at an advanced stage of the recruitment process), a large number of potential 
participants was rejected (see Figure 4.1). 
 
The increasing use of telemarketing from call centres making it harder for non-commercial 
telephone health surveys, such as the present survey. In addition, the short period of survey 
may have influenced the response rate. Hence, the number of call-backs was limited, and there 
was not enough opportunity for optimising follow-ups. A large number of unresolved call-
back numbers (76 appointments in total) would also have impacted on the final response rate. 
Finally, recognised government authorities administer most population health surveys, and 
people may have a greater tendency to participate in these. The low response rate may have 
introduced a non-response bias. If those refused to participate were less likely to use CAM or 
had negative attitudes towards CAM, this could result in a decrease of the current overall 
estimation of CAM prevalence. 
 
The relatively small sample size in a number of states and territories (i.e. Australian Capital 
Territory, Northern Territory and Tasmania) may have limited the results that can be 
generated at a state level. With a larger sample size, additional information would have been 
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generated. The most important information would be the definitive differences on regional use 
of CAM, and on the use of each of the 17 forms of CAM. The current survey suggests marked 
regional differences among states. However, the sample size was too small to draw 
conclusions from Tasmania, Northern Territory and Australian Capital Territory. Similarly, 
some questions relating to specific CAM therapy (in particular, osteopathy) were administered 
to a relatively small group of users and restricted the reliability of the findings. 
 
In terms of outcome measures, perhaps the biggest limitation was that data on the specific 
medical conditions treated by each form of CAM were not collected. Such specific questions 
on each of the 17 CAM therapies would have been time-consuming, and it was impossible to 
collect adequate relevant data in the relatively short interview time available. Information 
about the medical conditions for which CAM, as a whole, is being used is of general interest 
but more specific data about each individual form of CAM would have been of greater 
interest. On the other hand, data were collected on medical conditions that resulted 
participants visiting a GP. Analyses were then performed to examine the association between 
participants having such a medical condition and visiting a CAM practitioner or using CAM. 
In addition, data were also collected on which acupuncture, Chinese herbal medicine, 
chiropractic and osteopathy were used to treat specific medical conditions. 
 
Due to the limitation on interview times, it was not possible to obtain detailed data on the 
perceived benefits and risks of using each of the 17 forms of CAM. This information should 
be particularly valuable for regulatory bodies and policy makers. Nevertheless, general 
opinions on the overall helpfulness of CAM and the actual benefits and risks after using the 
four regulated forms of CAM were collected. 
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Several common problems encountered in similar CAM studies remain unsolved. Previous 
researchers have commented on the fact that discrepancies in CAM classification have led to 
discrepancies in the data relating to CAM prevalence even within a specific country.18 This 
creates great difficulties in interpreting survey results and comparing data from different 
studies.282 There is no general agreement on what constitutes the totality of CAM therapy. In 
particular, the matter of precisely classifying different forms of vitamins and supplements as 
complementary medicine products or non-CAM products is critical and impacts on the overall 
prevalence significantly. The argument being that most studies found that the highest 
prevalence of a single form of CAM was generally in the use of vitamins and minerals. For 
example, the current study found 45.8% participants used multivitamins, and the majority 
(86.4%) of these users had not visited a CAM practitioner. If self-administered multivitamins 
are excluded, a lower overall CAM prevalence will certainly be estimated.  
 
This situation becomes more complicated when considering the modality of multivitamins 
included in the definitions of CAM in previous studies. For example, people may purchase 
supplements over the counter on the recommendation of friends or relatives who had 
originally received prescriptions from their medical doctors or CAM practitioners. The 
indirect “prescription” is contradictive with the definition being used in the 1996 US CAM 
study –CAM was defined with the exclusion of vitamins prescribed by a medical doctor and 
daily vitamins.3 Another US study employed an alternative definition of self-measurement of 
vitamins in terms of “overdose in excess of the Recommended Daily Allowance”.1 The issues 
about vitamins and supplements also presented dilemma for the current survey in regard to 
participants making a decision about what constitutes CAM and what doesn’t. This implies 
that arriving at a precise and acceptable definition of each CAM modality requires further 
research. 
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There are substantial differences between countries and regions in the relative popularity of 
many therapies usually considered as CAM, presumably reflecting different social and health 
care contexts. A pilot study of the current study to determine the types of CAM used most 
commonly in Australia revealed the relatively high popularity of aromatherapy (subsequently 
confirmed by the main survey), which concurred with previous Australian regional surveys9-
11
. Surprisingly, aromatherapy was not included in the total CAM prevalence of relevant US 
national health surveys.1,4  
 
Through this study, other issues that need to be addressed in future studies are identified. 
These problems and limitations are consistent with existing literature on population surveys283 
(e.g. the difficulty of accessing mobile phones). This may be justified, based on the fact that 
fixed telephones are used by over 97.5% of households in Australia.284 In this respect, gaining 
access to mobile phone has only been incorporated into limited numbers of Australian 
population surveys. Another complexity is that the use of multi-phone lines within 
households. This is relevant, because more than one line in a household, will increase the 
chances of that household being selected. 
 
It was determined that English would be used as the language for the interviews, therefore 
people from ethnic groups that do not speak English have not been included in this study. 
Fortunately, throughout the interviews very few people were excluded due to language 
barriers. To date, no study has been conducted in Australia to examine CAM use in the 
indigenous population. Future follow up studies should address the above matters, and 
possibly include participants from diverse social culture backgrounds. 
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8.3 General Conclusions  
Prior to the conduct of the survey, three systematic reviews were completed to summarise the 
current overall utilisation of CAM, and the specific use of Chinese medicine in general 
populations around the world. CAM use in different regional and clinical populations in 
Australia has also been systematically evaluated. As noted above, the uncertainties of CAM 
definitions and classifications may affect estimates of the true prevalence of CAM. 
Nevertheless, there is evidence that the prevalence of most forms of CAM (e.g. herbal 
medicine and acupuncture) in many countries has increased steadily. 
 
This study took an important step in initiating a national population-based survey in Australia 
to provide critical data on the current use of CAM in Australia. The findings indicate that the 
use of CAM in Australia is considerably higher than that extrapolated from previous regional 
studies. National expenditure on CAM appears to account for almost half the total expenditure 
on non-subsidised health-care products. Moreover, it was estimated that Australians made 
almost the same number of visits over a 12-month period to CAM practitioners as they did to 
conventional medical practitioners. This study again raises serious concerns about the 
concurrent use of Western and CAM therapies, and the lack of communication between 
patients and medical practitioners with regard to CAM use. 
 
In addition to estimations of the utilisation of CAM from a national perspective, this study 
also explores possible regional differences, which shows that there were marked differences 
between states, for example, South Australia has lower overall prevalence of CAM use when 
compared with other states. In addition, the present survey also suggested that regional 
differences in the use of several specific forms of CAM were apparent. Thus, extrapolation of 
national CAM use based on regional studies should be undertaken with caution.
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As Straus (2005) stated, understanding who uses CAM and why they do so informs the 
research goals, initiatives and collaborations of the NCCAM.8 Thus, the current study 
provides a useful national resource base for further research, including intervention studies. 
The outcomes of this investigation will be relevant to a broad range of health-care 
professionals and researchers, therapeutic regulators, and educators in the areas of public 
health, health policy, general medicine, and complementary medicine. In all, in Australia, 
what was known previously in the field of this study and what this study adds can be 
summarised in the table below (Table 8.1). 
 
Table 8.1 What was known previously and what this study adds 
What was known previously on this topic  
• There has been no previous national Australian study on the use of CAM. National 
estimates of CAM use have been extrapolated from a regional study in 2004. 
• There is evidence from studies in the US and the UK of increasing CAM use. Previous 
studies have highlighted major concerns about the concurrent use of CAM and 
conventional medical treatments. 
What this study adds 
• A reliable estimate of CAM use by the Australian population. 
• Evidence of marked regional differences in CAM use in Australia. 
• Evidence of significant regional differences in the use of specific forms of CAM 
• Expenditure on CAM products by Australians is estimated to account for almost half 
of their “out-of-pocket” expenditure on non-subsidised health-care products. 
• Comparison of national expenditure on CAM and conventional medical services. 
• Specific benefits and risks perceived by the users of common forms of CAM 
• Specific benefits and adverse events that users of common forms of CAM considered 
they have experienced. 
• The discussion of CAM use between CAM users and their medical doctors. 
• The extent, the demand for and consequences of health insurance cover for CAM. 
• Public attitudes towards statutory CAM product and practitioners regulation. 
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8.4 Policy Implications 
 
The findings of the current study have a number of implications for ongoing health policy 
development. Firstly, given ongoing shortages in the medical workforce, particularly general 
medical practitioners, and the increasing public and private costs of medical services, the 
increasing popularity of certain CAM therapies may offer opportunities to reduce the burden 
of heath-care services. This could be done by identifying CAM modalities which, based on 
evidence of their safety and effectiveness, could effectively contribute to health service 
delivery, in concert with conventional health-care services. To achieve such outcomes would 
require understanding by practitioners of the relevant CAM and conventional therapies of how 
the two systems could be effectively harmonised to achieve agreed health-economic 
outcomes. Such “harmonisation” could probably best be achieved through the curricula of 
CAM and conventional health practitioner training programs, and would need to be updated 
and strengthened by ongoing professional educational programs. In some cases, specific forms 
of CAM might prove be more cost-effective, either alone or in combination with conventional 
therapies, than conventional treatments alone. However, little is known about the economic 
implications of CAM from a macro and/or a micro level. Cost-effectiveness studies on CAM 
should be part of a future research program. 
 
Secondly, the increasing popularity of CAM therapies offers alternative avenues to patients 
who have not been effectively managed by conventional medicine. However, there is 
inadequate research that produces critical data concerning the quality, efficacy and safety of 
these CAM therapies. And critically, the current funding model of National Health and 
Medical Research Council does not provide a mechanism to support such research. In 
addition, there is no national policy that recognises the role of CAM in the health care system 
and as a result, these therapies were not managed in the same manner as western medicines 
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with respect to quality, safety and efficacy. Consequently, patients who use these therapies 
may be exposed to additional risks due to the inadequate information available. The 
contribution by consumers to these therapies is substantial, thus, it should be the government’s 
role to ensure research in CAM therapies are supported to ensure public safety. 
 
Thirdly, comprehensive knowledge of the forms of CAM that are most commonly used within 
the community, the purposes for which they are being used, and the demographics of the users 
are essential for effective health service planning. It is also important to understand how much 
consumers know about the efficacy and safety of the CAM products and therapies they choose 
to use, particularly in regard to the concurrent use of multiple therapies, irrespective of 
whether these are CAM or conventional. Based on this information, appropriate strategies can 
be developed to educate CAM users about the appropriate use of the therapies, their benefits 
and risks, and the importance of discussing the use of concurrent therapies with qualified 
practitioners. 
 
Fourthly, quality of CAM practitioner training needs to incorporate sufficient Western 
medical knowledge and clinical assessment skills to ensure timely identification of risks and 
proper referral is made. In addition, practitioner training should also incorporate recent 
research findings. Furthermore, compulsory continuing professional education is needed to 
ensure that practitioners are providing the best possible care to their patients by applying new 
research results into practice and to ensure public safety. 
 
Finally, the issue of health insurance coverage of CAM products and services requires further 
consideration. It is clear from the current study and a number of previous studies in Australia 
and overseas, that there is a high demand for insurance cover of CAM from users, both 
through the national health insurance system and private health insurance. Such demand is 
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likely to increase with increasing evidence of efficacy of certain forms of CAM and the 
introduction of regulation of both CAM products and services by governments. However, 
increasing access to insurance cover for CAM will certainly have major economic 
implications which will need to be fully considered in the context of overall public and private 
health expenditure. 
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8.5 Recommendations and Future Studies 
 
In relation to further regulatory control of CAM therapies, products and practitioners, a large 
proportion of the participants in the current survey considered that regulation of CAM should 
be as rigorously as that for Western medicine and other conventional health services. Whilst 
several CAM therapies, are already subject to statutory regulation, in the interest of public 
safety and confidence in CAM, it is desirable that regulation be extended to other CAM 
modalities, particularly substance-based therapies such as naturopathy and types of herbal 
medicine in addition to Chinese herbal medicine. 
 
Considerable efforts were to make the current study on CAM use by the Australian population 
as comprehensive as possible and to ensure that the validity of the data obtained. However, 
some issues related to CAM use could not be investigated in the current survey, such as the 
specific medical conditions for which each individual form of CAM was being used, and the 
outcomes of the treatments. To address the safety and efficacy concerns, these are perhaps the 
next aspects of CAM use that need to be investigated. In extending the study in this way it 
would be appropriate to give particular consideration to the use of specific CAM therapies for 
the treatment of chronic diseases, particularly in the elderly. It is often proposed that 
conventional medical treatments are not coping well with chronic illnesses and that forms of 
CAM for which treatment is based “holistic” principles may achieve better outcomes. At this 
time, rigorous evidence for this contention is lacking. 
 
Prevalence of use data for most forms of CAM is patchy, even within specific countries and 
comparisons between surveys and between countries are difficult and often not meaningful. 
Future studies might focus on a group of common forms of CAM (e.g. the current 17 forms of 
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CAM investigated in the current study) in a particular region or country. Rather than exploring 
general demographic characteristics related to CAM use, such a study could focus on the 
factors that influence people’s choice and use of CAM, such as, access to health insurance 
cover, regulatory controls, referrals from health professionals, and user’s knowledge of 
evidence of efficacy, and safety. 
 
Future Australian studies should also address the current lack of information about the use of 
CAM by population sub-groups, such as older people, children, adolescents, and the 
indigenous population. It would be important to establish an Australian national resource 
database to better comprehend matters surrounding CAM use, such as perceived and actual 
benefits and risks, as experienced by consumers. Ideally, these should be on an individual 
CAM modality basis, rather than overall CAM. From this aspect, consumer knowledge and 
beliefs of CAM is another area for further investigation. 
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Appendix A Brief explanations of the 17 forms of CAM that used 
in the survey 
[Explain to survey participants by the interviewers, if asked] 
Modified from the NCCAM and other sources. 
 
1. Acupuncture 
A Chinese medical system, involves penetrating the skin with needles in acupuncture 
points  
 
2. Chinese herbal medicine 
A Chinese medical system, using different types of herbs including plants, minerals and 
animal substances  
 
3. Chinese therapeutic massage 
A Chinese medical system, based on Chinese medicine theory, it manipulates muscle 
and connective tissue to promote relaxation and well-being. 
 
4. Chinese medicine dietary therapy 
A Chinese medical system, the idea is: “food is also medicine”, practitioners will 
consider the food’s colour, taste, texture and shape. 
 
5. Qigong ("Chee-Gong"), martial art or Tai Chi ("Tai-Chee") 
Qigong---Combines movement, meditation, and regulation of breathing to enhance the 
flow of qi–energy of a human body. 
Martial art---In Chinese, it means “Wu Shu ("Wu-Su")”also known as “Flighting 
system”. But it is different from body balance and body combat. 
Tai Chi---A traditional Chinese exercise, a series of movements normally done very 
slowly to move the body's qi. 
 
6. Western herbal medicine not including Chinese herbal medicine 
Western herbalists use a mixture of herbs in their preparations eg. Garlic and St John’s 
Wort, but generally do not use animal or mineral materials.  
 
7. Massage therapy not including Chinese therapeutic massage  
A manipulate therapy, for the purpose of this study, it distinguishes to Chinese 
therapeutic massage. The common ones include Thai massage, Swedish massage and 
Japanese massage. 
 
8. Chiropractic ("kie-roh-PRAC-tic") 
A manipulation therapy, it focuses on the relationship between body structure (primarily 
that of the spine) and function. 
 
9. Osteopathy ("ahs-tee-oh-PATH") 
A full-body manipulation therapy, it believes that diseases arising in the musculoskeletal 
system. 
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10. Homeopathy ("home-ee-oh-PATH") 
A medical system bases on the belief that "like cures like," or “The Law of Similar”. A 
medicine is homeopathic only if it is taken based upon the similar nature of the 
medicine to the illness. 
 
11. Naturopathy ("nay-chur-o-PATH") 
A therapy by natural approaches using medicinal plants, nutrition, dietary supplements, 
lifestyle and exercise etc. 
 
12. Meditation   
A variety of techniques to enhance people’s mind, such as stress relief, pain 
management etc. 
 
13. Aromatherapy 
Aromatherapy involves the use of essential oils, such as rose oil, peppermint oil, often 
apply through massage. 
 
14. Clinical nutrition eg. taking multivitamins or minerals  
Diseases and health that may benefit from dietary counselling and using multivitamins 
and minerals. 
 
15. Energy healing such as reiki ("RAY-kee") & Therapeutic Touch 
Reiki---is a Japanese word representing universal life energy.  
Therapeutic Touch---A technique called “laying-on of hands”, therapist passing their 
hands over the patient, healers can identify energy imbalances. 
 
16. Reflexology 
Foot therapy, believes foot is a corresponding part of the body. 
 
17. Yoga 
Mind body therapy, using different techniques, for example, coordination of breath and 
movement, and holding the postures. 
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Appendix B Survey questionnaire (sample) 
Complementary Medicine Utilisation in Australia: A National Study (2005) 
 
 
Section B: Use of and expenditure on complementary medicine 
 
People use different types of complementary medicine for their health conditions or for 
improving general health. In order to obtain accurate information, I will need to read to you a 
list of types of complementary medicine. 
 
QB1. In the last 12 months, have you used any one of the following types of complementary 
medicine? Please say “yes” or “no” when it is named, I may also ask you whether or not 
you have visited a practitioner and the number of visits in the last 12 months [for that 
complementary medicine]. Did you use: 
 
Use in past 12 
months 
Visited practitioners in past 
12 months 
 
Type of complementary medicine 
 
Yes No Yes No No. of 
visits 
1. Acupuncture 
     
2. Chinese herbal medicine  
     
3. Chinese therapeutic massage  
     
4. Chinese medicine dietary therapy 
     
5. Qigong, martial art or Tai Chi  
     
6. Western herbal medicine not including 
Chinese herbal medicine 
     
7. Massage therapy not including Chinese 
therapeutic massage  
     
8. Chiropractic  
     
9. Osteopathy 
     
10. Homeopathy 
     
11. Naturopathy 
     
12. Meditation   
     
13. Aromatherapy 
     
14. Clinical nutrition eg. taking 
multivitamins or minerals  
     
15. Energy healing such as reiki and 
therapeutic touch 
     
16. Reflexology 
     
17. Yoga 
     
18. Prayer [Prevalence only] 
     
66. Other forms of CAM (Specify) 
     
[Name of other forms of CAM]: 
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QB2. Consider the total amount you spent on complementary medicine products over the last 
12 months, not including the cost of visiting practitioners, how much would you 
estimate this to be? [Examples of complementary medicine products are herbs, 
multivitamins, homeopathic and naturopathic medicines etc. Ignore any rebates 
subsequently received, if there is any, and do not include the cost of visiting 
practitioners] 
 
1. Enter amount: A$: 
2. Do not remember 
99. Refuse to answer 
 
 
Now, I would like to ask you about your expenditure on visits to complementary 
medicine practitioners. 
 
QB3. Considering the total amount your complementary medicine practitioners charged you 
for consultation fees and treatments fees, how much was your personal out-of-pocket 
expenditure in the last 12 months? [Do not include the cost of complementary medicine 
products, either prescribed by practitioners, or self-prescribed.] [Confirm it is out-of-
pocket expenditure, that is, after deducting rebates received from any sources such as 
insurance or employer.][If participant mentions the use of direct billing system from 
complementary medicine practitioners, tells participant that we are interested in their 
out-of-pocket expenditure only] 
 
1. Enter amount: A$: 
2. Do not remember 
99. Refuse to answer 
 
 
QB4. Over the last 12 months, did you spend any additional money on things like courses, 
books, equipment or any other items related to complementary medicine? If yes, how 
much would you estimate this to be? [Do not include the cost answered in QB2 and 
QB3, that is, expenditure on complimentary medicine products and consultation fee] 
 
1. [Yes] Enter amount: A$: 
2. [Yes] Do not remember 
3. [No] 
99. Refuse to answer 
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Appendix C Computer programming scripts for the interview 
(sample) 
 
 
COMMENT:  COMPLEMENTARY MEDICINE UTILISATION IN AUSTRALIA 
COMMENT:  MAY 2005  - WG2932  -  FINAL VERSION 
 
COMMENT:  Screening section 
comment set for live project with sample and quotas 
 set intype='Live' 
 set projname='wg2932' 
 
COMMENT: SECTION B: USE OF AND EXPENDITURE ON COMPLEMENTARY 
MEDICINE 
 
PREBTXT display '@ 
 People use different types of complementary medicine for their health 
@ conditions or for improving general health. In order to obtain accurate 
@ information, I will need to read to you a list of types of complementary 
@ medicine. My apologies for the long list but this is the only one in this 
@ study. 
@@ [If interviewee asks WHAT ARE SOME EXAMPLES OF COMPLEMENTARY 
MEDICINE. 
@   Answer: Examples include acupuncture, herbal medicine, chiropractic and so 
@   on, but DO NOT include allied health such as physiotherapy, occupational 
@   therapy, podiatry and speech pathology] 
@@ [If interviewee asks WHAT ARE EXAMPLES OF A COMPLEMENTARY MEDICINE 
PRODUCT. 
@ Answer: Examples include herbs, multivitamins, homeopathic and naturopathic 
@ medicines etc.] 
@@ [If interviewee asks WHAT ARE EXAMPLES OF COMPLEMENTARY MEDICINE 
PRACTITIONER 
@ Answer: Examples include acupuncturist, Chinese medicine practitioner, 
@ chiropractor, herbalist and Osteopath]@' 
 pause 
 
qb1list define [NAMES OF ALL FORMS OF CAM] 
 
qb1alst define 
  'CHINESE HERBAL MEDICINE'/ 
  'CHINESE THERAPEUTIC MASSAGE'/ 
  'WESTERN HERBAL MEDICINE NOT INCLUDING CHINESE HERBAL MEDICINE'/ 
  'MASSAGE THERAPY NOT INCLUDING CHINESE THERAPEUTIC MASSAGE'/ 
  'CHIROPRACTIC'/ 
  'OSTEOPATHY'/ 
  'HOMEOPATHY'/ 
  'NATUROPATHY'/ 
  'AROMATHERAPY' 
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qb1blst define 
  'CHINESE MEDICINE DIETARY THERAPY'/ 
  'QIGONG, MARTIAL ART OR TAI CHI'/ 
  'MEDITATION'/ 
  'CLINICAL NUTRITION EG. TAKING MULTIVITAMINS OR MINERALS'/ 
  'ENERGY HEALING SUCH AS REIKI AND THERAPEUTIC TOUCH'/ 
  'REFLEXOLOGY'/ 
  'YOGA'/ 
 
COMMENT : questions for acupuncture only [Additional questions are required] 
QB1AA ask '@ 
QB1AB ask '@ 
QB1AC ask '@ 
QB1AD ask '@ 
 
QB1TXT display '@ 
QB1. In the last 12 months, have you used any one of the following types of 
@ complementary medicine? Please say "yes" or "no" when it is named, I may 
@ also ask you whether or not you have visited a practitioner and the number 
@ of visits in the last 12 months for that complementary medicine.@' 
 pause 
 
 set user=0 
 set major=0 
 set minor=0 
 set cmp=0 
 
 unset qb1adum 
 unset qb1bdum 
 
QB1ADUM dummyask 'Major CAM used' 
 resp mp qb1alst 
 
QB1BDUM dummyask 'Minor CAM used' 
 resp mp qb1blst 
 
QB1TDUM dummyask 'All CAM used' 
 resp mp qb1list 
 
 for QB1L = qb1list ran 
 
 set i=iteration 
 
QB1 ask '@ 
QB1    Did you use ... 
@@    '+QB1L+'?@' 
 resp sp 
 'Yes'/ 
 'No' 
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Appendix D Initial telephone contact (with plain language 
statement) 
 
 
⇒ Good [morning/afternoon/evening], my name is [Researcher name] from [Survey 
research company name]. I am conducting a national study for RMIT University on 
complementary medicine use. 
 
Your telephone number was randomly selected. I need to conduct the survey with a 
member of your household over the age of 18. If more than one person over 18, I would like 
to speak with the person over 18 whose birthday occurs next. Would that member of your 
household be available? 
 
[NOT PREPARED TO PARTICIPATE: RECORD REFUSAL] 
 
[THE NOMINATED HOUSEHOLD MEMBER IS NOT AVAILABLE 
 
Would it be possible to arrange a time when I could speak with the person that you have 
identified?] 
 
[IF THIS IS AGREED, ASK FOR THE FIRST NAME OF THE NOMINATED 
PERSON (IF NOT ALREADY KNOWN) 
 
⇒Thank you, I will call at (time, day) to speak with (name).] 
 
[IF THE PERSON NOMINATED IS AVAILABLE AND IS A DIFFERENT PERSON 
TO THE ONE WHO ANSWERED, REPEAT PARAGRAPH 1, ABOVE BEFORE 
PROCEEDING] 
 
⇒ The information you provide will be treated in the strictest confidence and 
anonymously. No personal identifying information will be collected. You are free to withdraw 
at any time during the interview, in which case your responses will be deleted. 
 
The study has been approved by the Human Research Ethics Committee of RMIT 
University. If, you have any questions about the study, please feel free to telephone the 
Research Team on 03-9925 7002 at RMIT University, or if have any complaints, you may 
contact the Ethics Committee on 03-9925 1745. 
 
⇒ The interview will take about 15 minutes, are you prepared to participate in this 
survey now? 
 
[NOT NOW 
 
Could I call you at another time?] [ARRANGE APPOINTMENT] 
 
[NO – REFUSE TO PARTICIPATE] ⇒[RECORD REFUSAL] 
[YES – AGREE TO BE INTERVIEWED NOW 
Thank you very much.] [START THE INTERVIEW] 
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Appendix E Plain language statement (print version) 
A National Study on Complementary & Alternative Medicine Utilisation 
 
You are being invited to participate in a research project called “Complementary and 
Alternative Medicine National Study”. Thanks for your consideration in take part in this 
important study, which is a joint initiative of the Division of Chinese Medicine, RMIT 
University and School of Public Health, LaTrobe University. 
 
1. The purpose of the study 
This study is the first Australian nationwide study to investigate the use of complementary and 
alternative medicine (CAM). The purpose of this study is to obtain accurate information on 
the current prevalence, rationale and public expenditure on the use of various forms of CAM 
by the Australian population. 
 
2. Study Investigators 
The principal investigator is Mr. Lin Zhang, PhD candidate, RMIT University. The other 
members of the investigating team include Professor Charlie Xue, Head, Division of Chinese 
Medicine, RMIT University; Professor Vivian Lin, Head, School of Public Health, LaTrobe 
University; Professor David Story, Professor in Therapeutic Sciences, RMIT University; Prof. 
Marc Cohen, Professor in Complementary Medicine, RMIT and, Ms Anne-Louise Carlton, 
Senior Policy Analyst, Victorian Department of Human Services. 
 
Wallis Consulting Group has been contracted to conduct the telephone interviews for the 
study, if you have any questions regarding the procedure of the interview, please contact them 
on 03-96211066. 
 
3. Benefits of the study 
The findings of this study are intended to provide reliable and comprehensive information on 
the prevalence, socio-economic implications and rationales for the use of CAM in Australia. It 
will also research attitudes to, and the influence of health insurance cover for CAM 
treatments.  The outcomes are intended to provide reliable information of relevance to 
governments, health professional organisations, government, regulatory bodies and training 
institutions. This study will make a significant contribution to ensure the public confidence in 
the effective and safe health care choices of complementary medicine. 
 
4. The selection of interview participants 
Your telephone number was randomly selected along with other households across Australia 
by a computer system. As you requested additional information of the project and provided 
your contact details, we send this information sheet to you.  No record of this information 
will be retained after sending you the requested information. Therefore your privacy will be 
preserved. 
 
When the interviewer calls, you will be asked a few questions to select an individual within 
your household. Our target population is adult who is 18 years of age or older. People who 
have used CAM service and who have never used CAM service are both eligible to 
participate. When there is more than one eligible person in the household, the methodology 
used to select the participant will be the “next birthday” technique. 
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5. The procedure of the interview 
We are using an interviewing system called computer assisted telephone interview (CATI), 
the information you provided to the interviewer will be entered into a computer database 
directly and anonymously. When a “call back” is requested, you will be asked to provide your 
first name in order to facilitate the re-contact. No record of this information will be retained 
after the purpose for which it was collected has been satisfied. 
 
Immediately on completion of an interview, the data collected will be incorporated into the 
aggregate data file and the temporary file deleted to ensure anonymity. The telephone 
interview should take approximately 15 minutes to complete. In general, you just need to 
answer questions relevant to your experience and opinion of using CAM services. You are 
welcome to skip among questions, but we are very much appreciating if you can answer as 
many questions as possible. 
 
6. Confidentiality 
Your participation is completely voluntary, and you may withdraw from the study at any time 
during the interview. The information you provide to us will be treated in the strictest 
confidence and stored in a computer database anonymously. The only people who will have 
access to the information will be the research team of the study. No personal identifying 
information will be collected in this study. Publication and presentation of this study result 
will not identify you as a participant.  
 
7. Ethical issues 
This study has been reviewed and approved by the Human Research Ethics Committee of 
RMIT University. If you have any complaints about your participation in this study, you may 
contact directly to the Secretary, RMIT Human Research Ethics Committee, University 
Secretariat, RMIT, GPO Box 2476V, Melbourne, 3001 or by telephone on (03) 9925 1745. 
 
8. Questions 
The principal investigator, Mr Lin Zhang will be happy to answer any questions at any time, 
and he may be contacted in the School of Health Sciences, RMIT University on 03-99257002 
or on Mobile 0412030771. 
 
We appreciate your time to take part in this important national study. Thank you very much. 
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Appendix F Human ethics study approval form 
 
 
2nd February 2005 
 
 
 
Lin Zhang   
Division of Chinese Medicine  
School of Health Sciences  
RMIT University  
Bundoora Campus  
 
 
 
 
Dear Lin, 
 
FLSAPP 30 – 04 ZHANG Prevalence, expenditure and trends of complementary and 
alternative medicine usage in Australia: a national population-based study 
 
Thank you for submitting your amended application for review. 
 
I am pleased to inform you that the committee has approved your application for a period of 3 
years to February 2008 and your research may now proceed. 
 
The committee would like to remind you that annual reports are due during December for all 
research projects that have been approved by the Human Research Ethics Sub-Committee. 
 
The necessary form can be found at: 
http://www.rmit.edu.au/browse;ID=sp7y1u3kp66w;STATUS=A?QRY=ethics&STYPE=ENT
IRE 
 
Yours faithfully, 
 
 
 
 
Diana Donohue, 
Deputy Chair, Science, Engineering & Technology  
Portfolio HREC Sub-committee Life Sciences  
 
cc:  Charlie Xue 
   Barbara Polus 
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Appendix G Additional statistical outputs 
 
 
Appendix G1 Variables employed in the survey 
Id IDENTIFICATION 
Phone PHONE PREFIX 
Pcode POSTCODE 
Region STATE OR TERRITORY 
f1 QF1 AGE 
f2 QF2 GENDER 
f3 QF3 HIGHEST LEVEL OF EDUCATION 
f4 QF4 EMPLOYMENT STATUS 
f5 QF5 ANNUAL HOUSEHOLD INCOME 
f6 QF6 COUNTRY OF BIRTH  
a1 A1 PERSONAL HEALTH RATING 
a2 A2 CONSULTED A MEDICAL DOCTOR IN LAST 12 MONTHS 
a3 A3 MEDICAL CONDITIONS VISITED MD FOR 
a4 A4 NUMBER OF VISITS TO MD 
B1@1 B1 USED ACUPUNCTURE 
B1@2 B1 USED CHINESE HERBAL MEDICINE 
B1@3 B1 USED CHINESE THERAPEUTIC MASSAGE 
B1@4 B1 USED CHINESE MEDICINE DIETARY THERAPY 
B1@5 B1 USED QIGONG, MARTIAL ART OR TAI CHI 
B1@6 B1 USED WESTERN HERBAL MEDICINE NOT INCLUDING CHM 
B1@7 B1 USED MASSAGE THERAPY NOT INCLUDING CTM 
B1@8 B1 USED CHIROPRACTIC 
B1@9 B1 USED OSTEOPATHY 
B1@10 B1 USED HOMEOPATHY 
B1@11 B1 USED NATUROPATHY 
B1@12 B1 USED MEDITATION 
B1@13 B1 USED AROMATHERAPY 
B1@14 B1 USED CLINICAL NUTRITION 
B1@15 B1 USED ENERGY HEALING 
B1@16 B1 USED REFLEXOLOGY 
B1@17 B1 USED YOGA 
B1@18 B1 USED PRAYER 
B1@x B1 USED OTHER CAM  
B1ba@1 B1AB VISITED PRACTITIONER FOR ACUPUNCTURE IN LAST 12 MONTHS 
B1ab B1AB ACUPUNCTURE PRACTITIONER IS A MEDICAL DOCTOR? 
B1ac B1AC TIMES VISITED A MD FOR ACUPUNCTURE TREATMENT 
B1ad B1AD TIMES VISITED NON-MD FOR ACUPUNCTURE TREATMENT 
B1ba@2 B1BA VISITED A PRACTITIONER FOR CHINESE HERBAL MEDICINE 
B1ba@3 B1BA VISITED A PRACTITIONER FOR CHINESE THERAPEUTIC MASSAGE 
B1ba@4 B1BA VISITED A PRACTITIONER FOR CHINESE MEDICINE DIETARY THERAPY 
B1ba@5 B1BA VISITED A PRACTITIONER FOR QIGONG, MARTIAL ART OR TAI CHI 
B1ba@6 B1BA VISITED A PRACTITIONER FOR WESTERN HERBAL MEDICINE 
B1ba@7 B1BA VISITED A PRACTITIONER FOR MASSAGE THERAPY 
B1ba@8 B1BA VISITED A PRACTITIONER FOR CHIROPRACTIC 
B1ba@9 B1BA VISITED A PRACTITIONER FOR OSTEOPATHY 
B1ba@10 B1BA VISITED A PRACTITIONER FOR HOMEOPATHY 
B1ba@11 B1BA VISITED A PRACTITIONER FOR NATUROPATHY 
B1ba@12 B1BA VISITED A PRACTITIONER FOR MEDITATION 
B1ba@13 B1BA VISITED A PRACTITIONER FOR AROMATHERAPY 
B1ba@14 B1BA VISITED A PRACTITIONER FOR CLINICAL NUTRITION 
B1ba@15 B1BA VISITED A PRACTITIONER FOR ENERGY HEALING 
B1ba@16 B1BA VISITED A PRACTITIONER FOR REFLEXOLOGY 
B1ba@17 B1BA VISITED A PRACTITIONER FOR YOGA 
b1ba@18 B1BA VISITED A PRACTITIONER FOR PRAYER 
b1bb@1 B1BB TIMES VISITED A PRACTITIONER FOR ACUPUNCTURE 
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b1bb@2 B1BB TIMES VISITED A PRACTITIONER FOR CHINESE HERBAL MEDICINE 
b1bb@3 B1BB TIMES VISITED A PRACTITIONER FOR CHINESE THERAPEUTIC MASSAGE 
b1bb@6 B1BB TIMES VISITED A PRACTITIONER FOR WESTERN HERBAL MEDICINE 
b1bb@7 B1BB TIMES VISITED A PRACTITIONER FOR MASSAGE THERAPY 
b1bb@8 B1BB TIMES VISITED A PRACTITIONER FOR CHIROPRACTIC 
b1bb@9 B1BB TIMES VISITED A PRACTITIONER FOR OSTEOPATHY 
b1bb@10 B1BB TIMES VISITED A PRACTITIONER FOR HOMEOPATHY 
b1bb@11 B1BB TIMES VISITED A PRACTITIONER FOR NATUROPATHY 
b1bb@13 B1BB TIMES VISITED A PRACTITIONER FOR AROMATHERAPY 
b2 B2 AMOUNT SPENT ON CAM 
b3 B3 AMOUNT SPENT ON CAM PRACTITIONERS 
b4 B4 SPENT ON RELATED CAM YES/NO 
b4x B4 SPENT ON RELATED CAM 
b5 QB5. EVER USED ANY FORM OF CAM 
c1@1 Q1C WESTERN MEDICINE WOULD NOT IMPROVE YOUR MEDICAL CONDITIONS 
c1@2 Q1C WM WOULD IMPROVE MEDICAL CONDITIONS BUT NOT CURE THEM 
c1@3 Q1C WM HAS A RELATIVELY HIGHER RISK OF SIDE EFFECTS 
c1@4 Q1C SERVICE PROVISION BY WMP IS GENERALLY UNSATISFACTORY 
c1@5 Q1C COMPLEMENTARY MEDICINE IS RELATIVELY SAFE 
c1@6 Q1C CAM PROVIDES A MORE HOLISTIC APPROACH TO HEALTH 
c1@7 Q1C CAM IS A MORE NATURAL APPROACH TO TREATMENT 
c2 QC2. USED CAM TOGETHER WITH WM 
c3 QC3. TELL DOCTOR WHEN USE COMPLEMENTARY MEDICINE 
@c41 QC4. REASONS TELL DOCTOR ABOUT CAM USAGE (1) 
@c42 QC4. REASONS TELL DOCTOR ABOUT CAM USAGE (2) 
@c43 QC4. REASONS TELL DOCTOR ABOUT CAM USAGE (3) 
@c44 QC4. REASONS TELL DOCTOR ABOUT CAM USAGE (NONE) 
@c51 QC5. REASON DO NOT TELL DOCTOR ABOUT CAM USAGE (1) 
@c52 QC5. REASON DO NOT TELL DOCTOR ABOUT CAM USAGE (2) 
@c53 QC5. REASON DO NOT TELL DOCTOR ABOUT CAM USAGE (3) 
@c54 QC5. REASON DO NOT TELL DOCTOR ABOUT CAM USAGE (4) 
@c55 QC5. REASON DO NOT TELL DOCTOR ABOUT CAM USAGE (5) 
@c56 QC5. REASON DO NOT TELL DOCTOR ABOUT CAM USAGE (NONE) 
c6 QC6. CONSIDER USING CAM IN THE FUTURE 
c7 QC7. BELIEVE CAM SHOULD BE REGULATED AS RIGOROUSLY AS WM 
d1 QD1 CURRENTLY HAVE PRIVATE HEALTH INSURANCE 
d2 QD2. PRIVATE HEALTH INSURANCE COVER COST OF CAM 
d3 QD3 OBTAINED A REBATE FOR CAM FROM PHI IN LAST 12 MONTHS 
@d41 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (ACU) 
@d42 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (CHM) 
@d43 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (CTM) 
@d44 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (CMDT) 
@d45 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (QIGONG) 
@d46 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (WHM) 
@d47 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (MASSAGE) 
@d48 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (CHIROPRACTIC) 
@d49 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (OSTEOPATHY) 
@d410 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (HOMEOPATHY) 
@d411 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (NATUROPATHY) 
@d412 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (MEDITATION) 
@d413 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (AROMATHERAPY) 
@d414 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (CLINICAL NUTRITION) 
@d415 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (ENERGY HEALING) 
@d416 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (REFLEXOLOGY) 
@d417 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (YOGA) 
@d418 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (PRAYER) 
@d419 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (OTHER) 
@d420 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (DON'T KNOW) 
@d421 QD4 FORM OF CAM RECEIVED A REBATE FROM PHI (REFUSED ANSWER) 
d5 QD5 COVERAGE OF CAM PRODUCTS INFLUENCE INSURANCE PURCHASE? 
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e1 E1 AMOUNT SPENT ON ITEMS RELATED TO ACUPUNCTURE 
e2 QE2 REASONS USED ACUPUNCTURE TREATMENT 
e3@1 QE3 CURE THE DISEASE/ SOLVE THE PROBLEM (BEFORE ACU) 
e3@2 QE3 RELIEVE THE SYMPTOMS (BEFORE ACU) 
e3@3 QE3 IMPROVE YOUR GENERAL HEALTH AND WELL-BEING (BEFORE ACU) 
e4@1 QE4 CURE THE DISEASE/ SOLVE THE PROBLEM (AFTER ACU) 
e4@2 QE4 RELIEVE THE SYMPTOMS (AFTER ACU) 
e4@3 QE4 IMPROVE YOUR GENERAL HEALTH AND WELL-BEING (AFTER ACU) 
e4x QE4X DID THE ACUPUNCTURE HAVE NO EFFECT 
e5 QE5 ENCOUNTERED ANY ADVERSE EFFECTS OR SIDE EFFECTS (ACU) 
e6 QE6 HOW HELPFUL IN IMPROVING GENERAL HEALTH (ACU) 
@e71 QE7 USED ACUPUNCTURE ON ADVICE FROM A MD? 
@e72 QE7 USED ACUPUNCTURE ON ADVICE FROM A CAM PRACTITIONER? 
@e73 QE7 USED ACUPUNCTURE ON ADVICE FROM FRIENDS/RELATIVES? 
@e74 QE7 USED ACUPUNCTURE ON ADVICE FROM NEWS/TV/INTERNET 
@e75 QE7 USED ACUPUNCTURE ON ADVICE FROM OTHER HEALTH PROFESSIONALS 
@e76 QE7 USED ACUPUNCTURE WITHOUT ADVICE 
@e77 QE7 USED ACUPUNCTURE ON ADVICE FROM (DON'T KNOW) 
e8 QE8 CONSIDER USING ACUPUNCTURE IN THE FUTURE? 
e9 QE9 REGULATION PROVIDES FOR GREATER PUBLIC SAFETY & CONFIDENCE (ACU) 
e10 QE10 ALL STATES/TERRITORIES SHOULD REQUIRE GOVERNMENT REGULATION (ACU) 
e11 QE11 MEDICARE SHOULD COVER TREATMENT PROVIDED BY ACUPUNCTURISTS 
e12 QE12 VISITS TO ALL ACUPUNCTURISTS SHOULD BE COVERED BY PHI 
e13 E13 AMOUNT SPENT ON CHINESE HERBS IN LAST 12 MONTHS 
e14 E14 AMOUNT SPENT ON ITEMS FOR CHINESE HERBAL MEDICINE 
e15 QE15 REASONS USED CHINESE HERBAL MEDICINE TREATMENT 
e16@1 QE16 CURE THE DISEASE/ SOLVE THE PROBLEM (BEFORE CHM) 
e16@2 QE16 RELIEVE THE SYMPTOMS (BEFORE CHM) 
e16@3 QE16 IMPROVE YOUR GENERAL HEALTH AND WELL-BEING (BEFORE CHM) 
e17@1 QE17 CURE THE DISEASE/ SOLVE THE PROBLEM (AFTER CHM) 
e17@2 QE17 RELIEVE THE SYMPTOMS (AFTER CHM) 
e17@3 QE17 IMPROVE YOUR GENERAL HEALTH AND WELL-BEING (AFTER CHM) 
e17x QE17X DID THE CHINESE HERBAL MEDICINE HAVE NO EFFECT 
e18 QE18 ENCOUNTERED ANY ADVERSE EFFECTS OR SIDE EFFECTS (CHM) 
e19 QE19 HOW HELPFUL IN IMPROVING GENERAL HEALTH (CHM) 
@e201 QE20 USED CHM ON ADVICE FROM MD 
@e202 QE20 USED CHM ON ADVICE FROM CAM PRACTITIONERS 
@e203 QE20 USED CHM ON ADVICE FROM FRIENDS/RELATIVES 
@e204 QE20 USED CHM ON ADVICE FROM NEWS/TV/INTERNET 
@e205 QE20 USED CHM ON ADVICE FROM OTHER HEATH PROFESSIONALS 
@e206 QE20 USED CHM WITHOUT ADVICE 
@e207 QE20 USED CHM ON ADVICE FROM (DON'T KNOW) 
e21 QE21 CONSIDER USING CHINESE HERBAL MEDICINE IN THE FUTURE 
e22 QE22 REGULATION PROVIDES FOR GREATER PUBLIC SAFETY & CONFIDENCE (CHM) 
e23 QE23 ALL STATES/TERRITORIES SHOULD REQUIRE GOVERNMENT REGULATION (CHM) 
e24 QE24 MEDICARE SHOULD COVER TREATMENT PROVIDED BY CHM PRACTITIONERS 
e25 QE25 VISITS TO CHM PRACTITIONERS SHOULD BE COVERED BY PHI 
@e261 QE26 REASONS FOR VISITING CHIROPRACTOR (1) 
@e262 QE26 REASONS FOR VISITING CHIROPRACTOR (2) 
@e263 QE26 REASONS FOR VISITING CHIROPRACTOR (3) 
@e264 QE26 REASONS FOR VISITING CHIROPRACTOR (4) 
@e265 QE26 REASONS FOR VISITING CHIROPRACTOR (NONE OF ABOVE) 
e27 E27 AMOUNT SPENT ON CHIROPRACTIC ITEMS IN LAST 12 MONTHS 
e28 QE28 ENCOUNTERED ANY ADVERSE EFFECTS OR SIDE EFFECTS (CHIRO) 
@e291 QE29 OUTCOME OF THE CHIROPRACTIC TREATMENT (1) 
@e292 QE29 OUTCOME OF THE CHIROPRACTIC TREATMENT (2) 
@e293 QE29 OUTCOME OF THE CHIROPRACTIC TREATMENT (3) 
@e294 QE29 OUTCOME OF THE CHIROPRACTIC TREATMENT (4) 
@e295 QE29 OUTCOME OF THE CHIROPRACTIC TREATMENT (NONE OF ABOVE) 
e30 QE30 HOW HELPFUL IN IMPROVING GENERAL HEALTH (CHIRO) 
@e311 QE31 USED CHIRO ON ADVICE FROM MD 
@e312 QE31 USED CHIRO ON ADVICE FROM CAM PRACTITIONER 
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@e313 QE31 USED CHIRO ON ADVICE FROM FRIENDS/RELATIVES 
@e314 QE31 USED CHIRO ON ADVICE FROM NEWS/TV/INTERNET 
@e315 QE31 USED CHIRO ON ADVICE FROM OTHER HEATH PROFESSIONALS 
@e316 QE31 USED CHIRO WITHOUT ADVICE 
@e317 QE31 USED CHIRO ON ADVICE FROM (DON'T KNOW) 
e32 QE32 CONSIDER USING CHIROPRACTOR IN THE FUTURE 
e33 QE33 MEDICARE SHOULD COVER TREATMENT PROVIDED BY CHIROPRACTOR 
e34 QE34 VISITS TO CHIROPRACTOR SHOULD BE COVERED BY PHI 
e35 QE35 AGREE CHIROPRACTIC CARE IS A SAFE FORM OF TREATMENT 
@e361 QE36 REASONS FOR USING OSTEOPATHY (1) 
@e362 QE36 REASONS FOR USING OSTEOPATHY (2) 
@e363 QE36 REASONS FOR USING OSTEOPATHY (3) 
@e364 QE36 REASONS FOR USING OSTEOPATHY (4) 
@e365 QE36 REASONS FOR USING OSTEOPATHY (NONE OF ABOVE) 
e37 E37 AMOUNT SPENT ON ITEMS RELATED TO OSTEOPATHY 
@e381 QE38 TYPE OF TREATMENT THE OSTEOPATH USED (1) 
@e382 QE38 TYPE OF TREATMENT THE OSTEOPATH USED (2) 
@e383 QE38 TYPE OF TREATMENT THE OSTEOPATH USED (3) 
@e384 QE38 TYPE OF TREATMENT THE OSTEOPATH USED (4) 
@e385 QE38 TYPE OF TREATMENT THE OSTEOPATH USED (5) 
@e386 QE38 TYPE OF TREATMENT THE OSTEOPATH USED (NONE OF ABOVE) 
@e391 QE39 OUTCOME OF THE OSTEOPATHY TREATMENT (1) 
@e392 QE39 OUTCOME OF THE OSTEOPATHY TREATMENT (2) 
@e393 QE39 OUTCOME OF THE OSTEOPATHY TREATMENT (3) 
@e394 QE39 OUTCOME OF THE OSTEOPATHY TREATMENT (4) 
@e395 QE39 OUTCOME OF THE OSTEOPATHY TREATMENT (NONE OF ABOVE) 
e40 QE40 ENCOUNTERED ANY ADVERSE EFFECTS OR SIDE EFFECTS (OSTEO) 
e41 QE41 HOW HELPFUL IN IMPROVING GENERAL HEALTH (OSTEO) 
@e421 QE42 USED OSTEOPATH ON ADVICE FROM MD 
@e422 QE42 USED OSTEOPATH ON ADVICE FROM CAM PRACTITIONERS 
@e423 QE42 USED OSTEOPATH ON ADVICE FROM FRIENDS/RELATIVES 
@e424 QE42 USED OSTEOPATH ON ADVICE FROM NEWS/TV/INTERNET 
@e425 QE42 USED OSTEOPATH ON ADVICE FROM OTHER HEALTH PROFESSIONALS 
@e426 QE42 USED OSTEOPATH WITHOUT ADVICE 
@e427 QE42 USED OSTEOPATH ON ADVICE FROM (DON'T KNOW) 
e43 QE43 CONSIDER USING OSTEOPATH IN THE FUTURE 
e44 QE44 MEDICARE SHOULD COVER TREATMENT PROVIDED BY OSTEOPATH 
e45 QE45 VISITS TO OSTEOPATH SHOULD BE COVERED BY PHI 
QA3@0 A3 MEDICAL CONDITIONS VISITED MD FOR 
QA3@1 A3 MEDICAL CONDITION (1) VISITED MD FOR 
QA3@2 A3 MEDICAL CONDITION (2) VISITED MD FOR 
QA3@3 A3 MEDICAL CONDITION (3) VISITED MD FOR 
QA3@4 A3 MEDICAL CONDITION (4) VISITED MD FOR 
QA3@5 A3 MEDICAL CONDITION (5) VISITED MD FOR 
QE2X@0 QE2 REASONS USED ACUPUNCTURE TREATMENT 
QE2X@1 QE2 REASON (1) USED ACUPUNCTURE TREATMENT 
QE2X@2 QE2 REASON (2) USED ACUPUNCTURE TREATMENT 
QE15X@0 QE15 REASONS USED CHINESE HERBAL MEDICINE TREATMENT 
QE15X@1 QE15 REASON (1) USED CHINESE HERBAL MEDICINE TREATMENT 
QE15X@2 QE15 REASON (2) USED CHINESE HERBAL MEDICINE TREATMENT 
QE26X@0 QE26 SYMPTOMS FOR VISITING CHIROPRACTOR 
QE26X@1 QE26 SYMPTOM (1) FOR VISITING CHIROPRACTOR 
QE26X@2 QE26 SYMPTOM (2) FOR VISITING CHIROPRACTOR 
QE26X@3 QE26 SYMPTOM (3) FOR VISITING CHIROPRACTOR 
QE36X@0 QE36 SYMPTOMS FOR VISITING OSTEOPATH 
QE36X@1 QE36 SYMPTOM (1) FOR VISITING OSTEOPATH 
QE36X@2 QE36 SYMPTOM (2) FOR VISITING OSTEOPATH 
QE36X@3 QE36 SYMPTOM (3) FOR VISITING OSTEOPATH 
QE36X@4 QE36 SYMPTOM (4) FOR VISITING OSTEOPATH 
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Appendix G2 Frequency of visits to CAM practitioners (unadjusted data) 
 
Acupuncture CHM CTM WHM WTM Chiropractic Osteopathy Homeopathy Naturopathy Aromatherapy 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
No. of 
visits 
Frequ
ency 
1 5 1 4 1 7 1 13 1 42 1 22 1 7 1 8 1 18 1 10 
2 11 2 4 2 4 2 12 2 39 2 24 2 5 2 9 2 13 2 10 
3 18 3 4 3 8 3 9 3 30 3 14 3 6 3 2 3 7 3 3 
4 8 4 2 4 6 4 5 4 24 4 10 4 7 4 3 4 6 4 3 
5 9 5 4 5 4 5 1 5 8 5 10 6 6 5 1 5 2 5 2 
6 9 6 4 6 1 6 4 6 18 6 15 8 1 6 3 6 6 6 1 
8 4 10 1 8 1 8 1 7 3 7 1 10 1 12 2 8 1 12 2 
10 2 12 1 10 1 10 3 8 4 8 8 12 2 52 2 10 2 30 1 
12 7 16 1 12 1 12 1 9 1 9 1 14 1 DK 1 12 5 300 1 
16 1 20 1 24 1 20 1 10 8 10 9 15 1 Total 31 52 2 365 1 
20 2 26 1 25 1 DK 2 12 19 11 1 20 1   DK 1 Total 34 
26 1 Total 27 26 1 Total 52 14 1 12 25 24 1   Total 63   
30 1   Total 36   15 1 14 3 25 1       
32 1       19 1 15 6 Total 40       
45 1       20 4 20 1         
50 1       24 2 24 4         
112 1       30 2 26 1         
Total 82       35 1 35 1         
        40 1 40 1         
        50 2 50 1         
        52 1 60 1         
        55 1 120 1         
        DK 2 Total 160         
        Total 215           
DK: Don’t know, CHM: Chinese herbal medicine, CTM: Chinese therapeutic massage, WHM: Western herbal medicine, WTM: Western therapeutic massage 
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Appendix G3 Statistics of frequency of CAM practitioner visits (adjusted data) 
 
Statistics/CAM therapies Acupuncture CHM CTM WHM WTM Chiropractic Osteopathy Homeopathy Naturopathy Aromatherapy 
N Valid 80 24 34 48 213 155 37 30 62 31 
  Missing/ 
outliers 0 0 0 2 2 0 0 1 1 2 
Mean 8.75 5.98 5.43 3.75 6.29 8.44 5.69 6.65 5.32 3.98 
Std. Error of Mean 1.82 1.27 1.14 0.53 0.60 1.00 0.97 2.44 1.21 1.12 
Median 4.00 4.00 3.00 2.06 3.00 5.00 4.00 2.00 2.00 2.00 
Mode 3.00 3.00 3.00 1.00 1.00 2.00 1.00 2.00 1.00 1.00 
Std. Deviation 16.32 6.25 6.60 3.65 8.70 12.53 5.92 13.26 9.55 6.24 
Variance 266.19 39.06 43.50 13.34 75.72 156.88 35.03 175.82 91.22 38.97 
Skewness 5.05 2.12 2.53 2.41 3.48 5.75 1.97 3.22 4.28 3.69 
Std. Error of Skewness 0.27 0.47 0.40 0.34 0.17 0.19 0.39 0.43 0.30 0.42 
Kurtosis 29.08 4.43 5.56 7.46 14.26 44.62 3.62 9.51 19.25 14.18 
Std. Error of Kurtosis 0.53 0.91 0.79 0.67 0.33 0.39 0.76 0.84 0.60 0.82 
Minimum 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Maximum 112.00 26.00 26.00 20.00 55.00 120.00 25.00 52.00 52.00 30.00 
Sum 699.86 145.92 182.57 179.98 1337.59 1311.43 211.49 196.85 331.11 123.22 
Percentiles 95 33.11 24.84 25.34 10.84 20.00 24.00 23.30 52.00 12.61 26.57 
CHM: Chinese herbal medicine, CTM: Chinese therapeutic massage, WHM: Western herbal medicine, WTM: Western therapeutic massage
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Appendix G4 Expenditure on CAM products (unadjusted data) 
 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
0 115 15.6 16.4 16.4 
1 1 .1 .1 16.5 
5 2 .3 .3 16.8 
6 1 .1 .1 17.0 
8 1 .1 .1 17.1 
10 5 .7 .7 17.8 
12 1 .1 .1 17.9 
15 2 .3 .3 18.2 
16 2 .3 .3 18.5 
18 1 .1 .1 18.7 
20 36 4.9 5.1 23.8 
25 6 .8 .9 24.6 
26 1 .1 .1 24.8 
30 27 3.7 3.8 28.6 
35 2 .3 .3 28.9 
36 1 .1 .1 29.1 
40 9 1.2 1.3 30.3 
45 2 .3 .3 30.6 
50 58 7.9 8.3 38.9 
55 1 .1 .1 39.0 
60 24 3.3 3.4 42.5 
65 1 .1 .1 42.6 
70 7 .9 1.0 43.6 
75 3 .4 .4 44.0 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
80 13 1.8 1.9 45.9 
90 2 .3 .3 46.2 
99 1 .1 .1 46.3 
100 75 10.2 10.7 57.0 
110 2 .3 .3 57.3 
120 5 .7 .7 58.0 
130 1 .1 .1 58.1 
134 1 .1 .1 58.3 
140 2 .3 .3 58.5 
150 31 4.2 4.4 63.0 
160 1 .1 .1 63.1 
170 1 .1 .1 63.2 
180 1 .1 .1 63.4 
200 79 10.7 11.3 74.6 
230 1 .1 .1 74.8 
240 2 .3 .3 75.1 
250 14 1.9 2.0 77.1 
275 1 .1 .1 77.2 
300 30 4.1 4.3 81.5 
350 8 1.1 1.1 82.6 
360 3 .4 .4 83.0 
400 15 2.0 2.1 85.2 
450 5 .7 .7 85.9 
480 1 .1 .1 86.0 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
500 31 4.2 4.4 90.5 
600 10 1.4 1.4 91.9 
650 1 .1 .1 92.0 
700 2 .3 .3 92.3 
750 3 .4 .4 92.7 
800 3 .4 .4 93.2 
850 1 .1 .1 93.3 
1000 23 3.1 3.3 96.6 
1040 1 .1 .1 96.7 
1200 5 .7 .7 97.4 
1400 1 .1 .1 97.6 
1500 5 .7 .7 98.3 
1950 1 .1 .1 98.4 
2000 1 .1 .1 98.6 
3000 3 .4 .4 99.0 
3120 1 .1 .1 99.1 
3500 1 .1 .1 99.3 
4500 1 .1 .1 99.4 
5000 2 .3 .3 99.7 
6000 1 .1 .1 99.9 
10000 1 .1 .1 100.0 
Sub- 
total 702 95.3 100.0  
Don't 
Know 35 4.7   
 
Total 737 100.0 
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Appendix G5 Expenditure on CAM practitioners (unadjusted data) 
 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
0 93 19.7 20.6 20.6 
5 2 .4 .4 21.0 
8 1 .2 .2 21.2 
10 2 .4 .4 21.7 
13 1 .2 .2 21.9 
15 1 .2 .2 22.1 
20 3 .6 .7 22.8 
30 9 1.9 2.0 24.8 
32 2 .4 .4 25.2 
35 2 .4 .4 25.7 
37 1 .2 .2 25.9 
40 6 1.3 1.3 27.2 
45 1 .2 .2 27.4 
48 2 .4 .4 27.9 
50 11 2.3 2.4 30.3 
55 1 .2 .2 30.5 
60 8 1.7 1.8 32.3 
65 2 .4 .4 32.7 
70 4 .8 .9 33.6 
80 9 1.9 2.0 35.6 
88 1 .2 .2 35.8 
90 5 1.1 1.1 36.9 
99 1 .2 .2 37.2 
100 33 7.0 7.3 44.5 
102 1 .2 .2 44.7 
108 1 .2 .2 44.9 
120 9 1.9 2.0 46.9 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
137 1 .2 .2 47.1 
140 2 .4 .4 47.6 
150 11 2.3 2.4 50.0 
160 3 .6 .7 50.7 
170 1 .2 .2 50.9 
180 3 .6 .7 51.5 
192 1 .2 .2 51.8 
200 45 9.5 10.0 61.7 
220 2 .4 .4 62.2 
230 1 .2 .2 62.4 
239 1 .2 .2 62.6 
240 4 .8 .9 63.5 
250 8 1.7 1.8 65.3 
280 1 .2 .2 65.5 
300 23 4.9 5.1 70.6 
312 1 .2 .2 70.8 
320 1 .2 .2 71.0 
330 1 .2 .2 71.2 
350 6 1.3 1.3 72.6 
360 1 .2 .2 72.8 
361 1 .2 .2 73.0 
380 1 .2 .2 73.2 
385 1 .2 .2 73.5 
400 24 5.1 5.3 78.8 
440 1 .2 .2 79.0 
450 1 .2 .2 79.2 
500 18 3.8 4.0 83.2 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
550 1 .2 .2 83.4 
575 1 .2 .2 83.6 
600 15 3.2 3.3 86.9 
630 2 .4 .4 87.4 
640 1 .2 .2 87.6 
650 1 .2 .2 87.8 
700 8 1.7 1.8 89.6 
720 1 .2 .2 89.8 
750 2 .4 .4 90.3 
800 1 .2 .2 90.5 
840 1 .2 .2 90.7 
900 1 .2 .2 90.9 
1000 19 4.0 4.2 95.1 
1200 1 .2 .2 95.4 
1205 1 .2 .2 95.6 
1250 1 .2 .2 95.8 
1300 1 .2 .2 96.0 
1500 6 1.3 1.3 97.3 
2000 8 1.7 1.8 99.1 
3000 1 .2 .2 99.3 
6500 1 .2 .2 99.6 
7000 1 .2 .2 99.8 
10000 1 .2 .2 100.0 
Total 452 95.6 100.0  
Don't 
Know 21 4.4   
Total 473 100.0   
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Appendix G6 Expenditure on CAM-related items (unadjusted data) 
 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
3 1 .6 .6 .6 
7 1 .6 .6 1.1 
10 2 1.1 1.1 2.3 
12 1 .6 .6 2.9 
15 1 .6 .6 3.4 
20 9 5.0 5.1 8.6 
25 3 1.7 1.7 10.3 
30 12 6.7 6.9 17.1 
35 2 1.1 1.1 18.3 
40 5 2.8 2.9 21.1 
45 2 1.1 1.1 22.3 
50 17 9.5 9.7 32.0 
60 5 2.8 2.9 34.9 
70 2 1.1 1.1 36.0 
75 3 1.7 1.7 37.7 
80 4 2.2 2.3 40.0 
90 1 .6 .6 40.6 
100 22 12.3 12.6 53.1 
110 1 .6 .6 53.7 
120 4 2.2 2.3 56.0 
140 2 1.1 1.1 57.1 
150 6 3.4 3.4 60.6 
160 1 .6 .6 61.1 
170 2 1.1 1.1 62.3 
 
Dollar Frequency % 
Valid 
(%) 
Cumulative 
(%) 
176 1 .6 .6 62.9 
180 2 1.1 1.1 64.0 
190 1 .6 .6 64.6 
195 1 .6 .6 65.1 
200 21 11.7 12.0 77.1 
240 1 .6 .6 77.7 
250 2 1.1 1.1 78.9 
300 6 3.4 3.4 82.3 
400 6 3.4 3.4 85.7 
500 4 2.2 2.3 88.0 
600 4 2.2 2.3 90.3 
650 1 .6 .6 90.9 
800 2 1.1 1.1 92.0 
1000 5 2.8 2.9 94.9 
1500 3 1.7 1.7 96.6 
1800 1 .6 .6 97.1 
2000 1 .6 .6 97.7 
3000 2 1.1 1.1 98.9 
5000 1 .6 .6 99.4 
6000 1 .6 .6 100.0 
Total 175 97.8 100.0  
Don't 
Know 
 
4 
 
2.2 
  
Total 179 100.0   
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Appendix G7 Statistics of expenditure on CAM (unadjusted data) 
 
 
 
B2 AMOUNT SPENT ON CAM  
 
 
N Valid 702 
  Missing 35 
Mean 260.54 
Std. Error of Mean 24.322 
Median 100.00 
Mode 0 
Std. Deviation 644.430 
Variance 415290.2 
Skewness 8.305 
Std. Error of Skewness .092 
Kurtosis 95.470 
Std. Error of Kurtosis .184 
Range 10000 
Minimum 0 
Maximum 10000 
Sum 182902 
 
 
B3 AMOUNT SPENT ON CAM PRACTITIONER 
 
 
N Valid 452 
  Missing 21 
Mean 341.63 
Std. Error of Mean 35.020 
Median 155.00 
Mode 0 
Std. Deviation 744.529 
Variance 554322.9 
Skewness 8.082 
Std. Error of Skewness 
.115 
Kurtosis 86.456 
Std. Error of Kurtosis 
.229 
Range 10000 
Minimum 0 
Maximum 10000 
Sum 154416 
 
B4 AMOUNT SPENT ON RELATED CAM  
 
 
N Valid 175 
  Missing 4 
Mean 311.07 
Std. Error of Mean 53.939 
Median 100.00 
Mode 100 
Std. Deviation 713.540 
Variance 509139.7 
Skewness 5.434 
Std. Error of Skewness 
.184 
Kurtosis 34.953 
Std. Error of Kurtosis 
.365 
Range 5997 
Minimum 3 
Maximum 6000 
Sum 54438 
  
331 
Appendix G8 Statistics of expenditure on CAM (adjusted data) 
 
 
B2 AMOUNT SPENT ON CAM 
 
N Valid 665 
  Missing 34 
Mean 182.30 
Std. Error of Mean 9.253 
Median 100.00 
Mode 0 
Std. Deviation 238.672 
Variance 56964.515 
Skewness 2.290 
Std. Error of Skewness .095 
Kurtosis 5.641 
Std. Error of Kurtosis .189 
Range 1400 
Minimum 0 
Maximum 1400 
Sum 121298 
Percentiles 95 700.00 
 
 
 
 
 
 
 
B3 AMOUNT SPENT ON CAM PRACTITIONER 
 
N Valid 427 
  Missing 19 
Mean 263.64 
Std. Error of Mean 15.389 
Median 150.58 
Mode 0 
Std. Deviation 317.813 
Variance 101004.956 
Skewness 2.000 
Std. Error of Skewness .118 
Kurtosis 4.643 
Std. Error of Kurtosis .236 
Range 2000 
Minimum 0 
Maximum 2000 
Sum 112445 
Percentiles 95 1000.00 
 
 
 
 
 
 
 
 
B4 AMOUNT SPENT ON RELATED CAM 
 
N Valid 168 
  Missing 4 
Mean 212.33 
Std. Error of Mean 23.601 
Median 100.00 
Mode 100 
Std. Deviation 305.879 
Variance 93562.038 
Skewness 3.222 
Std. Error of Skewness .187 
Kurtosis 12.034 
Std. Error of Kurtosis .373 
Range 1988 
Minimum 12 
Maximum 2000 
Sum 35665 
Percentiles 95 1000.00 
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Appendix G9 Individual expenses on four forms of CAM (unadjusted data) 
 
Acupuncture CHM (actual herbs) CHM related items Chiropractic Osteopathy 
Dollar ($) Frequency Dollar ($) Frequency Dollar ($) Frequency Dollar ($) Frequency Dollar ($) Frequency 
1 1 1 3 2 1 50 2 20 3 
20 1 10 4 15 1 55 1 50 3 
25 1 12 1 20 1 100 7 100 1 
50 2 15 2 25 1 120 1 200 1 
60 1 30 3 30 1 150 1 700 1 
70 1 40 1 50 6 200 3 2000 1 
85 1 50 9 60 1 240 1 Total 10 
100 1 60 7 100 4 300 2   
150 1 70 1 150 1 500 1   
200 1 80 1 180 1 800 1   
220 1 90 1 250 1 1000 3   
300 2 100 16 400 1 Total 23   
800 1 150 4 500 1     
1000 1 160 1 1000 1     
6000 1 200 6 6000 1     
Total 17 240 1 10000 1     
  300 2 Total 24     
  500 3       
  1000 4       
  1040 1       
  4500 1       
  10000 1       
  Total 73       
CHM: Chinese herbal medicine 
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Appendix G10 Statistics of expenses on four forms of CAM (adjusted data) 
 
 
Statistics Acupuncture CHM (actual herbs) 
CHM 
(related items) Chiropractic Osteopathy 
N Valid 16 68 23 24 9 
 Outliers 1 2 2 0 0 
Mean  203.4229 167.56 145.97 298.65 429.57 
Std. Error of Mean  70.17481 30.151 43.233 64.154 242.280 
Median  88.13868 100.00 60.00 200.00 50.00 
Mode  50 100 50 100 20 
Std. Deviation  281.7954 248.832 208.984 311.020 722.760 
Variance  79408.65 61917.351 43674.132 96733.714 522381.856 
Skewness  2.266923 2.690 3.076 1.611 1.999 
Std. Error of Skewness  0.56242 .291 .478 .477 .720 
Kurtosis  4.676604 6.594 11.000 1.321 3.331 
Std. Error of Kurtosis  1.08719 .574 .928 .926 1.407 
Range  999 1039 998 950 1980 
Minimum  1 1 2 50 20 
Maximum  1000 1040 1000 1000 2000 
Sum  3280.237 11412 3411 7019 3823 
Percentile 95 1000.0 1000.00 869.63 1000.00 2000.00 
CHM: Chinese herbal medicine
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Appendix G11 Inter-correlations of CAM use and potential predictor variables 
(blocks one, two and three) 
Kendall’s Tau_b 
Use 
CAM 1 2 3 4 5 6 7 8 9 10 11 12 13 
Use CAM Correlation Coefficient 1.000                           
  Sig. (2-tailed) .                           
  N 1067                           
1. Gender Correlation Coefficient -.115(**) 1.000                         
  Sig. (2-tailed) .000 .                         
  N 1067 1067                         
2. Age Correlation Coefficient -.104(**) -.038 1.000                       
  Sig. (2-tailed) .000 .191 .                       
  N 1064 1064 1064                       
3. Region Correlation Coefficient -.036 -.050 -.002 1.000                     
  Sig. (2-tailed) .214 .081 .950 .                     
  N 1006 1006 1003 1006                     
Correlation Coefficient .123(**) .097(**) -.098(**) -.093(**) 1.000                   4. Post-secondary 
education  Sig. (2-tailed) .000 .002 .001 .001 .                   
  N 1067 1067 1064 1006 1067                   
5. Employment Correlation Coefficient .074(*) .170(**) -.268(**) .004 .205(**) 1.000                 
  Sig. (2-tailed) .016 .000 .000 .902 .000 .                 
  N 1067 1067 1064 1006 1067 1067                 
6. Income Correlation Coefficient .098(**) .113(**) -.203(**) -.012 .277(**) .470(**) 1.000               
  Sig. (2-tailed) .002 .000 .000 .694 .000 .000 .               
  N 925 925 924 873 925 925 925               
7. Country of birth Correlation Coefficient .044 -.097(**) -.044 -.002 -.109(**) -.023 -.034 1.000             
  Sig. (2-tailed) .148 .002 .131 .940 .000 .455 .277 .             
  N 1060 1060 1057 1000 1060 1060 922 1060             
8. Personal health rating Correlation Coefficient .021 .004 .148(**) -.003 -.138(**) -.170(**) -.229(**) .019 1.000           
  Sig. (2-tailed) .489 .906 .000 .917 .000 .000 .000 .536 .           
  N 1066 1066 1063 1005 1066 1066 924 1059 1066           
Correlation Coefficient .111(**) -.134(**) .172(**) .022 -.001 -.093(**) -.069(*) .058 .153(**) 1.000         9. Consulted GP in past 
12 months  Sig. (2-tailed) .000 .000 .000 .450 .972 .002 .028 .060 .000 .         
  N 1067 1067 1064 1006 1067 1067 925 1060 1066 1067         
Correlation Coefficient .080(**) -.130(**) .195(**) .022 -.116(**) -.224(**) -.192(**) .002 .328(**) .394(**) 1.000       10. Consulted GP 4 
times or more in past 12 
months  
Sig. (2-tailed) 
.010 .000 .000 .449 .000 .000 .000 .946 .000 .000 .       
  N 1056 1056 1053 995 1056 1056 917 1049 1055 1056 1056       
Correlation Coefficient .096(**) -.039 .085(**) .054 .185(**) .147(**) .300(**) .061(*) -.119(**) .106(**) -.021 1.000     11. Covered by private 
health insurance  Sig. (2-tailed) .002 .208 .004 .058 .000 .000 .000 .048 .000 .001 .500 .     
  N 1061 1061 1058 1000 1061 1061 922 1055 1060 1061 1050 1061     
Correlation Coefficient .274(**) -.046 -.164(**) .013 .118(**) .135(**) .089(**) -.001 -.031 .028 -.075(*) .171(**) 1.000   
Sig. (2-tailed) .000 .156 .000 .680 .000 .000 .007 .985 .338 .394 .021 .000 .   
12. Coverage of CAM 
influences insurance 
purchase   N 954 954 952 899 954 954 835 948 953 954 946 951 954   
Correlation Coefficient -.020 -.089(**) .039 .055 -.057 -.013 -.037 .067(*) .026 .044 .044 .028 -.034 1.000 13. CAM should be 
regulated as rigorously 
as Western medicine 
Sig. (2-tailed) 
.535 .006 .208 .071 .077 .689 .268 .041 .419 .178 .176 .392 .321 . 
  N 944 944 941 895 944 944 834 939 943 944 937 940 852 944 
**  Correlation is significant at the 0.01 level (2-tailed).*  Correlation is significant at the 0.05 level (2-tailed).
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Appendix G11 Inter-correlations of CAM use and potential predictor variables (continued, block four) 
 
Kendall’s Tau_b Use CAM 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Use CAM Correlation Coefficient 1.000                                     
  Sig. (2-tailed) .                                     
  N 1067                                     
1. Health check-up Correlation Coefficient -.024 1.000                                   
  Sig. (2-tailed) .440 .                                   
  N 1067 1067                                   
Correlation Coefficient .016 - 1.000                                 2. Cold/flu/fever Sig. (2-tailed) .597 .001 .                                 
  N 1067 1067 1067                                 
Correlation Coefficient .022 -.045 -.069(*) 1.000                               3. High blood 
pressure Sig. (2-tailed) .464 .138 .025 .                               
  N 1067 1067 1067 1067                               
4. Trauma/injury Correlation Coefficient .067(*) - -.060(*) -.006 1.000                             
  Sig. (2-tailed) .030 .007 .049 .835 .                             
  N 1067 1067 1067 1067 1067                             
5. Arthritis Correlation Coefficient -.008 - -.068(*) .092(**) -.050 1.000                           
  Sig. (2-tailed) .801 .003 .028 .003 .103 .                           
  N 1067 1067 1067 1067 1067 1067                           
6. Heart problems Correlation Coefficient -.021 -.050 -.048 .030 -.048 .147(**) 1.000                         
  Sig. (2-tailed) .494 .104 .119 .322 .120 .000 .                         
  N 1067 1067 1067 1067 1067 1067 1067                         
7. Gastrointestinal Correlation Coefficient .052 -.017 -.061(*) .000 -.023 .009 .013 1.000                       
  Sig. (2-tailed) .090 .586 .046 .996 .462 .769 .669 .                       
  N 1067 1067 1067 1067 1067 1067 1067 1067                       
8. Diabetes Correlation Coefficient -.053 -.044 -.062(*) .147(**) -.046 .057 .063(*) .043 1.000                     
  Sig. (2-tailed) .081 .148 .043 .000 .134 .063 .039 .156 .                     
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067                     
9. Skin problems Correlation Coefficient .011 -.030 -.037 -.011 -.041 -.010 -.036 -.004 -.034 1.000                   
  Sig. (2-tailed) .728 .328 .228 .729 .177 .737 .245 .892 .263 .                   
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067                   
10. Asthma Correlation Coefficient -.009 -.040 .005 -.050 -.015 -.008 .024 -.033 -.003 .037 1.000                 
  Sig. (2-tailed) .773 .194 .875 .105 .633 .789 .436 .286 .924 .232 .                 
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067                 
11. Depression Correlation Coefficient .040 -.054 .024 .034 -.040 .048 .024 -.002 .027 .003 -.029 1.000               
  Sig. (2-tailed) .189 .077 .425 .260 .191 .120 .436 .946 .373 .913 .345 .               
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067               
12. Back problems Correlation Coefficient .049 -.052 -.053 .015 .038 -.035 -.004 -.001 -.033 .004 .076(*) .006 1.000             
  Sig. (2-tailed) .106 .088 .083 .616 .212 .247 .891 .973 .288 .886 .013 .834 .             
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067             
13. Pregnancy Correlation Coefficient .051 -.069(*) .002 -.041 -.003 -.030 -.029 -.027 -.028 -.025 -.024 .017 -.024 1.000           
  Sig. (2-tailed) .096 .024 .957 .176 .920 .326 .349 .374 .368 .416 .431 .585 .439 .           
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067           
14. Cancer Correlation Coefficient .040 -.071(*) .000 -.018 -.005 .002 .072(*) -.028 -.028 -.026 -.025 .015 -.024 -.021 1.000         
  Sig. (2-tailed) .191 .021 .988 .558 .881 .956 .018 .363 .356 .405 .420 .619 .428 .502 .         
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067         
15. Gynaecologic Correlation Coefficient .026 -.071(*) -.023 -.042 -.034 .002 -.029 -.028 -.028 .013 -.025 .015 -.024 -.021 .025 1.000       
  Sig. (2-tailed) .401 .021 .447 .166 .265 .956 .338 .363 .356 .668 .420 .619 .428 .502 .408 .       
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067       
16. Other pains Correlation Coefficient .033 -.032 -.044 -.015 -.033 -.029 -.028 .048 .010 -.024 .018 -.024 .062(*) -.020 -.020 -.020 1.000     
  Sig. (2-tailed) .286 .291 .151 .630 .288 .338 .361 .117 .746 .428 .550 .443 .043 .523 .513 .513 .     
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067     
17. High cholesterol Correlation Coefficient -.018 -.021 -.039 .107(**) -.029 .012 .015 -.024 .099(**) -.022 .026 .026 -.021 -.017 -.018 -.018 .040 1.000   
  Sig. (2-tailed) .567 .492 .200 .000 .343 .701 .632 .439 .001 .479 .402 .402 .501 .568 .559 .559 .194 .   
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067   
18. Lung problems Correlation Coefficient .063(*) -.038 -.010 -.035 .008 -.025 -.024 -.023 -.023 .026 .076(*) -.020 .029 -.017 -.017 -.017 .101(**) -.015 1.000 
  Sig. (2-tailed) .041 .214 .734 .254 .804 .408 .430 .454 .448 .402 .013 .507 .344 .581 .572 .572 .001 .630 . 
  N 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 1067 
*  Correlation is significant at the 0.05 level (2-tailed). **  Correlation is significant at the 0.01 level (2-tailed).
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Appendix G12 Statistics of a regression model on CAM use 
(based on unweighted data) 
Case Processing Summary 
 
Unweighted Cases(a) N Percent 
Selected Cases Included in Analysis 819 76.8 
  Missing Cases 248 23.2 
  Total 1067 100.0 
Unselected Cases 0 .0 
Total 1067 100.0 
a  If weight is in effect, see classification table for the total number of cases. 
 
 
Dependent Variable Encoding 
 
Original Value Internal Value 
No 0 
Yes 1 
 
 
Categorical Variables Codings 
 
Parameter coding 
  Frequency (1) (2) 
Less than $20,000 148 .000 .000 
$20,000-$40,000 171 1.000 .000 
6. Income 
Over $40,000 500 .000 1.000 
18 - 34 years 249 .000 .000 
35 - 64 years 451 1.000 .000 
2. Age 
65 years+ 119 .000 1.000 
 
 
Block 0: Beginning Block 
 
Iteration History (a,b,c) 
 
Coefficients 
Iteration 
-2 Log 
likelihood Constant 
1 1006.467 .784 
2 1006.125 .828 
Step 0 
3 1006.125 .828 
a  Constant is included in the model. 
b  Initial -2 Log Likelihood: 1006.125 
c  Estimation terminated at iteration number 3 because parameter estimates changed 
by less than .001. 
 
Classification Table (a,b) 
 
Observed Predicted 
  Use CAM Percentage Correct 
  No Yes   
Step 0 Use CAM No 0 249 .0 
    Yes 0 570 100.0 
  Overall Percentage   69.6 
a  Constant is included in the model. b  The cut value is .500 
 
Variables in the Equation 
B S.E. Wald df Sig. Exp(B) 
  
      
Step 0 Constant .828 .076 118.862 1 .000 2.289 
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Block 1: Method = Forward Stepwise (Wald) 
 
Iteration History (a,b,c,d) 
Iteration 
-2 Log 
likelihood Coefficients 
    Constant 
Postsec
ondary Gender Age(1) Age(2) 
Step 1 1 986.932 .454 .585    
  2 985.843 .462 .686    
  3 985.842 .462 .689    
  4 985.842 .462 .689    
Step 2 1 972.382 .190 .609 .497   
  2 970.442 .151 .728 .605   
  3 970.439 .149 .733 .610   
  4 970.439 .149 .733 .610   
Step 3 1 966.398 .411 .569 .510 -.241 -.492 
  2 963.989 .432 .685 .627 -.315 -.600 
  3 963.983 .434 .691 .634 -.320 -.607 
  4 963.983 .434 .691 .634 -.320 -.607 
a  Method: Forward Stepwise (Wald); b  Constant is included in the model. 
c  Initial -2 Log Likelihood: 1006.125; d  Estimation terminated at iteration number 
4 because parameter estimates changed by less than .001. 
 
Omnibus Tests of Model Coefficients 
  Chi-square df Sig. 
Step 1 Step 20.282 1 .000 
  Block 20.282 1 .000 
  Model 20.282 1 .000 
Step 2 Step 15.403 1 .000 
  Block 35.686 2 .000 
  Model 35.686 2 .000 
Step 3 Step 6.456 2 .040 
  Block 42.142 4 .000 
  Model 42.142 4 .000 
Model Summary 
Step 
-2 Log 
likelihood 
Cox & Snell 
R Square 
Nagelkerke R 
Square 
1 985.842(a) .024 .035 
2 970.439(a) .043 .060 
3 963.983(a) .050 .071 
a  Estimation terminated at iteration number 4 because parameter estimates changed 
by less than .001. 
 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 .000 0 . 
2 1.384 2 .501 
3 2.897 6 .822 
 
Contingency Table for Hosmer and Lemeshow Test 
Use CAM = No Use CAM = Yes 
  Observed Expected Observed Expected Total 
1 138 138.000 219 219.000 357 Step 1 
2 111 111.000 351 351.000 462 
1 74 77.749 94 90.251 168 
2 64 60.251 125 128.749 189 
3 74 70.251 166 169.749 240 
Step 2 
4 37 40.749 185 181.251 222 
1 56 58.127 63 60.873 119 
2 33 35.124 57 54.876 90 
3 42 41.960 85 85.040 127 
4 49 43.272 91 96.728 140 
5 32 30.122 89 90.878 121 
6 8 6.724 20 21.276 28 
7 18 22.060 97 92.940 115 
Step 3 
8 11 11.611 68 67.389 79 
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Classification Table (a) 
Observed Predicted 
  Use CAM Percentage Correct 
  No Yes   
Step 1 Use CAM No 0 249 .0 
    Yes 0 570 100.0 
  Overall Percentage   69.6 
Step 2 Use CAM No 0 249 .0 
    Yes 0 570 100.0 
  Overall Percentage   69.6 
Step 3 Use CAM No 16 233 6.4 
    Yes 12 558 97.9 
  Overall Percentage   70.1 
a: The cut value is .500 
 
Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 95.0% C.I. for EXP(B) 
              Lower Upper 
Step 1(a) Postsecondary .689 .154 20.081 1 .000 1.993 1.474 2.694 
  Constant .462 .109 18.055 1 .000 1.587   
Step 2(b) Gender .610 .157 15.129 1 .000 1.841 1.354 2.504 
  Postsecondary .733 .156 22.072 1 .000 2.082 1.533 2.826 
  Constant .149 .135 1.227 1 .268 1.161   
Step 3(c) Gender .634 .158 16.062 1 .000 1.885 1.382 2.570 
  Age   6.392 2 .041    
  Age(1) -.320 .183 3.074 1 .080 .726 .507 1.039 
  Age(2) -.607 .247 6.047 1 .014 .545 .336 .884 
  Postsecondary .691 .158 19.228 1 .000 1.995 1.465 2.717 
  Constant .434 .188 5.329 1 .021 1.543   
a  Variable(s) entered on step 1: Postsecondary. b  Variable(s) entered on step 2: Gender. c  Variable(s) entered on step 3: Age.
  
339 
Block 2: Method = Forward Stepwise (Wald) 
 
 
Omnibus Tests of Model Coefficients 
 
  Chi-square df Sig. 
Step 1 Step 11.686 1 .001 
  Block 11.686 1 .001 
  Model 53.828 5 .000 
Step 2 Step 4.085 1 .043 
  Block 15.771 2 .000 
  Model 57.912 6 .000 
 
Model Summary 
 
Step 
-2 Log 
likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 952.297(a) .064 .090 
2 948.212(a) .068 .097 
a  Estimation terminated at iteration number 4 because parameter estimates changed 
by less than .001. 
 
Hosmer and Lemeshow Test 
 
Step Chi-square df Sig. 
1 5.582 8 .694 
2 7.380 8 .496 
 
 
Contingency Table for Hosmer and Lemeshow Test 
 
Use CAM = No Use CAM = Yes 
  Observed Expected Observed Expected Total 
1 40 41.660 37 35.340 77 
2 33 35.177 48 45.823 81 
3 32 29.311 41 43.689 73 
4 27 26.288 51 51.712 78 
5 29 27.993 63 64.007 92 
6 33 33.658 89 88.342 122 
7 25 18.830 57 63.170 82 
8 6 9.628 42 38.372 48 
9 16 18.296 86 83.704 102 
Step 1 
10 8 8.159 56 55.841 64 
1 40 41.798 37 35.202 77 
2 41 39.094 46 47.906 87 
3 26 26.926 45 44.074 71 
4 28 25.543 45 47.457 73 
5 15 17.063 39 36.937 54 
6 23 25.044 61 58.956 84 
7 34 25.093 66 74.907 100 
8 12 14.668 55 52.332 67 
9 12 15.873 67 63.127 79 
Step 2 
10 18 17.898 109 109.102 127 
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Classification Table (a) 
Observed Predicted 
  Use CAM Percentage Correct 
  No Yes   
Step 1 Use CAM No 31 218 12.4 
    Yes 24 546 95.8 
  Overall Percentage   70.5 
Step 2 Use CAM No 24 225 9.6 
    Yes 15 555 97.4 
  Overall Percentage   70.7 
a: The cut value is .500 
 
Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 95.0% C.I. for EXP(B) 
              Lower Upper 
Step 1(a) Gender .541 .161 11.221 1 .001 1.717 1.252 2.357 
  Age 
  9.560 2 .008    
  Age(1) -.403 .187 4.657 1 .031 .668 .464 .964 
  Age(2) -.764 .253 9.108 1 .003 .466 .283 .765 
  Postsecondary .694 .159 19.067 1 .000 2.001 1.466 2.732 
  ConsultedGPinpast12months .676 .196 11.876 1 .001 1.966 1.338 2.887 
  Constant .013 .224 .003 1 .953 1.013   
Step 2(b) Gender .517 .162 10.180 1 .001 1.678 1.221 2.305 
  Age 
  10.998 2 .004    
  Age(1) -.418 .187 4.997 1 .025 .658 .456 .950 
  Age(2) -.838 .257 10.616 1 .001 .433 .261 .716 
  Postsecondary .722 .160 20.338 1 .000 2.058 1.504 2.816 
  ConsultedGPinpast12months .522 .209 6.213 1 .013 1.686 1.118 2.541 
  ConsultedGP4timesormoreinpast12months .370 .184 4.045 1 .044 1.447 1.009 2.075 
  Constant .016 .225 .005 1 .943 1.016   
a  Variable (s) entered on step 1: ConsultedGPinpast12months. b  Variable (s) entered on step 2: ConsultedGP4timesormoreinpast12months.
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Block 3: Method = Forward Stepwise (Wald) 
 
Omnibus Tests of Model Coefficients 
 
  Chi-square df Sig. 
Step 1 Step 44.911 1 .000 
  Block 44.911 1 .000 
  Model 102.823 7 .000 
 
Model Summary 
 
Step -2 Log likelihood 
Cox & Snell R 
Square 
Nagelkerke R 
Square 
1 903.302(a) .118 .167 
a  Estimation terminated at iteration number 4  
because parameter estimates changed by less than .001. 
 
 
Hosmer and Lemeshow Test 
 
Step Chi-square df Sig. 
1 4.228 8 .836 
 
Classification Table (a) 
 
Observed Predicted 
 Use CAM Percentage Correct 
 No Yes  
Step 1 Use CAM No 66 183 26.5 
    Yes 46 524 91.9 
  Overall Percentage   72.0 
a  The cut value is .500
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Variables in the Equation 
  B S.E. Wald df Sig. Exp(B) 95.0% C.I. for EXP(B) 
              Lower Upper 
Step 1(a) Gender .477 .167 8.181 1 .004 1.612 1.162 2.235 
  Age 
  6.160 2 .046    
  Age(1) 
-.331 .193 2.930 1 .087 .718 .492 1.049 
  Age(2) 
-.644 .265 5.902 1 .015 .525 .312 .883 
  Postsecondary .640 .165 15.064 1 .000 1.896 1.372 2.618 
  ConsultedGPinpast12months 
.461 .217 4.521 1 .033 1.586 1.037 2.427 
  ConsultedGP4timesormoreinpast12months 
.464 .190 5.976 1 .014 1.590 1.096 2.306 
  Coverage of CAM influences insurance 1.096 .167 42.955 1 .000 2.991 2.155 4.150 
  Constant 
-.492 .244 4.066 1 .044 .611   
a Variable(s) entered on step 1: Coverage of CAM influences insurance. 
 
Block 4: Method = Forward Stepwise (Wald): none entered Casewise List (b) 
Observed Temporary Variable 
Case 
Selected 
Status(a) Use CAM Predicted 
Predicted 
Group Resid ZResid 
5 S N** .899 Y -.899 -2.977 
94 S N** .899 Y -.899 -2.977 
176 S N** .899 Y -.899 -2.977 
177 S N** .864 Y -.864 -2.523 
302 S N** .934 Y -.934 -3.753 
377 S N** .881 Y -.881 -2.726 
547 S N** .864 Y -.864 -2.523 
574 S N** .899 Y -.899 -2.977 
585 S N** .881 Y -.881 -2.726 
683 S N** .881 Y -.881 -2.726 
691 S N** .899 Y -.899 -2.977 
987 S N** .897 Y -.897 -2.957 
1005 S N** .897 Y -.897 -2.957 
a: S = Selected, U = Unselected cases, and ** = Misclassified cases. b: Cases with studentised residuals greater than 2.000 are listed.
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 Residual and scatter plot of the predictive probability – Regression analysis 
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Normal P-P Plot of Standardised Residual 
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